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2 - Chapter 1
Rheumatoid arthritis (RA) is a systemic, inflammatory disease characterized by 
persistent inflammation of the joints, leading to irreversible damage. Patients suffer 
predominately from swollen joints, pain, and stiffness, accompanied by more 
general symptoms, such as fatigue and weakness, all of which may affect well­
being and functioning in daily life. The course of RA fluctuates, alternating 
between remission and exacerbation. The fluctuating and unpredictable course of 
the disease leads to uncertain prognoses in individual patients. The prevalence of 
RA is approximately 1-2%. It affects two to three times as many women as men. 
Symptoms most commonly manifest in midlife, between the ages of forty and 
sixty. The etiology of RA is only partially known, and treatment predominantly 
focuses on alleviation of symptoms of inflammation and maintenance of functional 
status. Drug therapy is the chief mode of treatment, in addition to physical therapy, 
occupational therapy, surgery and patient education. In recent years, clinical 
practice has shifted towards more aggressive pharmacological treatment at an early 
stage of the disease and more integrated multidisciplinary care.
Psychological research in RA has become a topic of increasing attention in 
recent decades. Early attempts were directed at psychological factors, particularly 
personality characteristics and stressors that may affect the onset of the disease, 
without gaining much empirical support. Since the beginning of the 1980s, 
researchers have focused on the role of psychological factors in the course of RA 
disease outcome, including disease activity, functional disability, pain and 
psychological functioning. In this line of research, the consequences of RA in daily 
life as perceived by patients (quality of life), the way patients and significant others 
deal with these consequences (e.g., with coping and social support) and how these 
factors in turn may affect disease outcome, have received attention. At the same 
time, the effects of psychological interventions, particularly self-management 
programs and cognitive-behavioral therapy, have been examined. Although 
interventions have been found to be possibly beneficial for patients with RA, 
effects have usually been small and of short duration. The limited findings of 
psychological interventions were the basis of the studies conducted in this thesis 
(Kraaimaat et al., 1995a), which was aimed at gaining more insight into the role of 
psychological factors for RA disease outcome to enable the development of more 
goal-oriented, effective treatments.
ASSESSMENT OF DISEASE OUTCOME:
HEALTH DIMENSIONS OF RA
In line with multidimensional definitions of general health and disability and RA 
disease outcome more specifically, at least three major dimensions of disease 
outcome can be distinguished in RA: disease activity, physical functioning and
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psychological functioning (Meenan et al., 1980; Fries et al., 1983; Wilson & 
Cleary, 1995; Wolfe et al., 1999; WHO, 2001; see Figure 1).
Indicators of disease activity most directly reflect the pathophysiological process 
itself. To enhance comparability, core sets of disease activity measures and 
standardized disease activity scores have been developed (van Riel, 1992; Felson 
et al., 1993; Prevoo et al., 1995), consisting of at least an acute phase reactant, 
such as erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP), and 
joint scores for swollen and tender joints. Physical functioning includes the main 
physical symptoms from which patients suffer, particularly the characteristic 
symptoms of pain and functional disability as well as more general symptoms of 
fatigue. As a result of the pathophysiological disease process and the physical 
symptoms, RA can have multiple effects on patient functioning, such as limitations 
in performing activities of daily life, dependance on others, decreased social 
contacts, unemployment and economic impairments (van Lankveld et al., 1993; 
Fex et al., 1998; van Jaarsveld et al., 1998). The extent to which patients 
experience limitations in daily life is reflected by the psychological functioning 







Acute phase reactant Functional disability Anxiety
Joint score Pain Depressed mood
Fatigue
Figure 1 Indicators of disease outcome in RA
The reliable and valid assessment of RA disease outcome is a prerequisite in the 
study of psychological factors and the effects of therapeutic interventions. While 
disease activity is preferably measured by validated clinical and laboratory 
assessments, such as ESR or another acute phase reactant and a joint score, the 
dimensions of physical and psychological functioning are most frequently assessed 
by self-report measures. Self-report health status instruments, such as the Arthritis 
Impact Measurement Scales 2 (AIMS2; Meenan et al., 1992) and the Impact of 
Rheumatic diseases on General health and Lifestyle (IRGL; Huiskes et al., 1990a), 
have become complementary tools in rheumatology assessment and offer an easy, 
time-efficient way of gaining insight into health areas that are affected by the 
disease and are a focus of long-term care and therapeutic interventions.
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PREDICTION OF DISEASE OUTCOME:
RISK FACTORS IN RA
There is a relatively long research history focusing on the role of psychological 
factors in RA disease outcome. Research in this area is primarily based on two 
models from theoretical approaches to chronic diseases and chronic pain disorders. 
Stress-vulnerability models of chronic immune and autoimmune diseases and 
chronic diseases in general primarily attempt to predict disease activity and 
psychological functioning, respectively. Fear-avoidance models from the chronic 
pain literature can be viewed as a specification of stress-vulnerability models. In 
these models, the role of psychological predictors is studied with regard to a 
specific stressor, i.e. pain, for the prediction of primarily functional disability and 
pain.
In this section, the two theoretical models are introduced, followed by an 
overview of psychological predictors that are specified in the models. If terms for 
predictors in the models are used that are unfamiliar to the reader, it is possible to 
first read the overview of psychological predictors. The stress-vulnerability and 
fear-avoidance models are presented in Figures 2 and 3, respectively. Disease 
characteristics that may affect the role of psychological predictors in RA disease 
outcome will be discussed at the end of this section.
THEORETICAL MODELS
Stress-Vulnerability Models
In immune and autoimmune diseases, such as RA, the study of psychological 
factors and disease activity is largely based on the assumptions of stress- 
vulnerability models (Figure 2). Stress-vulnerability models (or diathesis-stress 
models or stress-coping models) for RA and other immune and autoimmune 
diseases propose that specific external stressors, such as major life events or 
disease-related stressors, and internal vulnerability factors, such as personality 
characteristics, can affect disease activity, due to altered functioning of the 
immune system (for RA, see Huyser & Parker, 1998; Walker et al., 1999). Coping 
with stress, social support and illness cognitions can be viewed as additional 
vulnerability factors that affect RA disease activity. In contrast to relatively 
enduring personality characteristics and irreversible stressors, it is assumed that 
coping, social support and illness cognitions can be changed by psychological 
treatments. In addition, these variables are thought to mediate the relationship of 
personality characteristics and stressors to disease activity, i.e. it is assumed that 
they at least partly account for the effects of stressors and personality 
characteristics on disease activity. For example, the influence of a stressful event 
on disease activity might be explained by how patients cope with the stressful
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event. Finally, it is proposed that the different stressors and vulnerability factors 
affect each other. A well-known example is the buffer effect of social support on 
the relationship between stressors and disease activity, which means that stressors 
unfavorably affect disease activity only in the event of low levels of social support. 
In this example, social support is a moderating factor that affects the strength of 
the relationship between stressors and disease activity.
S tressors V ulnerab ility  factors
Major life events Personality characteristics
Disease-related stressors
M ediating  factors
Illness cognitions 




Figure 2 Stress-vulnerability models in chronic diseases
Although underlying mechanisms may differ, stress-vulnerability models aimed at 
predicting disease activity in immune diseases correspond to those used for 
predicting psychological distress in chronic diseases in general. That is, stress- 
vulnerability factors are assumed also to determine whether an individual develop 
heightened distress when faced with a chronic disease (e.g., Leventhal et al., 1984; 
Stanton et al., 2001). Corresponding stress-vulnerability models have also been 
applied for predicting physical and psychological health outcomes in the general 
population (e.g., Brown & Harris, 1978; Lazarus & Folkman, 1984; Steptoe, 
1991a).
It should be emphasized that although stressors and vulnerability factors are 
viewed as distinct entities, it is not always possible to distinguish them in practice.
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For example, lower levels of social support as the result of a smaller social 
network can be conceived both as an external stressor and an internal vulnerability 
factor.
Fear-Avoidance Models
In the chronic pain literature, fear-avoidance models have received 
considerable attention and there is supportive evidence that components of these 
models affect outcomes for chronic pain patients, specifically functional disability 
and pain (Lethem et al., 1983; Linton, 1985; Philips, 1987; see for review, e.g., 
Vlaeyen & Linton, 2000) (Figure 3). Fear-avoidance models propose that pain- 
related avoidance factors, i.e. avoidance of activity, catastrophic cognitions about 
pain and altered autonomic and muscular reactivity, contribute to physical 
deconditioning and heightened preoccupation with bodily symptoms, which in turn 
may enhance functional disability and pain in chronic pain patients. Social 
resources, such as a more extended social network and higher levels of perceived 
support, are assumed to stimulate social and physical activities and problem­
solving capacities and beneficially affect functional disability and pain.














Figure 3 Fear-avoidance models in chronic pain
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PSYCHOLOGICAL PREDICTORS
Based on these theoretical approaches to chronic immune diseases, chronic pain 
disorders, and chronic diseases in general, different psychological predictors have 
been studied in relationship to disease outcome in RA. Although not exclusive, 
main predictors can be divided into the categories of stressors, personality 
characteristics, coping, social support, illness cognitions, and - for chronic pain 
disorders - physiological pain-reactivity.
Stressors
There is a relatively long research history focusing on the role of stressors in 
RA disease outcome, particularly because of the supposed link between stress and 
RA disease activity via immunological pathways (see e.g., Anderson et al., 1984; 
Huyser & Parker, 1998; Walker et al., 1999). The main focus of attention has been 
the occurrence of major life events, assuming that these stressful events may 
unfavorably affect RA disease outcome. However, empirical studies linking major 
life events to different dimensions of RA disease outcome showed inconclusive 
results (e.g., Thomason et al., 1992; Koehler & Vertheim, 1993; Potter & Zautra, 
1997; Dekkers et al., 2001). Less attention has been paid to the role of more long- 
lasting stressors that are a consequence of the disease itself, such as pain and 
functional disability, and the impact of the disease on daily life (cf. van Lankveld 
et al., 1993). Chronic, disease-related stressors can be expected to particularly 
affect the long-term course of disease outcome, due to their lasting impact on 
nearly every aspect of life (Solomon, 1981; Zautra, et al., 1989). These stressors 
are also expected to indirectly affect the RA disease outcome, e.g. through 
mediating or moderating effects of illness cognitions, coping and social support 
(Figure 2).
Personality Characteristics
Personality characteristics are defined as relatively stable tendencies of 
individuals to behave habitually across situations and over time. The most 
common classification of personality characteristics relates to the Big Five. Two of 
these five factors have been shown to be most relevant for physical and 
psychological health outcomes in the general population and patients with chronic 
diseases, including RA: neuroticism (i.e. the tendency to be relatively more tense 
and emotionally unstable) and extraversion (i.e. the tendency to be relatively more 
sociable and impulsive).
Relationships between personality characteristics, including neuroticism and 
extraversion, and disease activity or RA progression were repeatedly studied in 
early research, without gaining much support (see e.g., Moos, 1964; Anderson et 
al., 1984). Irrespective of the lack of relationships with biological markers, 
neuroticism has been linked to the report of higher levels of physical complaints in
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the general population (Watson & Pennebaker, 1989; McCrae, 1990), but support 
for such a relationship seems to be limited in patients with RA (Affleck et al., 
1992, 1994; Smith et al., 1995). Most evidently, individuals scoring high in 
neuroticism and, to a lesser extent, individuals scoring low in extraversion are 
known to experience greater psychological distress (Clark, 1994). Research in RA 
patients supported the role of neuroticism in future changes in psychological 
distress (Affleck et al., 1992). Personality characteristics are also assumed to 
indirectly affect the future disease outcome, as the result of mediating or 
moderating effects of illness cognitions, coping and social support (Figure 2).
Coping
Coping can be defined as individuals’ behavioral and cognitive attempts to 
manage or tolerate stress (Lazarus & Folkman, 1984; Jensen et al., 1991b). Two main 
areas of coping research have been distinguished in RA: coping with stress in 
general and coping with the specific, disease-related stressor of pain (see e.g., 
Manne & Zautra, 1990). Stress-vulnerability models propose that an individual’s 
reaction to stressors in general, including coping with stress, primarily affects 
outcomes of disease activity and psychological distress. The way individuals cope 
with pain, particularly cognitive and behavioral avoidance factors, is expected to 
play a major role in functional disability and pain, as proposed by fear-avoidance 
models. In both areas, the most common distinction between different categories of 
coping is the classification between active and passive strategies that are supposed to 
have favorable and unfavorable effects, respectively. In line with research on other 
chronic diseases and chronic pain disorders (see e.g., Jensen et al., 1991b; Stanton et 
al., 2 0 0 1 ), it has repeatedly been shown that more passive-avoidant coping with 
stress or pain is related to worse future physical and psychological functioning in 
patients with RA (Felton & Revenson, 1984; Brown & Nicassio, 1987, Keefe et 
al., 1989; Smith & Wallston, 1992; van Lankveld et al., 1999; Scharloo et al., 
1999). Much less support has been reported for the adaptive function of active 
coping strategies when faced with stress or pain, suggesting that not using passive 
coping may be more important than the use of specific active strategies for the 
disease outcome in RA and other chronic diseases.
Social Support
Social support can be broadly defined as interactions or resources provided by 
others that may help an individual cope with stress (Wills & Fegan, 2001). 
Although conceptualizations of social support widely differ, the most consistent 
distinction comprises qualitative and quantitative aspects of social support, 
including aspects of perceived availability of support and the size of the social 
network, respectively (Cohen & Wills, 1985; Wills & Fegan, 2001). Both 
indicators, but particularly the qualitative aspects of social support, have been 
shown to be related to various disease outcomes in the general population, chronic
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diseases and chronic pain disorders (see for reviews e.g., Uchino et al., 1996; Wills 
& Fegan, 2001). As for patients with RA, there seems to be broad support for the 
idea that social support can affect disease outcome. For example, prospective RA 
studies have demonstrated that a lower level of social support is related to greater 
disease activity when faced with stress (Zautra et al., 1998), more interference in 
daily life (Smith & Wallston, 1992), more pain (Waltz et al., 1998) as well as more 
psychological distress (Brown et al., 1989b).
Illness Cognitions
In the literature on chronic diseases, it is commonly assumed that the way 
patients perceive and think about their disease accounts for much of the individual 
differences in their physical and psychological health status. Although 
conceptualizations of illness cognitions differ between models (e.g., Leventhal et 
al., 1984; Turk et al., 1986), there is relatively consistent evidence that specific 
cognitions related to the concept of control, such as helplessness, unfavorably 
affect the future disease outcome in RA and other chronic diseases (e.g., Smith et 
al., 1994; Everson et al., 1996; Parle et al., 1996; see for RA, Keefe et al., 2002). 
However, there are no generic self-report instruments that allow comparisons of 
disease-related helplessness cognitions across different chronic diseases. Far less is 
known about possible adaptive cognitions for individuals faced with a chronic 
disease, which means illness cognitions that show consistently beneficial and 
health-promoting effects (see Gillham & Seligman, 1999). For example, although 
the lack of perceived control has generally been demonstrated to be maladaptive, 
perceived control does not appear consistently beneficial and can adversely affect 
well-being in patients with RA and other chronic diseases, for example during 
disease flare-ups (e.g., Helgeson, 1999; Newsom et al., 1996; Schiaffino et al., 
1991; Tennen et al., 1992, see also Stanton et al., 2001). It is consequently unclear 
whether there are generic, maladaptive and adaptive cognitions that uniformly 
predict disease outcome in chronic diseases, such as RA.
Physiological Pain Reactivity
Fear-avoidance models propose that not only cognitive and behavioral factors, 
but also physiological reactions to pain, such as enhanced autonomic and muscular 
reactivity, may affect pain outcomes in chronic pain patients (Figure 3). Evidence 
for pain-related patterns of altered autonomic and somatosensory responses has 
been provided for various chronic pain patients, including those with RA (e.g., 
Flor et al., 1985, 1992a, 1997; Jammer & Tursky, 1987; Geenen et al., 1996; see 
for review on RA, Anderson et al., 1985; for review on chronic pain, Flor & Turk, 
1989). However, in contrast to cognitive and behavioral factors, physiological 
reactivity patterns in response to pain have received less attention in chronic pain 
literature in recent years. Support is particularly scarce for the possible 
maladaptive function of physiological reactivity patterns for pain outcomes. For
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example, a cross-sectional study indicated that self-reported physiological 
reactivity to pain is related to increased pain severity in heterogeneous groups of 
chronic pain patients (McCracken et al., 1996), but the role of physiological pain 
reactivity has not yet been studied in prospective studies among RA and other 
chronic pain patients.
DISEASE CHARACTERISTICS
It has been repeatedly suggested that the effects of psychological predictors on RA 
disease outcome may depend on specific disease characteristics, such as the stage 
of the disease and differences between short-term and long-term outcomes.
Stage o f the Disease
It has been assumed that psychological predictors are differently related to 
future disease outcomes at different stages of RA (Zautra et al., 1989; McFarlane 
& Brooks, 1990; Smith et al., 1997; Huyser & Parker, 1998). For example, 
psychological factors in RA have been shown to be affected by the inflammatory 
processes of the disease itself, its biopsychosocial consequences and pharma­
cological treatment with prolonged medication (van Lankveld et al., 1993; Fex et 
al., 1998; van Jaarsveld et al., 1998, 2000; Penninx et al., 1999, Jacobs et al., 
2 0 0 1 ), and they may be differently related to disease outcome in early and 
longstanding RA. However, the role of psychological predictors for future disease 
outcomes has usually been studied with patients with longstanding RA. By 
definition, early detection and modification of psychological risk factors is more 
likely to provide long-term benefits and to decrease an unfavorable long-term 
outcome of a chronic disease, such as RA. For the application of interventions at 
an early stage of the disease, it is important to know whether psychological 
predictors in early RA (e.g., at the earliest point in time - at diagnosis) affect 
disease outcome and whether relationships between psychological factors and 
disease outcome correspond to those found in patients with longstanding RA.
Duration o f Effects
There is some evidence from epidemiological studies in the general population 
and chronic diseases that factors, such as social support, can have long-term 
effects on aspects like physical health and mortality (see e.g., Wills & Fegan,
2001). For patients with RA, effects of psychological factors have almost 
exclusively been studied for periods of approximately 1 year or less. It can be 
assumed that the kind of variables and the direction of effects found for short-term 
outcomes are not the same as for long-term outcomes over several years. For 
example, due to changes brought about by the disease itself or its treatment, 
disease-related psychological factors, such as pain coping, may have rather short­
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term effects on RA disease outcome, while more general factors, such as chronic 
stressors and relatively stable personality characteristics, may primarily influence 
long-term outcomes. In addition, the strength and direction of relationships 
between psychological predictors and disease outcome may differ between short­
term and long-term outcomes. For example, relatively generic and stable 
predictors, such as personality characteristics, may become evident only in the 
long term and factors may even work in opposite directions in different time 
periods, as has been found for avoidance coping (Mullen & Suls, 1982; Suls & 
Fletcher, 1985). To gain greater insight into the possible effects of psychological 
predictors on longer-term RA disease outcomes, it will be necessary to study their 
effects over periods of time exceeding 1  year.
MODIFICATION OF DISEASE OUTCOME:
TAILORED TREATMENT IN RA
Since beginning of the 1980s, researchers have studied the effects of psychological 
treatments for RA patients. Interventions have usually been applied to all patients 
as generic group treatments. There are three main categories of interventions 
which differ in the degree to which changes in psychological predictors (such as 
coping, social support and illness cognitions) are a focus of treatment: patient 
education, self-management approaches and cognitive-behavioral therapy (CBT). 
Although interventions, particularly CBT, have been shown to be possibly 
effective for RA patients, recently conducted meta-analyses have indicated that 
psychological interventions in RA in general, and more specifically CBT and other 
behavioral treatments, have only marginal effects, which usually disappear at 
follow-up assessments (e.g., Hawley, 1995; Riemsma et al., 2002). Recent 
developments in RA and other chronic pain disorders suggest that customizing 
treatments more closely to patient characteristics in terms of patient selection and 
types and timing of treatment might optimize treatment effectiveness (e.g., Turk, 
1990; McCracken, 1991; Devellis & Blalock, 1993; Turk & Okifuji, 1998, 2002; 
Gatchel, 2001), but this approach has not yet been subjected to empirical research 
of randomized, controlled trials in RA or other chronic pain patients.
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PURPOSE OF THE STUDIES IN THIS THESIS
The studies in this thesis were conducted to gain more insight into psychological 
factors that affect disease outcome in RA patients. The thesis consists of three 
main parts, including assessment, prediction and modification of disease outcome 
with psychological factors and tailored treatment for RA patients. Particular 
attention was given to those factors that are a focus of psychological interventions, 
including illness cognitions, coping, and social support.
ASSESSMENT OF DISEASE OUTCOME:
HEALTH DIMENIONS OF RA
Reliable and valid assessment of RA disease outcome is a prerequisite to studying 
the role of psychological factors and the effects of therapeutic treatments. In 
contrast to the clinical and laboratory assessment of disease activity, the 
dimensions of physical and psychological functioning are most frequently assessed 
by self-report health status measures. The goal of the first study (chapter 2) was to 
further validate a health status instrument for arthritis patients - the IRGL - by 
comparing this inventory to another widely used, international health status 
instrument for arthritis patients, the Dutch-AIMS2, with respect to internal 
consistencies, higher-order factor structures, intercorrelations, and relationships to 
clinical and laboratory markers in a sample of 284 RA patients.
PREDICTION OF DISEASE OUTCOME:
RISK FACTORS IN RA
There is increasing evidence that psychological factors affect the RA disease 
outcome, especially supplied by prospective studies, in addition to a large body of 
cross-sectional studies and some experimental studies. Prospective studies enable 
the predictive value of specific factors (e.g., coping) for the future course of 
specific outcomes (e.g., disease activity) in a specific population (e.g., patients 
with RA) to be assessed. Consequently, prospective studies offer an opportunity to 
get an indication of possible causal relationships between the predictor and the 
outcome measure (in contrast to cross-sectional studies) and about the relevance 
and generalizability of this relationship to the population under study (in contrast 
to experimental research). The main part of this thesis consists of examining 
specific psychological predictors for the course of the RA disease outcome, using a 
prospective design.
The psychological predictors studied were based on two theoretical models in 
accordance with the psychological literature on predicting disease activity and
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psychological distress in chronic (immune) diseases with stress-vulnerability 
models, and predicting functional disability and pain in chronic pain disorders with 
fear-avoidance models. Attention was given to the role of coping, social support, 
illness cognitions and physiological pain-reactivity. Specifically, we studied the 
role of coping and social support in disease outcome (disease activity, functional 
disability and pain, psychological distress) after 1, 3 and 5 years in a sample of 
recently diagnosed patients (chapters 3.1.1 - 3.1.3). There is preliminary evidence 
that coping and social support affect short-term outcomes of approximately 1  year 
in patients with longstanding RA. Of particular interest was whether coping and 
social support assessed very early in the disease process, i.e. at the time of 
diagnosis, would predict short-term changes in RA after 1 year as well as more 
long-term changes after 3 and 5 years. In addition to these studies conducted 
among recently diagnosed patients, the role of psychological predictors, not 
previously assessed in the RA literature, was studied for disease outcome after 1 
year in longstanding RA patients. disease-generic illness cognitions and 
physiological pain reactivity (chapters 3.2 and 3.3).
Coping and Social Support
Predictors o f disease activity. There is some theoretical and empirical support 
for a role of psychological factors in disease activity in autoimmune and immune 
diseases, such as RA. Although the role of mediating immunological changes is 
still unclear, research in the last decade has supplied preliminary support that 
psychological factors may affect RA disease activity. However, previous studies 
did not study the relative contribution of different stressors and vulnerability 
factors, including coping with stress and social support. In addition, these factors 
have not been studied in recently diagnosed patients and rarely for periods longer 
than 1 year. In the present study (chapter 3.1.1), different stressors (major life 
events and disease-related stressors) and vulnerability factors (personality 
characteristics, stress coping and social support) at the time of diagnosis were 
studied to predict the course of clinical measures of disease activity after 1, 3 and 5 
years in 78 RA patients.
Predictors o f functional disability and pain. Fear-avoidance models assume 
that pain-related avoidance factors and social resources affect disease outcome in 
chronic pain patients, specifically functional disability and pain. There is some 
support for these models from experimental research with chronic pain patients. 
Prospective research has provided preliminary evidence that these factors may also 
be relevant to patients with longstanding RA. However, the role of these factors 
had not yet been assessed in recently diagnosed patients or for outcomes exceeding 
1 year. In the present studies, cognitive-behavioral avoidance factors and social 
resources were assessed on the basis of passive pain coping strategies and social 
support. Specifically, the role of cognitive and behavioral pain coping and social 
support at the time of diagnosis was studied to predict pain and functional
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disability in 91 RA patients after 1 year as well as in 78 RA patients for whom data 
was available after 3 and 5 years (chapters 3.1.2.1 - 3.1.2.2).
Predictors o f psychological distress. Stress-vulnerability models attempt to 
explain whether patients develop psychological distress when faced with a chronic 
disease. Prospective studies with RA patients have shown that stress-vulnerability 
factors, particularly coping with stress and social support, can predict 
psychological distress within a period of approximately 1 year. However, previous 
studies have only incidentally studied the relative contribution of divergent 
stressors and vulnerability factors. In addition, the predictive value of stress- 
vulnerability factors has not been assessed in recently diagnosed patients or for 
periods longer than 1 year. In the present studies, different stressors (major life 
events, disease-related stressors) and vulnerability factors (personality 
characteristics of neuroticism and extraversion, stress coping and social support) at 
the time of diagnosis were studied to predict the course of psychological distress 
(anxiety and depressed mood) in 91 recently diagnosed patients after 1 year and in 
78 patients for whom follow-up assessments were available after 3 and 5 years 
(chapters 3.1.3.1 - 3.1.3.2).
Illness Cognitions
The chronic diseases literature has provided promising evidence for the 
predictive value of illness cognitions for future disease outcomes. Illness 
cognitions of perceived helplessness have especially been demonstrated to have 
relatively uniform, maladaptive effects on disease outcomes in various chronic 
diseases, including RA. Far less is known about possible adaptive cognitions when 
individuals are faced with uncontrollable, long-term stress, such as a chronic 
disease. In addition, there are no generic self-report instruments that allow 
comparisons of maladaptive and adaptive illness cognitions across different 
chronic diseases. Based on the theoretical and empirical literature, it was supposed 
that cognitions demonstrating uniform, maladaptive and adaptive effects in chronic 
diseases should reflect different ways of evaluating the inherently negative 
meaning of a chronic disease, as indicated by cognitions of helplessness, 
acceptance and perceived benefits. A self-report instrument was developed to 
assess these illness cognitions in different chronic diseases, including RA (chapter 
3.2). Psychometric characteristics of the instrument (reliability and concurrent and 
predictive validity) were studied in the total sample and randomly selected 
subsamples of 263 RA patients and 167 multiple sclerosis (MS) patients. Of 
specific interest was whether the illness cognitions would relatively uniformly 
predict the future disease outcome in RA and MS patients after 1 year.
Physiological Pain Reactivity
Fear-avoidance models propose that not only cognitive and behavioral factors, 
but also physiological reactions to pain may affect pain outcomes in chronic pain
General Introduction - 15
patients. In contrast to cognitive and behavioral factors, physiological reactivity 
patterns to pain have received less attention in chronic pain literature in recent 
years. Support is particularly scarce for the possible maladaptive function of 
physiological reactivity patterns for pain outcomes. In addition, the role of 
physiological pain reactivity has not yet been examined in prospective studies 
among chronic pain or RA patients. In the present study, the contribution of self 
reported physiological pain reactivity in comparison with cognitive and behavioral 
avoidance factors (passive pain coping) was studied for the capacity to predict the 
course of pain after 1 year in a sample of 95 RA patients (chapter 3.3).
MODIFICATION OF DISEASE OUTCOME:
TAILORED TREATMENT IN RA
Customizing treatments more closely to patient characteristics, in terms of patient 
selection and types and timing of treatment, has been suggested as a way to 
optimize treatment effectiveness in RA and other chronic pain disorders. Based on 
the main findings from the present prospective studies, it was hypothesized that the 
effectiveness of psychological interventions for RA patients might be improved if 
tailor-made interventions were offered to patients at risk at a relatively early stage 
of the disease. Consequently, an intervention study explored whether tailored 
treatment to patients at risk with relatively early RA is a promising way to 
optimize treatment effectiveness (chapter 4). A randomized, controlled trial with 
tailor-made treatment modules was conducted with 64 patients with relatively 
early RA, who had been screened for psychosocial risk profiles. All patients 
received standard medical care from a rheumatologist and rheumatology nurse 
consultant. Half of the patients also received an individual, tailored cognitive- 
behavioral treatment (CBT). It was expected that the CBT condition would 
demonstrate beneficial effects on indicators of disease outcome at post-treatment 
and at the 6 -month follow-up in comparison to the control condition.

2Assessment of Disease Outcome
Health Dimensions of RA
A comparison of two recently developed health status 
instruments for patients with arthritis: Dutch-AIMS2 
and IRGL
Evers, A.W.M., Taal, E., Kraaimaat, F.W., Jacobs, J.W.G., Abdel-Nasser, A., Rasker, J.J. & 
Bijlsma, J.W.J. (1998). A comparison of two recently developed health status instruments 
for patients with arthritis: Dutch-AIMS2 and IRGL. British Journal of Rheumatology, 37, 
157-164.
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ABSTRACT
Two multidimensional health status instruments of rheumatic diseases, the Dutch- 
AIMS2 and the IRGL, were compared in a sample of 284 rheumatoid arthritis 
patients with regard to their measurement properties and usefulness for research 
purposes. Both questionnaires showed an excellent reliability (Cronbach's a), and 
were highly comparable with regard to their construct and convergent validity. 
Second-order factor analysis confirmed the physical, psychological and social 
health dimensions for both questionnaires. The comparability between the 
instruments was established by high intercorrelations between the physical and 
psychological health dimensions. Sufficient convergent validity was indicated by 
the strong correlations between the physical functioning scales and clinical and 
laboratory measures. The main differences between both questionnaires relate to 
their length and emphasis on health aspects. The Dutch-AIMS2 is characterised by 
a more extensive assessment of the physical dimension and the additional 
measurement of general health aspects. The shorter IRGL exclusively assesses the 
main health dimensions with a more comprehensive measurement of the 
psychological and social dimensions. The instrument that reflects the subject in 
question most adequately should be chosen.
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INTRODUCTION
Outcome assessment of rheumatic diseases is increasingly characterised by 
multidimensional approaches to assess the health status of patients which is, in 
accordance with the World Health Organisation (WHO, 1958), defined as physical, 
psychological and social well-being. Assessing these health dimensions requires 
other instruments than the sole use of clinical and laboratory data, and has resulted 
in the development of different self-report health status instruments. The 
conceptual and practical usefulness of self-report data has, for example, been 
demonstrated for the outcome assessment of natural history and treatment effects 
in rheumatoid arthritis (RA), the prediction of mortality or the utilisation and 
demand for health care services (Wolfe et al., 1988, 1991; Pincus et al., 1989; 
Bijlsma et al., 1991; Mason et al., 1992; Jacobs et al., 1993; Pincus, 1995).
In recent decades, various multidimensional health status instruments have 
been developed, translated and validated for the Dutch RA population: the Arthritis 
Impact Measurement Scales (AIMS; Meenan et al., 1980; Taal et al., 1989), the 
Sickness Impact Profile (SIP; Bergner et al., 1981; de Witte et al., 1987), and the 
Health Assessment Questionnaire (HAQ; Fries et al., 1980; Siegert et al., 1984; 
Bijlsma et al., 1990). Of these instruments, the AIMS most comprehensively 
reflected the physical, psychological and social health dimensions (Taal et al., 
1989; Jacobs et al., 1992), but it was at that time also characterised by a number of 
psychometric problems (Huiskes et al., 1990a; Meenan et al., 1992). For these 
reasons, a new instrument that was derived from the AIMS was empirically 
developed for the Dutch arthritis population to assess the physical, psychological 
and social aspects of health status in a more sophisticated way: the IRGL (Impact 
of Rheumatic diseases on General health and Lifestyle; Huiskes et al., 1990a,b). 
Recently, a revised and strengthened version of the AIMS, the AIMS2, was 
developed and translated for application in the Dutch population of RA patients 
(Meenan et al., 1992; Riemsma et al, 1996). Both questionnaires, the IRGL and the 
Dutch-AIMS2, have proved to be reliable and valid instruments (Huiskes et al., 
1990a,b; Riemsma et al., 1996) and are widely used in the Dutch arthritis 
population.
When selecting an instrument for use in clinical practice and research, its 
suitability depends on the assessment of intended health constructs, the 
measurement efficiency and its user friendliness. In order to facilitate the making 
of a decision regarding an outcome measure and to allow direct comparisons of RA 
samples in which one of the questionnaires was used, the Dutch-AIMS2 and the 
IRGL were compared with regard to their psychometric properties and usefulness 
for different research purposes.
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METHODS
Procedure
Three hundred and thirty-seven consecutive outpatients from three hospitals in 
widely separated parts of the Netherlands were asked by their rheumatologists to 
participate in this study. Questionnaires were administered during a routine visit 
when clinical and laboratory data were also collected. Inclusion criteria were a 
minimum age of 20 years, and a diagnosis of RA assessed by a rheumatologist 
according to the 1987 American College of Rheumatology (ACR) criteria (Arnett 
et al., 1988). Correctly completed questionnaires were returned by 284 patients 
(85%).
Measures
Self-report data. Patients completed the two questionnaires: the Dutch-AIMS2 
(Riemsma et al., 1996) and the IRGL (Huiskes et al., 1990a,b). In order to control 
order effects, a cross-balanced procedure was applied (for a further description of 
the questionnaires see the Results; for a detailed description of the AIMS2 see 
Meenan et al., 1992; for the IRGL see Huiskes et al., 1990a,b). In addition, the sex, 
age, social status, level of education, income, disease duration of patients, and use 
of medication were recorded.
Clinical and laboratory data. Prior to administering the questionnaires, the 
following disease measures were obtained: ARA functional classes (Steinbrocker 
et al., 1949), erythrocyte sedimentation rate (ESR), absence or presence of 
rheumatoid factor and bone erosions. From a subsample of 80 consecutive patients 
from one hospital, additional data were available on joint scores (Ritchie score; 
Ritchie et al., 1968), grip strength and radiographics according to the classification 
of Steinbrocker (Steinbrocker et al., 1949).
Statistical Analysis
Only those scales were used in the analyses which allowed comparisons 
between the two questionnaires, that is the physical, psychological and social 
functioning scales, and the disease impact scales. The two questionnaires were 
analysed as follows.
(1) Reliability was assessed by determining the internal consistency (Cronbach's a) 
(Nunnally & Bernstein, 1994) and the stability of the scales (test-retest-reliability). 
Test-retest reliability was assessed by determining internal consistency as well as 
Pearson's product moment correlation coefficients between two measurement 
points within a subsample of 67 consecutive patients from one hospital who 
completed the Dutch-AIMS2 twice with a time interval of one month.
(2) Construct validity was explored by conducting a principal component factor 
analysis with varimax rotation.
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(3) Comparability of the instruments was assessed by computing Pearson's product 
moment correlation coefficients between the corresponding scales of both 
questionnaires.
(4) Convergent validity was assessed by computing Pearson's product moment 
correlation coefficients with clinical and laboratory measures, disease duration and 
demographic variables (age, education, income).
Normal distribution of the self-report, clinical and laboratory data was 
determined by skewness and kurtosis cut-offs of < 0 . 1  and by viewing the normal 
probability plots. In the case of skewness (Depressed mood scale of the IRGL, 
Self-care scale of the Dutch-AIMS2 and grip strength), square root transformation 
was applied which resulted in normal distributions of the skewed variables. All 




The sample was predominantly female (70%) and married or living with a 
partner (6 8 %). Of the subjects, 25% had primary and 60% had secondary 
education. The mean age was 60 years (SD 14.5). Mean disease duration was 15.1 
years (SD 11.2). The majority of the patients were classified according to func­
tional class II or III (class I: 4%, class II: 64%, class III: 29%, class IV: 3%). The 
rheumatoid factor was positive in 75% and erosions were established in 76% of the 
patients. The mean ESR was 29.4 (SD 19.9). Most of the patients used non­
steroidal anti-inflammatory drug (NSAID) and/or disease-modifying anti­
rheumatic drug (DMARD) medication (80% and 81%, respectively); only a 
minority had oral corticosteroids or paracetamol (27% and 23%, respectively). Pa­
tients who did not return the questionnaires did not differ significantly from 
respondents with respect to sex, age, social status, disease duration, clinical status 
(ARA-class, ESR, the absence or presence of the rheumatoid factor and erosions) 
or the use of medication. The patients of the two subsamples who were selected for 
the purpose of convergent validity (n=80) and test-retest reliability (n=67) did also 
not differ from the main sample with respect to these characteristics.
Descriptive Comparison o f the Dutch-AIMS2 and the IRGL
Questionnaires were compared with regard to their content and construction, 
use of response categories and time interval, scoring and the length of the 
questionnaires.
Content and construction. The instruments differ with respect to their method 
of construction and emphasis on different health aspects. The Dutch-AIMS2 was
Table 1 Health Status Scores and Internal Consistency (Cronbach's a) of the Dutch-AIMS2 and the IRGL Scales a
Dutch-AIMS2 
Scales (number of items) M SD a
IRGL
Scales (number of items) M SD a
Physical functioning
Mobility (5) 2.68 2.22 0.82 Mobility (7) 17.31 6.52 0.93
Walking and bending (5) 5.46 2.56 0.80
Hand and finger function (5) 3.64 2.53 0.89 Self-care (8) 22.60 6.61 0.94
Arm function (5) 2.59 2.47 0.88
Self-care (4) 1.54 2.19 0.85
Household tasks (4) 2.93 3.04 0.88
Pain (6) 5.18 2.29 0.86 Pain (6) 15.58 4.75 0.89
Psychological functioning
Level of tension (5) 3.89 1.97 0.88 Anxiety (10) 18.64 5.65 0.92
Mood (5) 2.86 1.55 0.80 Depressed mood (6) 3.42 3.65 0.92
Cheerful mood (6) 11.42 4.22 0.93
Social functioning
Support (4) 3.25 2.55 0.90 Perceived support (5) 15.77 3.80 0.94
Social activities (4) 5.08 1.16 0.65 Actual support (3) 6.69 1.81 0.68
Mutual visit (2) 5.80 1.37 0.72
Social network b
Neighbours (1) 2.27 0.85
Friends (1) 2.10 0.77
Disease impact
Satisfaction (12) 3.93 2.16 0.91 Disease impact (10) 21.79 6.62 0.91
Work (4) 4.39 2.70 0.77 Impact activities (5) 12.73 4.34 0.88
Arthtritis impact (1) 4.95 2.04
Theoretical scale range. Dutch-AIMS2: for all scales 0-10. IRGL: mobility 7-28; self-care 8-32; pain 6-25; anxiety am 
cheerful mood 0-20; perceived support and impact activities 5-20; mutual visit 2-8; actual support 3-12;social network 1-4. 
Scores are categorized in norm classes (Huiskes et al., 1990a)
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designed a priori and focuses more on the assessment of physical aspects than on 
psychological and social aspects. The aim of the empirically developed IRGL was 
to measure the different health dimensions in an equal constraint. Consequently, 
the psychological and social functioning scales are assessed more comprehensively 
(see Table 1 for number of scales and number of items for each health dimension). 
The health dimensions are assessed by the two questionnaires as follows.
(1) Physical functioning. The Dutch-AIMS2 measures the physical dimension 
through six functional status scales (Mobility, Walking and Bending, Hand and 
Finger Function, Arm Function, Self-care, Household Tasks) and one Pain scale. 
The IRGL dimension of physical functioning is an abridged adaptation from the 
Dutch-AIMS and consists of three scales (Mobility, Self-care and Pain). The 
functional status is measured by assessing the use of upper and lower extremities 
(Self-care and Mobility, respectively).
(2) Psychological functioning. Two new scales of negative affect were added in 
the Dutch-AIMS2 to measure psychological functioning: Mood and Level of 
Tension. The IRGL assesses the psychological dimension somewhat more 
comprehensively as positive and negative affect by three already existing scales 
(Anxiety, Depressed Mood and Cheerful Mood), of which the reliability and 
validity have been studied in the Dutch population (van der Ploeg et al., 1980; 
Zwart & Spooren, 1982).
(3) Social functioning. Corresponding to the broad conceptualization and 
operationalization of social well-being in other research areas, the social health 
aspects are measured differently in both questionnaires. In the Dutch-AIMS2, two 
new designed scales refer to the quality of social functioning: Social Activities and 
Support from Family and Friends. The IRGL distinguishes between qualitative and 
quantitative aspects of social functioning in accordance to the conceptualization of 
Cohen and Wills (1985). The qualitative aspect in the IRGL is measured by three 
scales of a Dutch validated social support scale (van Dam-Baggen & Kraaimaat, 
1992): Perceived Support, Actual Support and Mutual Visits. The quantitative 
aspect is assessed by the size of the social network (number of friends and the 
number of neighbours with who one associates).
(4) Disease impact. Both questionnaires contain scales which assess the impact 
the disease has on the patient's life. For the Dutch-AIMS2, that is the Satisfaction 
scale which establishes the patient's satisfaction with 12 health areas, and the Work 
scale which measures the ability of the patients to carry out work (if they still 
work). The Arthritis Impact scale of the Dutch-AIMS2 measures the evaluation of 
their own health status in comparison to others and may be less comparable to the 
impact scales of the IRGL. The IRGL assesses the impact of the disease with one 
Disease Impact scale that measures the general impact of RA on several domains 
of daily life (e.g. work, activities, leisure, relationships, sexuality, food, sleep). The 
scale can be divided into four subscales of which only the Impact on Activities 
scale is applied for the purpose of this study.
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Response category and time interval. The questionnaires differ in the 
application of response categories for the three health dimensions: the Dutch- 
AIMS2 predominantly uses two kinds of 5-point scales (always/every day - 
usually/most days - sometimes/some days - rarely/never); the IRGL mainly uses 
one kind of 4-point scale (almost never -  sometimes -  often - almost always). A 
further aspect concerns the use of time intervals. Most questions of the Dutch- 
AIMS2 refer to the patient's functioning within the last month, whereas time 
intervals in the IRGL are taken from the original scales: the physical functioning 
scales refer to the previous month, the psychological scales to the previous week 
(depressed and cheerful mood) and previous month (anxiety), and the social 
functioning scales to the previous half year.
Scoring. In the Dutch-AIMS2, item responses are adjusted to a 0-10 range, with 
0  representing a good health status and 1 0  representing a poor health status (e.g. 
higher values of pain, mobility, and hand and finger function indicate a poor health 
status). By calculating the average mean, an overall physical, psychological and 
social interaction scale can be produced. In the IRGL, scales differ in their ranges 
(see Table 1) and are scored in the original direction (e.g. higher values on pain, 
and lower values on mobility and self-care indicate a poor health status).
Length o f the questionnaires. The Dutch-AIMS2 is a more extensive 
questionnaire than the IRGL, mainly because of the assessment of additional health 
aspects, such as patients' priority areas for improvement, attribution of health 
problems, perception of current and future health, and a number of medical aspects 
(co-morbidity, medication usage, type of rheumatic disease, disease duration). The 
Dutch-AIMS2 consists of 71 questions with 112 single items. It takes about 20 
minutes to complete. The IRGL focuses exclusively on the aforementioned health 
dimensions and consists of 16 questions with 6 8  single items. It takes about 15 
minutes to complete.
User friendliness. Both questionnaires are self-administered and can be 
completed without (professional) assistance. As far as is known, there are no major 
comprehension problems with the questionnaires. In addition, the response rate 
was high (85%) and almost all questions were answered by the respondents.
Reliability
As demonstrated in Table 1, the internal consistency of the scales of both 
questionnaires is highly satisfactory. The alpha coefficients in most cases exceed 
0.80 for the Dutch-AIMS2 and 0.90 for the IRGL, which indicates sufficient 
reliability for clinical use and patient selection, respectively (Nunnally & 
Bernstein, 1994). Even the somewhat lower alphas of the Social Activities and 
Work scales of the Dutch-AIMS2 (0.65 and 0.77, respectively), as well as the 
Actual Support and Mutual Visit scales of the IRGL (0.68 and 0.72, respectively), 
exceed the threshold value of 0.60, which indicates sufficient reliability for 
research purposes (Nunnally & Bernstein, 1994).
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In order to assess the test-retest reliability of the Dutch-AIMS2, Cronbach's a 
as well as Pearson's product moment correlations between the two assessment 
points with a time interval of one month were calculated in the subgroup of 67 
patients. Results of internal consistencies (between 0.86 and 0.96) and Pearson's 
product moment correlations (between 0.73 and 0.92) revealed a high test-retest 
reliability for the physical, psychological and social health dimensions of the 
Dutch-AIMS2. The strength of the alpha coefficients was similar to those 
previously established for the physical and psychological dimensions of the IRGL 
(Geenen et al., 1995).








Mobility .80 .18 -.18
Walking and bending .80 .17 - . 1 0
Hand and finger function .78 . 1 1 -.07
Arm function .80 .08 -.03
Self-care .78 .13 -.05
Household tasks .85 .09 -.06
Pain . 6 8 .40 . 0 0
IRGL
Mobility -.80 - . 1 0 .17
Self-care -.83 -.16 .07
Pain .64 .36 -.03
Dutch-AIMS2
Level of tension . 2 0 .74 -.17
Mood .38 .73 -.17
IRGL
Anxiety .19 .84 -.21
Depressed mood . 2 1 .84 -.10
Cheerful mood -.14 -.75 .24
Dutch-AIMS2
Support .07 .28 -.56
Social activities .27 . 0 0 -.69
IRGL
Perceived support - . 0 2 -.31 .59
Actual support .08 -.05 .67
Mutual visit -.18 - . 2 2 .72
Social network
Neighbours -.16 .07 .62
Friends .08 -.24 .49
a Loadings above 0.45 are printed in bold.
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Mobility -.74 -.65 .46
Walking & bending -.76 -.54 .51
Hand & finger function -.56 -.78 .43
Arm function -.52 -.70 .52
Self-care -.57 -.65 .42
Household tasks -.69 -.70 .43




Level of tension .67 .63 -.45
Mood .64 .67 -.52
Social functioning
Perceived Actual Mutual Social network
support support visit Neighbours Friends
Support .48 .24 .35 .25 .26





Work . 6 6 .63
Arthritis impact .45 .40
a All correlations significant at p  < 0.001. Associations between similar scales are printed in bold.
Construct Validity
In order to determine the construct validity of the health dimensions, a principal 
component factor analysis with varimax rotation was conducted. The Disease 
Impact scales were excluded from this analysis, because we assumed that they 
would be related to all health dimensions. The criterion for factor extraction was 
the scree-test (Cattell, 1966) which resulted in a three-factor solution. As 
demonstrated in Table 2, the intended constructs of physical, psychological and 
social functioning were strongly supported in both questionnaires (loadings above 
0.45 are printed bold). In particular, the high loadings of the physical and
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psychological functioning scales (around 0.80) confirmed the assessment of clearly 
distinguishable dimensions. Only the pain scale of both questionnaires also loaded 
modestly on the psychological factor (0.40 and 0.36, respectively), reflecting the 
multidimensional nature of pain (Brown, 1990). The moderate loadings of the 
social functioning factor (between 0.49 and 0.72) indicate the more heterogeneous 
assessment of this construct. In total, the three-factor solution explains 61% of the 
total variance.
Comparability between the Dutch-AIMS2 and IRGL
Comparability was assessed by calculating bivariate correlations between the 
corresponding scales of the two questionnaires. As demonstrated in Table 3, the 
correlations between the corresponding scales (printed in bold) were high for the 
physical and psychological dimensions and disease impact scales (all exceeding
0.60) and indicate the measurement of rather identical constructs (see the Note). 
The weaker relationship between the social functioning scales again demonstrates 
the somewhat different assessment of this dimension. Both scales of the Dutch- 
AIMS2  were moderately related to the comparable qualitative scales of the IRGL 
(between 0.41 and 0.48), but only weakly related to the quantitative scales of the 
IRGL (between 0.22 and 0.35).
Convergent Validity
Correlations with demographic variables and disease duration. As physical 
health in rheumatic diseases has partly been shown to be related to disease 
duration, age and socioeconomic status (Wolfe et al., 1988; Pincus et al., 1989; 
Hakala et al., 1994), these correlations were also calculated for the two 
questionnaires. Correlations of health aspects with demographic variables (age, 
education and income level) and with disease duration correspond greatly in the 
two questionnaires (because of the large sample size, only correlation coefficients 
of p  < 0.001 are mentioned). The physical functioning scales of both 
questionnaires were all related to age (between |0.22| and |0.30|) and disease 
duration (between |0.22| and |0.37|), indicating a worse functioning with older age 
and longer disease duration, with the exception of the relationship between age and 
the pain scales of both questionnaires. The impact scales of both questionnaires 
were also related to disease duration (between |0.24| and |0.30|), indicating a 
greater impact with longer disease duration. In addition, functional status scales of 
both questionnaires (Mobility and Hand and Finger Function of the Dutch-AIMS2 
and Self-care of the IRGL) were related to income and educational level (between 
|0.22| and |0.24|), indicating a worse functioning for a lower socio-economic status. 
As expected, no substantial correlations (above r  = 0.21) were found with the sex 
or the social status of the patients. In addition, none of the psychological and social 
functioning scales of both questionnaires were substantially related to demographic 
variables or disease duration.
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Table 4 Pearson Correlation Coefficients between Clinical and Laboratory Measures and 
















Mobility .51 -.54 .40 .34 .37
Walking and bending .50 -.30 .47 .27 .32
Hand and finger function .50 -.67 .41 .46 .28
Arm function .50 -.57 .36 .32 .26
Self-care .48 -.54 .35 .28 .26
Household tasks .61 -.55 .44 .33 .30
Pain .40 -.29 .50 . 2 2
IRGL
Mobility -.55 .54 -.54 -.30 -.41
Self-care -.52 .67 -.36 -.49 -.25
Pain .37 -.30 .57 .23
a All correlations significant.
If n = 284: p  < 0.001. If n = 80: r > 0.22, p  < 0.05; r > 0.30, p  < 0.01; r  > 0.37, p  < 0.001.
Correlations with clinical and laboratory data. The correlation coefficients 
between clinical and laboratory measures (ESR, Ritchie score, grip strength, 
functional ARA class and radiographic score) and the physical functioning scales 
were significant for all scales of both questionnaires, with the expected exception 
of the correlation between pain and the radiographic score (see Table 4). The 
strength of the correlations was almost the same for the questionnaires. The 
physical functioning scales were strongly related to functional class and grip 
strength, (between |0.27| and |0.67|, in most cases exceeding |0.50|) and moderately 
related to the Ritchie score (between |0.35| and |0.57|; in most cases exceeding 
|0.40|). The weaker correlations were with radiographics (between |0.27| and |0.49|; 
in most cases exceeding |0.30|) and ESR (between |0.20| and |0.41|; always 
exceeding |0 .2 0 |), probably reflecting current disease activity rather than the 
patient's health status.
Note. In order to facilitate comparisons between studies in which one of the two instruments 
has been used, regression formulae between the most comparable physical and 
psychological functioning scales of the questionnaires were computed that permit the 
estimation of scale scores from the Dutch-AIMS2 into the IRGL: Walking and bending = - 
0.30 x Mobility + 10.63; Hand and finger function = -0.30 x Self-care + 10.41; Pain = 0.39 
x Pain - 0.93; Level of tension = 0.23 x Anxiety - 0.41; Mood = 0.29 x Depressed mood + 
1 .8 8 .
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DISCUSSION
Self-report measures offer an easy and inexpensive possibility to gain insight into 
the patient's perceived health status and quality of life which is not offered by 
clinical and laboratory data. The advantages of disease-specific, multidimensional 
instruments compared to generic instruments or single-dimensional quality of life- 
measures consist of the detailed and specific information about health areas which 
are affected by the disease and which may change through therapeutic 
interventions. The comprehensive assessment of health aspects can serve as an 
important complementary tool in outcome assessment, therapeutic interventions, 
and long-term care (Wolfe et al., 1988, 1991; Pincus et al., 1989; Bijlsma et al., 
1991; Mason et al., 1992; Jacobs et al., 1993; Pincus, 1995).
For the evaluation and selection of an appropriate instrument, several criteria, 
such as the measurement of essential health areas, user friendliness, and high 
reliability and validity standards of an instrument may function as a necessary 
guide. The results of this study indicate that both instruments, the Dutch-AIMS2 
and the IRGL, meet the needs and criteria of a sophisticated and comprehensive 
multidimensional health instrument. In addition, both instruments provide similar, 
but slightly different indicators of health.
In line with previous findings (Huiskes et al., 1990a,b; Riemsma et al., 1996), 
reliability in terms of internal consistency is highly satisfactory for both 
instruments. The somewhat higher alpha of the IRGL may be due to the larger 
numbers of items within most scales as well as the empirical development of this 
questionnaire in contrast to the a priori development of the Dutch-AIMS2. In 
addition, a high test-retest reliability is indicated by our data for the Dutch-AIMS2, 
as it has been previously demonstrated for the physical and psychological scales of 
the IRGL (Geenen et al., 1995).
The construct validity of the Dutch-AIMS2 and the IRGL is confirmed by the 
results of the second-order factor analysis. The assessment of the three discrete 
components of health status, i.e. the physical, psychological and social functioning, 
is strongly supported for both questionnaires. Similar satisfactory results have also 
been demonstrated in previous studies for the Dutch-AIMS2 (Riemsma et al.,
1996) and the IRGL (Huiskes et al., 1990a,b).
Comparability and similarity between the questionnaires were supported by 
strong intercorrelations within the physical and psychological health dimensions 
and disease impact scales, and to a lesser extent within the social functioning 
scales. Whereas the social scales of the Dutch-AIMS2 emphasize the extent and 
possibility of participating in social activities and receiving support from family 
and friends, the social scales of the IRGL reflect the size of the social network as 
well as the extent and possibility of the exchanged support.
Convergent validity was highly satisfactory and nearly identical for both 
questionnaires. The modest correlations of both instruments with demographic
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variables, indicating a greater dysfunctioning with older age, a longer disease 
duration and a lower socioeconomic status, had been previously reported for the 
IRGL (Huiskes et al., 1990a,b) and for other health instruments (Wolfe et al., 1988; 
Pincus et al, 1989; Hakala et al., 1994). In addition, the strong correlations between 
the clinical and laboratory data and the physical functioning scales were similar to 
previous findings of the Dutch-AIMS2 (Riemsma et al., 1996), the IRGL (Bijlsma 
et al., 1991; Huiskes et al., 1990a,b; van der Heide et al., 1994) as well as other 
validated self-report questionnaires (Pincus et al., 1989; Mason et al., 1992; Hakala 
et al., 1994). Results indicate that the scales of both questionnaires assess the 
intended construct of physical functioning, and may serve as complementary 
information to clinical and laboratory data. Convergent validity of the 
psychological and social scales, which was not assessed in this study, had been 
previously established for the Dutch-AIMS2 (Riemsma et al., 1996) and for the 
IRGL (van der Ploeg et al., 1980; Zwart & Spooren, 1980; Kraaimaat et al., 1995b; 
Evers et al., 1997).
For the valid assessment of outcome research, sensitivity to change forms an 
essential part of the evaluation of an outcome measure. A sufficient sensitivity to 
change in order to detect clinically meaningful alterations after total hip 
replacement in osteoarthritis (OA) and RA patients has been shown in previous 
research for the IRGL (Borstlap et al., 1994). For the Dutch-AIMS2, studies are 
being undertaken to assess its sensitivity to change.
Results suggest that both questionnaires are almost identical in their high 
methodological standards. Differences between the instruments relate rather to 
their content and focus on different health aspects. The Dutch-AIMS2 measures the 
physical health dimension more extensively by the broader assessment of activities 
of daily living, and assesses additional health aspects that are not included in the 
IRGL, such as patients' evaluation of their health status in comparison to others, 
patients' priority areas for improvement, attribution of health problems, perception 
of current and future health, and a number of medical aspects (co-morbidity, 
medication usage, type of rheumatic disease, disease duration). The IRGL 
measures the psychological and social dimensions more comprehensively. For 
example, the assessment of positive affect in the psychological health dimension, 
which has shown to be independent of and distinctive from negative affect in 
previous research (Zautra et al., 1995), lacks an equivalent scale in the Dutch- 
AIMS2. Quantitative aspects of the social health dimension, such as the size of the 
social network, which is a major accompanying component of a chronic disease 
with ongoing disability (Evers et al., 1997), are also not represented in the Dutch- 
AIMS2.
The selection of an instrument must be guided by a clear definition of which 
health aspects are most important to assess. Depending on the research purposes 
and practical needs of health care providers, both questionnaires may be useful in a 
different way with regard to the field of interest. The focus of the Dutch-AIMS2 on
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the physical functioning dimension with the extensive assessment of activities of 
daily living may, for example, be preferred for evaluation of physiotherapeutic 
interventions or surgical procedures. As an internationally applied instrument, the 
Dutch-AIMS2 may also be more suitable for cross-cultural research purposes. The 
comprehensive assessment of psychological and social aspects, as is the case in the 
IRGL, may be recommended in the detection of beneficial or deleterious side- 
effects of therapeutic interventions, or the multidisciplinary planning and decision­
making of long-term care.
The brevity of an instrument and its user friendliness function as an additional 
selection criterion in the routine assessment of the patient's health status. For the 
clinical practice, the IRGL, with its exclusive focus on the main health dimensions, 
may be preferred because it takes less time to complete, whereas the uniform scale 
ranges of the Dutch-AIMS2 facilitate interpretation of the data.
The results of this study facilitate direct comparisons between two widely used 
multidimensional health instruments, the Dutch-AIMS2 and the IRGL, in order to 
make a decision regarding an appropriate outcome measure. The instruments are 
similar in their high reliability and validity standards, but differ slightly in their 
focus on different health aspects. Both can be used optimally as complementary 
evaluations of clinical outcome, therapeutic interventions and long-term care. The 
instrument that reflects the subject in question most adequately should be chosen.
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ABSTRACT
Stress-vulnerability factors were studied for their ability to predict long-term 
disease activity in early rheumatoid arthritis (RA). In a prospective study involving 
78 recently diagnosed rheumatoid arthritis patients, the role of personality 
characteristics (neuroticism, extraversion), physical and psychological stressors 
(chronic, disease-related stressors of functional disability, pain, disease impact on 
daily life, as well as major life events), coping and social support at the time of 
diagnosis was examined to predict changes in clinical indicators of disease activity
1, 3 and 5 years later. While stress-vulnerability factors failed to predict disease 
activity at the 1-year follow-up, disease activity at the 3 and 5-year follow-ups was 
predicted by coping and social support at the time of diagnosis, after adjusting for 
disease activity at first assessment, other biomedical and psychosocial factors and 
use of medication. Low levels of social support predicted increased disease activity 
at the 3-year follow-up, and high avoidance coping predicted increased disease 
activity at the 3 and 5-year follow-ups. Findings indicate the potential prognostic 
value of avoidance coping and social support for the long-term course of disease 
activity in early RA and suggest that the effects of these vulnerability factors 
predominantly operate in the long term.
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INTRODUCTION
In recent decades, the role of stressors and stress modulating factors has been 
repeatedly proposed in chronic inflammatory diseases, such as rheumatoid arthritis 
(RA) (Anderson et al., 1985; Koehler, 1985; Huyser & Parker, 1998; Walker et al., 
1999). In line with stress-vulnerability models (Steptoe, 1991a, 1998; Walker et al., 
1999), various stressors and stress modulating factors have been suggested to affect 
the course of RA disease activity, which is only modestly predicted by biomedical 
factors (van der Heijde et al., 1988). However, empirical findings are far from 
conclusive concerning the essential factors and the direction of their effects on 
disease activity. Comprehensive study of the extent to which different stressors and 
vulnerability factors contribute to the course of disease activity may provide a 
more integrated understanding of psychosocial factors that affect disease activity in 
RA.
Most attention in RA stress research has focused on the occurrence of stressful 
events, particularly major life events, which are assumed to precede and increase 
an unfavorable course of RA. Although relationships between the occurrence of 
major events at onset and unfavorable disease outcomes have occasionally been 
reported (Latman & Walls, 1996; Leymarie et al., 1997), other studies have 
indicated inconclusive results (Koehler & Vertheim 1993; Potter & Zautra, 1997), 
and a relationship to major events could hardly be supported when clinical 
indicators of disease activity were applied (Thomason et al., 1992; Leymarie et al., 
1997; Dekkers et al., 2001). Aside from major stressful events, minor daily 
stressors have been supposed to primarily affect short-term disease fluctuations in 
RA, but research findings have also been inconsistent (Affleck et al., 1997; Potter 
& Zautra, 1997; Zautra et al., 1997). Little attention has been directed to the role of 
more long-lasting stressors that are a direct consequence of the disease itself, such 
as pain and functional disability, and the impact of the disease on daily life, e.g. 
limited possibilities in terms of work and daily activities and changes in social 
relationships (van Lankveld et al., 1993; Evers et al., 1997). Due to their lasting 
impact on nearly every aspect of life, chronic, disease-related stressors could 
particularly affect the long-term course of the disease, resulting in a vicious circle 
of increased inflammation and chronic stress (Solomon, 1981; Zautra et al., 1989).
Aside from environmental stressors, individual and social vulnerability factors, 
such as personality characteristics, social support and the manner of coping with 
stress, have been assumed to have direct, mediating or moderating effects on RA 
disease activity. While personality characteristics were originally assumed to 
directly enhance vulnerability to the onset of RA, without gaining much support 
(Moos, 1964; Anderson et al., 1985), their impact on the course of disease activity 
has been less extensively studied. So far, the results of relationships to clinical 
indicators of disease activity or progression are inconclusive (Crown et al., 1975; 
Gardiner, 1980; Latman & Walls, 1996). Studies on physical and psychological
38 - Chapter 3.1.1
health outcomes rather support a mediating or modifying role for specific 
personality characteristics, such as neuroticism and extraversion, on exposure and 
reactivity to stressors (Costa & McCrae, 1987; Watson & Pennebaker, 1989; 
McCrae, 1990; Affleck et al., 1992, 1997; Phillips & Gatchel, 2000). The role of 
social support in predicting health outcomes has been widely accepted (Broadhead 
et al., 1983; Kaplan & Toshima, 1990; Uchino et al., 1996), and favorable direct or 
buffer effects of quantitative and qualitative aspects of social support, such as the 
size of the social network or the availability of perceived support, have been 
demonstrated in prospective studies for physical and psychological symptoms in 
RA (Brown et al., 1989b; Evers et al., 1997, 1998a). Regarding disease activity, a 
social support buffer effect has been suggested by the finding that the quality of 
spousal support moderates changes in immunological parameters in periods of 
interpersonal stress (Zautra et al., 1998). Another possible source of vulnerability is 
the coping responses individuals use when faced with stress. Based on the general 
distinction between active, problem-focused coping and passive avoidance coping, 
research has repeatedly demonstrated that the use of more passive coping, and 
incidentally also the use of less active coping, prospectively predicts physical and 
psychological symptoms in RA (Brown & Nicassio, 1987; Evers et al., 1998a; 
Scharloo et al., 1999). In addition, there is preliminary evidence from prospective 
studies for harmful effects of passive avoidance coping on RA disease activity after 
three years (McFarlane et al., 1987) and on self-reported disease flare-ups after one 
year (Brown & Nicassio, 1987). Due to the generally modest relationships found 
for these psychosocial factors, biomedical variables have also been posited as 
having a moderating effect on the stress-vulnerability relationship to disease 
activity. Specifically, patients without a rheumatoid factor have been reported to be 
more vulnerable to the stress-illness relationship (Crown et al., 1975; Gardiner, 
1980; Stewart et al., 1994).
So far, empirical evidence supports a link between stressors and vulnerability 
factors and the course of disease activity in RA. However, definite conclusions 
about the specific kind of variables affecting disease activity and their relative 
contributions cannot be drawn from present research, since a comprehensive test of 
various stressors and vulnerability factors that enables the investigation of direct, 
mediating or modifying effects on disease activity has rarely been conducted (cf. 
Dekkers et al., 2001). In addition, inconclusive results found in the literature may 
be ascribed to differences between studies in outcomes measures, time periods 
assessed and stages of the disease. For example, a wide range of outcome measures 
has been used and researchers do not always distinguish between indicators of 
disease activity, such as inflammatory activity and swelling of joints, and 
indicators of disease outcome, such as functional disability (McFarlane et al., 1987; 
McFarlane & Brooks, 1990). However, disease activity and disease outcome 
measures may be differently modulated by psychosocial factors (Leymarie et al., 
1997). In addition, the kind of variables and the direction of effects recently found
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for short-term disease fluctuations (Affleck et al., 1997; Zautra et al., 1997) may be 
irrelevant to long-term outcomes (McFarlane & Brooks, 1990; Affleck et al., 
1997). In contrast to short-term changes from incidental stress encounters and 
responses, long-term effects may be primarily influenced by chronic stressors and 
relatively stable personality, coping and social support characteristics. Also the 
strength and direction of relationships between stress and vulnerability factors and 
disease activity may vary over time and be different for short and long-term 
outcomes. Some effects may become evident only in the long term and factors may 
even work in opposite directions in different time periods, e.g. due to a biphasic 
pattern of immunological or behavioral responses that is differently related to 
disease activity during and after the occurrence of major stress (Mullen & Suls, 
1982; Koehler, 1985; Suls & Fletcher, 1985; McFarlane & Brooks, 1990; Huyser
& Parker, 1998). Finally, effects may also depend on the stages of disease assessed 
(McFarlane & Brooks, 1990; Huyser & Parker, 1998). Preliminary evidence 
suggests that stressors and vulnerability factors are differently related to physical 
and psychological symptoms in early and long-standing RA (Smith et al., 1997), 
possibly due to changes brought about by the disease itself. Stressors and 
vulnerability factors in established RA have been shown to be affected by the 
inflammatory processes of the disease, its biopsychosocial consequences and the 
pharmacological treatment with prolonged medication (Evers et al., 1997; Fex et 
al., 1998; van Jaarsveld et al., 1998, 2000; Penninx et al., 1999), and they may be 
consequently more validly assessed in recently diagnosed patients (Zautra et al., 
1989; Smith et al., 1997; Huyser & Parker, 1998).
The purpose of the present study was to examine the role of stress-vulnerability 
factors for their ability to predict long-term changes in disease activity in recently 
diagnosed RA patients. Specifically, we studied the relative contribution of 
personality characteristics (neuroticism and extraversion), physical and 
psychological stressors (chronic disease-related stressors of functional disability, 
pain, and disease impact on daily life, as well as major life events), coping and 
social support at the time of diagnosis to changes in disease activity 1, 3 and 5 
years later. In line with preliminary evidence suggested by current theories and 
research, it was hypothesized that a more unfavorable course in disease activity 
after 1, 3 and 5 years could be directly predicted by personality characteristics of 
more neuroticism and less extraversion, higher levels of physical and 
psychological stressors, more passive avoidant coping, less active problem-focused 
coping and less social support at the time of diagnosis. In addition to these direct 
effects, several mediator and moderator effects were exploratively investigated. 
First, the mediating function of coping and social support for the relationship 
between personality characteristics and change in disease activity and for the 
relationship between stressors and change in disease activity was examined. In 
addition, the mediation function of stressors for the relationship between 
personality characteristics and change in disease activity, and of coping for the
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relationship between social support and change in disease activity, was explored. 
Hypotheses of moderator effects included the moderating function of stressors on 
vulnerability factors, anticipating that the maladaptive effects of major life events 
and chronic disease-related stressors on disease activity would be greater in 
patients with more unfavorable personality characteristics, coping and social 
support. Moreover, moderator effects of the presence of the rheumatoid factor on 
all stressors and vulnerability factors were examined, assuming that the 
relationships of stressors and vulnerability factors to the course of disease activity 
might be stronger in patients with a negative rheumatoid factor. Finally, possible 
mediator and moderator effects between demographic variables (gender, age and 
educational level) and all stress-vulnerability factors were explored.
METHODS
Sample and Procedure
The sample consisted of outpatients with recently diagnosed RA from five 
hospitals in the Netherlands. All patients participated in one of two medical trials 
of second-line antirheumatic drugs (van Jaarsveld et al., 2000; van Everdingen et 
al., 2002). Inclusion criteria for the medical trials were a minimum age of 18 years, 
diagnosis according to the 1987 American College of Rheumatology (ACR) 
criteria (Arnett et al., 1988), and a duration of disease of less than one year. All 
incoming patients from the hospitals who met the inclusion criteria were asked to 
participate in the medical trials. About 25% of the patients did not agree to be 
randomized, but there were no differences found between these patients and 
participants in terms of their levels of disease activity. From the remaining 394 
patients participating in the medical trials, a subgroup of 1 0 0  patients were 
randomly selected for participation in the present study.
Patients were informed about this study by their rheumatologists during their 
first visit, when ACR criteria were assessed. About three weeks later (range 0-12 
weeks), clinical and self-report data were assessed during their second visit. This 
second visit was also the starting point for the prospective medical trials. Five 
patients did not return the questionnaires at this assessment point, resulting in 95 
patients who participated in the present study at the time of diagnosis. In addition 
to assessing clinical and self-report data at the beginning of the study (Evers et al.,
1997), data on disease activity, functional disability, and pain was again collected 
at the 1, 3 and 5-year follow-ups.
Of the 95 patients who correctly completed self-report data at the first 
assessment, 78 patients (82%) completed all assessment points during the 5-year 
study period. Participants in the follow-up were predominantly female (69%), 
married or living with a partner (76%), and had a primary (32%) or secondary
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(57%) educational level. Mean age at the time of entering the study was 57 years 
(range 20-82 years). The rheumatoid factor was positive for 50 patients (64%). In 
terms of dropouts, 7 patients died, 2 moved, 1 was in remission and not longer 
treated in the rheumatology outpatient clinic and 7 did not complete the 
questionnaires for the follow-up assessments. When entering the study, dropouts 
did not significantly differ from participants in terms of demographic variables 
(sex, age, marital status, educational level), presence of the rheumatoid factor, 
disease activity, pain, functional disability, disease impact on daily life, experience 
of major life events, personality dimensions of extraversion, coping or social 
support. However, dropouts scored higher on the personality dimension of 
neuroticism than patients who completed all assessment points (t = 2.87, p  < 0 .0 1 ).
When included in the medication trials, all patients were randomly assigned to 
one of the medication strategies. The drug trials lasted at least two years for all 
patients, but medication strategies were continued unless adverse reactions or 
ineffectiveness made discontinuation inevitable in the opinion of the attending 
doctor. In that case, one of the other medication strategies from the trials was 
usually prescribed. The distribution of medication strategies was as follows: 30% 
and 23% of the patients used non-steroidal anti-inflammatory drugs (NSAID) alone 
at first assessment and at the 5-year follow-up, respectively; the other patients took 
NSAID in combination with methotrexate (30% and 49%, respectively), 
intramuscular gold (14% at both assessment points), hydroxychloroquine (15% and 
9%, respectively), prednisone (11% and 1%, respectively) or other second-line 
medication, prescribed only for individual patients (4% at the 5-year follow-up). At 
the 5-year follow-up, 31% of the patients still used the initially prescribed 
medication, 65% used another medication strategy from the drug trial, and 4% of 
the patients used another second-line medication than those used in the medication 
trials. Finally, none of the patients in the psychosocial study met removal criteria 
during the study period, i.e. the occurrence of other serious disease processes or an 
incorrect RA diagnosis.
Measures
Demographic variables were assessed with a general checklist, assessing 
patients’ gender, age and educational level. Educational level was measured using
7 categories that can be classified as primary, secondary and tertiary educational 
levels, representing an average of 7, 12, and 17 years of education, respectively.
Disease activity was determined by Erythrocyte Sedimentation Rate (ESR; 1­
140mm first hour), an indicator of inflammatory activity, and by joint score ratings 
of the simultaneous presence of swelling and tenderness in 38 joints (range 0-534; 
Thomson, 1987). A composite score of both measures was used as an indicator of 
disease activity, in accordance to regular use of composite scores of disease 
activity that consist of at least ESR or another acute phase reactant and a joint 
score (van der Heijde et al., 1990, 1992; Prevoo et al., 1995). The composite score
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was calculated by adding the standardized scores (z-scores) of both indicators 
(actual range between -2.32 and 3.25). A higher composite score indicates higher 
levels of disease activity.
Rheumatoid factor was determined by a latex fixation test or Rose-Waaler test, 
for which the result is positive in < 5% of healthy control subjects.
Functional disability was assessed using a composite score of one clinical 
measure and two self-report measures (Evers et al., 1998a). The clinical measure 
consisted of grip strength assessments with a Martin vigorimeter (the mean of three 
measurements on both hands was calculated). Self-reported functional disability 
was assessed with the Mobility and Self-care scales of the Impact of Rheumatic 
Diseases on General Health and Lifestyle (IRGL; Huiskes et al., 1990a, Evers et 
al., 1998b). The IRGL is derived from the Arthritis Impact Measurement Scales 
(AIMS) and assesses physical, psychological and social health in patients with 
rheumatic diseases. Previous research has shown that the reliability and validity of 
the IRGL scales are highly satisfactory (Huiskes et al., 1990a, Evers et al., 1998b). 
Items in the IRGL scales are scored on a 4-point or 5-point Likert scale. The 
Mobility and Self-care scales assess the functional capacities of the lower and 
upper extremities, respectively, over the last month (15 items). Cronbach’s alpha in 
the present study was 0.89 for both scales. A composite score of the clinical 
measure and the two self-report scales was calculated by adding the standardized 
scores (z-scores) of all three indicators. A higher composite score indicates higher 
levels of functional disability.
Pain was assessed with the IRGL Pain scale ( 6  items), measuring the severity 
and frequency of painful episodes and swollen joints and the duration of early 
morning stiffness in the last month. Cronbach’s alpha in the present study was 
0 .8 8 .
Disease impact on daily life was measured with the IRGL Disease Impact scale 
( 1 0  items), which assesses the general impact of the disease on several areas of 
daily life (i.e. work, leisure, relationships, sexuality, eating). Cronbach’s alpha in 
the present study was 0.87.
Major life events were measured with a Dutch version of the Life Experience 
Survey (LES), assessing the occurrence of 60 stressful events related to health, 
work, financial circumstances, relationships, living, and personal matters in the last 
12 months (Sarason et al., 1978; van de Willige et al., 1985). To minimize 
confounding effects between major life events and disease impact on daily life, 
four disease-related events were excluded (occurrence of severe disease, important 
changes in health status, hospital admission, surgery).
Personality dimensions, i.e. neuroticism and extraversion, were measured with 
a Dutch version of the Eysenck Personality Questionnaire (17 and 12 items, 
respectively) (EPQ; Wilde, 1970; Eysenck & Eysenck, 1991). Cronbach’s alphas 
in the present study were 0.90 for neuroticism and 0.79 for extraversion.
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Coping strategies were assessed with the Utrecht Coping List (UCL; 
Sanderman et al., 1992; Schreurs et al., 1993), a well-documented coping 
questionnaire in the Netherlands (Evers et al., 1997, 2001a; Scharloo et al., 1998, 
1999), adopted from Westbrook (1979), which measures on a 4-point Likert scale 
active and passive coping strategies when dealing with everyday problems. Active 
coping was assessed with the Problem-focusing scale (7 items), measuring 
cognitive and behavioral efforts to apply goal-oriented problem-solving strategies 
(analyzing problems from various perspectives, generating different solutions, 
taking goal-oriented action, perceiving problems as a challenge). Passive coping 
was measured with the Avoidance scale ( 8  items), measuring cognitive and 
behavioral attempts to avoid, escape and acquiesce when facing everyday problems 
(giving in to avoiding and escaping difficult situations, withdrawing from 
situations, letting matters take their course, waiting to see which way the wind 
blows). Cronbach’s alphas in the present study were 0.85 for the Active and 0.67 
for the Passive coping scales.
Social support in the past six months was measured with the IRGL social 
functioning scales, reflecting quantitative and qualitative aspects of social support. 
The quantitative aspect was assessed by the size of the social network, i.e. the 
number of friends and family members with whom patients associate. The 
qualitative aspect was measured by the Perceived Support scale (5 items), inquiring 
about perceived availability of emotional and instrumental support (availability to 
share sad and pleasant events, get support when faced with stress and pain, get help 
for casual work). Cronbach’s alpha for the Perceived Support scale in the present 
study was 0 .8 8 .
Statistical Analyses
To study mean linear changes in clinical status over time in the group of RA 
patients, analyses of variance with repeated measurements were performed for the 
indicators of clinical status (disease activity, functional disability, pain), using the 
variables at the different assessment points as dependent variables, followed by 
posthoc tests in the case of significant linear changes. To explore the relationship 
between stress-vulnerability factors at the time of diagnosis and changes in disease 
activity after 1, 3 and 5 years, Pearson correlation coefficients were calculated 
between the stress-vulnerability factors at the time of diagnosis and the residual 
gain scores for disease activity at the 1, 3 and 5-year follow-ups (Kerlinger, 1975). 
Sequential regression analyses were then performed to examine the relative 
contribution of stress-vulnerability factors (including demographic variables) to 
disease activity at the 1, 3 and 5-year follow-ups. Disease activity at the 1, 3 and 5- 
year follow-ups were used as dependent variables. In the first step, disease activity 
assessed at the time of diagnosis was entered, followed by the predictors 
significantly related to disease activity at at least one follow-up assessment. 
Mediating effects were determined with the procedure described by MacKinnon
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and Dwyer (1993), calculating the difference between the regression coefficients of 
the unadjusted and adjusted (for the mediator) independent variable and dividing 
this mediated effect by the standard error of the mediated effect. Moderating 
effects were explored by calculating centered interaction terms between the 
predictor and the moderator and entering them in the regression analyses, after 
controlling for their main effects. Due to the relatively large number of explorative 
tests performed in these moderator analyses, a more conservative threshold of p  < 
0.01 was used. Finally, to control for possible confounding effects of medication, 
Pearson correlation coefficients were calculated between the use and duration of 
intake of every medication strategy separately (use vs. non-use) and the residual 
gain scores of disease activity at the 1, 3 and 5-year follow-ups.
Table 1 Means and SDs of Disease Activity Measures at the Time of Diagnosis and at 
the 1, 3, and 5-Year Follow-ups
ESR Joint score
M SD M SD
Diagnosis 29.4 22.3 97.5 100.7
1 -year follow-up 23.6 22.4 66.7 75.7
3-year follow-up 17.7 1 3.2 63.4 90.4
5-year follow-up 2 0 . 0 14.7 73.1 110.6
RESULTS
Change in Clinical Status during the Study Period
Disease activity scores at the time of diagnosis were in the normal range for 
representative samples with recent onset or longstanding RA (Huiskes et al., 
1990a; Meenan et al., 1991; Evers et al., 1998b). During the 5-year period, there 
was a significant mean decrease in disease activity (F(3,73) = 22.2, p  < 0.001 and 
F(3,73) = 10.6, p  < 0.01 for the ESR and joint score, respectively; see Table 1 for 
means and standard deviations during the study period). In addition, chronic- 
disease-related stressors of pain and functional disability (grip strength) 
significantly decreased within 5 years after diagnosis (F(3,75) = 9.6, p  < 0.01 for 
pain; F(3,75) = 14.5, p  < 0.001 for grip strength). Post-hoc tests indicated that this 
improvement in clinical status was most obvious in the first year of the disease: all 
indicators markedly decreased in this year (t = 3.06, p  < .01 for ESR; t = 3.25, p  < 
0.01 for the joint score; t = 2.20, p  < 0.05 for pain; t = 4.29, p  < 0.001 for grip
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strength), possibly due to the beneficial effects of medication (van Jaarsveld et al., 
2000; van Everdingen et al., 2002). After the first year of the disease, clinical 
status remained relatively stable, as indicated by nonsignificant posthoc tests 
between 1 and 3 and between 3 and 5 years, with one exception: an indicator of 
disease activity, ESR, significantly decreased further between the 1 and 3-year 
follow-ups (t = 3.11, p  < 0.01).
Correlates o f Disease Activity at the Time o f Diagnosis
Pearson correlation coefficients showed that the composite disease activity 
score was significantly related to higher levels of functional disability, pain, and 
disease impact on daily life at the time of diagnosis (r  = 0.46, p  < 0.001; r  = 0.43, 
p  < 0.001; r  = 0.30, p  < 0.01, respectively). In contrast, nonsignificant relationships 
were found between disease activity and presence of the rheumatoid factor, major 
life events, personality dimensions of neuroticism and extraversion, coping and 
social support at the time of entering the study.
Table 2 Correlations between Rheumatoid Factor and Stress-Vulnerability Factors at the 
Time of Diagnosis and Changes in Disease Activity after 1, 3, and 5 Years a
Change
1 year
in disease activity 
3 years 5 years
Rheumatoid factor .25* .23* . 2 2
Personality characteristics
Neuroticism .08 . 1 2 . 1 2
Extraversion -.15 -.19 -.03
Stressors
Physical stressors
Functional disability .14 .14 .06
Pain .08 .04 - . 0 2
Psychological stressors
Disease impact on daily life . 0 0 -.13 -.19
Major life events -.14 -.07 -.17
Coping
Active problem solving . 0 2 -.08 -.03
Passive avoidance .13 .33** .28*
Social support
Social network . 0 2 -.26* - . 1 1
Perceived support .07 -.24* - . 1 1
a A positive correlation indicates that a higher level of the stress-vulnerability factor is related to an 
increase in disease activity (residual gain scores).
* p  < 0.05 ** p  < 0.01
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Table 3 Multiple Regression Analyses Predicting Disease Activity at the 3 and 5-Year 
Follow-ups from Predictors at the Time of Diagnosis a
Disease activity Disease activity
after 3 yrs. after 5 yrs.
P A R2 P A R2
Disease activity .35** .13** .27* .09**
Rheumatoid factor .13 .05* .15 .04
Coping .07* .05*
Passive avoidance .30** .25*
Social support .09* . 0 2
Social network -.23* - . 1 1
Perceived support -.14 -.06
Total A R2 3 4 *** .2 0 ***
a Selection criterion for predictor variables was a significant correlation with changes in disease 
activity at least at a single follow-up assessment (see Table 2).
* p  < 0.05 ** p  < 0.01 *** p  < 0.001.
Predictors for Disease Activity at the 1, 3 and 5-Year Follow-ups
Correlation coefficients between the stress-vulnerability factors at the time of 
diagnosis and disease activity change scores at the follow-up assessments are 
presented in Table 2. At the 1-year follow-up, only the presence of the rheumatoid 
factor was related to an increase in disease activity, while stressors and 
vulnerability factors were all unrelated to changes in disease activity. At the 3 and 
5 -year follow-ups, significant correlations were found between coping and social 
support measures and changes in disease activity. The passive coping strategy of 
avoidance was significantly related to an increase in disease activity at the 3 and 5- 
year follow-ups. In addition, both social support measures (social network and 
perceived support) were inversely related to an increase in disease activity at the 3- 
year follow-up. No significant correlations were revealed between disease activity 
at follow-up assessments and other stress-vulnerability factors (personality 
dimensions, stressors and active coping) (see Table 2). In addition, demographic 
variables (gender, age, educational level) and the use or the duration of intake of 
the different medication strategies (NSAID alone, NSAID in combination with 
methotrexate, intramuscular gold, hydroxychloroquine, or prednisone) were not 
significantly related to changes in disease activity at the 1, 3 and 5-year follow-ups 
(data not shown).
Sequential regression analyses were performed to study the relative 
contribution of stress-vulnerability factors on changes in disease activity. Disease 
activity scores at the 1, 3 and 5-year follow-ups were used as dependent variables.
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In the first step, disease activity at first assessment was entered, followed by the 
predictor variables that were significantly related to changes in disease activity at 
least at a single follow-up assessment point: presence of the rheumatoid factor, the 
passive coping strategy of avoidance and both social support indicators. In line 
with the results of the correlational analyses presented in Table 2, predictor 
variables of coping and social support did not significantly contribute to disease 
activity at the 1-year follow-up (data not shown). At the 3 and 5-year follow-ups, 
passive avoidance coping predicted a significant proportion of 7 % and 5 % of the 
variance in disease activity, respectively, after controlling for disease activity and 
the presence of the rheumatoid factor at the time of entering the study (see Table 
3). Social support measures added 9% to disease activity variance at the 3-year 
follow-up, but failed to significantly predict disease activity at the 5-year follow- 
up. Beta coefficients for the final regression model showed that more avoidance 
coping predicted a more unfavorable course of disease at the 3 and 5-year follow- 
ups (t = 2.99, p  < 0.01 and t = 2.21, p  < 0.05, respectively), and a less extended 
social network predicted a more unfavorable disease course at the 3-year follow-up 
(t = -2.19, p  < 0.05). Figures 1 and 2 illustrate the main findings, presenting the 
mean course of disease activity during the study period for patients with high vs. 
low levels of avoidance coping and social support (median split).
Mediator analyses overall indicated nonsignificant effects, failing to support a 
possible mediating function of stressors, coping and social support for the 
relationship between personality characteristics and changes in disease activity, of 
coping and social support for the relationship between stressors and changes in 
disease activity, of social support for the relationship between coping and change 
in disease activity as well as of stressors, coping and social support for the 
relationship between demographic variables and changes in disease activity at all 
assessment points (MacKinnon & Dwyer, 1993). In addition, moderator analyses 
of stressors on vulnerability factors, of the rheumatoid factor on all stress- 
vulnerability factors and of demographic variables on all stress-vulnerability 
factors showed that none of these interaction terms was significantly related to 
changes in disease activity at the 1, 3 or 5-year follow-ups, failing to support any 
moderating function for these variables on the course of disease activity.
DISCUSSION
The present study has examined the potential of stressors and vulnerability 
factors for predicting long-term disease activity in early RA. Contrary to 
expectations, none of the psychosocial factors assessed at diagnosis predicted 
short-term outcomes for disease activity after one year. This may be due to the fact 
that the newly prescribed medication at diagnosis seemed to be largely effective in
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Time since diagnosis (yrs.)
Figure 1 Mean course of disease activity for five years after diagnosis for patients with 
low versus high levels of avoidance coping at time of diagnosis (median split)
reducing disease activity, as indicated by the mean decrease in disease activity in 
the first year and as proved in previous trials of second-line anti-rheumatic 
medication (Felson et al., 1990; van Jaarsveld et al., 2000; van Everdingen et al.,
2 0 0 2 ), and these generally beneficial medication effects may have overshadowed 
the effects of the stress-vulnerability factors on short term changes in disease 
activity after one year. However, the vulnerability factors of coping and social 
support were related to the long-term course of disease activity after 3 and 5 years. 
Specifically, greater use of passive avoidance coping was a prognostic marker for a 
more unfavorable course of disease activity after 3 and 5 years. In addition, a less 
extended social network was predictive for a more unfavorable course of disease 
activity after three years, suggesting overall that psychosocial factors can affect 
long-term RA disease activity, regardless of the influence of biomedical factors or 
use of medication.
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Figure 2 Mean course of disease activity for five years after diagnosis for patients with 
low versus high levels of social support at time of diagnosis (median split of 
composite score)
The relationships found between passive avoidance coping and the long-term 
course of disease activity after 3 and 5 years are in line with previous findings in 
RA patients and the general population. Passive avoidance coping has repeatedly 
been found to prospectively predict self-reported psychological and physical 
outcomes in RA patients (Brown & Nicassio, 1987; Evers et al., 1998a; Scharloo et 
al., 1999). In addition, avoidance coping has previously been reported to predict an 
exacerbated, long-term course of clinically assessed disease activity in RA patients 
(McFarlane et al., 1987), supporting the present finding that a general tendency to 
avoid and acquiesce to everyday problems could unfavorably affect disease activity 
in the long-term. The detrimental long-term effects are also in line with research in 
the general population, showing that avoidance can have beneficial effects on 
short-term outcomes but works unfavorably on various psychological and 
physiological outcomes in the long-term (Mullen & Suls, 1982; Suls & Fletcher,
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1985). Independently of coping, social support predicted changes in disease 
activity at the 3-year follow-up. Specifically, a less extended social network was 
predictive for increased disease activity at the 3-year follow-up, but not at the 5- 
year follow-up. Although the relationship between social support and the course of 
disease activity was found at only one assessment point, the results are in line with 
general findings that social support indicators favorably affect long-term physical 
health outcomes in both chronically ill and healthy populations (Broadhead et al., 
1983; Kaplan & Toshima, 1990; Uchino et al., 1996). In addition, there is some 
evidence that social factors are particularly relevant to RA disease activity, 
possibly due to the multiple consequences of RA on social relationships, such as 
increased dependency on others and decreased participation in social activities 
(Fex et al., 1998; van Jaarsveld et al., 1998; Penninx et al., 1999). For example, 
interpersonal stress factors have previously been reported to be related to disease 
fluctuations in RA patients (Potter & Zautra, 1997; Zautra et al., 1997, 1998), and 
the quality of spousal support has been shown to buffer short-term fluctuations of 
immunological parameters in periods of interpersonal stress (Zautra et al., 1998).
Previous studies in RA patients and the general population provide preliminary 
support for possible pathways linking avoidance coping and social support to 
increased disease activity in the long term. Passive avoidance coping has been 
shown to be related to specific neuroendocrine and immune responses (Steptoe, 
1991b; Dantzer, 1993), and it might, for instance, affect RA inflammation because 
it changes cellular and humoral immune responses. Evidence has also been 
reported in general and chronically ill populations of direct and buffering 
beneficial effects of social support on immunological parameters, such as more 
proliferative T cells or natural killer cells (Broadhead et al., 1983; Uchino et al., 
1996). One RA study supplied preliminary support for possible immunological 
pathways linking social support to disease activity, e.g. as a buffering factor for 
chronic interpersonal stress on T-cell activity (Zautra et al., 1998). Besides 
physiological pathways, cognitive-behavioral processes have been assumed to be 
crucial to explaining the relationship between coping and social support and the 
long-term course of disease activity (Broadhead et al., 1983; Steptoe, 1991a; Wills 
& Fegan, 2001). For example, passive avoidance coping and less social support 
have been shown to be related to cognitions of greater disease-related helplessness, 
less acceptance and less coping efficacy, which in turn have been demonstrated to 
concurrently or prospectively predict clinical indicators of disease activity or 
immunological parameters in RA patients (Zautra et al., 1989, 1994; Parker et al., 
1991; Evers et al., 2001a). In addition, behavioral pathways may be responsible for 
increased disease activity, since passive avoidance coping has been shown to be 
related to less favorable health behavior, such as reduced adherence to medical 
recommendations (Sherbourne et al., 1992), while higher levels of support have 
been shown to be related to less maladaptive disease-related coping in RA (Manne
& Zautra, 1989). Other cognitive-behavioral processes, such as paying less
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attention to physical signals and consequently displaying less health-promoting 
behavior, may likewise be prominent in patients with high avoidance coping and 
less social support, and may figure as additional mediators in relationship to 
disease activity (Steptoe, 1991a; Wills & Fegan, 2001).
In contrast to the results of coping and social support, other stress-vulnerability 
factors of stressors, such as chronic, disease-related stressors, major life events and 
the personality characteristics of neuroticism and extraversion, failed to 
demonstrate any direct, mediating or moderating effects on the course of disease 
activity over time. Nonsignificant results between the personality characteristics of 
neuroticism and extraversion and the course of disease activity seem to support 
previous findings that patients scoring particularly high on neuroticism tend to 
report higher levels of self-reported psychological and physical symptoms, without 
suffering from worse clinical outcomes (Costa & McCae, 1987; Watson & 
Pennebaker, 1989; Affleck et al., 1997). With regard to stressors, however, a 
previous study have provided preliminary evidence of relationships between major 
life events and the short-term course of disease activity (Potter & Zautra, 1997). 
One reason for the nonsignificant relationship between major life events and the 
long-term course of disease activity in our study could be that major events affect 
more short-term fluctuations of disease activity than coping and social support, and 
more statistical power may be needed to detect the long-term consequences. The 
role of chronic, minor and interpersonal stressors that have previously been shown 
to be concurrently or prospectively related to the course of disease activity (Affleck 
et al., 1997; Potter & Zautra, 1997; Zautra et al., 1997), may be an additional factor 
in how stress might affect RA disease activity in the long-term, directly or as a 
modifying factor for coping and social support on long-term disease activity 
(Zautra et al., 1998). Finally, there was no evidence suggesting that the relationship 
between psychosocial factors and disease activity was more evident in subgroups 
of patients with a negative rheumatoid factor, for whom RA is possibly less 
genetically determined.
Our prospective study offers several advantages for assessing the relationship 
between various stressors and vulnerability factors and clinical indicators of 
disease activity across several points in time in a sample of recently diagnosed 
patients, while simultaneously controlling for confounding biomedical factors. 
However, several of the study’s limitations should be recognized. The study might 
contain some selection bias, as all patients participated in medical trials and 
dropouts obtained somewhat higher scores on neuroticism than participants. 
Posthoc analyses indicated that neuroticism was significantly related to more 
passive avoidance coping (r = 0.35, p  < 0.01) at study entry, but not to indicators 
of social support. Consequently, the generalizability of the findings for passive 
avoidance may be limited to patients characterized by only moderate levels of 
passive avoidance coping. However, this finding could also have led to an 
underestimation of the effects of passive avoidance on disease activity. Prospective
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research is inherently threatened by aspects of internal validity, and unmeasured 
biomedical or psychosocial factors may account for effects on disease activity. For 
example, the lack of short-term effects for psychosocial variables at the 1 -year 
follow-up may be due to the specific stress situation patients are confronted with at 
the time of diagnosis. In addition, other stressors and vulnerability factors not 
measured in our study may account for changes in long-term disease activity, e.g. 
interpersonal stressors that have previously been shown to be related to the course 
of disease activity (Affleck et al., 1997; Potter & Zautra, 1997; Zautra et al., 1997,
1998). Moreover, although the sample was comparable to other samples with 
recent and longstanding RA and the mean decrease in disease activity is in 
accordance with what is usually found in recent and longstanding RA when 
applying second-line anti-rheumatic medication, the predictive capacity of coping 
and social support on long-term disease activity may be limited to a reduction in 
disease activity at an early stage of the disease. Finally, the relatively general 
assessment of coping and social support and the lack of assessment of possible 
mediators limit the opportunity to draw conclusions about the specific pathways 
through which coping and social support may affect disease activity.
Regardless of these limitations, our findings suggest that coping and social 
support affect long-term disease activity in early RA. Previous studies have shown 
that psychosocial treatments geared to modifying cognitive, behavioral or social 
stress responses can beneficially affect markers of disease activity in RA patients 
(Bradley et al., 1987; Radojevic et al., 1992), suggesting that an unfavorable course 
of disease may be modified by psychosocial factors. Our results further suggest 
that psychosocial vulnerability factors that predict a worse long-term course of 
disease are already established at the time of diagnosis, and early treatment for 
patients at risk may have a lasting impact on disease activity (Smith et al., 1997). 
With increasing knowledge of underlying mechanisms, psychosocial screening at 
diagnosis followed by psychosocial interventions for patients at risk may be used 
as an adjunctive strategy to standard biomedical RA treatment.
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ABSTRACT
In order to examine the influence of active and passive pain coping strategies and 
social support characteristics on the change in functional status in the first stage of 
the disease in rheumatoid arthritis patients, self-report data and clinical and 
laboratory measures were collected of 91 patients (70% female, mean age 57 
years) shortly after diagnosis and one year later. Multiple regression analyses 
indicated that, after taking the influence of demographic variables, disease activity 
and pain into account, a decrease in functional status (mobility, self-care, grip 
strength) after one year could be predicted by an initially more frequent use of the 
passive pain coping strategies of worrying and resting. A decrease in mobility 
could be additionally predicted by an initially smaller social network. Results 
indicate the impact of passive pain coping strategies and social network 
characteristics for the prognosis of functional outcome in the first stage of the 
disease and suggest the early manifestation of avoidance mechanisms, including 
behavioral, cognitive-emotional and social components, in face of a chronic 
stressor.
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INTRODUCTION
Functional disability is a major concern in rheumatoid arthritis (RA), a chronic, 
unpredictive disease, which affects about 1% of the western population. Already in 
the first year of the disease, functional disability is established (Meenan et al.,
1991), and it progressively deteriorates with an ongoing disease duration (Sherrer 
et al., 1986; Wolfe & Cathey, 1991). In addition, functional disability in the first 
year of the disease has been shown to be a prognostic marker for work loss at 2 - 
year follow-up (Eberhardt et al., 1993), for a worse prognosis at 10-year follow-up 
(Sherrer et al., 1986) and for future mortality at 15-year and 20-year follow-up 
(Rasker & Cosh, 1989; Corbett et al., 1993). As causal treatment of the disease is 
not available, therapy is primarily focused on the alleviation of the symptoms and 
the maintenance of functional status. Identifying mechanisms that affect the 
process of ongoing disability in an early state of the disease might be therefore 
highly desirable to predict and possibly prevent an unfavorable long-term outcome 
in RA patients.
In accordance to the WHO (1980), disability can be defined as difficulties in 
performing activities of daily living resulting from the disease which leads to 
impairment (pain, stiffness, restricted joint movement) and hence to disability. 
However, disease factors modestly predict future disability in early and 
longstanding RA (e.g., Wolfe & Cathey, 1991; van der Heide et al., 1995), which 
raises the question about the possible influence of psychosocial factors. The 
concept of avoidance offers a theoretical framework through which psychosocial 
factors affect the functional outcome (e.g. Philips, 1987; Dekker et al., 1992). The 
avoidance of activity is a natural and adaptive reaction to the sudden experience of 
pain (Wall, 1979), which becomes maladaptive when it is continuously used 
(Mullen & Suls, 1982; Suls & Fletcher, 1985; Holmes & Stevenson, 1990). Due to 
expectancies of increased pain (McCracken et al., 1993; Crombez et al., 1996), 
attention to symptoms (Crombez et al., 1995), and fear of pain or movement 
(Crombez et al., 1995; Vlaeyen et al., 1995) avoidance behavior is reinforced, 
consisting of restriction activities and resting. A cognitive-emotional pattern of 
negative outcome expectancies and worrying is expected to promote the avoidance 
behavior and vice versa. A lack of support by the environment which is supposed 
to decrease the ability of an individual to cope with the stress of a chronic disease, 
may additionally enhance the avoidant behavior (Cohen & Wills, 1985; Manne & 
Zautra, 1989). Avoidance behavior may hence induce harmful long-term effects on 
physical functioning by limiting joint movement and inducing muscle weakness 
which leads to functional disability (Kottke, 1966; Dekker et al., 1992, 1993b). 
Research on psychosocial factors in general supports this theoretical framework, 
and there is reasonable evidence that the way of coping with pain and the receipt of 
social support affect the functional status of RA patients, at least in relatively
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established and longstanding RA and other chronic pain populations, such as 
patients with osteoarthritis or chronic pain patients.
With regard to pain coping strategies, it can be concluded that specifically the 
absence of avoidance-oriented, passive coping strategies is related to a better 
functional status over time, while an adaptive function of active strategies has been 
less frequently demonstrated. Apart from suggestive evidence of studies measuring 
these relationships at one point in time (see for a review, Jensen et al., 1991b; 
Manne & Zautra, 1992), longitudinal studies in RA patients have yielded some 
promising results. For example, Brown and Nicassio (1987) have demonstrated 
that the greater use of passive pain coping strategies (tendency to depend on others, 
to engage in wishful thinking and to restrict one's functioning) predicted less 
physical activity and activities of daily living six month later, while a more 
frequent use of active pain coping strategies (attempts to distract oneself from the 
pain and to function in spite of the pain) predicted higher physical activity at 6 - 
month follow-up. Keefe et al. (1989) found that a greater use of the strategy 
catastrophizing predicted worse functional disability six month later. Revenson and 
Felton (1989) have demonstrated that an increased use of wish-fulfilling fantasy 
was related to increased physical disability after six months. In other chronic pain 
conditions, namely, sickle cell disease, Gil et al. (1992) reported that negative 
thinking (e.g. catastrophizing) and passive adherence (e.g. resting) were associated 
with greater activity reductions during the subsequent nine months. In addition, 
increase in this passive coping strategy was related to further reductions in the 
activity level during painful episodes.
In literature on social support it is assumed that social resources affect the 
health status of patients by enhancing the ability of an individual to cope with the 
stress of a chronic disease. Especially the functional, qualitative aspects of social 
support, such as the perceived availability of support, have been assumed to be 
more important in patients with a chronic stressor than structural, quantitative 
characteristics of an individual's support system, such as the size of the social 
network (Cohen & Wills, 1985). Research indeed demonstrated a link between 
social influences and functional status. Several studies reported that married RA 
patients have less functional disability (Verbrugge et al., 1991) and less 
progression of functional disability over the disease course than never married, 
divorced or widowed patients (Leigh & Fries, 1992; Ward & Leigh, 1993). In line 
with Cohen and Wills (1985), research in RA patients and other chronic pain 
populations suggest that this link may be mainly due to the qualitative aspects of 
social support. While the size of the social network was not related to functional 
status (Brown et al., 1989b) or its change within one year (Smedstad et al., 1995) 
in RA patients, Brown et al. (1989b) reported that the quality of emotional support 
was negatively related to functional disability at three measurement points within 
one year. In addition, Weinberger et al. (1990) demonstrated in osteoarthritis 
patients that physical disability was negatively related to the perceived availability
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of (tangible) support. In chronic pain patients, Jamison and Virts (1990) found that 
patients who perceived a greater lack of support from their families had more 
activity limitations at 1 -year follow-up than patients who felt supported by their 
families.
The extent to which the contribution and the adaptiveness of these pain coping 
strategies and social support characteristics on functional status can be generalized 
with respect to the first stage of the disease is questionable, as patients have to cope 
with different stressors and physical mechanisms in early and longstanding RA. 
However, the kind of stressors and physical mechanisms may suggest that 
avoidance mechanisms are already established at an early stage of the disease. In 
contrast to later phases of the disease, when joint damage is at stake and disability 
increases more regularly and slowly, functional status in early RA is predominantly 
affected by acute phases of inflammatory activity (Guillemin et al., 1992; 
Eberhardt & Fex, 1995). In addition, shortly after diagnosis patients are rather 
inexperienced in dealing with the disease, have less knowledge about possible 
noxious long-term effects of coping strategies, and may also be overwhelmed by 
negative emotions due to the new confrontation with a chronic disease. These 
kinds of stressors and physical mechanisms probably promote the use of strategies 
which have benefits in the short-term. The short-term effectiveness may enforce 
avoidance mechanisms with deteriorating long-term effects on functional status. In 
the case of low levels of social support, patients may even rely more on avoidant 
patterns with additional maladaptive long-term effects on functional status.
In order to determine these possible effects of psychosocial predictors on 
change in functional status in the first stage of the disease, we examined the 
predictive value of active and passive pain coping strategies and social support 
characteristics on change in self-report and clinical measures of functional status in 
the first year after diagnosis in rheumatoid arthritis patients. In accordance to the 
theoretical approach and empirical evidence in longstanding RA, it was 
hypothesized that a deterioration in functional status after one year could be 
predicted from an initially more frequent use of passive pain coping strategies and 
initially lower levels of social support.
METHODS
Participants
The sample consisted of successive outpatients with recently diagnosed RA 
from five hospitals in the Utrecht area, the Netherlands. Patients were participating 
in a prospective study on the effects of different medication strategies (van der 
Heide et al., 1996). Inclusion criteria were a minimum age of 18 years, a disease 
duration of less than one year, and a diagnosis of RA assessed by a rheumatologist
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according to the 1987 American College of Rheuamtology (ACR) criteria (Arnett 
et al., 1988). Patients were informed by their rheumatologists about this study 
during the first routine visit in which ACR criteria were assessed. One-hundred 
patients agreed to participate and received a questionnaire during the second 
routine visit which was scheduled about three weeks later (range 0-12 weeks). This 
second visit was also the starting point for the second-line anti-rheumatic 
medication. Correctly completed questionnaires were returned by 95 patients. One 
year later, 91 patients completed the questionnaires again. None of the patients had 
a spontaneous remission of the disease. The sample was predominantly female 
(70%), married or living together with a partner (74%), with primary (34%) or 
secondary (53%) education. The mean age was 57 years (range 20-82 years). The 
medication of the patients was as follows: 31% patients were only on non-sterodial 
anti-inflammatory drugs (NSAID); the other were on NSAID in combination with 
methotrexate (25%), intramuscular gold (16%), hydroxychloroquine (14%), or 
prednisone (14%).
Measures
Functional status was assessed by three variables, including clinical and self­
report data. The clinical measurement was grip strength assessed by a Martin 
vigorimeter (mean of three measurements of each hand was calculated). Self­
reports of functional status were measured by the physical functioning scales of the 
Impact of Rheumatic diseases on General health and Lifestyle (IRGL; Huiskes et 
al., 1990a). The IRGL is partly derived from the Arthritis Impact Measurement 
Scales (AIMS; Meenan et al., 1980) and assesses the physical, psychological and 
social aspects of health status in patients with rheumatic diseases. The Mobility (7 
items) and Self-care ( 8  items) scales measure functional status in the past month, 
assessing the use of lower and upper extremities, respectively. Items of the IRGL 
scales are scored on a 4-point or 5-point Likert-scale. In previous research, 
reliability and validity of the IRGL scales were shown to be highly satisfactory 
(Huiskes et al., 1990a), and the physical functioning scales have been demonstrated 
to be highly comparable to the corresponding scales of the Dutch version of the 
AIMS2 (Evers et al., 1998b).
Disease activity was assessed through standardized clinical and laboratory 
measurements. Data were collected on erythrocyte sedimentation rate (ESR), an 
indicator of the inflammatory activity, and on joint score (number of swollen and 
painful joints; Thompson et al., 1987).
Pain in the last month was assessed by the Pain scale ( 6  items) of the IRGL 
asking about the severity and frequency of painful episodes and swollen joints and 
the duration of morning stiffness.
Social support in the past six months was measured by the social functioning 
scales of the IRGL, reflecting a quantitative and qualitative aspect of social 
support. The quantitative aspect was assessed by the size of the social network, that
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is the number of friends one associates with (including family members). The 
qualitative aspect was measured by the scale Perceived Support (5 items), asking 
about the perceived availability of emotional and instrumental support (availability 
to share sad and pleasant events, to get support in face of stress and pain, to get 
help for casual work).
Pain coping strategies were assessed by the Pain Coping Inventory (PCI; 
Kraaimaat & Schevikhoven, 1988; Kraaimaat & Huiskes, 1989; Kraaimaat et al., 
1997), measuring behavioral and cognitive strategies when dealing with pain. 
Patients are instructed to indicate the frequency with which they engaged in 
various kinds of behavior and thoughts in the face of pain on a 4-point scale 
ranging from 'rarely or never' (1) to 'very frequently' (4). Six independent pain 
coping strategies can be identified, representing an active or passive way of dealing 
with pain. Active pain coping strategies reflect cognitive and behavioral efforts to 
distract oneself from the pain (Distraction, 5 items; Pain Transformation, 4 items) 
and to function in spite of the pain (Reducing Demands, 3 items). Passive pain 
coping strategies reflect behavioral tendencies to restrict one's functioning 
(Resting, 5 items), to avoid environmental stimuli (Retreating, 7 items) and 
negative cognitions about the pain (Worrying, 9 items). An overall unweighted 
sumscore of the active and passive pain coping strategies can be calculated. 
Confirmatory construct and criterion validity of the scales and of the second-order 
structure with respect to active and passive pain coping strategies were supported 
in previous research on RA patients, patients with chronic headache and patients 
attending pain clinics (Kraaimaat et al., 1997). The following Cronbach’s alpha 
coefficients in RA patients were obtained: Pain Transformation, 0.75; Distraction, 
0.69; Reducing Demands, 0.73; Retreating, 0.69; Worrying, 0.79; and Resting, 
0.72.
Statistical Analyses
Due to skewed distributions of scores at ESR and joint score, square root 
transformations were applied. In order to examine the relative contribution of pain 
coping strategies and social support on change in functional status within one year, 
hierarchical multiple regression analysis was performed with all predictors which 
were significantly related to change in at least one of the measures of functional 
status (residual gain scores of mobility, self-care, grip strength). After taken into 
account the influence of the initial functional status (step 1 ), demographic variables 
(step 2) and disease activity (step 3) into account, pain coping strategies and social 
support were entered at steps 4 and 5. Bivariate associations between all variables 
were calculated with Pearson correlation coefficients. Differences between the 
means of the first and second assessment were tested with Student's t-test and 
Wilcoxon Signed Rank Test in the case of ESR and Thompson's joint score. All 
statistical analyses were carried out with the SPSS 6.1/Windows statistical package 
with a minimum of 8 8  patients sharing complete data sets.
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Table 1 Functional Status, Disease Activity, Pain, Pain Coping Strategies, and Social 






SD p -value a
Functional status
Mobility (7-28) 19.6 6 . 1 20.9 5.7 0.003
Self-care (8-32) 24.3 5.9 25.3 5.6 0 . 1 1 2
Grip strength (0-130kPa) 32.7 23.0 40.4 26.2 0 . 0 0 0
Disease activity
ESR (1-140 mm 1st hr) 30.9 23.3 23.7 22.4 0 . 0 0 0
Joint score (0-534) 96.9 95.9 6 6 . 0 77.4 0 . 0 0 0
Pain (6-25) 15.6 4.9 14.1 5.3 0.008
Pain coping
Active (3-12) b 7.1 1.4 6.7 1.5 0.019
Pain transformation (4-16) 9.2 2 . 6 8 . 8 2 . 8 0 . 1 2 2
Distraction (5-20) 12.5 3.1 11.7 3.3 0.029
Reducing demands (3-12) 6.7 1.9 6.5 1.9 0.341
Passive (3-12) b 6 . 1 1.5 5.6 1 . 6 0 . 0 0 2
Resting (5-20) 11.9 3.1 11.4 3.3 0.097
Worrying (9-36) 17.4 5.6 15.5 4.9 0 . 0 0 0
Retreating (7-28) 1 2 . 2 4.0 1 1 . 6 4.2 0.051
Social support
Social network (1-4) c 3.2 0 . 8 3.0 0.9 0.013
Perceived support (5-20) 16.6 3.6 16.4 3.6 0.568
a Two-tailed properties o f  t-test or W ilcoxon Signed Rank Test in the case o f ESR and jo in t score. 
b Unweighted sumscore.
c Categorized into norm classes (Huiskes et al., 1990a).
RESULTS
Change in Health Status, Pain coping and Social Support within the First Year 
After Diagnosis
The means and standard deviations of health status measures, pain coping 
strategies and social support characteristics of the patients shortly after diagnosis 
and one year later are presented in Table 1. As evident, the mean health status of 
patients improved within the first year after diagnosis, indicated by an increase in 
functional status (mobility and grip strength), a decrease in disease activity (ESR 
and joint score), and a decrease in pain. At the same time, the use of the total set of 
active and passive pain coping strategies was decreased within one year. More 
specifically, patients used the strategies of distraction and worrying, and tended to
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use the strategies of resting and retreating less frequently. With regard to social 
support, the size of the social network decreased within one year. Patients reported 
having less friends one year after diagnosis than shortly after diagnosis, while the 
perceived availability of support was more or less constant.
Table 2 Pearson Correlation Coefficients with Measures of Functional Status Shortly 
After Diagnosis
Mobility Self-care Grip strength
Demographic variables
Sex - . 1 2 **0.3-. **6.2
Age -.14 -.06 .06
Education .06 .03 . 0 0
Marital status .05 -.13 -.03
Disease activity
ESR - 40*** **8.2-. -.41***
Joint score -.28** -.28** -.36***
Pain *.2-. -.19 -.27**
Pain coping 
Active
Pain transformation .09 .07 .04
Distraction -.06 **9.2-. . 0 0
Reducing demands -.2 2 * -.07 - . 0 2
Passive
Resting -.46*** **4.3-. -.38***
Worrying - 4 7 *** -.32** -.17
Retreating - 4 3 *** **3.3-. -.08
Social support
Social network .08 .16 .09
Perceived support . 1 2 .17 . 1 0
* p < 0.05 ** p < 0.01 *** p < 0.001.
Correlates o f Functional Status Shortly After Diagnosis and 1 Year Later
The relationship between functional status (mobility, self-care and grip 
strength) and demographic variables, disease activity, pain, pain coping strategies 
and social support shortly after diagnosis are presented in Table 2. Lowered 
functional status was significantly related to the female sex and to a higher level of 
disease activity and pain. In addition, the frequent use of passive pain coping 
strategies was strongly related to the self-report measures and to a lesser extent to
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the clinical measure of functional status, indicating poorer functional status when 
using the strategies of retreating, worrying and resting more frequently. The use of 
active pain coping strategies was hardly associated with functional status, and the 
significant associations that were revealed, indicated a negative relationship with 
functional status: the use of distraction was related to lower levels of self-care, and 
the strategy of reducing demands was associated with lower levels of mobility. For 
measures of social support, no significant relationship could be revealed with 
functional status shortly after diagnosis.
One year after the diagnosis, the strength of the cross-sectional relationships 
between functional status and the predictors was somewhat different (data not 
shown). Consistent for all measures of functional status, the relationship with the 
joint score, an indicator of the disease activity, was hardly significant one year 
after diagnosis (only for grip strength, r  = 0.22, p  < 0.05), while the relationships 
with pain (mobility: r  = -0.43; self-care: r  = -0.41; grip strength: r  = -0.43) and 
with the passive pain coping strategies (mobility: between 0.47 and 0.56; self-care: 
between 0.44 and 0.45; grip strength: between 0.22 and 0.44) were stronger than 
shortly after diagnosis. In addition, self-reports of functional status were also 
significantly related to the qualitative aspect of social support one year after 
diagnosis (mobility r  = 0.27; p  < 0.01 and self-care r  = 0.26, p  < 0.05), indicating a 
better functional status for patients who perceived a higher availability of support. 
All in all, while shortly after diagnosis functional disability scores were more 
strongly related to underlying disease processes, their relationship with pain, with 
the use of passive pain coping strategies and with the qualitative aspect of social 
support increased within one year.
Predictors o f Change in Functional Status in the First Year After Diagnosis
In order to evaluate the extent to which the independent variables shortly after 
diagnosis predicted the individual patient's course of functional status within one 
year, a hierarchical multiple regression analysis was conducted with the functional 
status measures one year after diagnosis as dependent variables, entering functional 
status measures shortly after diagnosis at the first step. Only those variables were 
entered in the regression model which were significantly related to at least one of 
the outcome measures. For this purpose, residual gain scores of mobility, self-care 
and grip strength were calculated. Of the set of predictors, sex, ESR, the passive 
pain coping strategies of resting and worrying and the social network were 
significantly related to change in at least one of the measures of functional status 
(see Table 3). Hierarchical regression analyses revealed a strong autoregressive 
effect for the functional status measures over time, accounting for 53% of the 
variance in mobility (Fchange = 101.78, p  < 0 .0 0 1 ), for 29% in self-care (Fchange 
= 36.62, p  < 0 .0 0 1 ), and for 55% in grip strength (Fchange = 114.56, p  < 0 .0 0 1 ), 
indicating that functional status just after the RA diagnosis proved to be the best 
predictor of functional status one year later. At step 2, sex (being female)
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contributed 2 % to a decrease in grip strength (Fchange = 4.96, p  < 0.05), and at 
step 3, an inital higher level of ESR accounted for a decrease in self-care of 3% 
(Fchange = 4.64, p  < 0.05). At step 4, the passive pain coping strategies resting and 
worrying explained 3% of the variance to change in all measures of functional 
status (mobility: Fchange = 3.31, p  < 0.05; self-care: Fchange = 3.17, p  < 0.05, 
grip strength: Fchange = 3.99, p  < 0.05), indicating a deterioration in self-reported 
and clinical functional status after one year when initially using the passive pain 
coping strategies of resting and worrying more frequently. Finally, at step 5, the 
size of the social network made an additional significant contribution of 3% to 
change in mobility (Fchange = 7.85, p  < 0.05), indicating a further decrease in 
mobility in the event of an initially smaller social network. When the size of the 
social network was entered before the pain coping strategies, the results were the 
same as in the reversed order, suggesting that the use of pain coping strategies and 
the size of the social network independently affect the change in functional status.
All in all, a decrease in all measures of functional status within the first year 
after diagnosis could be predicted by the initially more frequent use of the passive 
pain coping strategies of resting and worrying. A decrease in mobility could be 
additionally predicted by an initially smaller social network, independent of what 
could be explained by the initial functional status, demographic variables or by the 
disease itself.
DISCUSSION
The present study provides information about psychosocial factors to identify those 
individuals likely to deteriorate in functional status in an early stage of the disease. 
Results suggest that behavioral and cognitive pain coping strategies and social 
resources affect the clinical and self-reported functional status of RA patients in the 
first year of the disease. Recently diagnosed RA patients who use passive pain 
coping strategies more frequently and who have a smaller social network, are at 
risk for loss of functional status within one year.
Within the set of the passive pain coping strategies, two strategies affect the 
development of the functional status, namely resting and worrying, representing 
behavioral and cognitive-emotional coping patterns in the face of pain. The 
maladaptive long-term effects of resting have been frequently suggested (e.g. 
Kottke, 1966; Brown & Nicassio., 1987; Dekker et al., 1992), and cross-sectional 
relationships between resting and higher levels of functional disability have been 
demonstrated in patients with longstanding RA (Kraaimaat & Huiskes; 1989) and 
other chronic pain patients (Jensen et al., 1991a; Hopman-Rock et al., 1998). Our 
results extend previous work by providing evidence that resting has indeed 
deleterious long-term effects on functional status over time, probably mediated by








Mobility Q 73*** 0.62*** 0.53***
Self-care Q J4*** q 37*** q 29***
Grip strength q 7^*** 0.63*** Q 22***
Demographic variables
Age -0.14 -0.05 0.03
Sex -0.06 0.05 0.00 -0.12 -0.06 0.00 -0.23* -0.14 0.02*
Education 0.06 0.01 -0.05
Marital status 0.08 0.13 0.03
Disease activity Tl
ESR -0.16 -0.12 0.00 -0.24* -0.17 0.03* -0.13 -0.06 0.00
Joint score -0.04 -0.12 -0.10
Pain Tl 0.05 -0.07 -0.07
Pain-coping Tl
Active
Pain transformation 0.00 0.00 0.01
Distraction 0.02 0.04 0.07
Reducing Demands -0.03 -0.12 -0.06
Passive 0.03* 0.03* 0.03*
Resting -0.23* -0.22* -0.24* -0.10 -0.25* -0.10
Worrying -0.04 0.10 -0.26* -0.15 -0.29** -0.13
Retreating -0.12 -0.18 -0.15
Social Support Tl
Social network 0.26* 0.20** 0.03** 0.16 0.14 0.01 0.11 0.02 0.00
Perceived support 0.02 0.11 0.02
Total adj. AR1 q 59*** 0.36*** 0.60***
3 Selection criterion was the significant association with change in one o f the measures o f  fucntional status (residual gain scores). 
6 Correlations with residual gain scores o f  functional status (except in the case o f  functional status measures T l).
* p  < 0.05 * * p < 0 .0 1  * * * p < 0 .0 0 1 .
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physiological mechanisms, such as ensuing disuse of muscles and muscle 
weakness (Dekker et al., 1992, 1993b). These results are especially important, 
since resting is the strategy most frequently used in RA patients, outpatients of a 
pain clinic (Kraaimaat et al., 1997), and elderly people with chronic pain 
(Hopman-Rock et al., 1987), and is also evaluated as most effective in reducing 
pain (Kraaimaat & Huiskes, 1989). Although resting might be effective in the short 
run and be indicated in periods of disease flare-ups and active phases of the 
disease, its frequent use when the disease is declining probably causes harmful 
effects on functional disability (Kottke, 1966; Dekker et al., 1992, 1993b).
Apart from resting, the frequent use of worrying predicted a deterioration in 
functional status within one year. A relationship between similar constructs and 
functional disability has been frequently reported in RA patients, e.g. as coping 
factors which include catastrophizing (Hagglund et al., 1989; Keefe et al., 1989; 
Beckham et al, 1991, 1994) or wishful thinking (Parker et al., 1989; Revenson & 
Felton, 1989). The link with avoidance behavior (such as resting) may indicate that 
worrying is a strategy to remain vigilant and to direct attention to potential painful 
stimuli. Although this signal function may be adaptive for the experience of acute 
pain, the frequent use of worrying in the face of chronic pain, possibly linked to 
anticipatory anxiety processes such as fear of pain and an exaggerated attention to 
symptoms, has a negative effect on long-term functional status in early (this study) 
and more established RA (Keefe et al., 1989).
Our data give further support to the maladaptive long-term effects of passive 
pain coping strategies, and illustrate the early manifestation of avoidance behavior 
in the face of a chronic disease. In addition, the results permit the identification of 
specific kinds of avoidance behavior, namely the restriction of activities and 
worrying, that have deleterious long-term effects on functional status in early RA, 
while the passive pain coping strategy of retreating, measuring the avoidance of 
stimulation, did not affect functional status within one year, and seems to be less 
maladaptive for the development of functional disability in early RA. Although the 
explained variance of the predictors was rather small, results suggest that the link 
between avoidance behavior and functional status increases within the first years of 
the disease. While shortly after diagnosis functional disability was more strongly 
related to underlying disease processes, one year later its relationship with pain and 
the use of passive pain coping strategies increased. Such an increased relationship 
between avoidance behavior and pain with ongoing disease duration has also been 
reported in other chronic pain conditions (Philips & Jahanshahi, 1985), possibly 
suggesting that the contribution of avoidance behavior to functional status is a 
function of disease duration and that it becomes stronger within the course of the 
disease.
In contrast to the passive pain coping strategies, the active strategies were 
hardly related to functional status, and also did not predict its long-term change 
within one year, as has frequently been reported in longstanding RA and other
66 - Chapter 3.1.2.1
chronic pain conditions (see Jensen et al., 1991b). It is supposed that successful 
coping is not the consequence of using specific adaptive strategies, but an absence 
of the continuous use of maladaptive strategies, such as abstaining from, 
interrupting, and preventing avoidance behavior (e.g., Rosenstiel & Keefe, 1983; 
Turk & Rudy, 1992). Considering the fact that the functional status in early RA 
depends on inflammatory activity, and as a result patients have to cope with strong 
short-term fluctuations, the frequent attempts to control the pain or distract oneself 
from the pain may indeed not be beneficial when a continuous stressor is highly 
uncontrollable (Rosenstiel & Keefe, 1983). Adaptive coping in early RA may be 
reflected by flexible shifts between active and passive coping, adjusted to the 
demands of the stressor. Direct beneficial effects of the use of active strategies may 
occur in patients with relatively mild disease processes (Jensen & Karoly, 1991), 
be visible over the longer term (Mulen & Suls, 1982; Suls & Fletcher, 1985), and 
also be reflected in other outcome variables, such as a prolonged capacity to work, 
more independence in daily life and relatively less use of medication and health 
care facilities.
Of the measures of social support, the size of the social network shortly after 
diagnosis affected functional status within one year, indicating that patients with a 
smaller social network shortly after diagnosis are at risk of a decline in mobility in 
the first year of the disease. In line with the passive pain coping strategies, a 
smaller social network probably indicates an additional tendency to engage in 
avoidance behavior by limited social activities. Patients who have a more limited 
number of social network members are probably less sociable, make fewer visits 
and engage less in social activities which might induce harmful effects on their 
long-term mobility. In contrast to resting, these limited social activities only affect 
mobility of the patients and not self-care and grip strength (the use of upper 
extremities), which also explains previous nonsignificant findings of studies where 
composite disability scores were used (Smedstad et al., 1995). Results then suggest 
that, apart from the behavioral component of resting and the cognitive-emotional 
component of worrying, avoidance mechanisms in an early stage of the disease 
include an additional social component of limited social contacts which affect 
long-term disability in RA patients. In contrast to the quantitative aspects, 
qualitative aspects of social support, such as the perceived availability of support, 
may be less indicative of sociability, but rather enhance the ability of an individual 
to cope with the stress of a chronic disease, reinforce the use of more effective 
coping strategies (Manne & Zautra, 1989) and decrease the individual’s tendency 
of his/her avoidance behavior and hence induce long-term effects on functional 
status. In our sample, the qualitative aspect of social support was associated in the 
cross-sectional analyses with self-report measures of functional status one year 
after diagnosis, but not shortly after diagnosis. A relationship between the 
qualitative aspects of social support and functional status has also been 
demonstrated in patients with more established arthritis (Brown et al., 1989b;
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Weinberger et al., 1990), suggesting that qualitative aspects of social support 
become more important for the development of functional status in a later phase of 
the disease.
Our results have several implications for clinical practice. The identification of 
psychosocial factors which affect the long-term outcome in an early stage of the 
disease support the implementation of multidisciplinary treatment in an early stage 
of the disease, consisting of educational programs to inform patients early in the 
disease about the possible maladaptive effects of avoidance behavior, and of 
cognitive-restructuring and coping-skill training to teach individuals how they can 
most effectively stop and interrupt avoidance behavior when the disease is 
declining and develop compensatory strategies for engaging in activities. It also 
supports network- and activity-enhancing treatments, for example offering phone 
consultations, support groups, social activities or exercise therapy. Although most 
of these treatments have been applied to patients with more established RA, and 
beneficial effects on functional status have been demonstrated (e.g., Weinberger et 
al., 1986; Minor et al., 1989; Keefe et al., 1990a,b; Radojevic et al., 1992), their 
effects are rather small and most interventions failed to demonstrate a lasting effect 
at later follow-up (see for reviews, Dekker et al., 1993a; Keefe & Van Horn, 1993; 
Hawley, 1995; Taal et al., 1997). Establishing this treatment in early RA may be 
more effective. Considering that the coping repertoire is probably less established, 
it is easier to modify maladaptive coping patterns, learn an adaptive way to handle 
the consequences of the disease, and integrate this adaptive pattern in a life style. If 
the early phase of the disease is the critical one, when patients develop attitudes 
and patterns of long-term behavior and enduring patterns of adjustment, the 
modification of coping behavior will affect the patients' long-term outcome and 
treatment will maintain more lasting effects on functioning.
The present study offers empirical evidence for the implementation of 
psychological interventions in an early stage of the disease to possibly prevent an 
unfavorable long-term outcome in rheumatoid arthritis patients. Shortly after 
diagnosis, it was possible to identify psychosocial risk factors, such as the frequent 
use of passive pain coping strategies and a smaller social network, for a 
deterioration in functional status within one year, probably indicating the early 
manifestation of avoidance mechanisms in the face of a chronic stressor.
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ABSTRACT
Pain-related avoidance factors and social resources, as assessed by pain coping and 
social support, are supposed to have lasting effects on functional disability and 
pain in chronic pain disorders. As a follow-up to a prospective study demonstrating 
short-term effects after one year (Evers et al., 1998a), the role of pain coping and 
social support at the time of diagnosis was investigated in relationship to the long­
term course of functional disability and pain after 3 and 5 years in 78 patients with 
rheumatoid arthritis (RA), taking into account personality characteristics of 
neuroticism and extraversion, clinical status and use of medication. In line with 
findings at the 1 -year follow-up, results showed that more passive pain coping 
predicted functional disability at the 3-year, but not the 5-year follow-up. In 
addition, low levels of social support at the time of diagnosis consistently predicted 
both functional disability and pain at the 3 and 5-year follow-ups. Results indicate 
that pain coping and social support, assessed very early in the disease process, can 
affect long-term functional disability and pain in RA, and suggest that early 
interventions focusing on pain-related avoidance factors and social resources for 
patients at risk may beneficially influence long-term outcomes in RA.
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INTRODUCTION
Rheumatoid arthritis (RA), a chronic inflammatory disease affecting the joints, is 
one of the most costly musculoskeletal disorders, primarily due to the impairment 
of daily activities and loss of work as a consequence of functional disability and 
pain (Allaire et al., 1994; Yelin & Callahan, 1995). In the first year of the disease, 
impaired functioning and elevated pain levels are already comparable to that of 
patients with longstanding RA (Meenan et al., 1991; Evers et al., 1997, 1998a), 
about 40% of the patients face occupational disability, and 75% suffer from 
limitations affecting their leisure time and social activities (Fex et al., 1998; van 
Jaarsveld et al., 1998; Albers et al., 1999). In addition, functional impairment in the 
first year of RA predicts future loss of employment, a worse long-term prognosis 
and mortality (Sherer et al., 1986; Rasker & Cosh, 1989; Corbett et al., 1993; 
Eberhardt et al., 1993; Fex et al., 1998). Consequently, medical treatment is 
increasingly geared toward more aggressive treatment in the initial stage of the 
disease to decrease unfavorable long-term disease outcomes (van de Putte et al., 
1998; van Jaarsveld et al., 2000).
Irrespective of the influence of biomedical factors, chronic pain research has 
supplied relatively convincing evidence that psychosocial factors can affect the 
course of functional disability and pain in patients with RA and other chronic pain 
disorders (see for reviews e.g., Linton, 2000; Keefe et al., 2002; Turk & Okifuji, 
2002). Specifically, fear-avoidance models have received wide attention and 
provided supportive evidence that pain-related avoidance factors, such as avoiding 
activity and catastrohpic pain cognitions, are linked to future pain outcomes in 
chronic pain patients (e.g., Lethem et al., 1983; Linton, 1985; Philips, 1987; 
Vlaeyen et al., 1995; Vlaeyen & Linton, 2000). Fear-avoidance and the associated 
avoidance of activity are supposed to result in enhanced physical impairment, e.g. 
due to physical deconditioning processes, decreased muscular endurance and 
strength. Cognitive responses consisting of fearful, catastrophizing beliefs about 
pain are thought to bring about a preoccupation with bodily symptoms and 
avoidance of activity, which in turn exacerbate pain and functional disability. 
Besides cognitive-behavioral factors, social resources are assumed to have an 
impact on long-term chronic pain outcomes, including social networks and 
perceived support from close others, which may inhibit avoidance of physical and 
social activities, and have a beneficial impact on functional disability and pain 
(e.g., Cohen & Wills, 1985; Uchino et al., 1996; Keefe et al., 2002).
In addition to experimental and cross-sectional research, prospective studies 
have demonstrated the relevance of pain-related avoidance factors and social 
resources in various chronic pain populations, including RA patients (see e.g., 
Jensen et al., 1991b; Linton, 2000; Keefe et al., 2002; Turk & Okofuji, 2002). For 
example, in one of the first prospective studies conducted by Brown and Nicassio 
(1987), passive coping with pain, including the restriction of activities and
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catastrophic pain cognitions, predicted functional disability and pain in RA patients 
after 6  months. Behavioral and cognitive factors also independently predicted 
future RA outcomes: avoidance of activity was related to increased functional 
disability after 1 year (Evers et al., 1998a; van Lankveld et al., 1998), while 
worrying and catastrophic pain cognitions predicted functional disability and pain 
after 6  months (Keefe et al., 1989) and functional disability after 1 year (Evers et 
al., 1998b). In contrast, active coping with pain by ignoring pain sensations, using 
distraction or continuing activities in spite of pain have only incidentally been 
linked to more favorable future outcomes (e.g., Brown & Nicassio, 1987), 
suggesting that not using passive coping strategies may be more crucial than the 
use of specific active strategies (see e.g., Jensen et al., 1991b; Turk & Rudy, 1992). 
Apart from pain coping, there is also increasing evidence that social support, such 
as qualitative aspects of perceived social support and quantitative aspects of the 
size of social networks, affect future functional limitations and pain in chronic pain 
patients. For example, lower levels of perceived support have been shown to be 
prospectively related to more interference in daily activities in RA patients after 1 
year (Smith & Wallston, 1992) and increased pain after 1 year (Waltz et al., 1998), 
while less extended social networks predicted functional disability after 1 year 
(Evers et al., 1998a).
In view of the empirical evidence on RA and comparable findings in other 
chronic pain disorders (see e.g., Jensen et al., 1991b; Linton, 2000; Keefe et al., 
2 0 0 2 ), there seems to be relatively clear support that pain coping and social 
resources affect future outcomes in chronic pain patients. However, prospective 
studies among RA and other chronic pain patients have generally assessed the 
impact of these factors on future outcomes over a relatively short period of time 
(no longer than 1 year), which can be considered rather short-term outcomes in the 
realm of chronic conditions. Fear-avoidance models usually propose that once 
avoidance mechanisms have been established they result in increasing detrimental 
effects over time and affect long-term outcomes (Lethem et al., 1983; Philips, 
1987; Vlaeyen et al., 1995). However, relevant variables could differ for short-term 
and long-term outcomes. For example, solely the combination of cognitive- 
behavioral and social factors - and not single factors - could have an impact on 
long-term outcomes, e.g. for patients with more passive pain coping and less social 
support. In addition, personality characteristics and biomedical factors may have 
long-term modifying effects. For example, the personality characteristics of 
neuroticism and extraversion and patients’ clinical status have been shown to 
possibly modify the relationship of pain coping and social resources to outcomes in 
chronic pain patients, suggesting that the detrimental effects of passive pain coping 
or fewer social resources might only occur in patients with more neuroticism, less 
extraversion and a worse clinical status (e.g. Brown et al., 1989b; Wade et al., 
1992; Vlaeyen et al., 1999; Phillips & Gatchel, 2000). Finally, pain coping and 
social resources have been shown to affect first year outcomes (Evers et al.,
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1998a), and correspondence with findings for longstanding RA suggests that the 
same mechanisms are involved both early in the disease and later on. Since pain 
coping and social resources may be a focus of early intervention, it is particularly 
relevant to show whether these factors affect long-term functional disability and 
pain in RA patients at the earliest point in time for intervention - at diagnosis.
The object of the present study was to examine the long-term effects of pain 
coping and social support on functional disability and pain in patients with early 
RA. This study was conducted as a follow-up to the previously reported effects of 
pain coping and social support (Evers et al., 1998a), showing that passive pain 
coping strategies, and to a lesser degree lower levels of social support, assessed at 
the time of diagnosis, predicted the course of functional disability in the first year. 
Additional analyses revealed that these factors did not predict the 1-year pain 
outcome in this sample. Our current study aims at follow-up results, studying the 
effects of active and passive pain coping and social support at the time of diagnosis 
on the course of functional disability and pain after 3 and 5 years. In line with the 
literature supporting short-term effects, less active and more passive pain coping 
and lower levels of social support were expected to predict a less favorable long­
term course of functional disability and pain. In addition to these main effects, it 
was examined whether the personality characteristics of neuroticism and 
extraversion account for the relationship between pain coping, social support and 
the long-term outcome. The possible moderator effects of personality 
characteristics and clinical status on pain coping and social support were also 
explored, assuming that the effects of less active and more passive pain coping and 
lower levels of social support on functional disability and pain would be greater in 
patients with personality characteristics of more neuroticism and less extraversion 
and in patients with a worse clinical status at the time of diagnosis. Finally, the 
moderator effects of social support on pain coping were exploratively examined, 
predicting that the detrimental effects of less active and more passive pain coping 
are increased in patients with lower levels of social support.
METHODS
Sample and Procedure
The sample consisted of outpatients with recently diagnosed RA from five 
hospitals in the Netherlands. All patients participated in one of two medical trials 
for second-line anti-rheumatic drugs (van Jaarsveld et al., 2000; van Everdingen et 
al., 2002). Inclusion criteria for the trials were a minimum age of 18 years, 
diagnosis according to the 1987 American College of Rheumatology (ACR) 
criteria (Arnett et al., 1988), and a duration of disease of less than one year. 
Exclusion criteria were comorbid conditions that might interfere with one of the
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medication strategies (such as malignancy, cardiac, respiratory, hepatic, and renal 
insufficiency), previous or current treatment with second-line anti-rheumatic drugs, 
glucocorticoids, cytotoxic or immunosuppressive drugs, possible pregnancy or 
breast feeding, and psychiatric or mental disturbances that severely interfere with 
adherence to the study protocol. Patients were informed about this study by their 
rheumatologists when ACR criteria were assessed. About three weeks later (range 
0  - 1 2  weeks), clinical and self-report data were assessed during their following 
visit. This visit was also the starting point for the prospective medical trials. Five 
patients did not return the questionnaires at this assessment point, resulting in the 
participation of 95 patients in the present study at the time of diagnosis. In addition 
to assessing clinical and self-report data at the beginning of the study and at the 1 - 
year follow-up (Evers et al., 1998a), data on disease activity, functional disability, 
and pain was again collected at the 3 and 5-year follow-ups.
Of the 95 patients who correctly completed self-report data at the first 
assessment, 78 patients (82%) completed all assessment points during the 5-year 
study period. In terms of dropouts, 7 patients died, 2 moved, 1 was in remission 
and no longer treated by the rheumatology outpatient clinic and 7 did not 
complete the questionnaires for the follow-up assessments. When entering the 
study, dropouts did not significantly differ from participants in terms of 
demographic variables (sex, age, marital status, educational level), disease 
activity, functional disability, pain, the personality characteristic of extraversion, 
pain coping or social support. However, dropouts scored higher on the personality 
characteristic of neuroticism than patients who completed all assessment points (t 
= 2.87, p  < 0.01).
Of the 78 participants in the follow-up, 69% were female, 76% married or 
living with a partner, and 32% and 57% had a primary or secondary educational 
level, respectively. Mean age at the time of entering the study was 57 years (range 
20 - 82 years). The distribution of medication strategies was as follows: 30% and 
23% of the patients used non-steroidal anti-inflammatory drugs (NSAID) alone at 
first assessment and at the 5-year follow-up, respectively; the other patients took 
NSAID in combination with methotrexate (30% and 49%, respectively), 
intramuscular gold (14% at both assessment points), hydroxychloroquine (15% 
and 9%, respectively), prednisone (11% and 1%, respectively) or other second- 
line medication, prescribed only for individual patients (4% at the 5-year follow- 
up). At the 5-year follow-up, 31% of the patients still used the initially prescribed 
medication, 65% used another medication strategy from the drug trial, and 4% of 
the patients used another second-line medication than that used in the medication 
trials.
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Measures
Demographic variables were assessed with a general checklist, assessing 
patient gender, age, marital status and educational level. Educational level was 
measured with 7 categories that can be classified as primary, secondary and tertiary 
educational levels, representing an average of 7, 12, and 17 years of education, 
respectively.
Disease activity was determined by erythrocyte sedimentation rate (ESR; 1­
140mm first hour), an indicator of inflammatory activity, and by joint score ratings 
of the simultaneous presence of swelling and tenderness in 38 joints (range 0-534) 
(Thompson et al., 1987). A composite score of both measures was used as an 
indicator of disease activity, in accordance with regular use of composite scores of 
disease activity that consist of at least ESR or another acute phase reactant and a 
joint score (van der Heijde et al., 1992; Prevoo et al., 1995). The composite score 
was calculated by adding the standardized scores (z-scores) of both indicators. A 
higher composite score indicates higher levels of disease activity.
Functional disability was assessed using a composite score of one clinical 
measure and two self-report measures (see Evers et al., 1998a). The clinical 
measure consisted of grip strength assessments with a Martin vigorimeter (the 
mean of three measurements on both hands was calculated). Self-reported 
functional disability was assessed with the Mobility and Self-care scales of the 
Impact of Rheumatic Diseases on General Health and Lifestyle (IRGL; Huiskes et 
al., 1990a; Evers et al., 1998b). The IRGL is derived from the Arthritits Impact 
Measurement Scales (AIMS) and assesses physical, psychological and social 
health in patients with rheumatic diseases. Previous research has shown that the 
reliability and validity of the IRGL scales are highly satisfactory (Huiskes et al., 
1990a; Evers et al., 1998b). Items in the IRGL scales are scored on a 4-point or 5- 
point Likert scale. The Mobility and Self-care scales assess the functional 
capacities of the lower and upper extremities, respectively, over the last month (15 
items). Cronbach’s alpha in the present study was 0.89 for both scales. A 
composite score of the clinical measure and the two self-report scales was 
calculated by adding the standardized scores (z-scores) of all three indicators. A 
higher composite score indicates higher levels of functional disability.
Pain was assessed with the IRGL Pain scale ( 6  items), measuring the severity 
and frequency of painful episodes and swollen joints and the duration of early 
morning stiffness in the last month. Cronbach’s alpha in the present study was 
0 .8 8 .
Personality dimensions, i.e. neuroticism and extraversion, were measured with 
a Dutch version of the Eysenck Personality Questionnaire (17 and 12 items, 
respectively) (EPQ; Wilde, 1970; Eysenck & Eysenck, 1991). Cronbach’s alphas 
in the present study were 0.90 for neuroticism and 0.79 for extraversion.
Pain coping was assessed by the Pain Coping Inventory (PCI; Kraaimaat et al., 
1997; Kraaimaat & Evers, 2003), measuring active and passive coping strategies
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when dealing with pain. Active pain coping strategies reflect three cognitive- 
behavioral strategies, measuring patients’ efforts to distract themselves from the 
pain (Distraction, 5 items), to reinterpret and transform the pain (Pain 
Transformation, 4 items) and to function in spite of the pain (Reducing Demands, 3 
items). Passive pain coping reflects three cognitive-behavioral strategies, assessing 
behavioral tendencies to restrict functioning (Resting, 5 items), to avoid 
environmental stimuli (Retreating, 7 items) and catastrophic cognitions about the 
pain (Worrying, 9 items). A composite score of active and passive pain coping can 
be calculated by summing up the nonweighted scores of the three active and 
passive coping strategies (Kraaimaat et al., 1997; Kraaimaat & Evers, 2003). 
Cronbach’s alpha for the active and passive scales were 0.79 and 0.90, 
respectively, in the present study.
Social support in the past six months was measured with the IRGL social 
functioning scales, reflecting a quantitative and qualitative aspect of social support. 
The quantitative aspect was assessed by the size of the social network, i.e. the 
number of friends and family members with whom patients associate. The 
qualitative aspect was measured by the Perceived Support scale (5 items), inquiring 
about the perceived availability of emotional and instrumental support (availability 
to share sad and pleasant events, obtain support when faced with stress and pain, 
get help for casual work). Cronbach’s alpha for the Perceived Support scale in the 
present study was 0 .8 8 .
Statistical Analyses
Mean linear changes in clinical status (disease activity, functional disability, 
pain) were studied by analyses of variance with repeated measurements, using the 
variables at the different assessment points as dependent variables, followed by 
posthoc tests in the event of significant linear changes. To explore the relationship 
between predictors at the time of diagnosis and changes in functional disability and 
pain after 3 and 5 years, Pearson correlation coefficients were calculated between 
the predictors at the time of diagnosis and the residual gain scores for functional 
disability and pain at the 3 and 5-year follow-ups (Kerlinger, 1975). Sequential 
regression analyses were then performed to examine the relative contribution of 
predictors on functional disability and pain at the 3 and 5-year follow-ups. 
Functional disability and pain at the 3 and 5-year follow-ups were used as 
dependent variables. In the first step, the baseline assessment of the dependent 
variable was entered, followed by the predictors significantly related to change in 
functional disability or pain at at least one follow-up assessment. Mediating effects 
were determined with the procedure described by Baron and Kenny (1986). 
Moderating effects were explored by calculating centered interaction terms 
between the predictor and the moderator and entering them in the regression 
analyses, after controlling for their main effects. Due to the relatively high number 
of explorative tests performed in these moderator analyses, a more conservative
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threshold of p  < 0.01 was used. Finally, to control for possible confounding effects 
of medication, Pearson correlation coefficients were calculated between the use 
(use vs. nonuse) and duration (number of years) of every medication strategy 
separately and the residual gain scores of functional disability and pain at the 3 and 
5-year follow-ups. In the event of a significant correlation, the effects of the 
medication strategy were taken into account by entering the medication strategy at 
step 2 , before the other predictors in the regression analyses.
RESULTS
Change in Clinical Status during the Study Period
During the 5-year period, there was a significant mean decrease in disease 
activity (F(3,73) = 22.2, p  < 0.001 and F(3,73) = 10.6, p  < 0.01 for the ESR and 
joint score, respectively). In addition, pain and one indicator of functional 
disability significantly decreased within 5 years after diagnosis (F(3,75) = 9.6, p  < 
0.01 for pain; F(3,75) = 14.5, p  < 0.001 for grip strength). Posthoc tests indicated 
that this improvement in clinical status was most obvious in the first year of the 
disease: all indicators markedly decreased in this year (t = 3.06, p  < 0.01 for ESR; 
t = 3.25, p  < 0.01 for the joint score; t = 2.20, p  < 0.05 for pain; t = 4.29, p  < 0.001 
for grip strength; see also Evers et al., 1998b), possibly due to the beneficial 
effects of medication (van Jaarsveld et al., 2000; van Everdingen et al., 2002). 
After the first year of the disease, clinical status remained relatively stable, as 
indicated by nonsignificant posthoc tests between 1 and 3 and between 3 and 5 
years, with one exception: an indicator of disease activity, ESR, significantly 
decreased further between the 1 and 3-year follow-ups (t = 3.11, p  < 0 .0 1 ).
Predictors o f Functional Disability at the 3 and 5-Year Follow-ups
The results of the correlational analyses between predictors at the time of 
diagnosis and change in functional disability are presented in Table 1. The use of 
more passive pain coping strategies at the time of diagnosis was significantly 
related to an increase in functional disability after 3 years, but not after 5 years. In 
addition, both indicators of social support, perceived support and social networks 
were significantly related to less increase in functional disability at the 3 and the 5- 
year follow-ups. No significant relationships were found between demographic 
variables, the personality characteristics of neuroticism and extraversion, disease 
activity, pain and active pain coping at the time of diagnosis and changes in 
functional disability at the 3 and 5-year follow-ups.
Sequential regression analyses were then conducted with the predictors 
significantly related to the change in functional disability at at least one assessment 
point: passive pain coping and both indicators of social support. After controlling
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for baseline levels of functional disability at the first step, passive pain coping and 
social support indicators assessed at the time of diagnosis were entered in the 
following steps. As demonstrated in Table 2, passive pain coping significantly 
contributed 4% to functional disability at the 3-year follow-up, but did not 
significantly add variance to functional disability at the 5-year follow-up. In 
addition, lower levels of social support explained 1 2 % and 1 1 % additional variance 
in functional disability at the 3 and 5-year follow-ups, respectively. Standardized 
beta coefficients indicated that passive coping with pain, lower levels of perceived 
support and a smaller social network at the time of diagnosis all significantly 
predicted functional disability at the 3-year follow-up (t = 2.49, p  < 0.05; t = -2.20, 
p  < 0.05; t = -2.98, p  < 0.01, respectively). Lower levels of perceived support and a 
less extended social network also predicted functional disability at the 5-year 
follow-up (t = -2.70, p  < 0.01; t = -2.07, p  < 0.05, respectively).
Table 1 Correlations between Predictors at the Time of Diagnosis and Changes in 
Functional Disability and Pain after 3 and 5 Years in 78 RA Patients a
Change in Change in
functional disability pain
3 yrs. 5 yrs. 3 yrs. 5 yrs.
Demographic variables
Age -.03 .07 - . 1 0 .09
Sex .16 .09 .06 .04
Educational level . 0 1 -.16 - . 0 2 -.31**
Marital status - . 1 1 -.04 - . 1 1 .15
Personality characteristics
Neuroticism . 2 1 .2 1 .15 . 1 1
Extraversion -.17 -.04 . 0 2 .14
Clinical status
Disease activity .09 .19 .17 . 1 0
Functional disability - - .27* .26*
Pain .13 .1 1 - -
Pain coping
Active -.17 . 0 0 -.18 - . 1 0
Passive .24* .19 . 2 0 . 1 0
Social support
Perceived support -.30** **4.3-. -.26* -.28*
Social network -.36** -.29* -.13 -.14
a A positive correlation indicates that the predictor is related to an increase in functional disability and 
pain (residual gain scores).
* p  < 0.05 ** p  < 0.01.
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To study whether the relationship between passive pain coping and increased 
functional disability at the 3 and 5-year follow-ups was mediated by social support, 
the order of entering passive pain coping and social support was reversed, 
revealing overall the same results. Passive pain coping at step 3 still significantly 
predicted functional disability at the 3-year follow-up but not at the 5 year follow- 
up, after controlling for social support at step 2 , indicating that passive pain coping 
was an independent predictor of functional disability.
Analyses of the moderator effects of personality characteristics and clinical 
status on pain coping and social support and of pain coping on social support 
indicated that the interaction terms were not significantly related to changes in 
functional disability at the 3 and 5-year follow-ups, failing to support any 
moderating function of the predictors for changes in long-term functional 
disability.
Table 2 Multiple Regression Analyses Predicting Functional Disability at the 3 and 5- 
Year Follow-ups from Predictors at the Time of Diagnosis a
Functional disability Functional disability
after 3 yrs. after 5 yrs.
B A R2 B A R2
Functional disability 52*** 3 7 *** .51*** .34***
Pain coping .04* .03
Passive .2 1 * .17
Social support .1 2 *** .1 1 **
Perceived support -.18* **4
<Ni'
Social network -.25** -.18*
Total A R2 .53*** .48***
a Selection criterion for predictor variables was a significant correlation with changes in functional 
disability at least at a single follow-up assessment (see Table 1).
* p  < 0.05 ** p  < 0.01 *** p  < 0.001.
Predictors o f Pain at the 3 and 5-Year Follow-ups
As presented in Table 1, correlational analyses between predictors at the time 
of diagnosis and changes in pain after 3 and 5 years revealed a significant 
relationship between lower educational level and an increase in pain at the 5-year 
follow-up, but not at the 3-year follow-up. In addition, higher levels of functional 
disability and lower levels of perceived support at the time of diagnosis were 
related to an increase in pain at the 3 and 5-year follow ups. In contrast, 
demographic variables (sex, age, marital status), the personality characteristics of 
neuroticism and extraversion, active and passive pain coping, and the size of the
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social network were not significantly related to changes in pain at the 3 and 5-year 
follow-ups.
When entering the predictors significantly related to changes in pain at at least 
one assessment point in sequential regression analyses, i.e. educational level, 
functional disability, perceived support, results indicated that perceived support 
significantly explained an additional 5% variance in pain at both assessment points, 
after controlling for baseline levels of pain, educational level and functional 
disability at the time of diagnosis (see Table 3). Standardized beta coefficients 
indicated that lower levels of perceived support at the time of diagnosis 
significantly predicted an increase in pain at the 3 and 5-year follow-ups (t = -2.34, 
p  < 0.05 and t = -2.43, p  < 0.05, respectively).
Finally, analyses of the moderator effects of personality characteristics and 
clinical status on pain coping and social support and of pain coping on social 
support were performed, indicating nonsignificant correlations between all 
interaction terms and changes in pain at the 3 and 5-year follow-ups, failing to 
support any moderating function of the predictors for changes in long-term pain.
Table 3 Multiple Regression Analyses Predicting Pain at the 3 and 5-Year Follow-ups 
From Predictors at the Time of Diagnosis a
Pain Pain
after 3 yrs.______  ______ after 5 yrs.
B A R2 B A R2
Pain .36** 17*** 4 4 *** .2 0 ***
Demographic variables . 0 0 .08**
Educational level .03 -.25*
Clinical status .06* .04
Functional disability .25* .19
Social support .05* .05*
Perceived support -.23* -.23*
Total A R2 .28*** 3 7 ***
a Selection criterion for predictor variables was a significant correlation with changes in functional 
disability at least at a single follow-up assessment (see Table 1).
* p  < 0.05 ** p  < 0.01 *** p  < 0.001.
Confounding Effects o f Medication
Correlation coefficients between the use (use/nonuse) and duration (number of 
years) of the different medication strategies and changes in functional disability 
and pain at the 3 and 5-year follow-ups indicated nonsignificant correlations 
between all strategies and changes in long-term functional disability and pain, with
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one exception: the use and duration of taking NSAID was related to a decrease in 
functional disability at the 3 year follow-up (r = 0.25, p  < 0.05 and r  = 0.24, p  < 
0.05, respectively), but not at the 5-year follow-up. However, when controlling for 
this medication strategy in the regression analyses by entering it at step 2  (see 
Table 2), passive pain coping and social support still significantly predicted 
functional disability at the 3-year follow-up. In addition, standardized beta 
coefficients showed the same significant predictors as previously found, i.e. 
passive pain coping and both indicators of social support (see Table 2), indicating 
that their effects could not be ascribed to the medication usage.
DISCUSSION
The role of pain coping and social support was examined in relationship to the 
long-term outcome of functional disability and pain in early RA. In line with 
previous results at the 1-year follow-up (Evers et al., 1998a), passive pain coping 
assessed at the time of diagnosis still had a detrimental effect on functional 
disability at the 3-year follow-up, but not at the 5-year follow-up. In addition, 
social support consistently predicted a less unfavorable course of functional 
disability and pain at the 3 and 5-year follow-ups, and these effects occurred 
irrespective of the personality characteristics of neuroticism and extraversion, 
clinical status and use of medication, generally suggesting that pain-related 
avoidance factors and social resources have a lasting impact on physical outcomes 
in early RA.
In patients with chronic pain, particularly RA, several studies supported the 
unfavorable effects of avoidance of activities and negative pain cognitions on 
future functional disability (Brown & Nicassio, 1987; Keefe et al., 1989; Smith & 
Wallston, 1992; van Lankveld et al., 1998, see also Jensen et al., 1991; Linton, 
2000; Vlaeyen & Linton, 2000; Turk & Okofuji, 2002). In line with these studies, 
assessing relatively short periods of time of a maximum of 1 year, our present 
study suggests that these effects are more long lasting than previously assessed. 
Passive pain coping, consisting of worrying cognitions about pain and the 
behavioral strategies of resting and retreating, assessed at the time of diagnosis still 
affected functional disability 3 years after diagnosis. Posthoc analyses indicated 
that these effects could be largely ascribed to the behavioral component of 
avoidance of activity. When analyzing the different contribution of the two 
behavioral and the cognitive scales to future functional disability, only resting 
significantly predicted additional variance in functional disability at the 3-year 
follow-up (p < 0.01). Worrying also tended to be related to functional disability at 
the 3-year follow-up, but its effect was nonsignificant in regression analyses. 
While resting and worrying both significantly contributed to short-term functional 
disability after one year (Evers et al., 1998a), the behavioral component of
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avoidance of activity appeared to be most crucial for more longlasting effects on 
functional disability. These findings may support the assumption of fear-avoidance 
models that the most direct links to long-term functional disability are 
physiological disuse processes of deconditioning and reduced muscle strength and 
coordination (see e.g., Bortz, 1984; Vlaeyen & Linton, 2000; Steultjens et al., 
2 0 0 2 ).
In contrast to expectations, passive pain coping did not predict long-term pain 
in this sample of patients with early RA. In fact, cognitive and behavioral pain 
coping strategies have been shown to predict future disability more consistently 
than future pain in chronic pain patients (see e.g., Evers et al., 2001b), and as far as 
we know there are only two prospective studies that have found detrimental effects 
for passive pain coping or catastrophizing on future pain in RA patients (Brown & 
Nicassio, 1987; Keefe et al., 1989). These studies were conducted with much larger 
sample sizes and a lack of power may be one reason for nonsignificant effects in 
the present study. In addition to cognitive-behavioral factors, our own research in 
longstanding RA indicated that self-reported physiological reactivity to pain was a 
better predictor than cognitive or behavioral pain coping for pain after 1 year 
(Evers et al., 2001b), suggesting that symptom-specific patterns of physiological 
pain reactivity or physiological fear reactions to pain may be more directly linked 
to changes in pain than cognitive and behavioral pathways (see e.g., Flor et al, 
1990; Turk & Flor, 1999). Aside from physiological factors, possible cognitive 
mediators not assessed in the present study have been shown to be relevant in the 
relationship to functional disability and pain in chronic pain patients, such as pain- 
related fears, heightened attention to bodily symptoms due to hypervigilance or 
expectations of increased pain (see e.g., Vlaeyen & Linton, 2000), and these 
factors may also be crucial for long-term functional disability and pain in this 
sample of patients with early RA.
Irrespective of pain coping, social support predicted long-term functional 
disability and pain in this sample of patients with early RA. Specifically, both 
indicators of social support, perceived support and the size of the social network, 
significantly predicted a less unfavorable long-term course of functional disability 
after 3 and 5 years. In comparison to the short-term follow-up after 1 year when 
only the size of the social network had a slight effect on future functional disability 
(Evers et al., 1998a), both indicators of social support were relatively strongly 
related to functional disability at the 3 and 5-year follow-ups. In addition, in 
contrast to the nonsignificant effects of all predictors for pain at the 1 -year follow- 
up, lower levels of perceived support also consistently predicted pain at the 3 and 
5-year follow-ups, generally indicating that the effects of social support 
particularly affect the long-term outcome of functional disability and pain in RA. 
These effects seem to supplement findings in the RA literature, showing that a lack 
of social support is prospectively related to greater interference in daily life after 1 
year (Smith & Wallston, 1992) and to more pain after 1 year (Waltz et al., 1998).
Coping and Social Support in Functional Disability and Pain II - 83
Questions arise about possible cognitive-behavioral or physiological mediators 
in the relationship between social support and long-term outcomes. From a 
cognitive-behavioral perspective, perceived support from significant others has 
been shown to be linked to less pain behaviors and greater activity levels in 
heterogeneous groups of chronic pain patients (Jamison & Virts, 1990), as well as 
to more information seeking and cognitive restructuring in RA patients (Manne & 
Zautra, 1989). The latter study also revealed a path model, in which perceived 
support leads to more adaptive coping which in turn predicted better adjustment in 
RA patients (Manne & Zautra, 1989), suggesting that social support may figure as 
coping assistance (Thoits, 1986) and result in more adaptive pain coping and less 
withdrawal from (social) activities, which beneficially affect long-term functional 
disability and pain. Similar mechanisms may be responsible for the favorable 
effects of a larger social network on long-term functional disability in the present 
sample, e.g. stimulating participation in social activities, inhibiting avoidance 
behavior and offering coping assistance by generating multiple solutions to 
problems. Apart from cognitive-behavioral pathways, physiological mediators in 
the relationship between social support and physical health have frequently been 
reported (see e.g., Uchino et al., 1996), and altered autonomic and muscular 
reactivity or immunological function may be responsible for the favorable effects 
of social support on long-term outcomes. A major challenge for future research is 
to link various social support components to specific cognitive, behavioral and 
physiological pathways in their relationship to patient long-term functioning
What might be the implications of our results with respect to fear-avoidance 
models for RA and other chronic pain patients? In line with assumptions of fear- 
avoidance models (e.g., Lethem et al., 1983; Philips, 1987; Vlaeyen et al., 1995), 
our study indicates that pain-related avoidance factors and social resources can 
have a lasting impact on patient functioning. In addition, these factors appear to be 
established at a very early stage of the disease, i.e. at the time of diagnosis, 
suggesting that they result from the patients’ prior learning history, pre- 
dispositional factors and/or cultural backgrounds (see e.g., Philips, 1987; Turk & 
Flor, 1999; Turk & Okofuji, 2002). Moreover, our results suggest that the relative 
contribution of pain-related avoidance factors and social resources change between 
short and long-term outcomes. The cognitive aspects of worrying and behavioral 
aspects of avoidance of activity seem to be especially relevant for short-term 
functional disability, with the behavioral component of avoidance of activity 
having a continuing effects on longer-term follow-ups. In contrast, social support 
appears to have initially only marginal effects, but its influence increases on long­
term functional disability and pain outcomes, suggesting that the role of social 
resources may have been largely underestimated in chronic pain research.
Some limitations of this study have to be considered. Our sample consisted of 
patients with early RA, for whom pharmacological treatment appeared to have 
beneficial effects (van Jaarsveld et al., 2000; van Everdingen et al., 2002).
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Although our results correspond to findings for other chronic pain disorders, the 
extent to which our results can be generalized to other chronic pain patients or 
patients with longstanding RA is unclear. Our results may be also influenced by 
some selection bias, since all patients participated in a clinical trial and dropouts 
scored somewhat higher on neuroticism than participants. The relatively general 
assessment of passive pain coping and social support in our study limits the 
possibility of drawing conclusions about specific pathways for how these factors 
may affect long-term functional disability and pain in early RA, and it remains 
unclear to what extent they are a consequence of fear-avoidance beliefs or 
hypervigilance, as suggested by fear-avoidance theories (see e.g. Vlaeyen & 
Linton, 2000), or other more depressogenic cognitive processes, such as 
helplessness (Evers et al., 2001a). In addition to these cognitive pathways, future 
studies should include an examination of behavioral pathways, such as observed or 
self-monitored activity assessments (e.g., Linton, 1985), physiological pathways, 
such as physiological pain reactivity, generalized fear reactions and measures of 
muscle strength (Flor et al., 1990; Vlaeyen et al., 1999; Evers et al., 2001b; 
Steultjens et al., 2002), as well as social pathways, including observed supportive 
and problematic indicators of social responses to pain (e.g., Flor et al., 1987; 
Manne & Zautra, 1989). Finally, multiple repeated measurements of pain coping, 
social support, pain and functional disability are needed to gain insight into 
possible reciprocal effects, in which pain-related avoidance factors, a lack of social 
resources and poorer physical functioning might enhance each other during the 
course of disease
For clinical practice, tailored cognitive-behavioral treatment at an early stage of 
the disease, aimed at decreasing pain-related avoidance factors and increasing 
social resources in RA patients at risk, has recently been shown effective in 
producing beneficial changes in physical and psychological functioning at post­
treatment and follow-up (Evers et al., 2002b). Results of the present study suggest 
that this kind of tailored treatment for patients at risk not only induce short-term 
changes, but might also lastingly modify long-term functioning, particularly when 
systematically promoting patients’ social support systems.
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33.1 Coping and Social Support
3.1.3 Predictors of psychological distress
3.1.3.1 Determinants of psychological distress and its 
course in the first year after diagnosis in 
rheumatoid arthritis patients
Evers, A.W.M., Kraaimaat, F.W., Geenen, R. & Bijlsma, J.W.J. (1997). 
Determinants of psychological distress and its course in the first year after 
diagnosis in rheumatoid arthritis patients. Journal of Behavioral Medicine, 
20, 489-504.
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ABSTRACT
In order to examine determinants of psychological distress and its course in the 
first year after diagnosis in rheumatoid arthritis patients, self-report data and 
clinical and laboratory measures were collected in 91 patients (70% female, mean 
age 57 years) shortly after diagnosis and one year later. Multiple regression 
analysis indicated that sex, pain and functional status, disease impact on daily life, 
life events, and perceived social support were related to psychological distress 
(anxiety and depressed mood) shortly after diagnosis. Coping strategies were 
related to distress levels only one year later. Multiple regression analysis of change 
in anxiety and depressed mood revealed that a decrease of psychological distress 
after one year could be predicted by male sex, an initially less severe inflammatory 
activity and an initially more extended social network. In addition, a decrease in 
distress was related to parallel improvements in clinical status. Results indicate the 
importance of a multimodal assessment of demographic variables, clinical and life 
stressors and social resources for the understanding of distress and the 
identification of risk factors in the first stage of the disease. Personal coping 
resources appear to become more important predictors of distress in a later phase 
of the disease.
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INTRODUCTION
Rheumatoid arthritis (RA) is a chronic, unpredictive and progressive inflammatory 
disease primarily affecting the joints. After diagnosis, the patient is confronted 
with a new, unexpected, and uncontrollable stressor with actual as well as 
foreseeable long-term consequences in physical, psychological, and social areas of 
life. Physical disability, pain, social dependency, uncertainty about disease 
progression, and threats to one's self-esteem are some of the consequences of the 
disease that impose great demands on the patient's adaptive capabilities and may 
increase psychological distress.
Raised levels of anxiety and depressive symptoms have frequently been 
reported and are indicative of a prevalence of about 2 0 % in patients with 
longstanding RA (e.g., Bishop et al., 1987; Frank et al., 1988; Murphy et al., 1988; 
Katz & Yelin, 1993). Whether the psychological status of recently diagnosed 
patients is different to that of patients with longstanding RA is not yet clear. It has 
been supposed that an increased level of psychological distress would be expected 
shortly after the diagnosis as a reaction to a personally threatening event, with an 
ensuring process of psychological adjustment to the disease, due to a growing 
capacity to cope with the stressor later on (Newman et al., 1989; Devins et al.,
1992). Shorter illness duration has been shown to be related to increased levels of 
depression by Deyo et al. (1982), Newman et al. (1989), Katz and Yelin (1993), 
Wolfe and Hawley (1993) and Chaney et al. (1996), while Meenan et al. (1991) 
reported no differences between recently diagnosed patients (disease duration of 
less than one year) and those with more established disease. Little is known about 
the factors which affect psychological status shortly after the diagnosis and which 
predict its course in the first stage of the disease. The relative amount of 
psychological distress as well as the process of adaptation to a chronic disease are 
supposed to be both affected by the encountered stressors and the resources 
available (Lazarus & Folkman, 1984).
Research in RA patients with established disease has indicated that a broad set 
of physical, psychological, and social stressors and resources are relevant for the 
understanding and prognosis of psychological distress. The disease itself and the 
clinical status figure as important stressors in RA patients. Especially pain and the 
patient's functional status have been shown to be related to depression in recently 
diagnosed patients (disease duration of less than one year) (van der Heide et al., 
1994a), in patients with more established disease (mean disease duration of three 
years) (Brown, 1990; Nicassio & Wallston, 1992) and in patients with 
longstanding RA (mean disease duration of more than ten years) (Newman et al., 
1989; Wolfe & Hawley, 1993). Less evidence has been found with regard to a 
relation between distress and clinical measures such as blood sedimentation rate 
and joint score (e.g. Newman et al., 1989; Bijlsma et al., 1991; Wolfe & Hawley,
1993). In addition, there is suggestive evidence that the impact of the disease on
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daily life, such as the impact on household activities, income, work, sexuality and 
leisure activities, figures as an important stressor affecting psychological distress in 
patients with longstanding RA. Indicative of a positive relationship between 
disease impact on daily life and depressed mood are the results of Devins et al. 
(1992), Brons et al. (1993) and Katz and Yelin (1995). Finally, stress research has 
focused on the occurrences of major life events. Studies in patients with 
longstanding RA yielded equivocal results, and significant relations between major 
events and health outcomes in RA patients were rather low (e.g., Rimon & Laakso, 
1985; Klages, 1991; Brons et al., 1993; Koehler & Vertheim, 1993).
Individual differences in psychological distress independent from health status 
suggest that various psychological processes, such as receiving social support and 
the way of coping with stressors, mediate or modify the relationship between 
stressors and the psychological reaction to a chronic disease (Lazarus & Folkman, 
1984; Cohen & Wills, 1985). One main conceptualization of social support is the 
distinction between qualitative aspects, such as the perceived availability of 
support, and quantitative aspects, such as the size of the social network (Cohen & 
Wills, 1985). In accordance with Cohen and Wills (1985), research suggested that 
qualitative aspects of social support are more important than quantitative aspects in 
patients with a disease duration of about three years (Brown et al., 1989b) and in 
patients with longstanding RA (Goodenow et al., 1990). From investigations of 
coping strategies among individuals with RA, it can be concluded that passive, 
avoidant and emotion-focused ways of coping are related to maladaptive 
functioning, whereas active and problem-focused coping strategies are associated 
with adaptive functioning (for review, see Manne & Zautra, 1992; Young, 1992).
The multimodal influence of these determinants on psychological distress 
shortly after diagnosis and its course in the first year of the disease have not yet 
been investigated in RA patients. The stressors and coping resources might be 
partly different for recently diagnosed patients which are relatively inexperienced 
with a chronic stressor. In order to gain insight into predictors of psychological 
distress and its course in the first year of the disease, we examined the extent to 
which demographic variables, clinical status, disease impact, life events, social 
support, and coping strategies shortly after diagnosis predict the level of 
psychological distress and its course in the first year after diagnosis. We expected 
that a high level of distress shortly after diagnosis as well as a smaller decrease in 
psychological distress within the first year of the disease would be related to an 
initially worse clinical status, a greater amount of disease impact on daily life, the 
occurrence of more life events, and less personal and social coping resources.
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METHODS
Patients
The sample consisted of successive outpatients with recently diagnosed RA 
from five hospitals in the Utrecht area, the Netherlands. Patients were 
participating in a prospective study on the effects of different medication 
strategies. Inclusion criteria were a minimum age of 18 years, a disease duration 
of less than one year, and a diagnosis of RA assessed by a rheumatologist 
according to the 1987 American College of Rheuamtology (ACR) criteria (Arnett 
et al., 1988). Patients were informed by their rheumatologists about this study 
during the first routine visit in which ACR criteria were assessed. One hundred 
patients agreed to participate and received a questionnaire during the second 
routine visit which was scheduled about three weeks later (range 0 - 1 2  weeks). 
This second visit was also the starting point for the second-line anti-rheumatic 
medication. Correctly completed questionnaires were returned by 95 patients. One 
year later, 91 patients completed the questionnaires again. In none of the patients 
remission occurred. The sample was predominantly female (70%), married or 
living together with a partner (74%), with primary (34%) or secondary (53%) 
education. The mean age was 57 years (range 20-82 years). The medication of the 
patients was as follows: 31% patients were on non-steroidal anti-inflammatory 
drugs (NSAID) alone; the other were on NSAID in combination with 
methotrexate (25%), intramuscular gold (16%), hydroxychloroquine (14%), or 
prednisone (14%). Means of psychological distress and clinical status measures of 
the patients on first and second assessments are presented in Table 1.
Measures
Psychological distress in the past month was measured with the Anxiety and 
Depressed Mood scales of the Impact of Rheumatic diseases on General health and 
Lifestyle (IRGL; Huiskes et al., 1990a). The IRGL is partly derived from the 
Arthritis Impact Measurement Scales (AIMS; Meenan et al., 1980) and measures 
the physical, psychological, and social aspects of health status in patients with 
rheumatic diseases. The Anxiety scale (10 items) of the IRGL is a condensed 
version of the the Dutch State Anxiety Scale (STAI-DY; Spielberger et al., 1970; 
van der Ploeg et al., 1980). The Depressive Mood scale ( 6  items) of the IRGL is 
derived from a questionnaire of Zwart and Spooren (1982). Any of these scales 
contains somatic items which could reflect the RA disease process or 
consequences. Items of the IRGL scales are scored on a 4 or 5-point Likert-scale. 
In previous research, reliability and validity of the IRGL scales were shown to be 
highly satisfactory (Huiskes et al., 1990a).
Clinical status measures were obtained through standardized clinical and 
laboratory data as well as self-report measures. Clinical and laboratory data were 
collected on erythrocyte sedimentation rate (ESR), joint scores according to the
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method described by Thompson (1987), and grip strength measured by a Martin 
vigorimeter (mean of three measurements of each hand was calculated). Self-report 
measures included assessments of pain and functional status. Pain in the past 
month were assessed by the Pain scale ( 6  items) of the IRGL. Self-reports of 
functional status in the past month were assessed by the Mobility (7 items) and 
Self-care scale ( 8  items) of the IRGL.
Disease impact on daily life was measured by the Disease Impact scale of the 
IRGL (10 items) referring to the general impact the disease has on several domains 
of daily life (i.e., work, leisure, relationships, sexuality, food).
Stressful life events were measured with a Dutch version of the Life Experience 
Survey (LES), assessing the occurrence of 60 events concerning health, work and 
financial situation, relationships, living, and personal matters during the past 1 2  
months (Sarason et al., 1978; van de Willige et al., 1985). In order to minimize 
confounding effects with disease impact, four disease related events were excluded 
(admission to hospital, surgical operation, occurrence of severe disease, important 
change in health status).
Social support in the past six months was measured by the social functioning 
scales of the IRGL, reflecting a quantitative and qualitative aspect of social 
support: the size of the social network was measured through the index Number of 
Friends; perceived availability of support was assessed by the scale Perceived 
Support (5 items).
Coping strategies were assessed using the Utrecht Coping List (UCL; Schreurs 
et al., 1993), partly adopted from Westbrook (1979). Patients were instructed to 
indicate the extent to which they used different kinds of coping behavior in dealing 
with stressors of everyday life. Items were scored on a 4-point Likert scale. Four of 
the seven scales of the questionnaire were used in the present study: Tackling 
Problems Actively (7 items), Comforting Cognitions (5 items), Distraction ( 8  
items) and Avoidance ( 8  items). Reliability and validity have been shown to be 
satisfactory (Sanderman & Ormel, 1992).
Statistical Analyses
Because of skewed distributions of scores at depressed mood and life events, 
square root transformations were applied. Social network scores were categorized 
according to norm classes (Huiskes et al., 1990a). In order to examine the relative 
contribution of demographic variables, clinical status, disease impact on daily life, 
life events, social support, and coping strategies on psychological distress shortly 
after diagnosis, hierarchical multiple regression analysis was performed with all 
predictors which were significantly related to at least one of the measures of 
psychological distress (anxiety or depressed mood). In order to predict the course 
of psychological distress within one year, the same procedure was followed for the 
longitudinal data with distress levels about one year after diagnosis, entering 
distress levels shortly after diagnosis at the first step. Bivariate associations
Coping and Social Support in Psychological Distress 1 - 91
between all variables were calculated with Pearson correlation coefficients. 
Differences between means of the first and second assessment were tested with 
Student's ¿-test and Wilcoxon Signed Rank Test in the case of ESR and 
Thompson's joint score. All statistical analyses were carried out with the SPSS 
6.1/Windows statistical package with a minimum of 8 8  patients sharing complete 
datasets.
RESULTS
Level o f Psychological Distress
Patients exhibited relatively high levels of psychological distress. In 
comparison to norm groups of the general population obtained by van der Ploeg et 
al. (1980) and Zwart and Spooren (1982), this group of recently diagnosed RA 
patients reported significantly higher levels of depressed mood (t = 4.42, p  < 0 .0 1 ) 
and anxiety (t = 4.92, p  < 0.01). When examining risk groups, 27 and 38 patients 
(28% and 40%), respectively, had an equal or higher anxiety and depressed mood 
value than the mean score of DSM-III diagnosed psychiatric outpatients, while 17 
and 19 patients (18% and 20%), respectively, reported an equal or higher level than 
the mean score of patients with a clinical anxiety or depression diagnosis (van der 
Ploeg et al., 1980; Zwart & Spooren, 1982).
Table 1 Means and SDs of Psychological Distress and Clinical Status Shortly After the 
Diagnosis (T1) and 1 Year Later (T2)
Variable (range)
T1 T2
M SD M SD
Psychological distress
Anxiety (10-40) 19.2 6.7 19.0 6 . 8
Depressed mood a(0-5) 1.5 1.3 1.3 1.3
Clinical status
ESR (1-140 mm 1st hr) 30.9 23.3 23.7 22.4
Joint score (0-534) 96.9 95.9 66.0 77.4
Grip strength (0-130 kPa) 32.7 23.0 40.4 26.2
Pain (6-25) 15.6 4.9 14.1 5.3
Mobility (7-28) 19.6 6 . 1 20.9 5.7
Self-care (8-32) 24.3 5.9 25.3 5.6
a Square root.
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Predictors o f Psychological Distress Shortly After Diagnosis and 1 Year Later
Hierarchical multiple regression analyses were used to examine the relationship 
between demographic variables (sex, age, educational level), clinical status (ESR, 
joint score, grip strength, mobility, self-care, pain), disease impact on daily life, life 
events, social support and coping strategies, and the level of psychological distress 
shortly after diagnosis. Only those variables were entered in the regression model 
which were significantly related to at least one of the measures of psychological 
distress (anxiety or depressed mood at T1); i.e. sex, pain, and self-report measures 
of functional status (mobility and self-care), disease impact on daily life, life 
events, social support and coping strategies (distraction and avoidance) (see Table 
2). The results of the last step of the cross-sectional regression analysis are shown 
in the left columns of Table 2.
At step 1, sex (being female) contributed 5% to the variance in anxiety 
(Fchange = 5.96, p  < 0.05), but it did not explain any significant variance in 
depressed mood. Clinical status variables (pain, mobility, self-care) entered at step 
2  added 1 2 % of the variance in anxiety (Fchange = 5.46, p  < 0 .0 1 ) and 2 0 % in 
depressed mood (Fchange = 8.51, p  < 0.001). In order to analyse the relative 
contribution of pain and functional status (mobility and self-care), both were also 
separately entered into the model. Pain accounted for significant variance when 
entered either before or after functional status. Functional status failed to make a 
significant contribution if it was entered after pain, suggesting that pain mediated 
the relationship between functional status and distress. At step 3, disease impact on 
daily life contributed a further 1 1 % to the variance in anxiety (Fchange = 14.37, p  
< 0 .0 0 1 ) and 7% of the variance in depressed mood (Fchange = 9.64, p  < 0 .0 1 ). 
Life events entered at step 4 explained an additional 9% of the variance in anxiety 
(Fchange = 12.32; p  < 0 .0 0 1 ), but did not contribute to the variance in depressed 
mood. When life events were entered before disease impact, the same results were 
revealed as in the reversed order. Social support at step 5 added 5% to the variance 
in anxiety (Fchange = 5.14, p  < 0 .0 1 ), and 4% to the variance in depressed mood 
(Fchange = 3.08, p  = 0.05). If social network and perceived support were entered 
separately, only perceived support made a significant contribution to the variance 
in anxiety and depressed mood. Coping strategies at step 6  did not add any more 
significant variance to anxiety or depressed mood. Also when entry order of social 
support and coping strategies was reversed, the latter did not make a significant 
contribution. All independent variables accounted for a total amount of 44% of the 
variance in anxiety and 36% of the variance in depressed mood.
One year after diagnosis, psychological distress was related to the same set of 
predictors at that time. Entering these predictors in multiple regression analyses, 
they explained even 55% variance in anxiety and 45% in depressed mood. The 
greater amount of explained variance mainly arose from a stronger contribution of 
social support variables (9% in anxiety and 8 % in depressed mood), and a
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significant contribution of the coping strategies (avoidance and distraction) in 
anxiety and depressed mood (4% and 6 %, respectively).
Taken together, the amount of psychological distress shortly after diagnosis 
could be best predicted by female sex, high levels of pain and disease impact on 
daily life, the occurence of more life events and low levels of perceived social 
support. Pain seems to mediate the relationship between functional status and 
psychological distress. One year after diagnosis, relationships were replicated, but 
the contribution of social and personal coping resources were stronger.
Predictors o f the Course o f Psychological Distress in the First Year After 
Diagnosis
Change in clinical status and psychological distress 1 year after diagnosis. One 
year after diagnosis, there was a mean decrease in five of the six clinical status 
measures (see Table 1). Improvements in clinical status were reflected by a 
decrease in ESR (z = -3.64, p  < 0.001), Thompson's joint scores (z = -3.24, p  < 
0.001), and pain (t = 2.71, p  < 0.01) as well as an increase in grip strength (t = - 
4.27, p  < 0.001) and mobility (t = -3.05, p  < 0.01) one year after diagnosis. 
However, psychological distress was rather stable (Table 1). The mean levels of 
anxiety and depressed mood were not changed after one year. Looking at 
individual changes, improvements (more than 0.5 SD) occurred in 18 patients 
(19%) in anxiety and 17 patients (18%) in depressed mood. A deterioriation in 
psychological distress occurred in 13 patients (15%) in anxiety and 24 patients 
(25%) in depressed mood.
Predictors o f change in psychological distress. In order to evaluate the extent to 
which the independent variables shortly after diagnosis predicted the individual 
patient's course of psychological distress within one year, a hierarchical multiple 
regression analysis was conducted with the distress levels one year after diagnosis, 
entering distress levels shortly after diagnosis at the first step. Again, only those 
variables were entered in the regression model which were significantly related to 
at least one of the outcome measures. For this purpose, residual gain scores of 
anxiety of depressed mood were calculated. Of the set of predictors, only sex, ESR 
and social network were significantly related to change in anxiety or depressed 
mood (see Table 2). Hierarchical regression analyses indicated a strong 
autoregressive effect for psychological distress over time, accounting for 57% of 
the variance in anxiety (Fchange = 118.23, p  < 0.001) and for 43% in depressed 
mood (Fchange = 68.95, p  < 0 .0 0 1 ). At step 2  and 3, sex (being female) 
contributed 2% and high levels of ESR contributed 1% to the variance in anxiety 
change (Fchange = 5.17, p  < 0.05; Fchange = 3.84, p  < 0.05 respectively), but did 
not add variance to depressed mood change. At step 4, the size of the social 
network did not make a significant contribution in anxiety change, but a smaller 
social network added 3% to the variance in depressed mood change (Fchange = 
4.83, p  < 0.05).
Table 2 Stepwise Multiple Regression Predicting Psychological Distress at Study Entry (Tl) and 1 Year Later (T2) from Selected
Predictors at Study Entry a
Anxietv Tl
P AR 2
Depressed mood Tl 
r p AR 2 r
Anxietv T2
P AR 2
Depressed Mood T2 
r p AR 2
Psychological distress Tl
Anxiety b 76** .6 8 ** 2 7 **
Depressed mood b .6 6 ** .61** .43**
Demographic variables .05* . 0 2 .0 2 * . 0 0
Age -.17 - .1 1 .07 .16
Sex .24* .1 1 .17 .09 .2 1 * .13 .13 .06
Education .07 .0 2 -.04 - . 0 2
Clinical status Tl .1 2 ** .2 0 ** .0 1 * .0 0
ESR .08 .05 .2 1 * .14* .1 0 .08
Thompson score .13 .1 2 -.03 .05
Grip strength -.15 -.05 -.14 - . 1 2
Pain 2 9 ** .03 .40** .2 0 * . 0 0 - .1 1
Mobility 29** .04 -.34** -.13 -.17 -.14
Self-care -.31** -.05 -.2 1 * .1 1 -.15 -.16
Disease impact Tl .54** 3 7 ** II** .52** .31** 0 7 ** .04 -.06
Life events Tl .40** .24** 09** .25* . 0 2 .0 0 -.14 - . 0 2
Social Support Tl .05** .04* .0 1 .03*
Social network -.28** - .1 1 -.2 1 * -.09 - . 2 0 - .1 1 -.2 2 * -.18*
Perceived support 3 9 ** -.2 0 * -.30** -.18* .15 -.09
Coping strategies Tl . 0 2 .03
Tackl. problems actively -.15 -.17 -.05 -.03
Comforting cognitions -.07 -.10 -.19 -.04
Distraction .2 2 * .03 2 9 ** .19* -.13 -.04
Avoidance .31** .16 .30** .07 .11 .13
Total adj. A i f 4 4 ** .36** .61** .46**
“ Two-tailed probabilities o f  A R2 ( / -change), r  (calculated with anxiety and depressed mood T l and the residual gain scores), and |3 (f-test). Selection 
criterion was the significant association with one o f the measures o f psychological distress (anxiety or depressed mood T l and the residual gain scores). 
b Zero order correlation. * p < 0 .0 5  ** p <  0.01.
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Due to the significant mean improvements in clinical status, the extent to which 
changes in psychological distress were related to parallel changes in clinical status 
were also examined. Pearson correlation coefficients revealed that a decrease in 
anxiety and depressed mood was significantly related to a decrease in pain (r  = 
0.42, p  < 0.001; r  = 0.23, p  < 0.05, respectively) and an increase in mobility (r = 
-0.35, p  < 0.01; r  = -0.36, p  < 0.01, respectively) and self-care (r  = -0.32, p  < 0.01; 
r  = -0.21, p  < 0.05, respectively), but not to changes in ESR, Thompson score or 
grip strength. If change in pain, mobility, and self-care were entered into the 
regression analysis at step 4 (after sex, ESR, and social network), they were 
responsible for a further 8 % of the variance in anxiety and 5% variance in 
depressed mood (Fchange = 7.99, p  < 0.001; Fchange = 3.48, p  < 0.05, 
respectively), accounting for a total variance of 69% in anxiety and 51% in 
depressed mood.
Taken together, a decrease in anxiety in the first year after the diagnosis was 
related to male sex and initial lower levels of ESR. A decrease in depressed mood 
was associated with an initially larger social network. In addition, a decrease in 
both distress measures were related to simultaneous improvements in clinical 
status.
DISCUSSION
The amount and prevalence of psychological distress is relatively high in recently 
diagnosed RA patients. Our sample reported significantly higher distress levels 
than healthy subjects with a depression and anxiety prevalence of about 2 0 %, 
which has also been reported in patients with established disease (Bishop et al., 
1987; Frank et al., 1988; Murphy et al., 1988). In line with research of Meenan et 
al. (1991), it can be concluded that recently diagnosed patients do not differ 
dramatically from chronic patients in the amount of distress they are experiencing. 
Psychological distress also appeared to be a rather stable phenomenon for our 
group RA patients, and an adaptation to the disease seems not to have taken place 
(yet) in the first year after diagnosis. Psychological adaptation may be indicated by 
a reduction or stability of distress with a simultaneous deterioriation of the disease 
state. While clinical status improved, probably due the positive effects of the 
medication therapy (van der Heide et al., 1994b), the mean level of psychological 
distress did not change, and percentages of patients whose distress improved or 
deterioriated were about the same.
For the understanding of psychological distress shortly after diagnosis, the 
multimodal assessment of demographic variables, clinical and life stressors, and 
social resources was shown to be important in the current study. The amount of 
distress shortly after diagnosis could be substantially explained by sex, functional
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status and pain, disease impact at daily life, stressful life events, and perceived 
social support. All these factors were also related to the amount of distress one year 
later. Their relationship with distress therefore seems to be relative stable within 
the first year of the disease.
How do our findings relate to findings in studies of patients with RA of longer 
disease duration? The role of pain and functional status with regard to distress have 
been previously demonstrated in recently diagnosed patients (van der Heide et al., 
1994a) and in patients with more established disease (Newman et al., 1989; Brown, 
1990; Nicassio & Wallston, 1992; Wolfe & Hawley, 1993). In our sample of 
recently diagnosed patients, pain mediates the relationship between functional 
status and distress; a finding that was not observed in patients with longstanding 
RA (Wolfe & Hawley, 1993). A worse functional status, such as found in 
longstanding RA (Wolfe & Cathey, 1991), may figure as an additional stressor to 
pain, while the less worse functional status of recently diagnosed patients may be 
more clearly associated with pain. Moreover, pain and functional status may be 
more clearly related to current disease activity in the early phases of RA, while 
being distinct outcomes of past disease activity in the advanced phases. In addition 
to pain and functional status, the experienced impact the disease has on daily life, 
such as work, recreation and relationships was very important for higher levels of 
distress, as has also been suggested in studies of patients with longstanding RA 
(Devins et al., 1992; Brons et al., 1993; Katz & Yelin, 1995). Less evidence in 
patients with longstanding RA has been found for the experience of major life 
events (e.g., Brons et al., 1993) which figures as an additional stressor in anxiety in 
recently diagnosed patients. Results suggest that the additional effects of clinical 
and life stressors are especially important at an early stage of the disease when 
patients are less experienced with the stressors of a chronic disease. Irrespective of 
stressors, qualitative aspects of social support, such as the perceived availability of 
support, seem to be beneficial for the amount of distress in recently diagnosed 
patients, as has been demonstrated in patients with a more established disease (i.e., 
Brown et al., 1989b; Goodenow et al., 1990). Considering the greater amount of 
variance social support explained one year later, this effect might increase with 
longer disease duration. Although the suggested direction of the predictors has 
been partly confirmed in patients with established disease, the direction of the 
relationships may be reversed or at least be reciprocal. For instance, it may be the 
case that higher distress levels also cause a higher sensitivity to pain, lead to the 
report of the occurence of more life events and affect the perception of experienced 
disease impact on daily life and receipt of support.
Predictors for an increase in psychological distress in the first year after 
diagnosis were female sex, an initially higher inflammatory activity as indicated by 
ESR, and an initially smaller social network. Women did not only have higher 
levels of anxiety shortly after diagnosis, but their sex in itself was also a risk factor 
for an increase in anxiety after one year. After taking the influence of sex into
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account, patients with a greater inflammatory activity, indicated by higher levels of 
ESR shortly after diagnosis, had a higher risk of an increase in anxiety one year 
later. However, ESR was not related to the amount of anxiety shortly after 
diagnosis. While the amount of psychological distress shortly after diagnosis is 
related to directly experienced health outcome measures such as pain and 
functional status, measures more clearly reflecting the disease process such as ESR 
are predictive of the course of distress in the first year of the disease. Longitudinal 
studies in patients with longstanding RA have demonstrated that sex as well as 
ESR are both predictors of future functional status (Sherrer et al., 1987). 
Considering that the course of psychological distress was relative strongly related 
to the course of functional status and pain in the first year after diagnosis in our 
sample, the relation between the predictors and the course of distress may be 
parallel to the development of function. Posthoc analyses indeed demonstrated that 
female sex and higher levels of ESR both also predicted a worse functional status 
after one year (self-care and grip strength, respectively). Results suggest that the 
course of psychological distress in the first year of the disease depend on similar 
factors than the course of the clinical outcome. Indicators of psychological 
adaptation may be therefore only visible in patients with a less severe disease 
process and less ongoing disability.
For changes in depressed mood, the magnitude of the social network predicted 
changes after one year. Patients who were less imbedded in a social network 
shortly after diagnosis showed an increase in depressed mood after one year. Such 
a prognostic effect for the quantitative aspect of social support seems to be in 
contrast with findings in patients with a more established disease (e.g., Brown et 
al., 1989b). An extended social network which probably offers broad resources of 
support (emotional as well as instrumental) seems to be more important for the 
psychological adaptation of a patient shortly after diagnosis, when usual patterns of 
life are disturbed and many life domains have to be reorganized, than at a more 
progressive stage of the disease. Network-enhancing interventions, for example, by 
offering support groups and facilities of interdisciplinary health care teams, may 
promote the well-being of recently diagnosed patients.
Our predictors allow the identification of risk factors for an increase in 
psychological distress in the first year after diagnosis, but their overall explained 
variance was rather small. One explanation may be that one year is too short to 
discover a larger influence of psychological factors on the development of distress. 
Probably due to beneficial effects of the medication therapy, psychological 
changes instead covary more strongly with changes in clinical status. Studies in 
patients with a longer disease duration partly failed to find a relationship between 
changes in clinical status and psychological functioning (McFarlane & Brooks, 
1988). If associations were found, they only occurred in patients with relatively 
dramatic flares of disease activity (Bishop et al., 1987) or seem to be most strong 
over a short period of time (Wolfe & Hawley, 1993). At a later phase of the
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disease, the function of social and personal coping resources seems to increase. In 
our study, contribution of social support was stronger one year after diagnosis than 
on first assessment, and coping strategies did modify the relationship between 
stressors and distress only one year after diagnosis. After a personally threatening 
event, such as the occurrence of a chronic disease, the general way to cope with 
stress of daily life may be disturbed, old types of coping behavior may not be 
appropriate any more to deal with new stressors, and new behavior has not been 
established yet. Effects of readjustment processes, which derive from the personal 
coping resources available, may be part of a more longstanding process and be 
only visible over a longer period of time and at later stages of the disease.
Results of our study underline the importance of a multimodal assessment and 
consultation in recently diagnosed patients, including demographic variables, 
clinical and life stressors, and social support characteristics which are relevant for 
the understanding of distress shortly after diagnosis and which highlight risk 
factors for less psychological adjustment to the disease in the first year. Besides 
medical treatment, psychological adjustment of patients may be optimized by 
support-enhancing health care facilities in the first year after diagnosis. The 
influence of personal coping factors seems to be more important at a later stage of 
the disease.
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3.1.3 Predictors of psychological distress
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ABSTRACT
Heightened levels of anxiety and depressed mood are known to be common 
consequences of rheumatoid arthritis (RA). We examined the role of stress- 
vulnerability factors in the long-term course of anxiety and depressed mood in 
patients with early rheumatoid arthritis. Specifically, the role of personality 
characteristics (neuroticism, extraversion), physical and psychological stressors 
(clinical status, disease impact on daily life, major life events), and coping and 
social support at the time of diagnosis were studied to predict changes in anxiety 
and depressed mood 3 and 5 years later. For this purpose, anxiety and depressed 
mood, predicted from clinical and self-reported assessments of stress-vulnerability 
factors at the time of diagnosis in 78 patients with RA, were assessed again after 3 
and 5 years. Results indicated that a worse clinical status, more neuroticism, and 
lower education level at the time of diagnosis were all significantly related to 
increased psychological distress at the 3 and 5-year follow-ups. However, the 
personality characteristics of neuroticism proved to be the most consistent and 
effective predictor of anxiety and depressed mood after 3 and 5 years, irrespective 
of initial distress levels, biomedical factors, use of medication, and other stressors 
or vulnerability factors. Results of this study demonstrate the prognostic value of 
personality characteristics for long-term susceptibility to distress in patients with 
early RA, and emphasize the importance of paying close attention to factors 
unrelated to RA when screening for patients at risk.
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INTRODUCTION
The diagnosis of a chronic, disabling disease such as rheumatoid arthritis (RA) can 
have a significant impact on an individual’s daily life, since patients have to deal 
with a potentially uncontrollable, unpredictable, long-term condition that may 
affect almost all aspects of their physical, psychological, and social functioning 
(Fex et al., 1998; van Jaarsveld et al., 1998). Although most patients seem to adjust 
well to the changes imposed by the disease and find an acceptable level of well­
being, about 2 0 % suffer heightened levels of anxiety and depression, comparable 
to those of people with anxiety and depressive disorders (Frank et al., 1988; 
Murphy et al., 1988; Hawley & Wolfe, 1993; Smedstad et al., 1996; Evers et al., 
1997). To understand the individual variability in psychological adjustment to RA, 
research has focused on identifying risk factors for patients for whom the 
confrontation with the chronic disease seem to exceed their adaptive capacities and 
who become highly distressed.
On the basis of stress-vulnerability models (Brown & Harris, 1978; Lazarus & 
Folkman, 1984; Leventhal et al., 1984; Steptoe, 1998), different stressors and 
vulnerability factors have been proposed to affect distress levels in patients with 
RA. For example, chronic, disease-related stressors, such as a worse clinical status 
due to more disease activity, pain and functional disability, and the psychological 
impact of the disease on daily life due to limited possibilities in daily activities or 
changes in social relationships have been shown to affect anxiety and depression in 
patients with RA (Hawley & Wolfe, 1988; Brown, 1990; van Lankveld et al., 
1993; van der Heide et al., 1994a). Further, major stressful life events are known to 
be important predictors of long-term distress in the general population (Kessler, 
1997; Mazure, 1998) and may similarly affect distress in patients with RA (Grady 
et al., 1991; Affleck et al., 1994; Dekkers et al., 2001). Regarding vulnerability 
factors, the manner of coping with stress and the level of social support have been 
shown to have an effect on well-being in patients with RA and direct, mediating, or 
moderating effects on the stress-illness relationship. Based on general distinctions 
between active, problem-focused coping and passive, avoidant coping, it has 
repeatedly been found that the use of more passive coping strategies is 
prospectively related to heightened distress in RA (Felton & Revenson, 1984; 
Brown et al., 1989a; Smith & Wallston, 1992; Scharloo et al., 1999). Similarly, 
patients with RA with less social support - in terms of the quantity, i.e., the size of 
their social network, as well as the quality, i.e., the perceived availability of 
support - have been shown to adjust less successfully to their chronic condition 
(Brown et al., 1989b; Affleck et al., 1994; Evers et al., 1997). Attention has also 
been directed to the influence of relatively stable personality characteristics as 
vulnerability factors for maladjustment in patients with RA (Affleck et al., 1992; 
Persson et al., 1999). Two dimensions in particular, neuroticism, the tendency to be 
relatively more tense and emotionally unstable, and extraversion, the tendency to
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be relatively more sociable and impulsive, are related to health and well-being in 
various chronic diseases, including RA (Harkins et al, 1989; Affleck et al., 1992; 
Smith et al., 1995; Persson et al., 1999; Phillips & Gatchel, 2000). In addition, 
personality characteristics are assumed to be crucial in accounting for the effects of 
stressors, coping, and social support on long-term distress, since people with high 
neuroticism and low extraversion report more physical complaints and stressful life 
events, experience less social support, and engage in more dysfunctional coping 
behavior (Costa & McCrae, 1987; Harkins et al, 1989; Watson & Pennebaker, 
1989; McCrae, 1990; Affleck et al., 1992; Smith et al., 1995; Persson et al., 1999; 
Phillips & Gatchel, 2000).
So far, empirical evidence supports a link between stress-vulnerability factors 
and psychological distress in RA patients. However, definite conclusions about the 
specific kinds of variables and their relative contributions cannot be drawn from 
present research, since a comprehensive test of various stressors and vulnerability 
factors has rarely been conducted. In addition, patients have usually been followed 
for relatively short periods of time in prospective studies, and the extent to which 
the kinds of predictors and strength and direction of effects for short-term 
outcomes can be generalized to long-term outcomes is largely unknown (Suls & 
Fletcher, 1985). Moreover, stressors and vulnerability factors have usually been 
assessed in patients with longstanding RA. Stress-vulnerability factors are known 
to be affected by the disease process, its biopsychosocial consequences, and 
pharmacological treatment (van Lankveld et al., 1993; Fex et al., 1998; van 
Jaarsveld et al., 1998, 2000; Penninx et al., 1999), and they may consequently be 
more validly assessed in recently diagnosed patients. In addition, an identification 
of stress-vulnerability factors in recently diagnosed patients may allow patients to 
be screened at the earliest possible time after contacting a rheumatologist, at 
diagnosis.
We investigated the predictive value of a comprehensive set of stress- 
vulnerability factors at the time of diagnosis for the long-term course of 
psychological distress in early RA. The role of stress-vulnerability factors at the 
time of diagnosis has previously been studied by our group, to predict 
psychological distress in the first year after diagnosis (Evers et al., 1997). 
However, stressors and vulnerability factors scarcely predicted the course of 
distress in the first year after diagnosis. In this study, follow-up results after 3 and 
5 years are presented. Specifically, the role of personality characteristics 
(neuroticism, extraversion), stressors (clinical status, disease impact on daily life, 
major life events), coping, and social support at the time of diagnosis was studied 
to predict anxiety and depressed mood 3 and 5 years later. It was expected that 
more neuroticism and less extraversion, higher levels of stressors, greater use of 
passive coping, and less use of active coping as well as less social support would 
predict an increase in psychological distress after 3 and 5 years. We further 
examined whether stressors, coping, and social support account for the effects of
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personality characteristics on long-term psychological distress (mediating effects 
of stressors, coping, and social support). Finally, we explored whether the 
maladaptive effects of stressors on psychological distress might be increased in 
patients with more unfavorable vulnerability factors (moderating effects of 
personality characteristics, coping, and social support on stressors).
METHODS
Sample and Procedure
The study sample consisted of outpatients with recently diagnosed RA from 
five hospitals in the Utrecht area of the Netherlands. All patients participated in 
one of two medical trials of second-line anti-rheumatic drugs (van Jaarsveld et al., 
2000; van Everdingen et al., 2002). Inclusion criteria for the medical trials were a 
minimum age of 18 years, diagnosis according to the 1987 American College of 
Rheumatology (ACR) criteria (Arnett et al., 1988), and a duration of disease of less 
than one year. Exclusion criteria were comorbid conditions that might interfere 
with one of the medication strategies (such as malignancy, cardiac, respiratory, 
hepatic, and renal insufficiency), previous or current treatment with second-line 
anti-rheumatic drugs, use of glucocorticoids, cytotoxic or immunosuppressive 
drugs, possible pregnancy or breast feeding, and psychiatric or mental disturbances 
that severely interfere with adherence to the study protocol. All incoming patients 
from the hospitals who met the inclusion criteria were asked to participate in the 
medical trials. About 25% of the patients did not agree to be randomized, but there 
were no differences found between these patients and participants in terms of their 
levels of disease activity. From the remaining 394 patients participating in the 
medical trials, a subgroup of 1 0 0  patients were randomly selected for participation 
in the present study.
Patients were informed about this study by their rheumatologists during their 
first visit, when ACR criteria were assessed. About three weeks later (range 0-12 
weeks), clinical and self-report data were assessed during their second visit. This 
second visit was also the starting point for the prospective medical trials. Five 
patients did not return the questionnaires at this assessment point, resulting in 95 
patients who participated in the study at the time of diagnosis. In addition to 
assessing clinical and self-report data at the beginning of the study and at the 1 - 
year follow-up (Evers et al., 1997), data on disease activity, functional disability, 
pain, and psychological distress was again collected at the 3 and 5-year follow-ups.
Of the 95 patients who correctlly completed self-report data at the first 
assessment, 78 (82%) completed all assessment points during the 5-year study 
period. Participants in the follow-up were predominantly female (69%), married 
or living with a partner (76%), and had a primary (32%) or secondary (57%)
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education level. Mean age at the time of entering the study was 57 years (range 
20-82 years). In terms of dropouts, 7 patients died, 2 moved, 1 was in remission 
and not longer treated in the rheumatology outpatient clinic, and 7 did not 
complete the questionnaires for the follow-up assessments. When entering the 
study, dropouts did not significantly differ from participants in terms of 
demographic variables (sex, age, marital status, education level), disease activity, 
pain, functional disability, disease impact on daily life, experience of major life 
events, personality dimensions of extraversion, coping, or social support. 
However, dropouts scored higher on both indicators of psychological distress (t = 
2.61, p  < 0.05 for anxiety and t = 2.24, p  < 0.05 for depressed mood) and on the 
personality dimension of neuroticism (t = 2.87, p  < 0.01) than patients who 
completed all assessment points.
When included in the medication trials, all patients were randomly assigned to 
one of the medication strategies. The drug trials lasted at least two years for all 
patients, but medication strategies were continued unless adverse reactions of 
ineffectiveness made discontinuation inevitable in the opinion of the attending 
doctor. In that case, one of the other medication strategies from the trials was 
usually prescribed. The distribution of medication strategies was as follows: 30% 
and 23% of the patients used non-steroidal anti-inflammatory drugs (NSAID) alone 
at first assessment and at the 5-year follow-up, respectively; the other patients took 
NSAID in combination with methotrexate (30% and 49%, respectively), 
intramuscular gold (14% at both assessment points), hydroxychloroquine (15% and 
9%), prednisone (11% and 1%) or other second-line medication, prescribed only 
for individual patients (4% at the 5-year follow-up). At the 5-year follow-up, 31% 
of the patients still used the initially prescribed medication (6 % NSAID alone, 17% 
methotrexate, 4% intramuscular gold, 3% hydroxychloroquine, and 1% 
prednisone), while 65% used another medication strategy from the drug trial (17% 
NSAID alone, 32% methotrexate, 10% intramuscular gold, 6 % hydroxy­
chloroquine), and 4% of the patients used another second-line medication than 
those used in the medication trials. Finally, no patient in the psychosocial study 
met removal criteria during the study period, i.e. the occurrence of other serious 
disease processes or an incorrect RA diagnosis.
Measures
Demographic variables were assessed with a general checklist for patients’ sex 
(0 = male, 1 = female), age, and marital status (0 = unmarried, 1 = married). In 
addition, education level was measured using 7 categories that can be classified as 
primary, secondary, and tertiary education levels, representing on average 7, 12, 
and 17 years of education, respectively.
Disease activity was determined by erythrocyte sedimentation rate (ESR; 1-140 
mm/h) and by Thompson’s joint score ratings of the simultaneous presence of 
swelling and pain in 38 joints (Thompson, 1987). A composite score of both
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variables was used, in accord with regular use of composite scores of disease 
activity that consist of at least ESR or another acute phase reactant and a joint 
score (e.g. the modified Disease Activity Score, Prevoo et al., 1995). The 
composite score was calculated by adding the standardized scores (z-scores) of 
both indicators.
Functional disability was assessed using a composite score of one clinical 
measure and two self-report measures (Evers et al., 1998a). The clinical measure 
consisted of grip strength assessments with a Martin vigorimeter (the mean of three 
measurements on both hands was calculated). Self-reported functional disability 
was assessed with the Mobility and Self-care scales of the Impact of Rheumatic 
Diseases on General Health and Lifestyle (IRGL; Huiskes et al., 1990a; Evers et 
al., 1998b), a questionnaire derived from the Arithritis Impact Measurement Scales 
(AIMS, Meenan et al., 1980), which assesses physical, psychological, and social 
health in patients with rheumatic diseases. Research has shown that the reliability 
and validity of the IRGL scales are highly satisfactory (Huiskes et al., 1990a; Evers 
et al., 1998b). The Mobility and Self-care scales, which assess the functional 
capacities of the lower and upper extremities, respectively, over the last month (15 
items) have been shown to be highly comparable to the AIMS physical functioning 
scales (Evers et al., 1998b). Cronbach’s alpha in the present study was 0.89 for 
both scales. A composite score of the clinical measure of grip strength and the two 
Mobility and Self-care self-report scales was calculated by adding the standardized 
scores (z-scores) of all indicators. A higher composite score indicates higher levels 
of functional disability.
Pain was assessed with the IRGL Pain scale ( 6  items), measuring the severity 
and frequency of painful episodes and swollen joints and duration of early morning 
stiffness in the last month. Cronbach’s alpha in the present study was 0.88.
Psychological distress was measured with the IRGL Anxiety and Depressed 
Mood scales. The Anxiety scale is a shortened version of the Dutch State Anxiety 
Scale (10 items) (Spielberger et al., 1970; van der Ploeg et al., 1980), assessing 
anxiety levels in the last month. The Depressed Mood scale ( 6  items) is derived 
from Zwart and Spooren’s questionnaire (Zwart & Spooren, 1982) and assesses 
various depressed mood states over the previous week. Cronbach’s alpha for the 
Anxiety and Depressed Mood scales in the present study were 0.91 and 0.94, 
respectively.
Disease impact on daily life was measured with the IRGL Disease Impact scale 
( 1 0  items), which assesses the general impact of the disease on several areas of 
daily life (i.e. work, leisure, relationships, sexuality, eating). Cronbach’s alpha in 
the present study was 0.87.
Major life events were measured with a Dutch version of the Life Experience 
Survey (LES), assessing the occurrence of 60 stressful events related to health, 
work, financial circumstances, relationships, living, and personal matters in the last 
12 months (Sarason et al., 1978; van de Willige et al., 1985). To minimize
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confounding effects between major life events and disease impact on daily life, 
four disease-related events were excluded (occurrence of severe disease, important 
changes in health status, hospital admission, surgery).
Personality dimensions, i.e., neuroticism and extraversion, were measured with 
a Dutch version of the Eysenck Personality Questionnaire (EPQ; Wilde, 1970; 
Eysenck & Eysenck, 1991). Cronbach’s alpha in this study was 0.90 for 
neuroticism and 0.79 for extraversion.
Coping strategies were assessed with the Utrecht Coping List (UCL; Schreurs 
et al., 1993), a well-documented coping questionnaire used in the Netherlands 
(e.g., Evers et al., 1997; Scharloo et al., 1999), adopted from Westbrook 
(Westbrook, 1979), which measures on a 4-point Likert scale active and passive 
coping strategies when dealing with everyday problems. Active coping was 
assessed with the Problem Focusing scale (7 items), measuring cognitive and 
behavioral efforts to apply goal-oriented problem-solving strategies. Passive 
coping was measured with the Avoidance scale ( 8  items), measuring cognitive and 
behavioral attempts to avoid, escape from, and acquiesce when facing everyday 
problems. Cronbach’s alpha in the study was 0.85 for the Active and 0.67 for the 
Passive coping scales.
Social support in the past six months was measured with the IRGL social 
functioning scales, reflecting a quantitative and qualitative aspect of social support. 
The quantitative aspect was assessed by the size of the social network, i.e. the 
number of friends and family members with whom patients associate. The 
qualitative aspect was measured with the Perceived Support scale (5 items), 
inquiring about perceived availability of emotional and instrumental support. 
Cronbach’s alpha for the Perceived Support scale was 0.88.
Statistical Analyses
The number of patients scoring on anxiety and depressed mood equal to or 
higher than mean scores of psychiatric outpatients and patients with a clinical 
anxiety and depression diagnosis was determined by comparing scores to mean 
scores of representative norm groups in Dutch populations of psychiatric 
outpatients and patients with a clinical anxiety or depression diagnosis (van der 
Ploeg et al., 1980; Zwart & Spooren, 1982). To study mean linear changes in 
clinical status and psychological distress over time, a general linear model with 
repeated measurements was applied for every indicator of clinical status (disease 
activity, functional disability, pain) and psychological distress (anxiety and 
depressed mood), using the variables at the different assessment points as 
dependent variables, followed by posthoc tests in the case of significant linear 
changes.
To explore the relationship between stress-vulnerability factors at the time of 
diagnosis and changes in anxiety and depressed mood after three and five years, 
Pearson correlation coefficients were calculated between the stress-vulnerability
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factors at first assessment and the change scores of anxiety and depressed mood at 
the 3 and 5-year follow-up. Residual gain scores were used to measure changes in 
anxiety and depressed mood (Kerlinger, 1975). Residual gain scores take into 
account the individual baseline levels and control for regression to the mean 
effects. Residual gain scores were calculated by regressing the outcome variable at 
the follow-up assessment (e.g. depressed mood at the 3-year follow-up) on the 
baseline score of the outcome measure (e.g. depressed mood at the time of 
diagnosis). Sequential regression analyses were then performed to study the 
relative contribution of the stress-vulnerability factors to anxiety and depressed 
mood at the 3 and 5-year follow-up. Anxiety and depressed mood at the 3 and 5- 
year follow-up were used as dependent variables. In the first step, anxiety and 
depressed mood assessed at the time of diagnosis were entered, reflecting residual 
gain scores. In the following steps, the different predictors were entered that were 
significantly related to the residual gain scores of anxiety and depressed mood at at 
least one follow-up assessment. These predictors were entered in consecutive steps 
in the regression analyses to test their additional contribution in terms of significant 
Fchange, after taking into account the variance explained by the other predictors. 
The grouping of variables in a step as well as the entry order of the steps was 
determined a priori by the stress-vulnerability model (e.g., indicators of clinical 
status were entered in one step together, and they were entered after the more 
stable characteristics of demographic variables and personality characteristics). 
However, entry order between steps was also changed to study the single 
contribution of every step, above the variance already explained by the baseline 
scores of anxiety and depressed mood. The strength of the beta (standardized 
regression coefficients) and the accompanying t-test were used as an indicator of 
the relative contribution of a predictor in comparison to all other predictors that are 
tested in the model, independent of entry order.
Possible mediating effects were determined according to the procedure 
described by Baron and Kenny (1986): when both a predictor and a possible 
mediator explain significant variance in a dependent variable, the mediator is 
entered before the predictor in the sequential regression analyses to reveal whether 
the predictor does not any longer explain significant variance, when taking the 
influence of the mediator into account. Moderating effects were explored by 
entering centered interaction terms between the predictor and the moderator in the 
regression analyses, after controlling for their main effects. Due to the relatively 
large number of explorative tests performed in these analyses, a more conservative 
threshold of p  < 0.001 was used. To control for possible confounding effects of 
medication, Pearson correlation coefficients were calculated between the use and 
duration of every medication strategy prescribed at the time of diagnosis and 
changes in anxiety and depressed mood at the 3- and 5-year follow-ups. In the 
event of a significant correlation, the effects of the medication strategy was taken 
into account by entering the medication strategy at step 2  before the stress-
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vulnerability factors in the regression analyses. Statistical analyses were all 
conducted with SPSS/Windows 9.0 with a minimum of 76 patients sharing 
complete data sets.
RESULTS
Clinical and Psychological Health Status during the Study Period
Levels of clinical status (disease activity, functional disability, and pain) and 
psychological distress (anxiety and depressed mood) when entering the study were 
comparable to those previously reported in representative samples with recent or 
longstanding RA (Huiskes et al., 1990a; Meenan et al., 1991; Evers et al., 1998b) 
(see Table 1 for means and SDs of clinical status and psychological distress levels 
during the study period).
During the 5-year period, there was a significant improvement in clinical 
status. Both indicators of disease activity, pain and one of the functional disability 
measures, grip strength, significantly decreased within 5 years after diagnosis 
(F(3,73) = 22.2, p  < 0.001 for ESR; F(3,73) = 10.6, p  < 0.01 for the joint score; 
F(3,75) = 9.6, p  < 0.01 for pain; F(3,75) = 14.5, p  < 0.001 for grip strength). 
Posthoc tests indicated that this improvement in clinical status was most obvious 
in the first year of the disease: all indicators decreased in this year (t = 3.06, p  < 
0.01 for ESR; t = 3.25, p  < 0.01 for the joint score; t = 2.20, p  < 0.05 for pain; t = 
4.29, p  < 0.001 for grip strength) (Evers et al., 1997), possibly due to the 
beneficial effects of medication (van Jaarsveld et al., 2000; van Everdingen et al., 
2002). After the first year of the disease, clinical status remained relatively stable, 
as indicated by nonsignificant posthoc tests between 1 and 3 years and between 3 
and 5 years, with one exception: ESR significantly decreased further between 1 
and 3-year follow-up (t = 3.11, p  < 0.01), but not between 3 and 5-year follow-up. 
In contrast to the considerable improvement in clinical status, mean psychological 
distress remained relatively stable during the study period. Although an overall 
decrease was found for anxiety during the 5-year study period (F(3,73) = 4.37, 
p  < 0.05), posthoc tests between the different assessments points were all 
nonsignificant. In addition, depressed mood did not change significantly during 
the study period.
Examining risk groups for psychological distress at the different assessment 
points, 32-39% and 18-26% of the patients scored equal to or higher than the 
mean scores of psychiatric outpatients on depressed mood and anxiety, 
respectively, while 17-21% and 12-21% scored equal to or higher than the mean 
scores of patients with a clinical depression or anxiety diagnosis, respectively 
(van der Ploeg et al., 1980; Zwart & Spooren, 1982).
Coping and Social Support in Psychological Distress II - 109
Table 1 Means and SDs of Clinical and Psychological Health Status at the Time of 
Diagnosis and at the 1, 3, and 5-Year Follow-ups in 78 RA Patients
Disease activity and pain
ESR Joint score Pain
M SD M SD M SD
Diagnosis 29.4 22.3 97.5 100.7 15.8 4.9
1-yr. Follow-up 23.6 22.4 66.7 75.7 14.6 5.4
3-yr. Follow-up 17.7 13.2 63.4 90.4 14.0 5.6
5-yr. Follow-up 2 0 . 0 14.7 73.1 1 1 0 . 6 13.7 5.3
Functional disability a
Grip strength Mobility Self-care
M SD M SD M SD
Diagnosis 32.2 2 2 . 0 19.5 6 . 1 24.2 5.9
1-yr. Follow-up 40.2 26.0 2 1 . 1 5.8 25.1 5.7
3-yr. Follow-up 43.1 24.4 20.9 6.4 25.9 6 . 1
5-yr. Follow-up 41.9 24.8 20.3 6 . 6 25.1 6.5
Psychological distress
Anxiety Depressed mood
M SD M SD
Diagnosis 18.75 6.23 3.72 4.76
1-yr. Follow-up 18.75 6.91 3.16 4.15
3-yr. Follow-up 18.07 5.39 3.32 4.08
5-yr. Follow-up 17.46 6.16 2.84 4.08
a Lower levels o f  grip strength, mobility and self-care indicate higher levels o f functional disability.
Predictors o f Anxiety and Depressed Mood at the 3 and 5- Year Follow-ups
Correlations between stress-vulnerability factors at the time of diagnosis and 
change of anxiety and depressed mood at the 3 and 5-year follow-ups are presented 
in Table 3. Results indicated that the personality dimension of neuroticism was 
significantly related to an increase in depressed mood at both assessment points 
and an increase in anxiety at the 5-year follow-up. Moreover, a worse clinical 
status was related to an increase in psychological distress: higher levels of disease 
activity and functional disability were associated with an increase in anxiety at the 
5-year follow-up, and higher levels of functional disability were related to an 
increase in depressed mood at the 3 and 5-year follow-ups. Nonsignificant 
correlations were revealed between changes in anxiety and depressed mood at both
Table 2 Correlations at the Time o f  Diagnosis




3. Educational level _ 4o*** -.31**
4. Marital status -.03 -.18 .09
Personality characteristics
5. Neuroticism . 0 0 . 2 1 - . 1 1 - . 1 2
6 . Extraversión -.13 -.15 . 0 1 . 1 0 - 3 5 **
Clinical status
7. Disease activity -.16 .18 . 0 2 . 0 0 .18 . 0 0
8 . Functional disability .07 .38** - . 1 1 .05 -.03 4 5 ***
9. Pain -.26* -.14 .17 . 1 0 .14 .04 4 5 *** . 2 1
Psychological stressors
10. Disease impact -.03 . 2 0 -.05 - . 2 1 4 3 *** -.15 .30** 41*** 32**
11. Major life events -.28* -.06 .31** . 0 0 .34** . 0 1 . 0 2 . 0 2 . 2 2 . 2 2
Coping
12. Active probl.-focusing -.33* 32** .14 -.18 .26* -.05 -.25* .08 - . 1 2 . 2 2
13. Passive avoidance . 1 0 .13 - . 0 2 -.06 32** -.23* .13 . 0 1 .19 . 1 1 .05 .06
Social Support
14. Social network -.08 -.30* .13 .14 -.18 .24* . 1 2 -.16 . 0 0 -.08 - . 1 2 .26* .08
15. Perceived support -.16 - . 1 0 . 1 0 .16 -.17 .03 .04 - . 0 2 .03 - . 0 2 -.19 .24* - . 0 2 .26*
Psychological distress
16. Anxiety . 0 0 .25* -.03 - . 2 0 7 4 *** _ 40*** .16 .26* .30** 5 5 *** 40*** - . 1 1 .28* -.28* -.24*
17. Depressed mood .04 .13 - . 1 0 -.14 g4*** _ 3i** .19 .17 4 3 *** 51*** . 2 0 -.18 .25* -.24* -.2 2 * 7 5 ***
* p  < 0.05 ** p  < 0.01 *** p  < 0.001.
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assessment points and the initial assessment of extraversion, pain, disease impact 
on daily life, major life events, coping, and social support. In addition, 
demographic variables of age, sex, and marital status were not related to changes in 
anxiety or depressed mood at follow-up assessments. However, lower education 
level was significantly related to an increase in anxiety and depressed mood at the 
5-year, but not at the 3-year follow-up.
Multiple regression analyses were then performed to study the relative 
contribution of the stress-vulnerability factors for long-term changes in 
psychological distress. Anxiety and depressed mood at the 3 and 5-year follow-up 
were used as dependent variables. In the first step, the initial assessments of 
anxiety and depressed mood at the time of diagnosis were entered, followed by the 
stress-vulnerability factors that were significantly related to changes in anxiety or 
depressed mood at at least one assessment point: education level, neuroticism and 
two indicators of clinical status (disease activity and functional disability), all 
measured at the time of diagnosis. As Table 4 reveals, results showed that lower 
education level significantly predicted anxiety at the 3 and 5-year follow-ups and 
depressed mood at the 5-year follow-up (Fchange = 4.80, p  < 0.05 and Fchange = 
10.00, p  < 0.01 for anxiety at the 3 and 5-year follow-ups, respectively; Fchange = 
5.71, p  < 0.05 for depressed mood at the 5-year follow-up), after taking into 
account the effects of initial levels of psychological distress in the first step 
(Fchange = 54.32, p  < 0.001 and Fchange = 31.04, p  < 0.001 for anxiety at the 3- 
and 5-year follow-up, respectively; Fchange = 44.61, p  < 0 . 0 0 1  and Fchange = 
23.10, p  < 0.001 for depressed mood at the 3 and 5-year follow-up, respectively). 
Neuroticism at step 3 explained significant additional variance to anxiety and 
depressed mood at the 3 and 5-years follow-ups (Fchange = 4.45, p < 0.05 and 
Fchange = 10.28, p  < 0 . 0 1  for anxiety at the 3- and 5-year follow-ups, respectively; 
Fchange = 20.90, p  < 0 . 0 0 1  and Fchange = 13.87, p  < 0 . 0 0 1  for depressed mood at 
the 3 and 5-year follow-ups, respectively), while clinical status at step 4 failed to 
predict additional variance in both measures of psychological distress. As 
presented in Table 4, beta coefficients for the full regression equation showed that 
lower education level significantly predicted more anxiety and depressed mood at 
the 5-year follow-up (t = -2.83; p  < 0.01 and t = -2.27, p  < 0.05, respectively). 
However, neuroticism proved to be the better predictor for depressed mood at the 3 
and 5-year follow-ups (t = 4.19, p  < .001 and t = 3.26, p  < 0.01, respectively) as 
well as for anxiety at the 5-year follow-up (t = 2.77, p  < 0.01). In addition, 
neuroticism tended towards significance in the prediction of anxiety at the 3-year 
follow-up (t = 1.77, p  = 0.08).
Results were very similar when the entry order of predictor variables was 
changed. Education level and neuroticism significantly predicted the same 
indicators of psychological distress, independently of entry order, except that 
education level only tended to predict anxiety at the 3-year follow-up, when 
entered after neuroticism or clinical status at step 3 or 4 (Fchange = 3.55, p  = 0.06
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at step 3 and Fchange = 3.28, p  = 0.07 at step 4). Similarly, when entering clinical 
status at step 2 or 3 in the regression analyses (before education level or 
neuroticism), it still failed to predict significant variance in anxiety at the 3-year 
follow-up and depressed mood at the 3 and 5-year follow-up. However, clinical 
status significantly predicted anxiety at the 5-year follow-up, when entered at step 
2  or 3 (Fchange = 3.98, p  < 0.05 at step 2  and Fchange = 3.79, p  < 0.05 at step 3), 
indicating that education level and neuroticism both accounted for the relationship 
between clinical status and anxiety at the 5-year follow-up. Separate analyses for 
both indicators of clinical status showed that neuroticism and education level only 
explained the variance of functional disability to anxiety at the 5-year follow-up. 
The effect of disease activity on anxiety at the 5-year follow-up still remained 
significant taking into account the effects of education level and neuroticism 
(Fchange = 4.27, p  < 0.05), indicating that disease activity was an additional 
independent predictor of anxiety at the 5 year-follow-up.
Moderator effects were then explored by entering centered interaction terms 
between all stressors and vulnerability factors in the regression analyses, after 
controlling for their main effects. Results indicated that none of the interaction 
terms predicted anxiety or depressed mood at the 3 and 5-year follow-up.
Confounding Effects o f Medication
Correlations between the medication strategies prescribed at the time of 
diagnosis (NSAID alone, NSAID in combination with methotrexate, intramuscular 
gold, hydroxychloroquine, or prednisone) and changes in anxiety and depressed 
mood at the 3 and 5-year follow-up indicated that the use and duration of the 
various medication strategies were not significantly related to changes in anxiety at 
the 3 and 5-year follow-ups or to changes in depressed mood at the 5-year follow- 
up. The only significant associations were those between two medication strategies 
and changes in depressed mood at the 3-year follow-up: the use and duration of 
intake of hydroxychloroquine were related to an increase, and the use and duration 
of intake of prednisone were related to a decrease of depressed mood at the 3-year 
follow-up (r  = 0.33, p  < 0.01 and r  = 0.37, p  < 0.001 for the use and duration of 
hydroxychloroquine, respectively; r  = -0.29, p  < 0.05 and r  = -0.29, p  < 0.05 for 
the use and duration of prednisone, respectively). However, when controlling for 
these variables in the regression analysis (Table 4) by entering these medication 
strategies at step 2  in the regression analyses, neuroticism still significantly 
predicted depressed mood at the 3-year follow-up (Fchange = 11.75, p  < 0 .0 0 1 ), 
after controlling for the baseline levels of depressed mood (Fchange = 42.52, p  < 
0.001) and the effects of the medication strategies (Fchange = 4.29, p  < 0.01). In 
addition, beta coefficients indicated that neuroticism remained the best predictor of 
depressed mood at the 3-year follow-up (beta = 0.41; t = 3.48, p  < 0.001) together 
with the only other significant predictor, the baseline level of depressed mood (beta 
= 0.32, t = 2.84, p  < 0.01).
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Table 3 Correlations between Stress-Vulnerability Factors at the Time of Diagnosis and 
Change in Anxiety and Depressed Mood after 3 and 5 Years a
Change in Change in
anxiety depressed mood
3 yrs. 5 yrs. 3 yrs. 5 yrs.
Demographic variables
Age .05 . 1 2 .03 . 1 2
Sex .04 .09 .17 .13
Educational level - . 2 2 -.34** -.17 -.27*
Marital status . 0 2 . 0 2 .06 .05
Personality characteristics
Neuroticism . 2 0 .27* .39** .33**
Extraversion -.07 -.05 -.08 - . 1 0
Clinical status
Disease activity . 1 1 .23* .18 .19
Functional disability . 2 0 .28* .25* .28*
Pain . 1 0 -.09 -.04 -.04
Psychological stressors
Disease impact .15 . 0 0 .17 .18
Major life events - . 1 2 -.07 .09 .09
Coping
Active problem-focusing - . 1 1 - . 1 0 .08 - . 1 1
Passive avoidance . 1 2 . 1 0 . 2 1 .03
Social support
Perceived support -.09 -.08 -.04 -.06
Social network . 1 0 . 0 0 . 0 2 -.07
a Positive scores indicate that stress-vulnerability factors are related to an increase in anxiety and 
depressed mood.
* p  < 0.05 ** p  < 0.01.
DISCUSSION
A comprehensive set of stressors and vulnerability factors was examined at the 
time of diagnosis for its ability to predict long-term anxiety and depressed mood in 
patients with RA. Results revealed that a worse clinical status, more neuroticism 
and lower education level at the time of diagnosis were all related to an increase in 
indicators of psychological distress after 3  and 5  years, demonstrating that both 
disease-related stressors and psychosocial vulnerability factors can affect long-term 
distress in patients with early RA. However, neuroticism proved to be the most 
consistent and effective predictor, reflecting that this relatively stable personality 
dimension has the best prognostic value for long-term distress susceptibility in 
patients, irrespective of biomedical variables, use of medication, or other stressors 
and vulnerability factors.
Table 4 Multiple Regression Analyses Predicting Anxiety and Depressed Mood at the 3 and 5-year Follow-ups from Stress-Vulnerability Factors 
at the Time of Diagnosis a
Anxiety Depressed mood
3 yrs. 5 yrs. 3 yrs. 5 yrs.
B b A R2 c B A R2 B A R2 B A R2
Psychological distress
Anxiety 4 4 ** 42** .2 1 .30**
Depressed mood .26* .38** .15 24**
Demographic variables
Educational level -.16 .04* -.24** .08** - . 1 0 .0 1 -.2 1 * .05*
Personality characteristics
Neuroticism .24 .03* .37** .08** 48*** 14*** .42** 1 2 ***
Clinical status .0 1 .04 .0 2 .0 2
Disease activity .03 .14 . 1 2 .13
Functional disability .08 . 1 0 - .0 1 -.06
Total A i f 50*** 50*** 5 5 *** 4 3 ***
3 Selection criterion for the inclusion o f  stress-vulnerability factors in the regression analyses was a significant correlation with changes in psychological distress at 
at least one follow-up assessment point (see Table 3). 
b Probability level o f /-test. 
c Probability level o f F-change.
* p <  0.05 ** p <  0.01 *** p  < 0.001.
Coping and Social Support in Psychological Distress II - 115
The predictive value of neuroticism for future distress levels is well 
documented in the general population (Clark et al., 1994). Neuroticism also 
prospectively predicted daily mood disturbances in patients with RA (Affleck et 
al., 1992), suggesting, together with our findings, that this relatively stable 
personality characteristic has prognostic value for short and long-term 
psychological distress in patients with RA. Independently from neuroticism, a 
lower level of education predicted anxiety at the 3  and 5 -year follow-up and 
depressed mood at the 5-year follow-up. As for neuroticism, the prognostic value 
of lower socioeconomic status on future distress is well established in the general 
population (Dohrenwend, 1990) and concurrent and prospective links have also 
been reported in patients with RA (Hawley & Wolfe, 1988; Berkanovic et al., 
1996; Brekke et al., 1999). Irrespective of whether individuals are confronted with 
a long-term chronic condition, such as RA, distress levels seem to be similarly 
affected by the relatively stable personality characteristic of neuroticism and 
education level. In contrast, the relationship of clinical status to future distress did 
not remain significant in regression analyses, except for anxiety levels at the 5 -year 
follow-up. Detailed analyses also revealed that both neuroticism and education 
level accounted for the relationship of functional disability to anxiety at the 5 -year 
follow-up, but not that of disease activity to anxiety at the 5-year follow-up. These 
results are in accord with previous findings showing that individuals with higher 
neuroticism scores and lower education levels are more disabled and complain 
more about physical symptoms, while their biomedical status of disease activity is 
about the same (Costa & McCrae, 1987; Watson & Pennebaker, 1989; Berkanovic 
et al., 1996; Brekke et al., 1999). Consequently, reasons other than RA disease 
activity, such as a lack of health behaviors and perceptions of control or more 
selective processing of bodily signals (Larsen, 1992; Pincus & Callahan, 1995; 
Brekke et al., 1999), may account for the relationship between the physical 
symptoms reported and future distress. Together, these findings strongly suggest 
that RA itself has relatively little, if any, effects on the long-term course of 
psychological distress, and whether individuals become more depressed or anxious 
in the long run is determined by relatively general and stable vulnerability factors.
Although vulnerability factors for psychological distress found in our study 
seem to correspond closely to those in the general and psychiatric populations, this 
does not necessarily imply that neuroticism and education level act in the same 
way in patients with RA as in controls. Indeed, research has revealed specific, 
disease-related mediators in patients with RA for both vulnerability factors. For 
example, the relationship between lower education level and mortality rates in 
patients with RA has been shown to be mediated by an attitude of helplessness 
toward the disease (Callahan et al., 1996), while the relationship of neuroticism to 
future pain reports could be explained by the tendency of patients to catastrophize 
when faced with pain (Affleck et al., 1992). These findings suggest that links of 
neuroticism and education level to future outcomes might be differently
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determined in patients with RA than in the general population, at least with regard 
to physical outcomes. Perhaps even more important, these results also indicate that 
their effects are mediated by actual cognitive and behavioral responses to the 
disease, which can be modified by psychosocial interventions. It may be crucial in 
future research to specify the physiological, cognitive-emotional, behavioral, and 
social mechanisms, in terms of how these factors operate when people are faced 
with a chronic disease and how they affect RA patients’ physical and psychological 
outcomes.
Investigating stress-vulnerability factors at the time of diagnosis enables risk 
factors to be identified in an early stage of RA. However, some possible limitations 
of the study should be recognized. Prospective research is inherently threatened by 
aspects of internal validity, and other unmeasured biomedical or psychosocial 
factors may account for the relationship to long-term distress. In addition, the 
generalizability of our findings might be limited due to some selection bias. All 
patients took part in a long-term clinical trial. Dropouts were also more distressed 
and scored higher on neuroticism than patients who completed all assessment 
points, possibly limiting the generalizability of our findings to patients with RA 
who are only moderately distressed. However, this finding may also be interpreted 
as further evidence of the role neuroticism plays in psychological distress and may 
even have led to an underestimation of its effect on long-term distress.
Irrespective of these limitations, the relative strength of the effects found, 
particularly for the personality characteristic of neuroticism, underline the 
importance of paying close attention to factors other than RA when studying risk 
factors for heightening distress over time. In addition, screening for patients with 
lower education levels and higher levels of neuroticism may be highly 
recommended in clinical practice, since these patients are known to report physical 
symptoms that do not stem purely from RA disease activity. Consequently, they 
may benefit more from educational and multidisciplinary treatments than 
pharmacological treatment alone. While multidisciplinary treatments have been 
shown to be possibly effective in RA (Keefe & van Horn, 1993; Hawley, 1995), 
narrowly focusing on individual variability in these vulnerability factors may 
considerably improve their effects on long-term physical and psychological 
outcomes.
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33.2 Illness Cognitions
Beyond unfavorable thinking: The Illness 
Cognition Questionnaire for chronic diseases
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ABSTRACT
The literature on chronic diseases recognizes the role of illness cognition as a 
mediator between stress and illness. Few conceptualizations and instruments, 
however, give an indication of both unfavorable and favorable ways of adjusting to 
an uncontrollable long-term stressor, such as a chronic disease. The authors 
propose three generic illness cognitions that reflect different ways of reevaluating 
the inherently aversive character of a chronic condition: helplessness as a way of 
emphasizing the aversive meaning of the disease, acceptance as a way to diminish 
the aversive meaning, and perceived benefits as a way of adding a positive 
meaning to the disease. A self-report instrument, the Illness Cognition 
Questionnaire, was developed to assess these cognitions across different chronic 
diseases. The results support the reliable and valid assessment of these illness 
cognitions in patients with rheumatoid arthritis and multiple sclerosis and indicate 
the maladaptive function of helplessness and the adaptive function of acceptance 
and perceived benefits for the long-term physical and psychological health of 
patients with a chronic disease.
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INTRODUCTION
In recent decades, the role of cognition has been extensively recognized in the 
development, maintenance, and modification of emotional disorders and 
psychological well-being (e.g., Beck et al., 1979; Bower, 1981; Lang, 1984). 
Health psychologists have extended this line of research to the impact of health- 
related cognitions on physical health and disease outcomes, largely stimulated by 
stress-illness and self-regulatory approaches (Lazarus & Folkman, 1984; Leventhal 
et al., 1984). In this tradition, it has been commonly assumed that illness cognitions 
are an important mediator between disease and patients’ well-being and that the 
way patients perceive and think about their diseases accounts for much of the 
individual differences in their physical and psychological health status.
A main focus of attention has been the structure of illness cognitions when 
patients are faced with a chronic disease - by definition, an inherently aversive, 
long-term condition with a relatively high degree of uncontrollability and 
unpredictability. Various empirical approaches have identified multidimensional 
patterns of illness cognitions and provided a better understanding of possible 
cognitive reactions to long-term stress (e.g., Leventhal & Nerenz, 1985; Turk et al., 
1986; Weir et al., 1994; Weinman et al., 1996; see also Scharloo & Kaptein, 1997). 
However, evidence of the generic structure across different populations (e.g., 
Schiaffino & Cea, 1995; Heijmans & de Ridder, 1998) and consistent prediction of 
future health status is rare (e.g., Stanton & Snider, 1993; Schiaffino et al., 1998; 
Pakenham, 1999). Instead, constructs broadly related to the concept of control, 
such as helplessness, hopelessness, and cognitive distortion, have most consistently 
been found to predict unfavorable long-term outcomes in various chronic diseases 
(e.g., Greer et al., 1990; DeVellis & Blalock, 1992; Smith et al., 1994; Everson et 
al., 1996; Parle et al., 1996) suggesting that individual differences in adjusting to 
long-term stress can largely be explained by a single dimension of maladaptive 
thinking.
Consistent with the supposed independence of positive and negative affect 
systems (e.g., Costa & McCrae, 1980; Watson & Tellegen, 1985), preliminary 
evidence indicates that assessing positive in addition to negative cognitions 
enhances the predictability of outcomes, such as depression (e.g. Kendall et al., 
1989), suggesting that both adaptive and maladaptive cognitions may be crucial to 
fully understanding individual differences in adjusting to chronic diseases. 
However, the role of possible adaptive cognitions has received far less attention, 
and there is a general lack of cognitive dimensions demonstrating consistently 
beneficial and health-promoting effects (see Gillham & Seligman, 1999). For 
example, although the lack of perceived control has generally been demonstrated to 
be maladaptive, perceived control does not appear consistently beneficial and can 
adversely affect well-being in uncontrollable situations, like disease flare-ups (e.g., 
Schiaffino et al., 1991; Tennen et al., 1992; Newsom et al., 1996; Helgeson, 1999).
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This lack of uniform effects of factors assumed to be adaptive has been frequently 
ascribed to the complexity of adaptive processes in highly uncontrollable situations 
(e.g., Averill, 1973; Silver & Wortman, 1980; Thompson et al., 1988; Smith et al., 
1997). However, recent theoretical approaches have focused more on the cognitive 
reevaluation of the stressor as a necessary component of successfully adjusting to 
reduce adverse effects, without controlling the stressor per se (e.g., Rothbaum et 
al., 1982; Brandtstaedter & Renner, 1992; Thompson et al., 1994; Heckhausen & 
Schulz, 1995).
Considering that evaluative processes, in terms of the meaning ascribed to the 
event, are inherent to adjusting to long-term stress, maladaptive and adaptive 
processes might be relatively uniformly described as cognitive reevaluations of the 
stressor. In relation to positive-negative valence, three types of reevaluations can 
be distinguished when one is faced with long-term stress: (1) cognitions that 
emphasize the negative meaning of the stressor (e.g., with an attitude of 
helplessness or hopelessness), (2) cognitions that diminish the aversive meaning of 
the stressful event (e.g., by accepting the negative impact of the stressor and 
learning to live with it), and (3) cognitions that add a positive meaning to the event 
(e,g, by focusing on additional positive consequences of the stressor). This 
conceptualization of positively and negatively valenced cognitions, reflecting 
dimensions of increased negative, decreased negative, and increased positive 
thinking when one faces long-term stress (see also Kendall, 1992), may provide a 
comprehensive pattern of cognitive adjustment that can uniformly predict the long­
term health status of patients with chronic diseases.
Emphasizing the negative meaning entails focusing on the adverse aspects of 
the disease as an uncontrollable, unpredictable, and unchangeable condition and 
generalizing these consequences to daily functioning. This kind of cognitive 
reaction has been described in helplessness-hopelessness theory as a negative 
explanatory style when faced with a stressful event (Seligman, 1975; Abramson et 
al., 1978, 1989), consisting of negative outcome expectancies, global and stable 
attributions ascribed to the event, and inferred negative characteristics ascribed to 
the self. Considerable research has demonstrated the prominent role of 
helplessness-hopelessness constructs, indicating that they are a prospective risk 
factor for an unfavorable physical and psychological health status in various 
chronic diseases (e.g., Greer et al., 1990; DeVellis & Blalock, 1992; Smith et al., 
1994; Everson et al., 1996; Parle et al., 1996).
In contrast, the aversive meaning of the disease can also be diminished by 
patients’ acknowledging that they are chronically ill and simultaneously perceiving 
the ability to live with and master the consequences of their disease. This cognition 
has previously been described in terms of acceptance (see e.g., Hayes et al., 1994; 
McCracken, 1998). Acceptance means recognizing the need to adapt to a chronic 
illness while perceiving the ability to tolerate the unpredictable, uncontrollable 
nature of the disease and handle its averse consequences. The possible beneficial
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function of this cognition has been supported by concurrent associations with a 
more favorable physical and psychological health status in various chronic 
conditions (e.g., Revenson & Felton, 1989; Summers et al., 1991; Li & Moore, 
1998; McCracken, 1998). Prospective studies have also provided preliminary 
evidence for beneficial long-term effects of this cognition on psychological health 
in patients with cancer and multiple sclerosis (Brooks & Matson, 1982; Carver et 
al., 1993).
One can also add a positive meaning to the disease by perceiving additional 
positive consequences of the stressful condition. A perception of benefits has been 
frequently reported as a reaction to highly uncontrollable and stressful life events 
and to confronting loss (for overviews, see Affleck & Tennen, 1996; Tedeschi & 
Calhoun, 1996; Park, 1997). Three major benefits seem applicable to most patients: 
changes in life priorities and personal goals, positive personality changes, and 
strengthened personal relationships. Aside from preliminary evidence from cross­
sectional studies, prospective studies on rheumatoid arthritis patients and heart 
attack victims have supported the adaptive, long-term impact of perceived benefits 
on psychological and physical health indicators (Affleck et al., 1987; Tennen et al.,
1992).
The concepts of helplessness, acceptance and perceived benefits have been 
studied for various chronic diseases, and findings give preliminary evidence of 
generic, long-term effects on physical and psychological well-being. However, 
various instruments have been used to assess these concepts, measuring them as 
disease-specific cognitions or as traitlike constructs unrelated to chronic illnesses. 
For example, helplessness has been assessed with disease-specific scales for 
various chronic diseases (e.g., Nicassio et al., 1985; Watson et al., 1988; Flor et al.,
1993) or with traitlike measures of general helplessness-hopelessness constructs 
(e.g., Beck et al., 1974; Millon et al., 1982). Similarly, acceptance has been 
assessed with disease-specific scales for patients with disabilities, chronic pain or 
HIV (e.g., Linkowski, 1972; Felton & Revenson, 1984; Thompson et al., 1994; 
McCracken, 1998), and with general coping questionnaires (e.g., Carver et al., 
1989). Self-report instruments for assessing perceived benefits have been 
developed for patients with chronic pain (Tennen et al., 1992) and for individuals 
experiencing severe stress or trauma (Park et al., 1996; Tedeschi & Calhoun,
1996). So far, we know of no instrument that measures these constructs as generic 
illness cognitions across chronic diseases.
The object of our study was to develop a short, reliable, valid questionnaire for 
assessing the a priori constructs of helplessness, acceptance, and perceived benefits 
in patients with chronic diseases. We intended to identify a basic set of illness 
cognitions applicable across a range of chronic diseases that indicate both 
unfavorable and favorable ways of adjusting to chronic diseases. For this purpose, 
we developed the Illness Cognition Questionnaire (ICQ) in a sample of rheumatoid 
arthritis (RA) patients, and we cross-validated the factor structure in a sample of
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multiple sclerosis (MS) patients. Test-retest reliability was assessed in subsamples 
of these groups. We hypothesized that three relatively distinct, reliable, and stable 
dimensions of the a priori illness cognitions would emerge from both patient 
groups. In addition, we examined concurrent validity by studying relationships 
between the ICQ scales and constructs assumed related to illness cognitions in 
stress-illness approaches, such as physical and psychological health outcomes, 
process measures of coping and social support, and two basic personality 
dimensions of the Big Five - neuroticism and extraversion - that have been 
demonstrated to be most significant for health and well-being. On the basis of 
theoretical and empirical literature indicating that helplessness is relatively closely 
related to unfavorable physical and psychological health status, moderately to 
closely related to more neuroticism and less extraversion, and weakly to 
moderately related to more passive coping and less social support (e.g., Costa & 
McCrae, 1980; Nicassio et al., 1985; DeVellis & Blalock, 1992; Smith & Wallston, 
1992; Smith et al., 1994; Everson et al., 1996; Shnek et al., 1997), we expected 
similar relationships to support this scale’s concurrent validity. In contrast, 
relatively opposite relationships provide evidence for the concurrent validity of 
acceptance and perceived benefits (e.g., Affleck et al., 1987; Revenson & Felton, 
1989; Summers et al., 1991; Tennen et al., 1992; Carver et al., 1993; Affleck & 
Tennen, 1996; Li & Moore, 1998; McCracken, 1998). To obtain preliminary 
evidence for discriminant validity between cognitions assumed to be adaptive and 
maladaptive, we expected acceptance and perceived benefits to demonstrate the 
closest associations to positive outcome, personality, and process measures, such 
as positive mood, optimism, and active coping (e.g., Costa & McCrae, 1980; 
Watson & Tellegen, 1985; Zautra et al., 1995; Affleck & Tennen, 1996; Park et al., 
1996; Smith & Christensen, 1996), and we expected that the significance of these 
effects would continue when we controlled for their negative counterparts (i.e., 
negative mood, pessimism, and passive coping). Moreover, we prospectively 
investigated the predictive validity of ICQ scales for the long-term health status of 
RA and MS patients, hypothesizing that helplessness would be related to 
deterioration of patients’ physical and psychological health status, and acceptance 
and perceived benefits to improvement. To obtain additional support for the 
generic character of the illness cognitions, we expected all relationships to be 
relatively uniform in both RA and MS patients and unaffected by the type of 
chronic disease. Finally, because the specificity of health-related constructs has 
been questioned insofar as they reflect aspects of neuroticism or negative 
affectivity (Costa & McCrae, 1980; Watson & Pennebaker, 1989; McCrae, 1990), 
particularly in relation to positive personality, outcome, or process measures (e.g., 
Funk & Houston, 1987; Smith et al., 1989; Green et al., 1999), we controlled for 
confounding effects of neuroticism in all correlational analyses.
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METHODS
Generation o f Items and Scale Development o f the ICQ
On the basis of the proposed conceptualization of illness cognitions, an item 
pool was generated, consisting of newly constructed items and items from existing 
inventories that were revised slightly to assess illness cognitions (Linkowski, 1971; 
Felton & Revenson, 1984; Nicassio et al., 1985; Carver et al., 1989; Tennen et al., 
1992). All items had to meet the following scale construction criteria: be positive 
and unidirectionally formulated in simple, clear language, contain less than 20 
words, be unambiguous and relevant to the proposed construct, and contain a direct 
link between the person and the illness. Respondents were asked to indicate on a 4- 
point Likert scale the extent to which they agree with a list of statements by people 
with a long-term illness (1 = not at all, 2 = somewhat, 3 = to a large extent, 4 = 
completely). The following instruction was used: ‘On the next page is a list of 
statements by people with a long-term illness. Please indicate the extent to which 
you agree with these statements by circling one of the answers following the 
statement. Do not spend too much time considering your answer. Your first 
impression is usually the best.’ Then, an example of how to respond to these 
statements was given.
The item pool was judged on the basis of relevance and comprehensibility by 
several researchers or health care professionals working with patients having a 
wide range of chronic diseases. Subsequently, interviews were conducted with 
patients with different chronic diseases who again evaluated the relevance and 
comprehensiveness of the items. Forty-five items were then selected for future 
research. This initial pool was administered to the RA patients described below. 
Results indicated that none of the items had to be eliminated because of skewed 
distributions (skewness and kurtosis < 1). An exploratory principal-components 
factor analysis with oblique rotation was then performed with the 45-item version 
of the questionnaire. The scree test indicated that a 3-factor solution was 
preferable. Items with a loading above .65 and a difference in loading to the 
secondary factors of .40 or more were retained. Twenty-three items met this 
criterion. In addition, 5 items were discarded because of overlapping contents, 
resulting in 18 ICQ items.
Patients and Procedures
Participants were 263 outpatients with RA from seven participating hospitals 
and 167 patients with MS seeking treatment in one of two MS outpatient clinics in 
the Netherlands. Inclusion criteria for RA were a minimum age of 18 years and a 
diagnosis of RA according to American College of Rheumatology (ACR) criteria 
(Arnett et al., 1988). The RA sample was predominantly female (66%) and married 
(78%) with at least a primary educational level (an average of 7 years of formal 
education) or a secondary educational level (an average of 11-13 years of formal
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education) (25% and 64%, respectively). The mean age was 58.1 years (SD 13.6, 
range 20-85). Mean time since diagnosis was 10.3 years (SD 9.7, range 0-54). 
Inclusion criteria for the MS sample were a minimum age of 18 years and a 
diagnosis of MS according to the revised criteria for definite MS (Poser et al., 
1983). The total group involved 89 relapsing remitting, 68 secondary progressive, 
3 relapsing progressive, and 7 primary progressive patients. Most of the 
participants were female (67%) and married (81%) and had a secondary 
educational level (2% primary and 70% secondary). The mean age was 40.6 years 
(SD 8 .8 , range 21-67). Mean time since diagnosis was 9.4 years (SD 5.9, range 0­
29). In comparison to the RA patients, the MS patients were younger (t(428) = - 
16.15, p  < 0.001) and had a higher educational level (t(428) = 8.07, p  < 0.001); 
there were no differences with regard to gender, marital status, or duration of 
disease.
To examine the temporal stability of the instrument, we administered the 
questionnaire twice to a subsample of 81 RA patients and 67 MS patients, with a 1- 
year time interval. Although a 1-year time interval is rather long for analyzing test- 
retest reliability, the scales are supposed to reflect long-term adjustment and were 
expected to be relatively stable within one year. Patients from these subsamples 
took part in a long-term follow-up study and had a relatively long duration of 
disease (> 7 years). Besides the differences in disease duration (t(261) = 9.47, p  < 
0.001; t(165) = 4.25, p  < 0.001, for RA and MS, respectively), the MS patients in 
this subsample were also older than in the original sample (t(165) = 2.42, p  < 
0.05); there were no differences with regard to gender, marital status, or 
educational level.
For studying concurrent validity, subsamples of 208 RA patients and 134 MS 
patients from the original samples were randomly selected. Clinical and self-report 
measures of physical and psychological health, personality dimensions, coping, 
and social support were simultaneously administered to these patients with the 
ICQ. When possible, the same instruments were used in the two samples to allow 
comparisons of the relationships between different chronic diseases. An exception 
was the disease-specific measurement of the most prominent physical complaints, 
that is, pain in RA patients and fatigue in MS patients. In addition, disease-specific 
measures of disease activity were collected in randomly selected subsamples (106 
RA patients and 88 MS patients). To study predictive validity, we again compield 
the physical and psychological health status outcome measures one year later in 
randomly selected subsamples of 95 RA and 100 MS patients.
Measures
Disease activity was assessed in the RA sample by clinical joint score ratings 
(number of swollen and painful joints; Fuchs et al., 1989). In the MS sample, 
disability was scored by a neurologist on the basis of Kurtzke’s (1983) expanded
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disability status scale. A standardized composite score of these disease-specific 
measures was used as a common indicator of disease activity.
Functional disability was assessed in both samples with a composite score on 
the Mobility and Self-Care scale of the Impact of Rheumatic Diseases on General 
Health and Lifestyle (IRGL; Huiskes et al., 1990a; Evers et al., 1998b), a 
questionnaire derived from the AIMS, which was originally developed to assess 
various aspects of physical, psychological, and social health in arthritis patients. 
Previous research showed reliability and validity of the IRGL scales to be highly 
satisfactory in RA patients (Huiskes et al., 1990a; Evers et al., 1998b), and the 
instrument from which it was derived, the Arthritis Impact Measurement Scales 
(AIMS), has also been shown to be reliable and valid for use in MS patients 
(Schiaffino et al., 1996, 1998). Items of the IRGL scales are scored on a 4 or 5- 
point Likert scale. The Mobility and Self-care scales assess the functional 
capacities of the lower and upper extremities in the past month (15 items). Higher 
scores indicate higher levels of functional disability. Cronbach’s alpha for the 
Functional Disability scale in the present study was 0.98 for RA patients and 0.92 
for MS patients.
Physical complaints were assessed by a standardized composite score from the 
most prominent physical complaint (i.e., pain in RA patients and fatigue in MS 
patients). Pain was assessed with the IRGL Pain scale (6 items), which measures 
the severity and frequency of painful episodes and swollen joints and the duration 
of morning stiffness in the last month. Cronbach’s alpha for the Pain scale in the 
present study was 0.93. Fatigue was assessed with the Fatigue scale (8 items) of the 
Checklist Individual Strength (CIS; Vercoulen et al., 1996), which measures 
patients’ level of fatigue for the previous two weeks. Cronbach’s alpha for the 
Fatigue scale in the present study was 0.92.
Negative mood was measured in both samples with a standardized composite 
score on the IRGL Anxiety and Depressed Mood scales. The Anxiety scale is a 
shortened version of the Dutch State Anxiety Scale (10 STAI items; van der Ploeg, 
Defares, & Spielberger, 1980), that assesses anxiety level in the past month. The 
Depressed Mood scale (6 items) is derived from Zwart and Spooren’s 
questionnaire (1982) and assesses various depressed mood states over the previous 
two weeks. Cronbach’s alpha for the Negative Mood scale in the present study was 
0.97 and 0.94 in RA and MS patients, respectively.
Positive mood was measured in both samples with the IRGL Positive Mood 
scale. The Positive Mood scale (6 items) is derived from Zwart and Spooren’s 
questionnaire (1982) and assesses various positive mood states over the previous 
two weeks. Cronbach’s alpha for the scale in the present study was 0.96 and 0.92 
in RA and MS patients, respectively.
Disease impact on daily life was measured in both samples by the IRGL 
Disease Impact scale (10 items), which refers to the general impact the disease has 
on several areas of daily life (i.e. work, leisure, relationships, sexuality, and
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eating). Cronbach’s alpha in the present study was 0.96 and 0.89 in RA and MS 
patients, respectively.
Personality dimensions, that is, neuroticism and extraversion, were measured 
by a Dutch version of the Eysenck Personality Questionnaire (EPQ; Wilde, 1970; 
Eysenck & Eysenck, 1991). Optimism and pessimism were measured by a Dutch 
version of the Life Orientation Test (LOT; Scheier & Carver, 1985). Cronbach’s 
alpha in the present study were 0.85 and 0.89 for neuroticism, 0.81 and 0.83 for 
extraversion, 0.81 and 0.80 for optimism, and 0.82 and 0.88 for pessimism in RA 
and MS patients, respectively.
Coping strategies were assessed in both samples with the Utrecht Coping List 
(UCL; Schreurs et al., 1993), a well documented coping questionnaire in the 
Netherlands, adopted from Westbrook (1979), which measures active and passive 
coping strategies when dealing with everyday problems, on a 4-point Likert scale. 
Active coping was assessed by a composite score on the strategies of problem 
focusing and comforting cognitions (12 items). Passive coping was measured with 
the strategy of avoidance (8 items). Cronbach’s alpha in the present study was 0.85 
and 0.82 for active coping and 0.73 and 0.68 for passive coping in RA and MS 
patients, respectively.
Social support was measured in both samples with the social functioning scales 
of the IRGL, which assesses qualitative and quantitative aspects of social support 
in the past six months, that is, the level of perceived support (5 items) and the size 
of the social network (number of friends and family members with whom patients 
associate). Cronbach’s alpha for the Perceived Support scale in the present study 
was 0.98 for RA patients and 0.88 for MS patients.
RESULTS
Principal Components Analysis and Confirmatory Factor Analysis
A principal components factor analysis with oblique rotation was performed in 
the RA sample. The scree test and the eigenvalues above 1 indicated that a 3-factor 
solution was preferable, explaining 62% of the total variance. Table 1 shows the 
items of the 3 factors with the rotated factor loadings in this sample. The factors, 
labeled according to the a priori constructs as Helplessness, Acceptance and 
Perceived Benefits, all consisted of 6 items and explained 19%, 34%, and 10% of 
the variance, respectively. The composition of the factors was completely in 
accordance with the a priori assignment of items, demonstrating loadings on the a 
priori factor above .65, with a .40 or greater difference in loading on the secondary 
factors. The three-factor model for the ICQ items was then tested in the MS sample 
by using confirmatory factor analyses (AMOS 4.0; Arbuckle, 1994). Two different 
confirmatory factor analyses were performed, testing an orthogonal and an oblique
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Table 1 Principal-Component Factor Analysis with Oblique Rotation in Patients with RA, and 
Means and Standard Deviations, Cronbach’s Alpha and Test-Retest-Reliability in Patients 
with RA (n=263) and MS (n=167) a
Helplessness Acceptance Benefits
15. My illness frequently makes me feel helpless. .81 -.35 -.03
12. My illness limits me in everything that is .81 -.41 . 0 2
important to me.
5. My illness controls my life. .80 -.36 . 0 0
1 . Because o f my illness, I miss the things I like to do .76 -.23 - . 0 2
most.
9. My illness prevents me from doing what I would .76 -.27 -.03
really like to do.
7. My illness makes me feel useless at times. .77 -.33 - . 0 1
10. I have learned to accept the limitations imposed by - . 2 2 .85 .34
my illness.
3. I have learned to live with my illness. -.30 .84 .30
13. I can accept my illness well. -.34 .84 .24
17. I can cope effectively with my illness. -.39 .82 . 2 2
2 . I can handle the problems related to my illness. -.40 .79 .29
14. I think I can handle the problems related to my -.3S .73 .24
illness, even if  the illness gets worse.
4. Dealing with my illness has made me a stronger -.03 .27 .79
person.
6 . I have learned a great deal from my illness. . 0 0 .31 .79
18. My illness has taught me to enjoy the moment -.04 .27 .78
more.
8 . My illness has made life more precious to me. . 0 2 .35 .75
16. My illness has helped me realize w hat’s important - . 1 1 .31 .71
in life.
1 1 . Looking back, I can see that my illness has also -.04 .03 .65
brought about some positive changes in my life.
Means (SD)
RA 12.66 (4.24) 16.65 (4.20) 15.20 (4.22)
MS 13.44 (4.40) 15.7S (4.37) 15.53 (4.46)
Cronbach’s alpha
RA .SS .90 .S4
MS .SS .91 .S5
Test-retest reliability
RA .79 .76 .74
MS .73 .7S .6 S
a The following items are adjusted from existing scales: items 4, 6 , 8  and 16 (Tennen et al., 1992), 
items 1, 7 and 9 (Felton & Revenson, 1984; Linkowski, 1972), items 5 and 17 (Nicassio et al., 1985), 
and item 3 (Carver et al. 1989). Factor loadings above 0.60 are in boldface type.
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solution. The fit indices consistently indicated a highly satisfactory fit (with fit 
indices above 0.90) only for the oblique model (X (132, N=167) = 230.91, p  < 
0.001; Comparative Fit Index = 0.94; Tucker-Lewis Index = 0.93; Incremental 
Goodness-of-fit Index = 0.94). When comparing the two models, the oblique 
model also had a significantly better fit than the orthogonal model (x2 diff (3, 
N=167) = 79.02, p  < 0.001).
Psychometric Properties
Reliability. Means and standard deviations, Cronbach’s alpha, and test-retest 
reliability for RA and MS patients are presented in Table 1. Cronbach’s alpha 
demonstrated adequate internal consistencies for all scales, ranging from 0.84 to 
0.91 in the samples. In addition, Pearson product-moment correlation coefficients 
between the two measurement points indicated high test-retest reliability for all 
scales in both samples (all above 0.67).
Intercorrelations among the scales. Intercorrelations between the scales 
revealed nonsignificant to moderate relationships. Helplessness and Acceptance 
were moderately negatively correlated in both samples (r = -0.43, p  < 0.001; r  = 
-0.45, p  < 0.001 for RA and MS patients, respectively), whereas Acceptance and 
Perceived Benefits were moderately positively correlated (r  = 0.36, p  < 0.001; r  = 
0.46, p  < 0.001 for RA and MS patients, respectively). The correlation between 
Helplessness and Perceived Benefits was nonsignificant in the RA sample (r = 
-0.03, ns), and weakly negative in the MS sample (r = -0.19, p  < 0.05).
Relationship to demographic variables and duration o f disease. Gender 
differences were not found between the scales. Nor were the scales significantly 
related to age and educational level, with the exception of a weak negative 
correlation between Helplessness and education level in the RA sample (r  = -0.23, 
p  < 0.001) and a weak negative correlation between age and Perceived Benefits in 
the MS sample (r = -0.18, p  < 0.05), indicating greater Helplessness for patients 
with a lower education level in the RA sample and more Perceived Benefits among 
younger patients in the MS sample. In addition, duration of disease was related to 
Helplessness in both samples (r = 0.19, p  < 0.01; r  = 0.20, p  < 0.05 for RA and 
MS, respectively), to Perceived Benefits in the RA sample (r = 0.17, p  < 0.01), and 
when controlling for age, to Perceived Benefits in the MS sample, (r = 0.16, p  < 
0.05), indicating increased helplessness and perceived benefits for patients with 
longer duration of disease. Because there is preliminary evidence that cognitive 
adjustment takes place particularly in the initial years of a chronic disease (e.g., 
Cassileth et al., 1984; Smith et al., 1997; Evers et al., 1998a), correlations with 
duration of disease were also calculated for patients with a maximum disease 
duration of 5 years (123 RA patients and 47 MS patients). Whereas correlations 
with Helplessness and Perceived Benefits were no longer significant in these
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subgroups, significant correlations were found in both samples with Acceptance (r 
= 0.24, p  < 0.01; r  = 0.30; p  < 0.01 for RA and MS, respectively), indicating 
increased acceptance during the initial years of the disease.
Table 2 Correlations and Partial Correlations (Controlling for Neuroticism) between the 
Illness Cognition Questionnaire Scales and the Criterion Measures of 
Concurrent Validity in Patients with RA and MS (n=342)
Helplessness Acceptance Benefits
Criterion measures r pr r pr r pr
Physical health 




























































































a Disease activity was assessed in subsamples o f 194 patients (106 RA and 88 MS). 
b The most prominent physical symptom was assessed (i.e. pain in RA and fatigue in MS). 
* p  < 0.05 ** p  < 0.01 *** p  < 0.001 (two-tailed).
Concurrent Validity
Pearson’s correlation coefficients between the ICQ scales and the measures of 
concurrent validity were first calculated separately for the RA and MS samples. As 
expected, results demonstrated a very similar pattern in the direction and strength 
of correlations in both samples. Multiple regression analyses were then performed
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to examine possible differences in the relationships between the ICQ scales and the 
measures of concurrent validity between the two samples. In the first two steps, 
illness category (RA and MS) and one of the ICQ scales were entered, followed by 
their centered interaction term in the third step. As anticipated, the interaction 
between illness category and the scales of the ICQ were nonsignificant for all 
measures of concurrent validity with one exception: that between illness category 
and Acceptance for the prediction of functional disability. Separate analyses 
revealed that Acceptance was significantly related to lower levels of functional 
disability in RA patients but not in MS patients. Because of the uniform pattern of 
all other criterion measures in both illness groups, we subsequently calculated 
correlations for both samples together.
As shown in Table 2, the direction and magnitude of the correlations closely 
corresponded to hypothesized relations. Illness cognitions of Helplessness were 
moderately (r = 0.25 - 0.45) to relatively highly (r  > 0.45) related to a worse 
physical and psychological health status, that is, more pronounced levels of disease 
activity, functional disability and physical complaints, increased negative mood 
and decreased positive mood, and increased impact of the disease on daily life. In 
personality dimensions, helplessness was highly related to more neuroticism and 
less optimism and moderately related to less extraversion. For coping and social 
support measures, weak to moderate correlations were found with the more 
frequent use of passive coping, less frequent use of active coping, and less social 
support.
A nearly opposite pattern emerged for Acceptance. Although correlations with 
physical health were somewhat lower than for Helplessness, Acceptance was 
relatively highly related to a better psychological health, less neuroticism, and 
more optimism. In addition, weak to moderate correlations were found with more 
extraversion, higher levels of active coping, and more social support. A similar 
pattern became apparent for Perceived Benefits, although the general strength of 
the correlations was overall lower than for Acceptance. As expected, Acceptance 
and Perceived Benefits in particular correlated highly with positive outcome, 
personality, and process measures (positive mood, optimism, and active coping). 
This pattern became even more evident when we controlled for their negative 
counterparts (negative mood, pessimism, and passive coping), as correlations with 
positive outcome, personality, and process measures were substantially reduced for 
Helplessness but not for Acceptance and Perceived Benefits. When we controlled 
for the influence of neuroticism for all measures of concurrent validity, correlations 
were overall only marginally reduced for the three scales, and most correlations 
remained significant (see Table 2).
We then performend multiple regression analyses to evaluate the amount of 
variance explained by the three scales and their relative contribution to the criterion 
measures. When we entered all predictors together in one model, illness cognitions 
explained between 5% (for social network) and 45% (for negative mood) of the
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variance in the criterion variables. Beta coefficients indicated that Helplessness 
proved to be a significant predictor for all criterion measures, independent of the 
effects of Acceptance and Perceived Benefits. Acceptance significantly predicted 
all indicators of psychological health, the personality dimensions of neuroticism 
and optimism, and active and passive coping, beyond the effects of Helplessness 
and Perceived Benefits. Perceived Benefits was ultimately an additional significant 
predictor for positive mood, optimism, and active coping, when the effects of 
Helplessness and Acceptance were taken into account.
Table 3 Correlations and Partial Correlations (Controlling for Neuroticism) between the 
Illness Cognition Questionnaire Scales at First Assessment and the Criterion 
Measures of Predictive Validity in RA and MS patients (n=195) a
Helplessness Acceptance Benefits
Criterion measures r pr r pr r pr
Change in 
physical health
Disease activity b .21* .08 -.31** -.20* .00 .05
Functional disability **.2 23** -.09 -.07 -.09 -.07
Physical complaints c .15* .09 **.2-. -.20** -.08 -.05
Change in
psychological health
Negative mood .05 .05 -.17* -.09 -.08 -.04
Positive mood -.13 -.06 .18* .11 .22* **9
Disease impact .16* .15* -.13 -.12 -.07 -.06
a Criterion measures o f  predictive validity were the residual gain scores o f  the outcome measures.
Higher scores indicate an increase in the outcome measure. 
b Disease activity was assessed in RA patients only.
c The most prominent physical symptom was assessed (i.e. pain in RA and fatigue in MS).
* p  < 0.05 ** p  < 0.01 (two-tailed).
Predictive Validity
We examined predictive validity by studying the relationships between the ICQ 
scales at first assessment and change in physical and psychological health within 
one year. To produce reliable change scores, we regressed the health status 
measures at first assessment on the health status measures at second assessment, 
resulting in residual gain scores. Pearson correlation coefficients were then 
separately computed for RA and MS patients. As in the analyses of concurrent
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validity, the relationships between the ICQ scales at first assessment and changes 
in health status measures revealed a relative uniform pattern for the direction and 
strength of the correlations. To examine whether these relationships would be 
different for both samples, we studied the interaction between illness category and 
the ICQ scales for all criterion measures in a series of multiple regression analyses. 
The health status measure at first assessment was entered in the first step, followed 
by illness category (RA and MS) and one of the ICQ scales in steps 2 and 3 and 
their centered interaction term in step 4. According to the results of the single 
correlation analyses, the interaction between the ICQ scales and illness category 
was nonsignificant for all criterion measures with one exception: that between 
illness category and Perceived Benefits when the impact of the disease on daily life 
was the dependent variable. Separate analyses for RA and MS patients revealed 
that benefits significantly predicted a decrease in the impact of the disease on daily 
life in RA patients but not in MS patients.
Pearson correlation coefficients were then computed between the residual gain 
scores and the ICQ scales at first assessment for both samples. Although there was 
hardly any systematic change in physical and psychological health status, as 
indicated by nonsignificant changes in all outcome measures but one (disease 
activity), several significant correlations were found for all three scales in the 
expected direction (see Table 3). Helplessness was primarily related to a 
deterioration of physical health (i.e. an increase of disease activity, functional 
disability, and physical complaints) as well as to an increase in the impact of the 
disease on daily life. Acceptance, in contrast, was related to increases in physical 
and psychological health status. Significant correlations were found between 
Acceptance and a decrease in disease activity and physical complaints, a decrease 
in negative mood, and an increase in positive mood. Finally, Perceived Benefits 
were related to an increase in positive mood. When we adjusted these correlations 
for the influence of neuroticism, most correlations remained significant (see Table 
3). An exception were the correlations between Helplessness and an increase in 
disease activity and physical complaints and between Acceptance and a decrease in 
negative and an increase in positive mood.
Multiple regression analyses were then performed to evaluate the amount of 
variance explained by the three scales and their relative contribution to long-term 
health status measures. When we included all illness cognitions in one model, 
illness cognitions additionally explained between 2% and 9% of variance beyond 
the considerable variance explained by the baseline values of the outcome 
variables (between 27% and 75%). Beta coefficients indicated different predictors 
for all outcome measures. Helplessness significantly predicted an increase in 
functional disability and an increase in the impact of the disease on daily life. 
Acceptance predicted a decrease in disease activity, physical complaints, and 
negative mood. Perceived Benefits predicted an increase in positive mood.
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DISCUSSION
A common characteristic of chronic diseases is their inherently threatening nature, 
as patients are confronted with an incurable long-term condition that imposes 
multiple limitations on functioning in daily life. Individual differences in long-term 
adjustment may be explained by different ways of cognitively reevaluating the 
inherently aversive nature of the disease with constructs such as helplessness, 
acceptance, and perceived benefits. The development of the ICQ provides a self­
report instrument that reliably assesses these cognitions in various chronic diseases 
and shows both unfavorable and favorable ways for adjusting to a chronic 
condition.
The applicability of the questionnaire to different patient populations with 
chronic diseases was indicated by the invariant internal structure in patients with 
RA and MS, revealing a closely corresponding, reliable, and stable pattern of 
cognitive reactions to a chronic disease. Analyses of concurrent validity strongly 
supported the proposed stress-vulnerability approach, in which illness cognitions 
are related to physical and psychological health, personality dimensions, coping, 
and social support, and these relationships proved to be relatively independent of 
the influence of neuroticism. In addition, preliminary evidence for discriminant 
validity between cognitions assumed to be adaptive and maladaptive was provided 
by the relatively stronger correlations of acceptance and perceived benefits with 
positive outcome, personality, and process variables. The corresponding 
correlations in the two samples further indicate the generic nature of these 
cognitions in patients with different chronic diseases. In addition, correlations with 
duration of disease give an initial indication that the scales are sensitive to long­
term adjustment in chronic diseases, suggesting increased acceptance in the first 
years of the disease and increased helplessness and perceived benefits in the longer 
term. Analysis of predictive validity ultimately indicated the expected maladaptive 
and adaptive function of cognitions; that is, helplessness was related to unfavorable 
changes, and acceptance and perceived benefits were related to beneficial changes 
in physical and psychological health. And again, these relationships were relatively 
independent of the influence of neuroticism. The uniformity of these relationships 
in both samples, corresponding to previous findings in a wide range of chronic 
diseases, additionally supports the generic character of the cognitions. Moreover, 
the capacity of the scales to predict different outcome measures supports the utility 
of the multidimensional approach and indicates the distinct function of maladaptive 
and adaptive cognitions in terms of the long-term outcome in chronic diseases.
According to the conceptualization of illness cognitions, our assessment of 
helplessness differs slightly from the original helplessness-hopelessness theory, as 
it directly refers to the aversive consequences of a chronic disease. The advantage 
of this disease-specific concept of helplessness may correspond to its greater 
predictive validity for the physical health status. Our results generally support this
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assumption, demonstrating that helplessness predicted a deterioration of physical 
health, particularly an increase in functional disability. In contrast acceptance 
seemed to have benefits for both physical and psychological health, as 
demonstrated by a decrease in disease activity, physical complaints, and negative 
mood. Relationships to increased psychological health have previously been 
reported in patients with breast cancer and multiple sclerosis (Brooks & Matson, 
1982; Carver et al., 1993), whereas even maladaptive relationships between stoic 
or realistic acceptance and mortality have been reported in AIDS and cancer 
patients (Greer et al., 1990; Reed et al., 1994). The different relationships are 
probably due to differences in conceptualization. Acceptance was assessed as a 
type of resignation in the studies demonstrating maladaptive relationships (Greer et 
al., 1990; Reed et al., 1994), whereas our conceptualization entails the perceived 
ability to live with and master the aversive consequences of the disease. 
Relationships of perceived benefits corresponded most to the hypothesized effects 
of adaptive process variables on positive outcome measures. As in the cross­
sectional analyses, where perceived benefits were most closely related to positive 
outcome, personality, and process measures, the prospective analyses revealed a 
beneficial relationship to an increase in positive mood, corresponding to previous 
prospective findings in rheumatoid arthritis patients and individuals experiencing 
life stress (Tennen et al., 1992; Park et al., 1996).
Instrument development is an ongoing process requiring multiple studies over 
time. We have demonstrated some aspects of reliability and validity, but several 
important psychometric characteristics are missing. One limitation might be that 
the RA and MS populations studied share various common characteristics. Both 
conditions have a medically based diagnosis (unlike chronic fatigue syndrome), are 
in most cases progressive and highly uncontrollable and unpredictable (unlike 
diabetes), lead to physical impairment and confront patients with multiple losses in 
daily life (unlike asthma), and are not directly life threatening, consequently 
requiring long-term adjustment processes to find a way to live with the disease 
(unlike some forms of cancer). Although our conceptualization was theoretically 
and empirically founded on common elements in chronic diseases, future research 
would be warranted in studying psychometric properties in other patient 
populations with chronic illnesses. In terms of construct validity, we did not assess 
relationships between the ICQ scales and similar constructs more directly related to 
perceived control, such as self-efficacy or health locus of control. Previous studies 
comparing these constructs have suggested that the associations between 
acceptance and benefits and perceived control constructs vary particularly in the 
face of highly uncontrollable situations. For example, in RA patients with severe 
pain, perceived benefits and perceived control have been shown to be related to 
favorable versus unfavorable changes in subsequent health outcomes, respectively 
(Tennen et al., 1992). Finally, studies on sensitivity to change by treatment 
modules are clearly recommended.
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What is the additional value of a generic instrument of illness cognitions like 
the present one? Because it contains adjusted constructs of existing single­
dimensional questionnaires, the ICQ can be viewed as an instrument refinement, 
indicating the multidimensional representation of constructs for use in various 
chronic diseases. Instruments that generalize across chronic diseases offer an 
opportunity to compare different conditions and study the possible common 
mechanisms that contribute to individual differences in health outcomes (see e.g., 
Felton & Revenson, 1984). In addition, the simultaneous assessment of both 
maladaptive and adaptive cognitions offers an opportunity to study the relatively 
unexplored role of adaptive mechanisms, for example, how and under what 
circumstances adaptive cognitions buffer the effects of maladaptive ones or show 
rather independent protective effects in adjustments to uncontrollable long-term 
conditions. Finally, research on the possible physiological, affective, and 
behavioral paths linking these cognitions to health and well-being in patients with 
chronic diseases could be encouraged.
Aside from research purposes, the psychometric properties of the ICQ are 
sufficiently high for clinical purposes. The comprehensive assessment of illness 
cognitions, applicable across diverse patient populations with chronic diseases, can 
serve as a complementary tool to medical diagnosis in screening for psychological 
risk factors in patients who may benefit from psychosocial interventions. 
Increasing knowledge about the mechanisms underlying their uniform effects can 
then stimulate the development of generic treatment components for various 
populations. Perhaps even more importantly, the identification of adaptive 
cognitions can lead to expanding these interventions by systematically building 
health-promoting processes (see e.g., Hayes et al., 1999). Particularly in the case of 
an inherently threatening circumstance, like a chronic disease, when the focus of 
attention is automatically directed to negative consequences, an incorporated 
stimulation of adaptive cognitions may considerably enhance the effectiveness of 
psychosocial treatments. With our present conceptualization and assessment of 
illness cognitions, we intended to take one further step in this direction, going 
beyond unfavorable thinking to what others have called a more strength-oriented, 
positive psychology in the face of uncontrollable long-term stress, such as a 
chronic disease (e.g., Gillham & Seligman, 1999).
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ABSTRACT
A heightened reactivity to pain is assumed to play a significant role in the 
maintenance and exacerbation of pain in patients with chronic pain. In a 
prospective study involving 95 rheumatoid arthritis (RA) patients, the relative 
contribution of self-reported cognitive, behavioral and physiological components 
of pain reactivity were examined for a change in pain within 1 year. Regression 
analyses indicated that self-reported physiological reactivity predicted an increase 
in clinical and self-reported pain after 1 year, but not cognitive and behavioral 
reactivity. Neither disease activity nor neuroticism mediated or moderated the 
relationship of pain reactivity to long-term pain. However, structural equation 
modeling revealed that neuroticism directly affected physiological reactivity to 
pain, which in turn was the only significant predictor for subsequent pain. The 
results of this study underline the crucial role of physiological pain reactivity for 
exacerbation of pain in RA patients and are indicative for a symptom-specific 
pattern of physiological pain reactivity that is sustained by psychological 
predisposition and respondent learning processes.
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INTRODUCTION
Pain is the most prominent physical complaint in rheumatoid arthritis (RA), a 
chronic inflammatory disease that primarily affects the joints. Although pain is a 
direct consequence of the disease process, patients’ pain reports are usually only 
moderately related to the underlying pathology, and pain frequently becomes a 
problem in its own right. Variability in biomedical and psychosocial treatment 
outcomes, primarily geared to reducing the aversive consequences of pain instead 
of eliminating it, also indicate that pain remains one of the most complex factors in 
chronically painful disorders, such as RA.
In recent decades, biopsychosocial approaches have conceptualized pain as a 
multifaceted phenomenon that consists of at least three response systems, i.e. 
motor-behavioral, subjective-cognitive, and sensory-physiological components 
(Philips, 1977; Epstein et al., 1978; Lethem et al., 1983; Flor et al., 1990). In line 
with theories of emotion (e.g. Lang, 1968; Rachman & Hodgson, 1974; Borkovec 
et al., 1977), it is assumed that the degree of synchrony of these response systems 
varies: they are not necessarily commonly activated, might be maintained by 
different factors and might have differential effects on treatment outcomes. 
Studying their functional interrelationships and effects on long-term outcomes 
could provide a better understanding of the specificity of processes responsible for 
the maintenance and exacerbation of chronic pain.
In acute pain, pain responses involve the behavioral reaction of interrupting 
activity, cognitive attempts to direct attention to the aversive experiences to find a 
reasonable cause for the pain and prevent further damage, as well as physiological 
processes of heightened autonomic, somatosensory and central nervous system 
activity (see e.g. Flor et al., 1990). In as much as these responses are immediately 
triggered and functional for survival in instances of acute pain, they may be more 
loosely related and less protective in the event of chronic pain. In fact, maintenance 
of these reactions is thought to sustain and exacerbate pain and related outcomes, 
such as functional disability and depression. Based on predisposition and learning 
mechanisms, a habitual pattern of reactivity to pain, including avoidance behavior, 
cognitive preoccupation with bodily signals and heightened physiological arousal, 
might become increasingly chronic. This habitual pattern might be generalized to 
various stimuli associated with pain, function relatively independently of objective 
pathology and intensity of pain, and subsequently affect long-term pain outcomes 
(e.g. Lethem et al., 1983; Linton, 1985; Philips, 1987; Flor et al., 1990; Turk & 
Flor, 1999). Experimental and quasi-experimental studies have provided conside­
rable evidence for the existence of these response patterns in chronic pain patients 
and for their maladaptive effects on pain outcomes, including pain itself.
Behavioral approaches predominantly focus on the prominent role of avoidance 
behavior in the maintenance and exacerbation of chronic pain through processes of 
external reinforcement or anticipatory anxiety (Fordyce, 1976; Lethem et al., 1983;
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Linton, 1985; Philips, 1987). A considerable amount of research assessing 
avoidance behavior on the basis of observed or self-reported pain behavior (e.g. 
Philips & Jahanshahi, 1985b; Vlaeyen et al., 1990; Jensen et al., 1995) has 
demonstrated the major role of avoidance and its relationship to worse long-term 
outcomes in various chronic pain populations, including RA (Evers et al., 1998a; 
van Lankveld et al., 1998, 2000). Experimental studies have also supplied 
preliminary evidence for the maladaptive effects of avoidance on pain, 
demonstrating, for example, that avoidance of exposure can lead to decreased 
tolerance of stressful stimulation in migraine patients (Philips & Jahanshahi, 
1985a).
Research on cognitive factors has emphasized the role of negative outcome 
expectancies with concepts such as catastrophizing or excessive worrying in the 
face of pain (see Keefe et al., 1989; Jensen et al., 1991b; Turk & Rudy, 1992; 
Aldrich et al., 2000). Results from pain coping and cognition measures that assess 
the extent that patients tend to catastrophize in the face of pain (e.g. Rosenstiel & 
Keefe, 1983; Sullivan et al., 1995; Kraaimaat et al., 1997) have provided 
considerable evidence for the prominent role of these cognitions in various chronic 
pain patients and their relationships to unfavorable pain outcomes (e.g. Keefe et al., 
1989; Affleck et al., 1992; Martin et al., 1996). Moreover, experimental and 
longitudinal studies support the unfavorable effects of catastrophic thoughts on 
pain. For example, catastrophizing has been demonstrated to affect pain tolerance 
and pain intensity in experimentally induced pain (e.g. Spanos et al., 1979; Geisser 
et al., 1992; Sullivan et al., 1995). In prospective studies, catastrophizing or 
worrying in the face of pain predicted a worsening of various pain outcomes in RA 
patients (Keefe et al., 1989; Evers et al., 1998a), including pain itself (Keefe et al., 
1989).
On the sensory-physiological level, reactivity to pain has been assumed to be 
particularly manifest in increased autonomic and muscular reactivity as well as the 
sensitization of central structures (Flor et al., 1990; Turk & Flor, 1999). Based on 
predisposition and/or respondent learning processes, these responses might develop 
in a chronic condition into a consistent, habitual pattern of reactivity to pain and 
pain-related stimuli that affect pain and related outcomes (see e.g. Flor et al., 1990; 
Turk & Flor, 1999). Evidence for stress- or pain-related patterns of heightened 
autonomic, somatosensory and/or central responses has been provided among 
various chronic pain patients, including those with RA (Salamy et al., 1983; Flor et 
al., 1985, 1992a, 1997; Jamner & Tursky, 1987; Lutzenburger et al., 1997; see also 
Anderson et al., 1985; Flor & Turk, 1989). Preliminary support also exists for the 
maladaptive function of physiological reactivity patterns on pain outcomes. For 
example, stress-induced increases in symptom-specific muscular tension predicted 
greater pain severity in depressed patients with chronic low back pain (Burns et al.,
1997). In addition, self-reported autonomic arousal in the face of pain, assessed as
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pain-related fears, predicted greater pain severity and more physical complaints in 
heterogeneous groups of chronic pain patients (McCracken et al., 1996, 1998).
In conclusion, there is empirical support for a multidimensional reactivity 
pattern to pain and its maladaptive effects in chronic pain patients. However, 
research usually focuses on just one component of response systems, such as pain 
behaviors, cognitive constructs or physiological responses (see Philips, 1987; Flor 
et al., 1990; McCracken et al., 1996). Other conceptualizations assess reactivity to 
pain as composite constructs without differentiating between response systems (see 
Jensen et al., 1991), such as pain-coping measures with confounding behavioral 
and cognitive responses (e.g. Brown & Nicassio, 1987). Both approaches preclude 
information about the possibly variable interrelationship between the response 
systems under different conditions and their relative contribution to pain outcomes. 
Integration and systematic comparison of these response systems could possibly 
clarify their common and independent response effects on chronic pain and provide 
a better understanding of the specificity of mechanisms underlying long-term pain.
Stress-vulnerability models suggest that the possible independent effects of the 
response systems might be the result of being differently determined by biomedical 
pathology and psychological vulnerability factors. It is usually assumed that pain 
reactivity is initiated and maintained by biomedical factors in an acute stage, but 
functions increasingly independently in a chronic stage (e.g. Lethem et al., 1983; 
Flor et al., 1985, 1990; Philips, 1987). However, since most of the research has 
been conducted with benign pain syndromes, where there is no biomedical 
indicator of pathology, the role of biomedical factors may be systematically 
underestimated. In pain syndromes with an underlying pathology of inflammatory 
activity, such as RA, where patients are recurrently confronted with unpredictable 
pain flare-ups, a habitual pattern of pain reactivity may be directly triggered and 
maintained by the disease process. In addition, pain reactivity has been 
demonstrated to be affected by psychological vulnerability factors, such as 
neuroticism or negative affectivity. Neuroticism and negative affectivity have been 
demonstrated to be related to avoidance behavior (Harkins et al., 1989; Wade et al.,
1992), catastrophizing (Affleck et al., 1992; Martin et al., 1996) and physiological 
reactivity in chronic pain patients (Vlaeyen et al., 1999), suggesting a common 
underlying predisposition that possibly mediates or moderates the effect of pain 
reactivity on long-term pain (e.g. Affleck et al., 1992; Martin et al., 1996; Burns et 
al., 1997; Vlaeyen et al, 1999).
The purpose of the present study was to study the interrelationships of 
cognitive, behavioral and physiological response systems of pain reactivity in 
patients with RA and their concurrent relationships to disease severity and 
neuroticism. In addition, our object was to prospectively determine the role of 
these response systems for the long-term prediction of pain and study possible 
mediating or moderating effects of disease activity and neuroticism on this 
relationship. It was hypothesized (1) that the three response systems would
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demonstrate closer relationships to neuroticism than to measures of disease 
severity, and (2) that initially higher levels of the response systems would predict 




The sample consisted of 95 outpatients with RA from two participating 
hospitals in the Netherlands. Inclusion criteria were a minimum age of 18 years 
and a diagnosis of RA according to American College of Rheumatology (ACR) 
criteria (Arnett et al., 1988). The sample was predominantly female (61%) and 
married (85%) with at least a primary or secondary level of education (28% and 
63%, respectively). The mean age was 58.9 years (SD 11.6, range 33-82 years). 
The mean time since diagnosis was 15.9 years (SD 9.2, range 4-45 years).
Measures
Several clinical and self-report measures were assessed in the sample at two 
assessment points, with a mean time interval of one year.
Pain was assessed with a composite score of both clinical and self-report 
measures. Clinical pain ratings comprised the number of painful joints (Fuchs et 
al., 1989). Self-reports of pain were assessed with the Pain scale (6 items) of the 
Impact of Rheumatic Diseases on General Health and Lifestyle (IRGL; Huiskes, et 
al., 1990a; Evers et al., 1998b). The Pain scale is a disease specific scale for 
arthritis patients that assesses the severity and frequency of painful episodes and 
swollen joints and the duration of morning stiffness in the past month. Previous 
research showed reliability and validity of the IRGL to be highly satisfactory 
(Huiskes et al., 1990a; Evers et al., 1998b). Cronbach’s alpha of the Pain scale in 
the present study was 0 .86 .
Disease activity was assessed with standardized erythrocyte sedimentation rate 
(ESR) laboratory measurements, which is an indicator of inflammatory activity in 
RA.
Cognitive and behavioral reactiviy to pain were assessed with the Pain Coping 
Inventory (PCI; Kraaimaat et al., 1997; Evers et al., 1998a), a pain coping 
instrument which measures different cognitive and behavioral ways of dealing with 
pain on a 4-point Likert scale, ranging from ‘rarely or never’ (1) to ‘very 
frequently’ (4). Cognitive reactivity was assessed with the passive pain-coping 
scale Worrying (9 items), which measures negative pain cognitions. Representative 
items were: ‘I start worrying when in pain’ or ‘I think that the pain will worsen’. 
Behavioral reactivity was assessed with a composite score of the passive pain
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coping scales Resting and Retreating (12 items), measuring behavioral tendencies 
to restrict functioning and avoid environmental stimuli, respectively. 
Representative items of these scales were: ‘I quit my activities’, ‘I rest by sitting 
or lying down’ or ‘If I am outdoors, I try to return home as soon as possible’. The 
reliability and validity of the PCI was supported by previous research on patients 
with RA, patients with chronic headache pain and patients attending pain clinics 
(Kraaimaat et al., 1997; Evers et al., 1998a). Cronbach’s alpha in the present study 
was 0.74 for the cognitive and 0.77 for the behavioral reactivity to pain.
Physiological reactivity to pain was measured by various self-reported 
physiological reactions to pain, partly derived from the Physiological Anxiety 
Scale of the Pain Anxiety Symptoms Scale (PASS; McCracken et al., 1992). 
Respondents were asked to indicate how frequently they experience physiological 
reactions in the face of pain on a 4-point Likert scale, ranging from ‘rarely or 
never’ (1) to ‘very frequently’ (4). From a total pool of eight items, four items (i.e. 
trouble catching breath, heart racing, pressure in chest and panicking) had to be 
eliminated due to the infrequency of responses endorsed (skewness or kurtosis > 
1.5). The items retained were: ‘When in pain, I become dizzy or weak’, ‘I start 
sweating when in pain’, ‘I become restless when in pain’ and ‘When in pain, I have 
a tight or tense feeling in my body’. Internal scale consistency proved to be 
sufficient, as indicated by Cronbach’s alpha of 0.71.
Neuroticism was measured by a Dutch version of the Eysenck Personality 
Questionnaire (EPQ; Wilde, 1970; Eysenck & Eysenck, 1991). Cronbach’s alpha 
in the present sample was 0.85.
RESULTS
Patient Characteristics
Regardless of the long-term duration of arthritis in our sample (duration of 
disease was approximately 16 years), disease activity and pain levels were 
comparable to what have been previously reported in representative RA samples 
(Huiskes et al., 1990a; Evers et al., 1998b). On average, the moderate level of 
disease severity remained after one year, as indicated by nonsignificant changes in 
disease activity and pain. In addition, mean scores of the pain reactivity response 
systems were relatively stable and did not change within one year.
In terms of individual changes in the dependent variable, however, a review of 
the scatter plot indicated that there was considerable individual variation in pain, 
and 28% (n = 26) and 62% (n = 58) of the patients, respectively, showed a 
worsening or improvement in pain of 1 SD and 0.5 SD during the study period.
144 - Chapter 3.3
Correlates o f Pain and Pain Reactivity
Pearson correlation coefficients between the cognitive, behavioral and 
physiological components of pain reactivity at first assessment indicated a 
moderate correlation between the different response systems (between 0.43 and 
0.49; see Figure 1). In addition, all response systems demonstrated similar 
correlations with disease activity, pain and neuroticism (see Table 1). While 
correlations with disease activity were all nonsignificant, the response systems 
were weakly related or tended to be related to pain and all were moderately related 
to neuroticism, indicating more pain reactivity in patients with higher levels of pain 
and neuroticism. Finally, pain was also weakly related to higher levels of disease 
activity and neuroticism (for both r  = 0.28, p  < 0 .01).
Physiological
Behavioral 0.43 Cognitive
Figure 1 Interrelationships between response systems of pain reactivity. All correlations 
are significant at p < 0 .001.
Predictors o f Long-term Pain
Pearson correlation coefficients between the pain reactivity response systems at 
first assessment and residual gain scores of pain were calculated to explore the 
relationship between pain reactivity and long-term pain. Results indicated that one 
of the three response systems was significantly related to an increase in pain, i.e. 
physiological reactivity (r  = 0.40, p  < 0.001). In addition, behavioral reactivity 
tended to correlate with an increase in pain (r = 0 .20 , p  < 0 .10), while the 
correlation with cognitive reactivity was nonsignificant (r  = 0.07, ns).
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Table 1 Correlates of Response Systems of Pain Reactivity
Behavioral Cognitive Physiological
Disease activity 0.07 0.02 0.16
Pain 0.18 0.23* 0.23*
Neuroticism 0.42*** 0 49*** 0.35**
* p  < 0.05 ** p  < 0.01 *** p  < 0.001.
Stepwise multiple regression analyses were then performed to examine the 
relative contribution of pain reactivity to the change in pain within one year, after 
controlling for possible confounding variables. Pain at second assessment was used 
as the dependent variable, controlling for the baseline scores of pain in the first 
step. The other control variables were entered in step 2, i.e. demographic variables 
(gender, age and educational level), disease activity and neuroticism, all measured 
at first assessment. In step 3, the different components of pain reactivity at first 
assessment were entered in the regression analyses. Results indicated that the best 
predictor for pain at second assessment was the initial level of pain, explaining 
32% of the total variance. The control variables in step 2 did not add any variance. 
Pain reactivity in step 3, however, added 10% of the variance. Beta coefficients 
demonstrated that physiological reactivity significantly predicted an increase in 
pain after one year, but not cognitive and behavioral reactivity (see Table 2). When 
entering the different pain reactivity response systems separately in the regression 
analyses, again only physiological reactivity explained significant variance in long­
term pain.
Table 2 Multiple Regression Analy sis Predicting Long-term Pain
£_______________ Adj. AR2
Pain T1 a 0.38*** 0 32***
Control variables T1 b 0.00




Total adj. AR2 0.42***
a T1: first assessment.
b Control variables: demographic variables (gender, age and educational level), neuroticism T1 and 
disease activity T1.
** p  < 0.01 *** p  < 0.001.
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As visible from the results of Table 2, neither disease activity nor neuroticism 
mediated the effects of pain reactivity on long-term pain. To study possible 
moderator effects of disease activity and neuroticism, centered interaction terms 
with all pain reactivity components were entered in the regression analyses in step 
4. Results again indicated that neither disease activity nor neuroticism moderated 







Figure 2 The significant paths (standardized regression coefficients) of the structural 
equation modeling, testing effects of pain reactivity at first assessment (T1) 
against pain at second assessment (T2), controlling for pain and neuroticism at 
first assessment (T1). Nonsignificant paths are omitted from the analyses. In 
addition, error variances are omitted from the figure for convenience of 
presentation. All paths are significant at p < 0.01.
The relative contribution of pain reactivity to subsequent pain was then tested in 
structural equation modeling, when taking the effects of disease activity and 
neuroticism into account (AMOS 4.0; Arbuckle, 1994). The same models were set 
up for all pain reactivity components in which the effects of pain reactivity at first 
assessment were tested against subsequent pain, controlling for pain, neuroticism 
and disease activity at first assessment. As in the regression analyses, only the
Pain T1
.51
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model for physiological reactivity provided a significant path to long-term pain. 
After omitting nonsignificant paths from this model (from disease activity to 
physiological pain reactivity, as well as from disease activity and neuroticism to 
subsequent pain), an excellent fit was revealed for the final model, in which 
neuroticism directly affected the physiological reactivity to pain. In turn, 
physiological reactivity was the only significant predictor of subsequent pain (X  
(2) = 1.89, p  = 0.39; Goodness of Fit Index (GFI) = 0.99; Tucker Lewis Index 
(TLI) = 1.00; Incremental Goodness of Fit Index (IFI) = 1.00; see Figure 2).
DISCUSSION
A heightened reactivity to pain is assumed to contribute to the maintenance or 
exacerbation of pain in patients with chronic pain (e.g. Flor et al., 1990; Turk & 
Flor, 1999). However, little systematic research has been conducted on the 
different pain reactivity response systems (cognitive, behavioral and physiological) 
and their predictive value for pain in chronic pain patients. The focus of our study 
was to examine interrelationships of the pain reactivity response systems, their 
relationship to biomedical and psychological vulnerability factors and their effects 
on long-term pain in RA patients.
According to the assumed desynchrony of the response systems, the self­
reported behavioral, cognitive and physiological components were moderately 
intercorrelated. This moderate degree of interdependence indicates that the 
response systems are not necessarily commonly activated and represent different 
dimensions of the pain experience, although they affect and probably enhance each 
other. In addition, all response systems demonstrated relatively uniform 
relationships to measures of disease severity and neuroticism. In accordance with 
what has previously been proposed on the basis of stress-vulnerability models (e.g. 
Flor et al., 1985, 1990), pain reactivity was hardly affected by disease severity, 
suggesting that it becomes a habitual response pattern in chronic pain and functions 
independently of actual pathology. In addition, the uniform relationship to 
neuroticism indicates a common underlying predisposition for vulnerability to 
stress. This psychological diathesis seems to be a relatively general pre- 
dispositional factor for heightened reactivity to pain, since correlations between 
neuroticism and avoidance behavior (Harkins et al., 1989; Wade et al., 1992), 
catastrophizing (Affleck et al., 1992; Martin et al., 1996) and physiological 
reactivity (Vlaeyen et al., 1999) have previously been reported in various chronic 
pain populations. Regardless of the similar relationships to these stress- 
vulnerability factors, response systems differently affected long-term pain. Results 
of multiple regression and structural equation modeling clearly indicated that the 
self-reported physiological reactivity to pain was the only significant predictor of
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subsequent pain, independent of the effect of initial pain, disease activity, 
neuroticism and the other response systems. These results are in line with a 
previous cross-sectional study in which the self-reported physiological responses to 
pain predicted pain severity in a heterogeneous group of chronic pain patients, but 
not the behavioral or cognitive responses (McCracken et al., 1996). However, as 
far as we know, this is the first study that has compared response system effects on 
long-term outcomes and demonstrated maladaptive effects of self-reported 
physiological reactivity on chronic pain. Different physiological and/or cognitive- 
attentional mechanisms may account for these results.
Since the self-reported physiological reactivity was not related to disease 
activity and only very modestly to the intensity of present pain, it is unlikely that it 
represents symptomatic manifestations of the RA disease process. This lack of 
relationship to disease severity and the positive relationship to neuroticism instead 
suggest that it may be part of a psychophysiological response pattern. Peripheral 
physiological reactivity patterns in response to stressful and painful events as well 
as delayed return to baseline responses have previously been reported in various 
chronic pain patients (see Flor & Turk, 1989), including those with RA (e.g. Fisher 
& Cleveland, 1962; Moos & Engel, 1962; Walker & Sandman, 1977; Anderson et 
al., 1982), indicating heightened and/or prolonged muscular and autonomic 
reactivity when exposed to pain or stress.
The issue arises in so far as this self-reported physiological reactivity pattern 
reflects a symptom-specific physiological response in RA patients, as repeatedly 
reported in research on chronic benign pain (see Flor & Turk, 1989). Heightened 
EMG levels found only near painful joints support such a response specificity for 
RA patients as well (Moos & Engel, 1962; Walker & Sandman, 1977). In fact, the 
distribution of the self-reported physiological reactions initially assessed in our 
sample may indicate a symptom-specific pattern. Four items that primarily 
reflected respiratory and cardiovascular reactions had to be eliminated, due to the 
infrequency of endorsed responses. In contrast, this differentiation of the response 
pattern has not been reported in other chronic pain patients, where an adjusted 
version of the physiological reactivity scale (including respiratory and 
cardiovascular responses) has been used (McCracken et al., 1992, 1996, 1998; 
Larsen et al., 1997). To further explore the issue of response specificity, posthoc 
item analyses of the physiological reactivity scale were performed. Results 
indicated that all items demonstrated similar relationships to subsequent pain, 
suggesting a physiological response pattern consisting of both autonomic and 
somatosensory components that affect long-term pain. This pattern may be in 
agreement with the heightened and prolonged EMG and skin conductance levels 
that have been reported most consistently in RA patients when comparing 
physiological reactivity patterns to other chronic diseases (Fisher & Cleveland, 
1962; Moos & Engel, 1962; Walker & Sandman, 1977; Anderson et al., 1982; see 
Anderson et al., 1985). Assuming a physiological basis for our self-report scale,
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comparisons of psychophysiological response patterns between patients with RA 
and other chronic pain populations may clarify whether this reflects a RA-specific 
pattern or is part of a general reactivity pattern in chronic pain disorders.
Symptom-specific physiological patterns have frequently been found as 
reactions to pain-related or personally relevant stressors, suggesting that they may 
be enhanced by respondent learning processes (Flor et al., 1990; Turk & Flor, 
1999). Respondent learning processes may also explain the great individual 
differences in self-reported physiological pain reactivity in our sample. Only 40% 
of the patients reported the physiological reactions to pain at least sometimes. In 
this subgroup, autonomic and somatosensory reactivity might have become a 
conditioned response to pain that maintains a pain-tension circle and exacerbates 
pain in the long run (Flor et al., 1990; Knost et al., 1999; Turk & Flor, 1999). 
However, it could also be argued on the basis of respondent learning processes that 
the self-reported physiological reactivity reflects general anxiety arousal, as 
suggested by research on pain-related fears (e.g. McCracken et al., 1992, 1996). 
Pain may then be enhanced due to anxiety-related autonomic and somatosensory 
activation in anticipation and as a consequence of pain (Flor et al., 1990; Turk & 
Flor, 1999). Although the physiological responses of both pain and anxiety have 
been demonstrated to be highly confounding and have considerable overlap (Gross 
& Collins, 1981), the kind of self-reported physiological reactivity in our sample, 
lacking cardiovascular and respiratory responses that are typical for the presence of 
general anxiety syndromes (Borkovec et al., 1977), do not solely support anxiety- 
related physiological reactions.
Admitting the limitation of self-report measures, the self-reported physiological 
reactions may also reflect a bias in attentional and interpretational processes, for 
example, a tendency to amplify pain-related responses, as suggested by research on 
hypochondria and hypervigilance (Pennebaker & Skelton, 1978; Chapman, 1986; 
Barsky et al., 1988; Rollman & Lautenbacher, 1993). Chronic pain patients have 
been shown to overemphasize physical symptoms (Flor et al., 1992b; Flor et al., 
1999), and the high level of chronic pain patients’ physical complaints in general 
and of those with high negative affectivity in particular have been frequently 
ascribed to attentional and interpretational biases (Harkins et al., 1989; Watson & 
Pennebaker, 1989; Affleck et al., 1992; Larsen, 1992; Wade et al., 1992; Smith et 
al., 1995). However, as pain-related fears, attentional and interpretational processes 
can not sufficiently explain the response specificity of the self-reported 
physiological pain reactivity, suggesting that these processes may only indirectly 
affect long-term pain by their relationship to patterns of physiological reactivity.
In contrast to physiological reactivity, behavioral and cognitive reactivity failed 
to affect long-term pain. It could be argued that the lack of effects for cognitive and 
behavioral reactivity might be due to the limited assessment of these responses 
systems with worry and avoidance behavior constructs. However, the selected 
constructs are theoretically grounded, and the present and similar assessments of
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avoidance behavior and worry have previously been demonstrated as predictive of 
various long-term outcomes in arthritis patients (Keefe et al., 1989; Evers et al., 
1998a; van Lankveld et al., 1999, 2000; Steultjens et al., 2001). Preliminary 
evidence also supports specific modality-related effects, depending on the type of 
response system: behavioral responses might most directly affect activity-related 
outcomes; cognitive responses, subjective-cognitive outcomes; and physiological 
responses, sensory-related outcomes. For example, avoidance behavior has most 
consistently been shown to predict functional disability and use of medication in 
prospective and treatment studies (e.g. Linton, 1986; Evers et al., 1998a; van 
Lankveld et al., 1999; Steultjens et al., 2001). Cognitive constructs of worrying or 
catastrophizing, although related to various long-term outcomes, including pain 
(Keefe et al., 1989), have been shown to affect the affective and evaluative 
components of pain, but not the sensory component (Geisser et al., 1994). In 
contrast to the study by Keefe et al. (1989), where a visual analogue scale (VAS) 
pain measure was used, our pain assessment consisted of both clinical and 
comprehensive self-report measurements that mainly reflected sensory aspects of 
pain (Fuchs et al., 1989; Evers et al., 1998b), suggesting - in agreement with 
previous cross-sectional research (McCracken et al., 1996) - that the sensory pain 
aspects are most directly affected by physiological reactivity patterns.
The results of our study, demonstrating effects for physiological pain reactivity 
on long-term RA pain, but not for the behavioral and cognitive reactivity, 
underscore the importance of assessing the response systems separately and 
studying their relative contribution to different pain outcomes. Increasing 
knowledge of the underlying mechanisms could eventually provide a better 
understanding of active treatment components and lead to more effective chronic 
pain modification procedures. For example, a response-specific pattern of 
physiological pain reactivity brings into question the sole application of anxiety- 
based treatments for reducing pain, since they might mainly affect the anxiety 
aspect of pain instead of the actual pain symptoms (Gross & Collins, 1981). A 
better understanding of the specificity of these mechanisms seems to be 
particularly useful for predicting long-term pain, since multidisciplinary treatments 
are currently primarily aimed at modifying secondary outcomes, such as 
depression and disability, instead of pain itself.
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ABSTRACT
Recent developments in chronic pain research suggest that effectiveness of 
cognitive-behavioral therapy (CBT) may be optimized when applying early, 
customized treatments to patients at risk. For this purpose, a randomized, 
controlled trial with tailor-made treatment modules was conducted among patients 
with relatively early rheumatoid arthritis (RA disease duration of < 8 years), who 
had been screened for psychosocial risk profiles. All participants received standard 
medical care from a rheumatologist and rheumatology nurse consultant. Patients in 
the CBT condition additionally received an individual CBT treatment with two out 
of four possible treatment modules. Choice of treatment modules was determined 
on the basis of patient priorities, which resulted in most frequent application of the 
fatigue module, followed by the negative mood, social relationships and pain and 
functional disability modules. Analyses of completers and of intention-to-treat 
revealed beneficial effects of CBT on physical, psychological and social 
functioning. Specifically, fatigue and depression were significantly reduced at 
post-treatment and at the 6 -month follow-up in the CBT condition in comparison to 
the control condition, while perceived support increased at follow-up assessment. 
In addition, helplessness decreased at post-treatment and follow-up assessment, 
active coping with stress increased at post-treatment, and compliance with 
medication increased at follow-up assessment in the CBT condition in comparison 
to the control condition. Results indicate the effectiveness of tailor-made CBT for 
patients at risk in relatively early RA, and supply preliminary support for the idea 
that customizing treatments to patient characteristics may be a way to optimize 
CBT effectiveness in patients with RA.
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INTRODUCTION
In recent decades, the multiple disturbing effects of chronic pain on patients’ 
physical, psychological and social functioning, such as increased functional 
disability and fatigue, heightened levels of anxiety and depression, and impaired 
social and economic functioning, has been widely recognized (e.g., Anderson et 
al., 1985; Chapman & Gavrin, 1999; Maniadakis & Gray, 2000; Gatchel, 2001). 
Medical treatment only partly alleviates these consequences of chronic pain, and 
psychosocial interventions - particularly cognitive-behavioral therapy (CBT) - have 
been shown to be a possibly effective adjunctive treatment for reducing the 
unfavorable effects on patient functioning (see e.g., McCracken, 1991; Hawley, 
1995; Morley et al., 1999; van Tulder et al., 2000).
In spite of the encouraging effects of psychosocial interventions in chronic pain 
disorders, the variability in outcomes between patients and the magnitude and 
maintenance of effects in the long run is a point of continuing discussion (e.g., 
Turk, 1990; McCracken, 1991; DeVellis & Blalock, 1993; Keefe & van Horn, 
1993; Hawley, 1995; Turk & Okifuji, 1998; Gatchel, 2001). Specifically, in 
patients with rheumatoid arthritis (RA), a chronic disabling disease that primarily 
affects the joints, meta-analyses have indicated that psychosocial interventions in 
general, and more specifically also CBT and behavioral treatments, have 
nonsignificant to small effects on indicators of physical and psychological 
functioning at post-treatment, and nonsignificant effects at follow-up assessments 
(Hawley, 1995, Riemsma et al., 2002; see also, McCracken, 1991; Riemsma et al., 
1999). Meta-analyses of CBT for various chronic pain disorders, such as chronic 
low back pain or osteoarthritis, have revealed more promising effects, but 
improvement in magnitude and maintenance of effects is still desired (Hawley, 
1995; Morley et al., 1999; van Tulder et al., 2000). The limited effects of CBT for 
RA and other chronic pain disorders have frequently been ascribed to the 
heterogeneity of patients. Not all patients may receive benefits from generic 
treatments. Instead, customizing treatments more closely to patient characteristics, 
in terms of patient selection and types and timing of treatment, has been repeatedly 
suggested as a way to optimize treatment effectiveness (e.g., Turk, 1990; 
McCracken, 1991; DeVellis & Blalock, 1993; Turk & Okifuji, 1998; van Tulder et 
al., 2000; Gatchel, 2001).
In view of the individual variability between patients with chronic pain, various 
attempts have been made to classify patients into more homogeneous subgroups 
and identify patients that may benefit from psychosocial interventions. For 
example, it has been repeatedly shown in various chronic pain disorders that 
subgroups of patients are relatively well-adjusted and might only receive limited 
benefits from CBT. Instead, it has frequently been suggested that the repeatedly 
identified group of patients with heightened distress levels and dysfunctional 
cognitive-behavioral factors benefit most from CBT (e.g., Turk & Rudy, 1988,
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1990a; Turk, 1990; Main et al., 1992; Klapow et al., 1993, 1995; Strong et al., 
1994; Turk & Okifuji, 1998; Gatchel, 2001). Retrospective analyses of CBT effects 
in fibromyalgia patients provided preliminary support for this view, indicating that 
patients characterized by high distress levels and dysfunctional cognitive- 
behavioral factors benefited more from CBT than those relatively well-adjusted or 
whose impairment was mainly related to social functioning (Turk et al., 1998). In 
RA, it is a well-known fact that subgroups of 20-40% of the patients suffer from 
heightened anxiety and depression levels (e.g., Frank et al., 1988; Murphy et al., 
1988; Hawley & Wolfe, 1993; Evers et al., 1997, 2002a; Dickens et al., 2002). In 
addition, heightened distress levels in RA patients are directly related to cognitive- 
behavioral factors of illness cognitions, coping and social support, and these 
factors have in turn repeatedly been shown to prospectively predict the RA disease 
outcome. Specifically, there is evidence from prospective studies that illness 
cognitions of more helplessness and less acceptance, more passive coping with 
pain or stress, and lower levels of social support predict decreased physical, 
psychological and social functioning in RA patients in the long run (e.g., Brown & 
Nicassio, 1987; Brown et al., 1989a,b; Keefe et al., 1989; Smith & Wallston, 1992; 
Smith et al., 1994, 1997; Evers et al., 1997, 1998a, 2001a, 2002a; van Lankveld et 
al., 1999, 2000; Scharloo et al., 1999). In terms of patient selection, CBT treatment 
for RA patients is consequently likely to show increased magnitude and 
maintenance of effects for subgroups of patients with a psychosocial risk profile, 
including heightened distress levels and more dysfunctional cognitive-behavioral 
factors of illness cognitions, coping and social support.
In relation to treatment specificity, effect studies of CBT usually consist of 
generic treatments with multiple cognitive and behavioral modules, assuming that 
the different components are even relevant and effective for patients. However, in 
view of the various problems from which patients with chronic pain suffer, 
treatment programs applied modularly and tailored to patients’ clinical needs may 
increase the effectiveness of CBT in chronic pain patients (e.g., Turk, 1990; Fry & 
Wong, 1991; Turk & Okofuji, 1998; Gatchel, 2001). The most frequently affected 
areas of pain, functional disability, fatigue, distress and impaired social functioning 
in RA patients are only moderately correlated (e.g., Huiskes et al., 1990a; Evers et 
al., 1997, 1998b; Huyser et al., 1998; see also McCracken, 1991), and these 
outcomes have been shown to be differently predicted by specific cognitive- 
behavioral factors in the long run (e.g., Smith et al., 1994, 1997; Evers et al., 1997, 
1998a, 2001a,b, 2002a; Scharloo et al., 1999). Consequently, the effectiveness of 
CBT in RA may be optimized when interventions focus on specific outcomes of 
impaired functioning and the related cognitive-behavioral factors. In addition, 
applying treatment modules matched to individual patient profiles and directed to 
the outcome from which patients suffer most is likely to increase patient 
satisfaction with treatment and decrease attrition rates (see e.g., Turk & Rudy, 
1990b).
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It has also been assumed that treatment effectiveness depends on the timing of 
treatment, specifically the temporal stages of the illness. For example, it has been 
suggested that patients develop a relatively stable way of coping with chronic pain, 
and dysfunctional cognitive-behavioral factors may be less established and easier 
to modify at an earlier stage of the disease than later on, suggesting increased CBT 
effectiveness for patients suffering for a shorter time from their complaints (e.g., 
Philips & Jahanshahi, 1985b; DeVellis & Blalock, 1993; Peters et al., 2000; 
Sinclair & Wallston, 2001). In addition, interventions at an earlier stage of the 
disease have by definition a greater chance of having more long-term benefits and 
possibly preventing a worse long-term disease outcome, such as irreversible joint 
destruction in RA patients (Parker & Wright, 1995). Dysfunctional cognitive- 
behavioral factors’ predicting a worse long-term disease outcome in RA patients 
has been shown to be already established in the initial years of the disease (Evers et 
al., 1997, 1998a, 2002a; Smith et al., 1997). In addition, retrospective analyses of 
previous CBT trials suggest improved effectiveness in patients with earlier RA, 
indicating more favorable changes in patients with a shorter duration of disease, 
particularly within the first 7 years (Kraaimaat et al., 1995a; Sinclair & Wallston, 
2001). Moreover, a recently conducted CBT trial with early RA patients was the 
first controlled trial demonstrating beneficial effects on depression at post­
treatment and follow-up assessment (Sharpe et al., 2001). Taken together, this 
provides preliminary evidence that CBT conducted at a relatively early stage of RA 
may improve effectiveness in the short and long terms.
Recent developments in multidisciplinary treatment for chronic pain 
increasingly include the regular care of nurse specialists, consisting of providing 
information and education about the medical treatment and counseling and advice 
on disease-related problems in daily life (e.g., Hill, 1997; Madigan & FitzGerald, 
1999; Ryan, 2001; Temmink et al., 2001 for rheumatology). In rheumatology care, 
there is preliminary evidence supporting various beneficial effects of the care of a 
nurse specialist on indicators of physical and psychological functioning (Hill et al., 
1994). In the Netherlands, regular consultations with a specialized rheumatology 
nurse - the rheumatology consultant - is a relatively common part of the standard 
medical care. If customized CBT for RA patients is an effective treatment for use 
in clinical practice, it is important to show adjunctive effects in addition to the 
standard care from the rheumatologist and the rheumatology consultant on 
physical, psychological and social functioning.
In the present study, the effects of tailor-made CBT for patients with relatively 
early RA who had been screened for a psychosocial risk profile was studied in 
addition to the standard medical care received from the rheumatologist and a 
rheumatology consultant. It was hypothesized that, in comparison to the control 
condition, patients in the CBT condition would demonstrate more favorable 
changes on indicators of physical, psychological and social functioning with at 
least small to medium effects at post-treatment and follow-up assessment.
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METHODS
Patients and Procedure
Patients were randomly selected from patient medical records of three 
rheumatology outpatient clinics in the Netherlands. Inclusion criteria were a 
diagnosis of RA according to the American College of Rheumatology (ACR) 
criteria (Arnett et al., 1988), age above 18 years, and a duration of disease of less 
than 8 years. Patients with comorbid conditions that might interfere with the CBT 
treatment (such as malignancy, cardiac, respiratory, hepatic, and renal 
insufficiency) were excluded. In total, 407 patients who met inclusion criteria 
received a written invitation to take part in the questionnaire study. Of these 
patients, 278 (68%) agreed to participate. The participants were predominantly 
female (71%) and married or living with a partner (75%). The average age of 
patients was 55.24 (SD 12.20) with a 3.19 year mean duration of disease (SD 
1.99). Fifteen percent of the patients had a primary level of education and 68% a 
secondary educational level (an average of 7 and 12 years of formal education, 
respectively).
Questionnaires were administered in this sample to screen for previously 
determined risk profiles. Risk profiles were based on the prevalence of heightened 
anxiety and negative mood levels in patients with early RA, as well as 
dysfunctional cognitive-behavioral factors of illness cognitions, coping and social 
support that have all been shown to prospectively predict the course of physical 
and psychological functioning in RA patients (Evers et al., 1997, 1998a, 2001a; 
Scharloo et al., 1999). Cutoff scores were based on findings from previous 
research, which showed that subgroups of approximately 30% of the patients suffer 
from subclinical levels of anxiety and depression (Evers et al., 1997, 2002a). The 
cutoff scores for cognitive-behavioral factors were accordingly established at 30% 
of previous RA patient norm groups (Evers et al., 1997, 1998a, 2001a, 2002a). 
Specifically, patients were classified at risk when scoring in the upper 30% in 
either anxiety or negative mood in comparison to norm groups of patients with 
early RA (Evers et al., 1997, 2002a), in conjunction with a score in the upper 30% 
of at least two out of the following six cognitive-behavioral factors: illness 
cognitions of heightened helplessness and low levels of acceptance (Evers et al., 
2001a), a passive manner of coping with stress (Evers et al., 1997, 2002a), a 
passive manner of coping with pain (Evers et al., 1998a) and low levels of social 
functioning (size of social network and perceived support) (Evers et al., 1997, 
1998a). In addition to the questionnaires’ addressing the psychosocial risk profile, 
self-report measures of physical functioning (functional disability, pain and 
fatigue) were administered in this sample.
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Screening of patients 
with early RA
Patients at risk Patients not at risk
n=112 (40%) n=166
















Figure 1 Overview of study participants
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From the total sample of 278 patients, 112 patients (40%) met the criteria for a 
psychosocial risk profile (see Figure 1 for an overview of study participants). In 
accordance with the psychosocial risk profile criteria, patients at risk were 
characterized by significantly higher levels of negative mood and anxiety (t = 
16.04, p  < 0.001; t = 15.26, p  < 0.001, respectively), as well as more dysfunctional 
cognitive-behavioral factors of greater helplessness and less acceptance (t = 9.81, p  
< 0.001; t = -7.65, p  < 0.001, respectively), more passive coping with pain and 
stress (t = 7.24, p  < 0.001; t = 2.51, p  < 0.05, respectively), and lower levels of 
social functioning (t = -4.89, p  < 0.001; t = -4.81, p  < 0.001 for perceived support 
and the social network, respectively) in comparison to patients not at risk. In 
addition, patients at risk had a significantly lower educational level (t = -2.38, p  < 
0.05) and higher levels of functional disability, pain, and fatigue (t = 5.61; p  < 
0.001; t = 7.06, p  < 0.001; t = 8.94, p  < 0.001, respectively). No significant 
differences were found between the groups with regard to the demographic 
variables of gender, age, marital status or duration of disease.
Patients screened at risk received a written invitation within two weeks to take 
part in a randomized, controlled CBT trial for RA patients. From the 112 patients 
selected, 64 patients (57%) agreed to participate in the study. Reasons for refusing 
to participate related in most cases to practical concerns (63%), such as traveling 
distance and scheduling difficulties in combining the intervention with work and 
other daily activities. Twenty-five percent of the patients reported an unwillingness 
to participate due to a lack of interest, and 12% gave no reason for refusing. When 
comparing patients willing and unwilling to participate, there were no differences 
found between the groups in terms of demographic variables (gender, age, marital 
status, educational level), duration of disease, indicators of physical (functional 
disability, pain, fatigue) and psychological functioning (negative mood and 
anxiety), or any of the cognitive-behavioral factors (illness cognitions, coping with 
stress or pain, social functioning).
The 64 patients participating in the randomized trial were predominantly 
female (72%) and married or living with a partner (77%). Their average age was 
54.13 (SD 11.17). Nine percent of the patients had a primary educational level and 
75% a secondary educational level. Mean duration of disease was 3.45 years (SD 
2.08) with the following distribution: 13 patients (20%) had a duration of disease 
of equal to or less than 12 months, 14 patients (22%) 13-24 months, 11 patients 
(17%) 25-36 months, 5 patients (8%) 37-48 months, 7 patients (11%) 49-60 
months, 8 patients (13%) 61-72 months, 4 patients 73-84 months (6%) and 2 
patients 85-90 months (3%). Most patients (72%) were taking a combination of 
disease modifying drugs (DMARD) and non-steroid anti-inflammatory drugs 
(NSAID). Twenty and 8%, respectively, exclusively used DMARD and NSAID. 
The 64 patients were randomly assigned to one of the two conditions (n = 32, for 
both conditions) according to a previously determined pattern of random numbers. 
Patients in both conditions received standard medical care from the rheumatologist
Tailored CBT treatment - 159
as well as quarterly consultations with the rheumatology consultant. Consultations 
with the rheumatology consultant consisted of providing information and education 
about the medical treatment and counseling and advice on disease-related problems 
in daily life. Patients in the CBT condition also received the tailor-made CBT 
treatment. Assessments of clinical data of disease activity (laboratory erythrocyte 
sedimentation rate (ESR) data and clinical joint score ratings) and self-report data 
took place at pretreatment (4-8 weeks after the screening assessment), at 6 -month 
post-treatment and at a 6 -month follow-up after post-treatment during routine 
medical visits by the rheumatology consultants. Joint score ratings were assessed 
by four rheumatology consultants who followed the patients over time, i.e. the 
same consultant scored patients at three times, at pretreatment, post-treatment and 
follow-up assessment. During these visits, patients also received the questionnaires 
which they were asked to complete at home. Before starting pretreatment 
assessment, the rheumatology consultants checked whether patients received any 
other psychological group or individual treatment. No patient was affected by this 
exclusion criterion at pretreatment or later.
Tailor-made CBT Treatment
Patients in the CBT condition received an additional cognitive-behavioral 
treatment within 6 months, consisting of in total 10 biweekly, 1-hour sessions and 
1 final booster session scheduled four weeks later. The CBT condition consisted of 
individual treatment with 2 out of the 4 possible treatment modules that targeted 
the most frequently experienced problems with which RA patients have to cope: 
pain and functional disability, fatigue, negative mood and social relationships. 
Choice of treatment modules was determined on the basis of patient priorities. 
Information about the treatment and the different modules was given in the first 
session. In the following session, patients chose with the therapist assistance the 
treatment module they wanted to start with (first choice), as well as the module 
with which they wanted to continue (second choice). All treatment modules 
consisted of cognitive and behavioral interventions with homework assignments of 
about a half hour per day. The treatment modules were developed from 
standardized CBT protocols of RA patients (e.g., Kraaimaat et al., 1995a), as well 
as standardized CBT protocols of pain, fatigue, mood disorders and social 
functioning problems (e.g., Barlow, 1993; Hawton et al., 1989; Gatchel & Turk, 
1996). The pain and function disability module consisted of progressive relaxation, 
attention diversion, stimulation of physical exercising in daily life in the face of the 
current physical condition, activity pacing, problem-solving, adjustment of goal­
setting to the current physical condition, identification of pain-provoking cues in 
daily life, and cognitive restructuring of dysfunctional pain cognitions. The fatigue 
module included activity-pacing, adjustment of goal-setting to the current physical 
condition, setting priorities and structured planning of daily activities and time off, 
and cognitive restructuring of activity demands. The negative mood module
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consisted of problem-solving, cognitive restructuring of depressogenic and anxious 
cognitions, identification of stress-provoking cues in daily life, stimulating 
pleasurable activities and restructuring of goal-setting in the face of the current 
physical condition, emotional processing of the changes RA has brought about in 
daily life and finding benefits. The social module finally included identification of 
social stress provoking cues in daily life, cognitive restructuring of social anxious 
cognitions, stimulating social activities in the face of the current physical 
condition, and social skills training including help-seeking behavior and 
communication about RA. In all treatment modules, the final booster session dealt 
with relapse prevention and further improvement of the attained goals. Patients 
were treated by two therapists trained in the treatment modules and supervised by a 
cognitive-behavior supervisor. Sessions were tape recorded and reviewed by the 
supervising cognitive-behavioral therapist for the accuracy of applying the 
treatment modules. In addition, an independent cognitive-behavioral therapist 
uninvolved in the present study reviewed 10% of randomly selected tapes and 
confirmed the therapists’ adherence to the treatment modules.
Measures
Demographic variables were assessed with a general checklist, assessing 
patients’ gender, age and marital status. In addition, educational level was 
measured using 7 categories that can be classified as primary, secondary and 
tertiary educational levels, representing on average 7, 12, and 17 years of 
education, respectively.
Disease activity was assessed in patients participating in the randomized trial 
with the Disease Activity Score (DAS; Prevoo et al., 1995), which consists of a 
weighted composite score of ESR (1-140mm first hour) and clinical joint score 
ratings (number of painful and swollen joints; Fuchs et al., 1989).
Functional disability was assessed with a composite score of the Mobility and 
Self-care scales of the Impact of Rheumatic Diseases on General Health and 
Lifestyle (IRGL; Huiskes et al., 1990a; Evers et al., 1998b), a questionnaire 
derived from the Arthritis Impact Measurement Scales (AIMS; Meenan et al., 
1980), which assesses physical, psychological and social health in patients with 
rheumatic diseases. Previous research has shown that the reliability and validity of 
the IRGL scales are highly satisfactory (Huiskes et al., 1990a; Evers et al., 1998b). 
The Mobility and Self-care scales, which assess the functional capacities of the 
lower and upper extremities, respectively, over the last month (15 items) have been 
shown to be highly comparable to the AIMS physical functioning scales (Evers et 
al., 1998b). A composite score of the scales was calculated by adding the 
standardized scores (z-scores) of both indicators. A higher composite score 
indicates higher levels of functional disability.
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Pain was assessed with the IRGL Pain scale (6 items), measuring the severity 
and frequency of painful episodes and swollen joints and duration of early morning 
stiffness in the last month.
Fatigue was assessed with the Fatigue scale (8 items) of the Checklist 
Individual Strength (CIS; Vercoulen et al., 1996), measuring patients’ level of 
fatigue for the previous two weeks.
Psychological functioning was measured by the IRGL Anxiety and Negative 
Mood scales. The Anxiety scale is a shortened version of the Dutch State Anxiety 
Scale (10 items) (Spielberger, 1970; van der Ploeg et al., 1980), assessing anxiety 
levels in the last month. The Negative Mood scale (6 items) is derived from Zwart 
and Spooren’s questionnaire (Zwart & Sporen, 1982) and assesses various negative 
mood states over the previous two weeks. In addition, depression was assessed 
with a Dutch version of the Beck Depression Inventory (BDI; Beck et al., 1988) in 
the patients participating in the randomized trial.
Social functioning in the past six months was measured with the IRGL social 
functioning scales, reflecting a quantitative and qualitative aspect of social support. 
The qualitative aspect was measured with the Perceived Support scale (5 items), 
inquiring about perceived availability of emotional and instrumental support 
(availability to share sad and pleasant events, get support when faced with stress 
and pain, get help for casual work). The quantitative aspect was assessed by the 
size of the social network, i.e. the number of friends and family members with 
whom patients associate.
Illness cognitions were measured with the Illness Cognition Questionnaire 
(ICQ; Evers et al., 2001b), assessing different ways of cognitive adjustment to a 
chronic disease. Two scales were used in the present study: helplessness (focusing 
on the adverse aspects of the disease and generalizing them to daily functioning, 6 
items) and acceptance (recognizing the need to adapt to a chronic disease while 
perceiving the ability to tolerate and manage its aversive consequences, 6 items).
Coping with stress was assessed with the Utrecht Coping List (UCL; Schreurs 
et al., 1993), a well-documented coping questionnaire in the Netherlands (see e.g., 
Evers et al., 1997, 2001a, 2002a; Scharloo et al., 1999, for use in RA patients), 
adopted from Westbrook (1979), which measures active and passive coping 
strategies when dealing with everyday problems. Active coping was assessed with 
the Problem focusing scale (7 items), measuring cognitive and behavioral efforts to 
apply goal-oriented problem-solving strategies. Passive coping was measured with 
the Avoidance scale (8 items), measuring cognitive and behavioral attempts to 
avoid, escape from and acquiesce when facing everyday problems.
Coping with pain was assessed by the Pain Coping Inventory (PCI; Kraaimaat 
et al., 1997; Evers et al., 1998a) measuring active and passive coping strategies 
when dealing with pain. Active pain coping strategies reflect three cognitive- 
behavioral strategies, measuring patients’ efforts to distract themselves from the 
pain (Distraction, 5 items), to reinterpret and transform the pain (Pain
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Transformation, 4 items) and to function in spite of the pain (Reducing Demands, 3 
items). Passive pain coping reflects three cognitive-behavioral strategies, assessing 
behavioral tendencies to restrict functioning (Resting, 5 items), to avoid 
environmental stimuli (Retreating, 7 items) and catastrophic cognitions about the 
pain (Worrying, 9 items). A composite score of active and passive pain coping can 
be calculated by summing up the nonweighted scores of the three active and 
passive coping strategies (Kraaimaat et al., 1997; Evers et al., 1998a).
Compliance with RA medication was assessed on a 3-point scale by a single 
item, inquiring about the frequency of failing to take the prescribed RA medication 
during the previous month (1 = once a week or more, 2 = less than once in a week, 
3 = never).
Statistical Analyses
Due to slight skewed distributions of scores at negative mood (skewness or 
kurtosis above 1.5), square root transformation was applied. Social network scores 
were categorized according to norm classes (Huiskes et al., 1990a). Differences 
between subgroups at the time of screening (patients at risk versus not at risk, 
participants in the CBT trial versus refusers) and at pretreatment (CBT condition 
versus control condition, dropouts versus completers) were tested with chi-square 
analyses for categorical variables and Student’s t-test for continuous variables with 
a threshold of p  < 0.05 (two-tailed). In the event of significant differences or 
tendencies of differences (p < 0.10) between the CBT and control conditions, these 
variables were taken into account as covariates in the repeated measurement 
analyses. According to the treatment modules, treatment effects were expected in 
the primary outcome measures of physical (functional disability, pain, fatigue), 
psychological (depression, negative mood and anxiety) and social functioning 
(perceived support, size of the social network). Disease activity and cognitive- 
behavioral factors of illness cognitions, coping with stress and pain, and 
compliance were regarded as secondary outcome measures. A general linear model 
for repeated measurement was used to analyze the effects of CBT on the primary 
and secondary outcome variables, with time (three levels) as fixed factor. 
Multivariate analyses were conducted for the primary outcomes of physical, 
psychological and social functioning, and univariate analyses for the secondary 
outcomes. In the case of significant group x time interactions, paired t-tests 
between pretreatment and post-treatment and between pretreatment and follow-up 
assessment were conducted separately for both conditions to gain a better 
understanding of the nature of the interaction. Effect sizes were calculated by the 
difference between the means of the assessment points divided by their pooled 
standard deviations. All analyses were conducted with completers as well as with 
intention-to-treat analyses, using the last-observation-carried-forward method. 
Since both methods revealed the same results overall, only analyses with 
completers will be presented.
Tailored CBT treatment - 163
RESULTS
Pretreatment Condition Comparisons
Means and SDs of demographic variables, duration of disease, use of 
medication, disease activity, indicators of physical, psychological and social 
functioning and cognitive-behavioral factors are presented for both conditions 
separately in Tables 1, 3 and 4. Pretreatment comparisons of both conditions 
revealed no significant differences between the groups in relation to demographic 
variables (gender, age, marital status, educational status), duration of disease, use 
of medication, disease activity, the indicators of physical, psychological and social 
functioning or any of the cognitive-behavioral factors. However, a tendency was 
found for the level of education. Patients in the CBT condition tended to have a 
higher educational level than patients in the control condition (t = 1.85, p  = 007). 
Consequently, educational level was used as a covariate in all repeated 
measurement analyses. Finally, patients in the conditions did not differ on 
medication at post-treatment and follow-up assessment.
Table 1 Means (and SDs) or Percentages of Demographic Variables, Duration of Disease 
and Medication in the CBT Condition (CBT: n = 30) and the Control Condition 




Age (years) 53.9 (10.3) 53.5 (12.6)









Between pretreatment and follow-up assessment, 5 patients (8%) dropped out: 
3 patients from the control condition and 2 patients from the CBT condition. 
Reasons for dropping out were the occurrence of stressful life events for one 
patient from both conditions (divorce and a partner’s serious medical condition),
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lack of sustained motivation to participate in the study for two patients in the 
control condition, and incomplete questionnaire assessment for one patient in the 
treatment condition. When comparing the dropouts to the completers at 
pretreatment, no significant differences were found between the groups regarding 
demographic variables (gender, age, marital status, educational level), use of 
medication, duration of disease, or the indicators of physical, psychological and 
social functioning.
Treatment Modules in the CBT condition
The frequency of treatment modules applied, representing patients’ first and 
second choices, are presented in Table 2, indicating preference differences in 
treatment modules: the fatigue and negative mood modules were applied to about 
two third of the patients as first or second choice (63% and 57%, respectively), 
while the social relationship and pain and functional disability modules were 
applied to less than half of the patients (43% and 37%, respectively).
Table 2 Frequency of Treatment Modules Applied in the CBT Condition (n = 30)
Pain/Functional
disability
Fatigue Negative mood Social
relationships
First choice 5 15 10 0
Second choice 6 4 7 13
Not applied 19 11 13 17
Outcome in Disease Activity
The general linear model for repeated measurement regarding disease activity 
revealed a time effect for both conditions (F(2,55) = 3.77, p  < 0.05), indicating that 
disease activity decreased during the study period for both conditions (see Table 
3). No significant time x condition effect was found for disease activity (F(2,55) = 
2.03, p  < 0.14).
Outcome in Physical, Psychological and Social Functioning
The general linear models for repeated measurement did not reveal any 
significant time effects for the conditions for the indicators of physical, 
psychological and social functioning (see Table 3).
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Table 3 Means (and SDs) of Disease Activity, Physical, Psychological and Social 
Functioning in the CBT Condition (CBT: n = 30) and the Control Condition 




CBT 3.23 (1.45) 2.93 (1.49) 2.92 (1.57)
CC 3.00 (1.15) 2.85 (1.13) 2.46 (0.88)
Physical functioning
Funct. disability CBT 2.41 (0.43) 2.46 (0.47) 2.42 (0.47)
CC 2.44 (0.36) 2.40 (0.38) 2.37 (0.40)
Pain CBT 15.40 (3.86) 14.93 (5.32) 14.99 (5.12)
CC 16.28 (4.83) 15.35 (4.55) 15.79 (4.98)
Fatigue CBT 40.07 (8.90) 34.70 (10.56) 35.18 (11.51)
CC 39.38 (9.86) 37.41 (11.35) 41.38 (11.84)
Psychological functioning 
Depression CBT 12.79 (6.49) 9.98 (4.62) 9.51 (5.35)
CC 12.18 (6.70) 12.85 (7.87) 13.07 (7.51)
Negative mood CBT 2.20 (0.86) 1.77 (1.08) 1.81 (0.95)
CC 2.42 (0.98) 2.33 (1.04) 2.43 (0.98)
Anxiety CBT 22.23 (5.26) 19.37 (4.72) 20.66 (5.81)
CC 24.04 (5.56) 22.52 (6.30) 22.55 (5.45)
Social functioning
Perceived support CBT 13.30 (4.02) 13.90 (3.49) 14.74 (3.53)
CC 14.07 (3.75) 13.93 (3.78) 13.45 (3.87)
Social network CBT 1.87 (0.94) 1.93 (0.74) 1.78 (0.48)
CC 1.61 (0.56) 1.79 (0.62) 1.86 (0.92)
When comparing both conditions, multivariate analyses of the indicators of 
physical functioning (functional disability, pain, fatigue) revealed a significant 
time x condition effect, Wilks’ X = 0.73, F(6,51) = 3.16, p  < 0.05. Univariate tests 
indicated a significant time x condition effect for fatigue (F(2,55) = 4.17, p  < 0.05). 
Paired t-tests showed that fatigue significantly decreased in the CBT condition at 
post-treatment and follow-up assessment (t = 3.09, p  < 0.01 and t = 3.14, p  < 0.01, 
respectively), but not in the control condition (t = 1.18, p  = 0.25 and t = -1.44, p  = 
0.16, respectively). Univariate condition x time interactions were not significant 
for functional disability and pain (F(2,55) = 1.82, p  = 0.17 and F(2,55) = 0.27, p  = 
0.77, respectively).
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Table 4 Means (and SDs) of the Cognitive-Behavioral Factors in the CBT condition 
(CBT: n = 30) and the Control Condition (CC: n = 29) at Pretreatment, Post­




Helplessness CBT 12.93 (3.61) 11.33 (3.75) 11.79 (3.45)
CC 12.93 (3.41) 13.04 (3.82) 12.66 (3.41)
Acceptance CBT 14.13 (4.60) 15.70 (4.12) 16.26 (3.97)
CC 13.45 (3.63) 14.21 (3.82) 14.28 (3.55)
Coping with stress
Active CBT 2.48 (0.51) 2.67 (0.55) 2.60 (0.48)
CC 2.29 (0.41) 2.23 (0.45) 2.27 (0.44)
Passive CBT 2.00 (0.56) 1.95 (0.49) 1.96 (0.40)
CC 2.19 (0.38) 2.18 (0.33) 2.17 (0.36)
Coping with pain
Active CBT 2.35 (0.39) 2.27 (0.27) 2.19 (0.37)
CC 2.31 (0.41) 2.13 (0.40) 2.22 (0.38)
Passive CBT 2.08 (0.43) 2.04 (0.33) 1.98 (0.34)
CC 2.01 (0.41) 1.98 (0.45) 1.95 (0.42)
Compliance
CBT 2.67 (0.66) 2.73 (0.52) 2.85 (0.35)
CC 2.79 (0.49) 2.52 (0.78) 2.59 (0.78)
With regard to psychological functioning, a significant condition x time 
interaction was found in the multivariate analyses for the indicators of 
psychological functioning (depression, negative mood, anxiety), Wilks’ X = 0.73, 
F(6,51) = 3.20, p  < 0.05. Univariate tests showed a significant time x group 
interaction effect for depression (F(2,55) = 5.34, p  < 0.01), demonstrating that 
depression significantly decreased in the CBT condition at post-treatment and 
follow-up assessment (t = 3.02, p  < 0.01 and t = 3.10, p  < 0.01, respectively), but 
not in the control condition (t = -0.57, p  = 0.58 and t = -1.23, p  = 0.23, 
respectively). No significant effects of condition x time interactions were revealed 
for negative mood and anxiety (F(2,55) = 1.30, p  = 0.28 and F(2,55) = 0.67, p  = 
0.52, respectively). However, due to the significant effects on depression, the 
course of negative mood and anxiety were additionally explored for both 
conditions, indicating that negative mood significantly decreased in the CBT
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condition at post-treatment and follow-up assessment (t = 2.25, p  < 0.05 and t = 
2.02, p  = 0.05, respectively), but not in the control condition (t = 0.43, p  = 0.67 and 
t = -0.07, p  = 0.94, respectively). In addition, anxiety significantly decreased in the 
CBT condition at post-treatment (t = 3.46, p  < 0.01), but not at the follow-up 
assessment (t = 1.63, p  = 0.11). However, anxiety also tended to decrease in the 
control condition at both assessment points (t = 1.68, p  = 0.10 and t = 1.97, p  = 
0.06, respectively).
For indicators of social functioning, a nearly significant condition x time 
interaction was found in the multivariate analyses of social functioning (perceived 
support, size of the social network), Wilks’ X = 0.84, F(4,53) = 2.55, p  = 0.05. 
Univariate analyses revealed a significant time x group interaction for perceived 
support (F(2,55) = 4.17, p  < 0.05), showing that perceived support significantly 
increased in the CBT condition at follow-up assessment (t = -3.18, p  < 0.01), but 
not at post-treatment (t = -1.28, p  = 0.21). Perceived support did not significantly 
change in the control condition (t = 0.27, p  = 0.79 and t = 1.57, p  = 0.13, 
respectively). No significant time x condition effect was found for the size of the 
social network (F(2,55) = 1.45, p  = 0.24).
Outcome in Cognitive-Behavioral Factors
The general linear models for repeated measurement of the cognitive- 
behavioral factors of illness cognition, coping with stress or pain, and compliance 
did not indicate a significant time effect for both conditions (see Table 4). When 
comparing both conditions, a significant condition x time interaction was found for 
active coping with stress (F(2,55) = 3.85, p  < 0.05). Paired t-tests revealed that 
patients in the CBT condition used significantly more active coping strategies 
when dealing with stress at post-treatment (t = -2 .88 , p  < 0 .01), but not at follow- 
up assessment (t = -1.44, p  = 0.16), while active coping with stress did not 
significantly change in the control condition at both assessment points (t = 0.80, p  
= 0.43 and t = 0.22, p  = 0.83, respectively). Moreover, tendencies for condition x 
time interactions were found for cognitions of helplessness (F(2,55) = 2.47, p  = 
0.09) and compliance with RA medication (F(2,55) = 2.51, p  = 0.09). Paired t-tests 
demonstrated that helplessness significantly decreased in the CBT condition at 
post-treatment and follow-up assessment (t = 2.98, p  < 0.01 and t = 2.37, p  < 0.05, 
respectively), but not in the control condition (t = -0.22, p  = 0.83; t = 0.62, p  = 
0.54). In addition, compliance with RA medication significantly increased in the 
CBT condition at follow-up assessment (t = -2.08, p  < .05), but not at post­
treatment (t = -0.57, p  = 0.57), while compliance tended to decrease in the control 
condition at post-treatment and follow-up assessment (t = 1.98, p  = 0.06; t = 1.80, 
p  = 0.08, respectively). No significant time x interaction effects were revealed for 
illness cognitions of acceptance, active and passive coping with pain or passive 
coping with stress (F(2,55) = 1.13, p  = 0.33; F(2,55) = 2.15, p  = 0.13; F(2,55) = 
0.17, p  = 0.85; F(2,55) = 0.31, p  = 0.74, respectively).
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Effect Sizes
Effect sizes of the primary outcome measures with significant effects indicated 
overall medium effects for the CBT condition at post-treatment and follow-up 
assessment (Cohen, 1988): effect sizes were 0.55 and 0.48 for fatigue and 0.51 and 
0.55 for depression at post-treatment and follow-up assessment, respectively. In 
addition, small to medium effects were found for negative mood, anxiety and 
perceived support at post-treatment and follow-up assessment (0.44 and 0.43 for 
negative mood, 0.57 and 0.28 for anxiety, and 0.16 and 0.38 for perceived support 
at post-treatment and follow-up assessment, respectively). In contrast, effect sizes 
on these primary outcomes in the control condition were all negative, except for 
fatigue and negative mood at post-treatment (0.19 and 0.01, respectively) and 
anxiety at post-treatment and follow-up assessment (0.26 and 0.27, respectively).
DISCUSSION
This trial of customized CBT for patients with relatively early RA indicated that, in 
addition to the standard care provided by a rheumatologist and a rheumatology 
consultant, tailor-made treatment offered to individual patients at risk has 
beneficial effects on primary outcomes of physical, psychological and social 
functioning, and these effects were generally maintained at follow-up assessment. 
Specifically, favorable effects on primary outcomes were found for fatigue and 
depression at post-treatment and follow-up assessment, as well as for perceived 
support at follow-up assessment. Exploration of secondary outcomes of cognitive- 
behavioral factors supported additional beneficial effects, including increased 
active coping with stress at post-treatment, decreased helplessness at post­
treatment and follow-up assessment, as well as increased compliance at follow-up 
assessment in the CBT condition in comparison to the control condition, generally 
suggesting that offering tailored CBT to RA patients at risk may be a promising 
way to optimize treatment effectiveness.
Participants in the CBT trial consisted of patients with relatively early RA who 
had been screened for a psychosocial risk profile. The screening sample was 
comparable to representative samples of patients with early RA with regard to 
demographic variables, levels of physical, psychological and social functioning 
and cognitive-behavioral factors (Meenan et al., 1991; Evers et al., 1997, 1998a, 
2002a). In accordance with the empirically derived screening criteria (Evers et al., 
1997, 1998a, 2001a, 2002a; Scharloo et al., 1999), patients at risk were 
characterized by lower levels of physical, psychological and social functioning and 
more dysfunctional cognitive-behavioral factors, in comparison to patients not at 
risk. For patients participating in the CBT trial, results suggest that there was no 
systematic bias in the selection of patients. Reasons for refusing to take part in the 
CBT trial were in most cases related to practical concerns, and participants did not
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differ from nonparticipants with regard to demographic variables, levels of 
physical, psychological and social functioning or cognitive-behavioral factors. 
Finally, dropout rates were generally low for the CBT and the control conditions 
(6% and 10%, respectively), and statistical analyses of completers and intention-to- 
treat analyses revealed the same results overall.
Effects found on the primary outcomes of fatigue, depression and perceived 
support corresponded to the three treatment modules most frequently applied in the 
CBT condition. Application of treatment modules was based on patients’ priorities, 
which were highest for the fatigue module, followed by the negative mood, social 
relationships and pain and functional disability modules. In particular, fatigue has 
only recently received attention as a frequent problem for RA patients and as a 
possible focus for psychosocial interventions (Belza, 1995; Huyser et al., 1998; 
Barlow et al., 2000). In accordance with a nearly significant effect found for 
fatigue in a recently conducted self-management trial (Barlow et al., 2000), our 
results indicate that fatigue can be significantly reduced by CBT. In addition, 
psychological functioning was improved by decreased depression and, as in the 
case of fatigue, these effects were stable at follow-up. Previous CBT trials with RA 
patients only incidentally reported beneficial effects on depression or other 
outcomes of psychological functioning (cf., Bradley et al., 1987; O’Leary et al., 
1988; Sharpe et al., 2001). As for social functioning, there is only one study that 
previously reported beneficial effects of CBT on an indicator of social support at 
post-treatment (O’Leary et al., 1988), while perceived support in our study 
increased in the treatment condition at follow-up assessment.
Effect sizes found for these primary outcomes supply preliminary support for 
the idea that tailor-made treatment for patients with relatively early RA can 
improve treatment effectiveness. Effect sizes for the primary outcome measures 
indicated overall medium effects for fatigue and depression at post-treatment and 
follow-up assessment, as well as small to medium effects for perceived support at 
follow-up assessment (Cohen, 1988). In contrast, a recently conducted meta­
analysis of controlled trials of psychosocial interventions for patients with RA 
revealed nonsignificant to small effects for physical and psychological functioning 
at post-treatment, and nonsignificant effects at follow-up assessment (Riemsma et 
al., 2002; see also Hawley, 1995; Riemsma et al., 1999). When exclusively CBT 
trials or behavioral treatments for RA patients are considered (Hawley, 1995; 
Riemsma et al., 2002), results are about the same. Although comparisons to other 
trials must be cautiously interpreted due to differences between studies in type of 
intervention, control groups, designs, outcome measures and settings, these 
findings generally suggest that increased effect sizes at post-treatment and follow- 
up assessment may be an adjunctive value of tailor-made CBT in relatively early 
RA.
Treatment effectiveness could also be optimized when interventions change 
dysfunctional cognitive-behavioral factors at an early stage of the disease and
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possibly prevent a worse long-term disease outcome. Our results indicated 
beneficial changes at follow-up assessment in disease-related cognitive-behavioral 
factors, such as reduced helplessness in handling RA and its consequences and 
increased compliance with RA medication. In addition to previous findings of 
beneficial effects of CBT on helplessness in longstanding RA (Parker et al., 1995), 
our results indicate that helplessness can be modified at a relatively early stage of 
the disease, and effects were maintained at follow-up assessment. Taking into 
account that the findings for compliance should be regarded as explorative due to 
the single-item assessment, the effects on compliance may be particularly likely to 
provide a long-term benefit by reducing the risk of an unfavorable disease process 
(Radojevic et al., 1992) and decreasing the costs of medical treatment (Lorig et al.,
1993).
The beneficial effects of CBT were found as an addition to the standard 
medical care received from a rheumatologist and a rheumatology consultant. In 
view of the preliminary findings of beneficial effects of the rheumatology 
consultant on indicators of physical and psychological functioning (see, Hill et al.,
1994) and the fact that consultations with the rheumatology consultant have a 
variety of aspects in common with CBT, such as providing support and empathy, 
problem-solving related to the limitations of daily activities (e.g., returning to 
work, helping in housekeeping, adjustment of home facilities), as well as 
stimulation of favorable health behaviors (e.g., compliance, activity pacing and 
exercising), the present trial gives a rather conservative estimate of the contribution 
of tailored CBT.
A low rate of attrition has been suggested as another proxy outcome variable of 
treatment effectiveness (Turk & Rudy, 1990b). In contrast with dropout rates of 
about 45% found in a meta-analysis of psychosocial interventions (see Wierzbicki 
& Pekarik, 1993), the relatively low 6% dropout rate in the treatment condition 
indicated high treatment acceptance, possibly due to the use of customized 
treatment modules applied on the basis of patient priorities. In addition, patients 
with a psychosocial risk profile are likely to be motivated for CBT and 
pretreatment screening of patients at risk may have a favorable effect on attrition 
rates.
Despite its relatively promising results, the present study had several 
limitations. Most importantly, we did not directly test the hypothesis that tailored 
CBT for patients at risk at an early stage of the disease may be superior to general 
CBT treatments for all RA patients, and consequently information is unavailable 
about the specific treatment characteristics to which the beneficial results of the 
present study can be ascribed. To directly demonstrate the possible superior 
efficacy of the present approach, future studies will have to compare the 
effectiveness of CBT trials for patients screened at risk versus those not at risk, for 
patients with recent versus longstanding RA, and the application of tailored versus 
generic or mismatched treatments for RA patients. In addition, treatment effects
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were limited to specific indicators of physical, psychological and social 
functioning and cognitive-behavioral factors. Most evidently, the present trial was 
unsuccessful in altering primary disease outcomes of pain and functional disability. 
Previous CBT and self-management trials, usually focusing more exclusively on 
pain management, have occasionally found effects on pain and functional disability 
at post-treatment, although these effects were in most cases not maintained at 
follow-up (e.g., Parker et al., 1995; see also McCracken, 1991; Hawley, 1995; 
Riemsma et al., 1999, 2002). In the present study, the pain and functional disability 
module was the least frequently chosen and applied treatment module for only 11 
patients, which may be the reason for the lack of effects on these outcomes. A 
recent RA study also suggests that focusing this treatment module on 
physiologically mediated changes, such as the use of relaxation and biofeedback in 
patients with high physiological reactivity to pain, could improve its effects on 
pain outcomes (Evers et al., 2001b). Moreover, higher expectations of patients in 
the CBT condition or the greater degree of attention patients in the CBT treatment 
received might have contributed to the beneficial effects of CBT, requiring 
expectancy assessments and comparisons with an attention control group in future 
studies. A selection bias could not be detected in our sample. However, 
information is unavailable about patients who initially refused to take part in the 
screening study. To avoid any unmeasured selection bias, the screening procedure 
should be preferably carried out as part of the standard medical care. Further 
validation of the empirically derived psychosocial risk profile is also desired, e.g. 
by comparing questionnaire criteria with standardized interviews for diagnosis of 
subclinical anxiety and depression. Finally, replication of the effects in larger 
samples as well as maintenance of treatment effects at longer-term follow-ups, 
preferably accompanied by cost-effectiveness analyses and use of economic 
outcome measures - such as health care use, drug intake, and occupational status - 
is desired to further validate the significance of the findings for application in 
clinical practice (see e.g., Lorig et al., 1993).
In conclusion, the present study demonstrates that customized treatment for RA 
patients at risk offered at an relatively early stage of the disease is effective for 
indicators of physical, psychological and social functioning, and suggests that this 
approach is a promising way to optimize treatment effectiveness in terms of 
treatment acceptance and magnitude and maintenance of effects.
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The studies in this thesis were conducted to gain insight into the role of 
psychological factors in disease outcome for patients with rheumatoid arthritis 
(RA), a chronic, inflammatory disease affecting the joints. The thesis consists of 
three main parts, including assessment, prediction and modification of RA disease 
outcome with psychological factors and tailored treatment. Particular attention was 
given to factors that are a focus of psychological treatments, including illness 
cognitions, coping and social support.
ASSESSMENT OF DISEASE OUTCOME: 
HEALTH DIMENSIONS OF RA
Reliable and valid assessment of disease outcome is a prerequisite to studying the 
influence of psychological factors and the effects of therapeutic interventions in 
RA. In addition to the assessment of clinical and laboratory data, health status 
questionnaires can provide specific, detailed information about health areas that 
are affected by the disease and that closely reflects functioning and well-being of 
patients. The goal of the first study in 284 RA patients was to further validate a 
health status instrument for patients with arthritis, the IRGL, by comparing this 
inventory to another widely used international health status instrument for arthritis 
patients, the Dutch-AIMS2 (chapter 2). The IRGL consists of disease-specific 
scales of physical functioning and disease-generic scales of psychological 
functioning, social functioning and impact of the disease on daily life. Reliability 
and validity of the IRGL proved to be highly satisfactory, as indicated by overall 
high internal consistencies, comparability to the other health status instrument in 
terms of structure and content of scales, and moderate to high correlations between 
the physical functioning scales and clinical markers of disease outcome. To 
facilitate comparisons with the most common, international questionnaire, the 
AIMS2, regression formulas of the physical and psychological functioning scales 
were computed between the two questionnaires. In line with previous studies 
conducted by others, it was concluded that the IRGL is a reliable and valid 
multidimensional health status instrument for RA patients.
PREDICTION OF DISEASE OUTCOME: 
RISK FACTORS IN RA
The main aim of this thesis was to examine the role of specific psychological 
predictors in RA disease outcome, using a prospective design. The predictors 
studied were based on two theoretical models in accordance with the psychological 
literature on predicting disease activity and psychological distress in chronic 
(immune) diseases with stress-vulnerability models, and predicting functional 
disability and pain in chronic pain disorders with fear-avoidance models. Particular
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attention was given to the role of coping, social support, illness cognitions and 
physiological pain reactivity. Specifically, we studied the role of coping and social 
support in disease outcome (disease activity, functional disability and pain, 
psychological distress) after 1, 3 and 5 years in a sample of recently diagnosed 
patients (chapters 3.1.1 - 3.1.3). Of interest was whether coping and social support 
assessed very early in the disease process, i.e. at the time of diagnosis, would 
predict short-term changes in RA after 1 year as well as more long-term changes 
after 3 and 5 years. In addition to these studies conducted among recently 
diagnosed patients, the role of psychological predictors, not previously assessed in 
the RA literature, was studied for disease outcome after 1 year in longstanding RA 
patients: generic illness cognitions and physiological pain reactivity (chapters 3.2 
and 3.3).
Coping and Social Support
Predictors o f disease activity. Based on stress-vulnerability models, the relative 
contribution of different stressors (major life events and disease-related stressors) 
and vulnerability factors (personality characteristics of neuroticism and 
extraversion, stress coping and social support) at the time of diagnosis were 
studied to predict the course of disease activity after 1, 3 and 5 years in 78 RA 
patients (chapter 3.1.1). Stress-vulnerability factors failed to predict disease 
activity in the first year after diagnosis, possibly due to the relatively strong effects 
of medication in the first year. In the longer term, passive avoidance coping 
predicted a worse course of disease activity at the 3 and 5-year follow-ups, and 
lower levels of social support predicted a worse course of disease activity at the 3- 
year follow-up. In line with preliminary findings in longstanding RA, these results 
underscore the role of passive avoidance coping with stress and lower levels of 
social support as possible risk factors for longer-term disease activity in RA.
Predictors o f functional disability and pain. On the basis of fear-avoidance 
models, the role of cognitive and behavioral strategies of pain coping and social 
support at the time of diagnosis was studied to predict functional disability and 
pain in 91 RA patients in the first year after diagnosis and in 78 RA participants 
for whom data was available at the 3 and 5 year follow-ups (chapters 3.1.2.1 - 
3.1.2.2). Results indicated that passive pain coping, specifically avoidance of 
activity (resting) and catastrophic cognitions of pain (worrying) at the time of 
diagnosis predicted a worse course of functional disability after 1 and 3 years. In 
addition, social support marginally predicted a less unfavorable course of 
functional disability after 1 year and relatively strongly after 3 and 5 years. Social 
support also predicted less increased pain after 3 and 5 years. As proposed by fear- 
avoidance models, these findings indicate that pain-related avoidance factors and 
social resources can have relatively long-lasting effects on physical outcomes for 
RA patients.
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Predictors o f  psychological distress. Within the framework of stress- 
vulnerability models, different stressors (major life events and disease-related 
stressors) and vulnerability factors (personality characteristics of neuroticism and 
extraversion, stress coping and social support) were assessed at the time of 
diagnosis to predict the course of psychological distress (anxiety and depressed 
mood) after 1 year in 91 patients and after 3 and 5 years in 78 patients, for whom 
follow-up assessments were available (chapters 3.1.3.1 - 3.1.3.2). In accordance 
with findings among longstanding RA patients, about 30% of those with early RA 
were characterized by heightened levels of psychological distress, comparable to 
subclinical levels of anxiety and depressed mood. When predicting psychological 
distress in the first year of the disease, lower levels of social support marginally 
predicted a more unfavorable course for one indicator of psychological distress - 
depressed mood - after 1 year. In the longer term, the personality characteristic of 
neuroticism relatively strongly predicted a worse course of anxiety and depressed 
mood after 3 and 5 years, underscoring the role of neuroticism for longer-term 
psychological distress in RA.
Illness Cognitions
A self-report instrument was developed to assess generic, maladaptive and 
adaptive illness cognitions in different chronic diseases, including RA: cognitions 
of helplessness, acceptance and perceived benefits as different ways of evaluating 
the inherently negative meaning of a chronic disease (chapter 3.2). Psychometric 
characteristics of the instrument were studied in 263 patients with RA and 167 
patients with multiple sclerosis (MS). The Illness Cognition Questionnaire (ICQ) 
reliably and validly assessed the illness cognitions of helplessness, acceptance and 
perceived benefits. Results supported the comparable factor structure of the 
questionnaire between the chronic diseases as well as the relatively uniform, 
maladaptive and adaptive function of the cognitions for the concurrent and future 
disease outcome. Specifically, illness cognitions of helplessness, acceptance and 
perceived benefits distinctly predicted all indicators of disease outcomes after 1 
year (including disease activity, functional disability and pain, psychological 
distress), with helplessness demonstrating consistently negative relationships and 
acceptance and perceived benefits positive relationships with a better disease 
outcome. It was concluded that the ICQ is a reliable and valid self-report 
instrument for assessing generic, maladaptive and adaptive illness cognitions in 
different chronic diseases, including RA.
Physiological Pain Reactivity
On the basis of fear-avoidance models, the role of self reported physiological 
pain reactivity in comparison to cognitive and behavioral factors (passive pain 
coping) was studied to predict pain after 1 year in a sample of 95 RA patients 
(chapter 3.3). Physiological reactivity to pain, but not the cognitive and behavioral
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factors, predicted increased pain after 1 year, suggesting that physiological 
patterns of autonomic and muscular pain reactivity have detrimental effects on RA 
pain. A path model revealed that neuroticism affected physiological pain 
reactivity, which in turn was the only significant predictor for future pain. When 
analyzing the types of physiological reactions to pain, a different pattern of 
physiological responses to pain was reported by RA patients than what has been 
previously been found in other chronic pain patients, possibly suggesting a 
symptom-specific pattern of physiological pain reactivity in RA patients.
MODIFICATION OF DISEASE OUTCOME:
TAILORED TREATMENT IN RA
An intervention study was conducted to explore whether tailoring treatment to 
patients at risk with early RA is a promising way to optimize treatment 
effectiveness (chapter 4). Based on the main findings of the prospective studies, it 
was expected that the effectiveness of psychological interventions for RA patients 
might be optimized if tailor-made interventions were offered to patients at risk in a 
relatively early stage of the disease. A randomized, controlled trial with tailor- 
made treatment modules was conducted with 64 patients with relatively early RA, 
who had been screened for psychosocial risk profiles. All patients received 
standard medical care from a rheumatologist and rheumatology nurse consultant. 
Half of the patients also received an individual cognitive-behavioral treatment 
(CBT) with two out of four possible treatment modules. Choice of treatment 
modules was determined on the basis of patient priorities, which resulted in most 
frequent application of the fatigue module, followed by the negative mood, social 
relationships and pain/functional disability modules. Results indicated beneficial 
effects for CBT on physical, psychological and social functioning. Specifically, 
fatigue and depression were significantly reduced after treatment and at the 6- 
month follow-up, and perceived support increased at follow-up assessment in the 
CBT condition in comparison to the control condition. In addition, helplessness 
decreased at post-treatment and follow-up assessment, active coping with stress 
increased at post-treatment, and compliance with medication increased at follow- 
up assessment in the CBT condition in comparison to the control condition. The 
treatment condition was characterized by relatively low dropout rates and the 
effects on primary outcomes were overall moderate in size and maintained at 
follow-up. The current study demonstrates that customized treatment for RA 
patients at risk offered at a relatively early stage of the disease is effective for 
indicators of physical, psychological and social functioning and supplies 
preliminary support for the idea that customizing treatments to patient 
characteristics may be a way to optimize CBT effectiveness for RA patients.

6General Discussion
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The objective of the studies in this thesis was to gain insight into the role of 
psychological factors that are relevant to disease outcome of patients with 
rheumatoid arthritis (RA). The general findings of these studies will be separately 
discussed for the assessment (chapter 2), prediction (chapter 3) and modification 
(chapter 4) of RA disease outcome. The discussion of chapter 2  includes a 
discussion of the assessment of both disease outcome and psychological predictors. 
In the discussion of chapter 3, the role of the different psychological predictors and 
disease characteristics is discussed, followed by a discussion of the limitations of 
the prospective studies. The discussion of chapter 4 deals with the screening 
procedure for patients at risk and the effects of tailored CBT treatment. The chapter 
ends with a section about recommendations for future research and clinical 
implications.
ASSESSMENT OF DISEASE OUTCOME:
HEALTH DIMENSIONS OF RA
The reliable and valid assessment of disease outcome is a prerequisite for studying 
the impact of psychological factors and therapeutic interventions. In the first study 
in this thesis, a health status instrument for patients with arthritis, the IRGL, was 
further validated for RA patients (chapter 2). Results indicated the IRGL’s highly 
satisfactory reliability and validity in terms of high internal consistency, 
comparability of structure and content of scales to the Dutch-AIMS2, as well as 
moderate to high relationships between physical functioning scales and clinical and 
laboratory markers of disease outcome. Other aspects of reliability and validity 
have previously been studied by others, e.g. concurrent validity of the 
psychological and social functioning scales, test-retest reliability and sensitivity to 
change (e.g., Huiskes et al., 1990a,b; Geenen et al., 1995; Kraaimaat et al., 
1995b,c; Jacobs et al., 2001). Further data on reliability and validity were obtained 
in the following studies in this thesis (chapters 3 - 4). A slightly adjusted version of 
the IRGL also proved to be a reliable and valid instrument for multiple sclerosis 
patients (chapter 3.2), demonstrating the advantage of using disease-generic scales 
for the dimensions of psychological and social functioning. It can be concluded 
that the IRGL is a useful clinical instrument for screening and evaluating health 
aspects in patients with RA and possibly also other chronic diseases.
Recent developments in the RA literature have turned attention to a relatively 
unexplored area of RA disease outcome, i.e. fatigue. Fatigue has only recently 
received attention as a frequent problem in RA (Belza, 1995; Huyser et al., 1998). 
Similar to pain, fatigue seems to be affected by both the disease process and 
psychological factors (Huyser et al., 1998). Taking the small sample size into 
account, one of the studies in this thesis indicated that fatigue is a high priority
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when patients are asked which topic they wanted to deal with in psychosocial 
interventions (chapter 4), underscoring the role fatigue may play from a patient 
perspective. Like all health status instruments for arthritis patients, the IRGL does 
not assess this aspect of physical functioning. However, the intervention study in 
this thesis (chapter 4) suggests that the CIS, a questionnaire validated for various 
chronic diseases (Vercoulen et al., 1996), is a suitable instrument for assessing 
fatigue in RA patients. Reliable and valid measurement is obviously as important 
for psychological predictors. Although not a focal point of this thesis, the studies in 
this thesis showed sufficient reliability, concurrent and predictive validity for the 
PCI passive pain coping scales, the UCL passive avoidance stress coping scales, 
the ICQ illness cognitions scales of helplessness, acceptance and perceived 
benefits, the physiological pain reactivity scale, and the IRGL social support 
scales.
In view of the limitations of self-report measures, further validation should 
focus on the relationships with observed and physiological assessments. For 
example, comparing the IRGL social support scales to observed social interactions 
with significant others and daily monitoring of social activities, the PCI passive 
pain coping scales to observed pain behaviors and electronic activity devices, and 
the physiological pain reactivity scale to physiological measures of autonomic and 
muscular reactivity patterns can deliver important information about possible 
pathways of the predictors to RA disease outcome. To specify dimensions of the 
IRGL disease outcome, comparisons to qualitative interview assessments (e.g., for 
subclinical levels of anxiety and depressed mood), observational measurements 
(e.g., observed assessment of functional disability) and daily monitoring of 
symptoms (e.g., pain diary assessments) is recommended.
PREDICTION OF DISEASE OUTCOME:
RISK FACTORS IN RA
Different studies in this thesis have examined the role of psychological predictors 
in RA disease outcome, using a prospective design. Based on the main findings of 
the studies, the psychological predictors (coping, including physiological pain 
reactivity, social support, illness cognitions, personality characteristics, and 
stressors) and disease characteristics (stage of disease, duration of effects, 
specificity for RA) will be separately discussed, followed by a discussion of the 
limitations of the studies.
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PSYCHOLOGICAL PREDICTORS
Coping
Coping can be defined as individuals’ behavioral and cognitive attempts to 
manage or tolerate stress. Two main areas of coping research have been 
distinguished in RA: coping with stress in general and coping with a specific, 
disease-related stressor, i.e. pain (see e.g. Manne & Zautra, 1992; Jensen et al., 
1991b). Stress-vulnerability models propose that an individual’s reaction to 
stressors in general, including coping with stress, primarily affects the outcome of 
disease activity and psychological distress. The manner of coping with pain has 
been assumed to play a major role in functional disability and pain, as supposed in 
fear-avoidance models. In the present studies conducted with patients with early 
RA (chapters 3.1.1 - 3.1.3) support was found for both models. The passive 
avoidant strategy of coping with stress (assessing cognitive-behavioral attempts to 
avoid, escape and acquiesce when facing everyday problems) predicted a worse 
course of disease activity after 3 and 5 years. Passive coping with pain (assessing 
cognitive-behavioral factors of avoidance of activity and catastrophic cognitions 
when faced with pain) predicted a worse course of functional disability after 1 and 
3 years, indicating that passive avoidant ways of coping with stress and pain have 
detrimental effects on longer-term physical health in early RA. Corresponding 
relationships have previously been found in prospective studies with patients with 
longstanding RA, patients with chronic pain disorders and other chronic diseases, 
suggesting that passive coping with stress and pain is a relatively general risk 
factor for worse health and disease outcomes (see for RA, Brown & Nicassio, 
1987; McFarlane et al., 1987; Keefe et al., 1989; Smith & Wallston, 1992; van 
Lankveld et al., 1999; Scharloo et al, 1999, see for chronic pain, e.g. Jensen et al., 
1991b, see for chronic diseases, e.g. Stanton et al., 2001). In contrast, coping did 
not predict the course of psychological distress in our studies of early RA, possibly 
indicating that coping is less relevant for longer-term psychological than physical 
health outcomes.
In line with findings in longstanding RA and other populations, active 
strategies of coping with stress or pain systematically failed to demonstrate any 
effects for future disease outcomes. Different reasons have been discussed for this 
lack of effects. For example, there is some evidence that active coping, together 
with other concepts supposed to be adaptive, have a stronger predictive capacity 
for positive outcome measures, such as positive mood, than negative outcome 
measures, such as anxiety and depression (e.g., Manne & Zautra, 1992; Zautra et 
al., 1995; Smith et al., 1997; Stanton et al., 2001, see also chapter 3.2). The lack of 
effects for active coping has also been ascribed to a higher context-specificity of 
adaptive than maladaptive ways of coping (Smith et al., 1997, Stanton et al., 2001). 
For example, frequent use of active strategies may work beneficially at stages 
when the disease is relatively nonactive but unfavorably when faced with highly
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uncontrollable situations, such as during periods of RA inflammation. It may be 
consequently necessary to link the effects of active strategies more closely to the 
characteristics of stressors, particularly the level of controllability.
When considering different stress response systems, coping not only include 
cognitive and behavioral responses, but also physiological reactions to stressors, 
such as pain (Flor et al., 1990). In one of the studies in this thesis, the relative 
contribution of self-reported cognitive, behavioral and physiological reactivity to 
pain was compared in relation to future pain in longstanding RA (chapter 3.3). 
Results indicated that only self-reported physiological reactivity to pain predicted 
subsequent pain, suggesting detrimental effects of physiological patterns of 
autonomic and muscular pain reactivity on RA pain. Together with the findings in 
early RA that cognitive and behavioral pain responses (passive pain coping) 
predicted solely future functional disability, and not future pain (chapters 3.1.2.1 -
3.1.2.2), the results suggest that specific outcomes in chronic pain patients are 
predicted by specific cognitive, behavioral and physiological factors. These results 
also support the view that coping research might benefit from the systematic 
comparison of the cognitive, behavioral and physiological response systems to 
clarify their effects on disease outcomes, to specify the underlying processes 
responsible for these effects, and to identify the most active treatment components 
(cf. Flor et al., 1990, Turk & Flor, 1999).
Social Support
The most common conceptualization of social support comprises qualitative 
and quantitative indicators, including aspects of perceived availability of support 
and size of the social network (Cohen & Wills, 1985; Wills & Fegan, 2001). In 
accordance with findings in longstanding RA, other chronic diseases and the 
general population (see Wills & Fegan, 2001), these social support indicators 
relatively consistently predicted a less unfavorable disease outcome in early RA: 
less disease activity after 3 years, less functional disability after 1, 3 and 5 years, 
less pain after 3 and 5 years and less depressed mood after 1 year (chapters 3.1.1 -
3.1.3), suggesting that social support is a relatively general protective factor for 
future RA disease outcome. Effects of social support have previously been studied 
in RA patients over a period of 1 year or less. In our studies, social support, 
particularly the perceived availability of support, demonstrated the strongest effects 
at the later 3 and 5-year follow-ups on physical health outcomes. Together with 
findings in the general population showing that social support can have long-term 
physical benefits and decrease mortality rates (see Wills & Fegan, 2001), results 
suggest that the significance of social support for future physical health outcome 
have been underestimated in previous RA research.
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Illness Cognitions
As for coping, little is known about possible adaptive cognitive reactions when 
patients are faced with uncontrollable, long-term stress of a chronic disease. There 
is increasing evidence from prospective studies that cognitive attempts to control 
uncontrollable circumstances may work maladaptive in the long-term (cf. Stanton 
et al., 2001). It was assumed that illness cognitions showing consistently favorable 
effects should focus on the (re)evaluation of the negative meaning of a chronic 
disease instead on perceived control. A self-report instrument, the Illness Cognition 
Questionnaire (ICQ) was developed to assess maladaptive and adaptive disease- 
generic illness cognitions of helplessness, acceptance and perceived benefits in 
various chronic diseases, reflecting different ways of evaluating the negative 
meaning of a chronic disease (chapter 3.2). Results in patients with RA and MS 
indicated a high degree of correspondence between both diseases, in terms of factor 
structure and concurrent and predictive validity. The cognitions also separately 
predicted all future disease outcomes, including disease activity, functional 
disability and pain and psychological distress, with helplessness demonstrating 
consistently negative relationships and acceptance and benefits positive 
relationships to a better disease outcome. Although findings have to be replicated, 
results support the idea that there are generic maladaptive and adaptive cognitions 
that demonstrate relatively uniform effects when patients are confronted by a 
chronic disease.
The predictive value of these cognitions for different indicators of disease 
outcome and the relatively general assessment may suggest that illness cognitions 
at least partly mediate the effects of coping and social support to future disease 
outcomes (e.g. Leventhal et al., 1984). The relative impact of illness cognitions, 
coping and social support has not been assessed in the present study. However, a 
prospective study in RA have shown that, although illness cognitions of 
helplessness, passive coping and social support affected each other, they made all a 
unique contribution to future outcomes (Smith & Wallston, 1992), underscoring 
the distinct function of illness cognitions, coping and social support.
Personality Characteristics
Two personality characteristics of the Big Five, supposed to be most relevant to 
physical and psychological health outcomes in the general population and patients 
with chronic diseases, including RA, have been studied in the present studies: 
neuroticism and extraversion.
Neuroticism or negative affectivity is assumed to be a generic, underlying 
factor for psychological risk factors and to possibly account for the effects of 
illness cognitions, coping and social support on long-term outcomes (e.g., Watson 
& Pennebaker, 1989; McCrae, 1990). In the present studies, the role of neuroticism 
has been studied in relation to all disease outcome parameters (see chapters 3.1­
3.3). Corresponding to findings among patients with longstanding RA (see e.g.,
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Affleck et al., 1992, 1994; Smith et al, 1995), neuroticism did not substantially 
predict future physical health outcomes, such as disease activity, functional 
disability or pain, but proved to be a relatively strong predictor for psychological 
distress in the longer term in early RA. This finding is consistent with research in 
the general population, showing that neuroticism is a common risk factor for 
psychological distress (see Clark et al., 1994). However, neuroticism did not 
greatly account for the relationships of psychological risk factors to future disease 
outcomes in any of the studies in this thesis. Although neuroticism was related to 
most of the psychological predictors, it did not largely explain their relationship to 
future RA disease outcome, indicating that illness cogntions, coping, and social 
support made a specific, additional contribution to predicting longer-term health 
(see also Affleck et al., 1992, 1994; Stanton et al., 2001). An example of how 
neuroticism may indirectly affect future disease outcome was revealed in the study 
of physiological pain reactivity (chapter 3.3): a path model indicated that 
neuroticism predicted physiological reactivity to pain, which in turn was the only 
predictor of subsequent pain. Together, these results may support the role of 
neuroticism in precipitating specific risk factors, which for their part contribute to 
unfavorable health effects.
In contrast to neuroticism, extraversion has received far less attention in the 
health and chronic diseases literature (see e.g., Phillips & Gatchel, 2000). In the 
present studies in patients with early and longstanding RA (chapters 3.1.1 - 3.1.3,
3.2), there were no predictive effects for extraversion found for future disease 
outcomes in early RA. Extraversion was also not more than modestly related to 
illness cognitions, coping and social support, suggesting that the predictors are 
hardly affected by the tendency to be more impulsive and sociable. Overall, these 
results suggest that extraversion does not play a major role as a predictor of future 
RA disease outcomes or as factor underlying illness cognitions, coping, and social 
support.
Stressors
Stressors are considered as important predictors for disease outcome in RA, 
particularly due to the supposed link between stress and inflammatory activity via 
immunological pathways (see Huyser & Parker, 1998; Walker et al., 1999). Early 
stress research has mainly focused on major life events, while chronic disease- 
related stressors have received less attention. In line with stress-vulnerability 
models, the contribution of both types of stressors was studied in this thesis for 
disease activity and psychological distress in the first years of the disease (chapters
3.1.1 and 3.1.3). Results generally failed to demonstrate any direct, mediating or 
moderating effect of these stressors on longer-term disease outcome. Consistent 
with RA research, demonstrating only incidentally relationships between for 
example major life events and RA disease outcome (see e.g., Potter & Zautra, 
1997; Dekkers et al., 2001), results suggest that these stressors do not play a major
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role in RA. However, there is some evidence for relationships between specific 
stressors and future disease activity or immunological parameters in RA patients. 
Particularly minor and interpersonal stressors, not assessed in the present studies, 
have previously been shown to be concurrently or prospectively related to disease 
activity and immune functioning and may be an important additional factor in 
relation to how stress might affect RA disease activity in the long-term, directly or 
as a modifying factor for illness cognitions, coping and social support (Affleck et 
al., 1997; Potter & Zautra, 1997; Zautra et al., 1997, 1998).
DISEASE CHARACTERISTICS
Stage o f  the Disease
Early detection and modification of psychological risk factors is by definition 
more likely to have long-term benefits and decrease unfavorable long-term disease 
outcome in a chronic disease, such as RA. One of the purposes of the thesis was to 
study whether psychological risk factors at the earliest point in time - at diagnosis -  
could predict future RA disease outcome and if so, whether corresponding 
relationships would be found than in longstanding RA (chapters 3.1.1 - 3.1.3). 
Results indicated that psychological risk factors, such as coping, social support and 
personality characteristics, at the time of diagnosis predict the course of all 
indicators of the disease outcome, including disease activity, functional disability 
and pain and psychological distress. The specific psychological factors and 
direction of effects correspond to findings in longstanding RA, suggesting that the 
same psychological mechanisms are involved in early RA as at a later stage of the 
disease. The early manifestation of these factors at the time of diagnosis suggests 
that they at least partly result from prior learning histories or predisposition and 
that RA may have been the factor that has elicited or activated them.
Conclusions about factors specific to the first stage of the disease have to be 
drawn with caution, since there were no comparative studies conducted with 
patients with longstanding RA in the thesis. However, there are some indications 
for specific effects in the first year of the disease. The nonsignificant or slight 
contribution of psychological predictors to disease activity and psychological 
distress in the first year after diagnosis and the relatively great improvements in 
clinical status during this year, probably due the beneficial effects of the RA 
second-line medication (van Jaarsveld et al., 2000; van Everdingen et al., 2002), 
suggest that the effects of some psychological predictors may be overshadowed by 
medication effects in the first stage of the disease (chapters 3.1.1 and 3.1.3.1).
The fact that psychological predictors generally seem to have about the same 
relationship to future outcomes in early and longstanding RA does not imply that 
psychological risk factors do not change during the disease process. There is some 
support that psychological factors are affected by the inflammatory processes of
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the disease, its biopsychosocial consequences and pharmacological treatment with 
prolonged medication (van Lankveld et al., 1993; Fex et al., 1998; van Jaarsveld et 
al., 1998, 2000; Penninx et al., 1999; Jacobs et al., 2001). However, changes of 
psychological predictors were not a primary goal of the present study, i.e. the 
present studies did not compare specific predictors in patients with early and 
longstanding RA nor were predictors assessed over periods longer than 1 year. 
Repeated assessments of predictors over longer time periods are warranted to get 
more insight into possible changes of psychological predictors during the course of 
RA.
Duration o f Effects
There is some support in the general population that factors, such as social 
support, can have lasting effects on physical health outcomes (Wills & Fegan, 
2001). For patients with RA, psychological predictors have hardly been studied for 
periods longer than 1 year. One purpose of the present studies was to examine 
whether psychological factors affect disease outcome after 3 and 5 years in patients 
with early RA and whether relationships may differ between short-term and long­
term outcomes (chapters 3.1.1 - 3.1.3). It was assumed that more generic and 
stable predictors than specific disease-related predictors might affect longer-term 
changes. In addition, the strength and direction of relationships between 
psychological predictors and future outcomes was assumed to be possibly different 
for short- and long-term outcomes.
Results indicated that the personality characteristic of neuroticism, passive 
coping with stress and pain and social support predicted RA disease outcome after 
3 and 5 years. Long-term effects after 5 years were found for the relatively generic 
predictors of neuroticism, passive coping with stress and social support. More 
disease-related predictors of passive coping with pain were only significant up to 3 
years after diagnosis, possibly due to changes brought about by the disease and 
physical symptoms itself. In addition, the strength of effects for coping with pain 
was somewhat reduced after 3 years, while delayed or increased effects were 
overall found for the more generic predictors of neuroticism, stress coping and 
social support (in relationship to the physical outcomes) after 3 and 5 years. Effects 
were in line with previous studies in longstanding RA over shorter periods of time 
and no evidence was found that direction of effects changed during the study 
period. In addition to these results in our studies, long-term effects of illness 
cognitions of helplessness on RA disease outcome over a period of 4 years have 
previously been reported (Smith et al., 1994). Overall, the findings suggest that 
psychological factors, particularly the more generic predictors of personality 
characteristics, stress coping, and social support, can have lasting effects on RA 
disease outcome.
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Specificity for RA
In the present studies, we used theoretical models and validated findings from 
the general population and populations with chronic pain and chronic 
(autoimmune) diseases, which were assumed to be applicable to RA patients. The 
stress-vulnerability and fear-avoidance models appeared to be useful approaches to 
predicting RA disease outcome. Although only some of the hypothesized effects 
were found, direction of the significant effects for personality characteristics, 
illness cognitions, coping and social support all corresponded to theoretical models 
and empirical findings in the general population, populations with chronic pain 
disorders or other chronic diseases. It may be concluded that general psychological 
factors, such as neuroticism, passive coping with stress and pain, social support 
and helplessness, affect disease outcome similarly in RA as in a wide range of 
populations (cf. Steptoe, 1991a).
The fact that about the same relationships were found as in patients with other 
chronic diseases and chronic pain disorders does not imply that underlying 
mechanisms are the same in different populations. The mechanisms linking these 
factors to disease outcome and the kind of modification procedures necessary to 
change the psychological predictors are still scarcely understood. In addition, 
psychological predictors do not always work in the same direction in various 
populations, such as patients with different immune diseases. For example, the 
detrimental effects for passive avoidant stress coping on disease activity in early 
RA (chapter 3.1.1) are in line with general findings of longer-term effects of 
avoidance factors in the general population (see e.g., Suls & Fletcher, 1985; 
Stanton et al., 2001) and have also been found on future disease activity in cancer 
patients (Epping-Jordan et al., 1994). However, effects of passive avoidance in the 
other direction, i.e. more avoidance predicted decreases of future disease activity 
and immunological functioning, have been reported for the immune disease HIV 
(Mulder et al., 1999), demonstrating how complex the underlying mechanisms of 
relationships between psychological predictors and future disease and 
immunological outcomes in different populations might be. In this thesis, possible 
disease-specific effects for RA patients were found in the study on physiological 
pain reactivity (chapter 3.3), in which a different pattern of physiological 
responses to pain was reported by RA patients than what has been previously been 
found in heterogeneous groups of chronic pain patients (McCracken et al., 1996), 
suggesting a specific pattern of physiological reactivity to pain in at least 
subgroups of RA patients. Further study of the underlying mechanisms of these 
effects in different populations of chronic diseases and chronic pain is necessary to 
gain more insight into possible disease-specific relationships between 
psychological factors and RA disease outcome.
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LIMITATIONS OF THE PROSPECTIVE STUDIES
Generalizability o f  Findings
When studying the significance of specific risk factors in a population, a 
prerequisite for the generalizability of the findings is the representativeness of the 
study samples. Representativeness in prospective research is threatened by the 
initial inclusion of patients and subject dropout over time. Comparisons of 
demographic variables and disease outcome parameters with representative 
samples with early and longstanding RA indicated that the characteristics of our 
study samples were all highly comparable to the norm samples. However, the 
following selection bias may still have affected our samples. Patients were 
recruited from different university and general rheumatology outpatient clinics. 
Results might consequently not be applicable to patients under treatment in general 
practices, possibly limiting the findings of the present studies to patients with more 
severe RA. Patients with early RA also participated in a clinical protocol. In 
addition, dropouts scored somewhat higher on neuroticism and psychological 
distress in the studies on early RA (chapters 3.1.1-3.1.3). Due to the fact that 
neuroticism and psychological distress are related to most of the psychological 
predictors, our findings may be limited to patients characterized by moderate levels 
of psychological risk factors. However, this state of affairs might have also led to 
an underestimation of their effects in the patients with early RA. In patients with 
longstanding RA, there were no differences found between dropouts and 
participants after 1 year (these analyses are not reported in the studies in chapter 
3.2 and chapter 3.3).
Threats to Internal Validity
When monitoring a population over longer periods of time in a natural setting, 
conclusions about possible causal relationships between the predictors and the 
outcome are threatened by internal validity. That is, other biomedical and 
psychological variables not measured in the study may have affected the course of 
disease outcome and contributed to the relationships found, such as variables 
related to the disease process itself, its (pharmacological) treatment and 
biopsychosocial consequences. In the present study, possible relevant confounding 
variables were taken into account, such as demographic variables, clinically 
assessed outcomes of disease activity, neuroticism and, in the study on patients 
with early RA, also pharmacological treatment. However, we cannot exclude the 
possibility that additional treatments or other biomedical factors supposed to affect 
future RA disease outcome (e.g., continuing physical therapies) to some extent 
account for the relationships found.
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Statistical Analyses
It may be argued that, by using regression analyses, mainly the contribution of 
single factors to specific disease outcome parameters was studied, without testing 
more complex models in Structural Equation Modeling (SEM). One main 
advantage of SEM models is that the relationship between several predictors and 
different disease outcome parameters can be simultaneously analyzed. One 
example has been applied in the study of physiological pain reactivity in which 
neuroticism affected physiological pain reactivity which in turn predicted 
subsequent pain (chapter 3.3). However, the relatively small sample sizes in our 
prospective studies allowed only testing of very limited SEM models. 
Relationships between predictors were further explored in regression analyses by 
examining mediator and moderator effects in patients with early RA (chapters
3.1.1 -  3.1.3). Results indicated that the different predictors almost all indepen­
dently predicted future disease outcome, and no mediator effects were revealed 
with one exception (i.e. a mediating effect of neuroticism and educational level for 
the relationship between functional disability and anxiety after 5 years, chapter
3.1.3.2). Moderator analyses between the predictors were also relatively 
extensively studied, expecting for example that the detrimental health effects of 
more passive coping and lower levels of social support could increase in patients 
scoring higher in neuroticism or confronted with higher stressor levels. However, 
the results of our studies failed to support any moderating function of the 
predictors for changes in RA disease outcome.
MODIFICATION OF DISEASE OUTCOME:
TAILORED TREATMENT IN RA
Main findings of the prospective studies suggest that effectiveness of psychological 
interventions for RA patients may increase when applying tailored treatment to 
patients at risk at a relatively early stage of the disease. Consequently, a 
randomized, controlled trial with tailor-made treatment modules was conducted 
among patients with relatively early RA who had been screened for psychological 
risk profiles (chapter 4). Although results from this study were generally 
promising, limitations regarding the selection of patients at risk and interpretation 
of findings have to be considered.
SCREENING FOR PATIENTS AT RISK
A prerequisite for the application of tailored treatment for patients at risk is the use 
of validated screening instruments. Based on the findings of the prospective studies
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(chapter 3), indicators of illness cognitions, coping and social support that 
predicted future RA disease outcome were included in the screening procedure. 
Heightened distress was chosen as the main criterion, due to the fact that it is the 
most comprehensive indicator of the risk factors. At risk was consequently defined 
as heightened psychological distress together with at least two out of six 
psychological risk factors, using previously determined cutoff scores from the 
prospective studies. Although these criteria were empirically derived, the validity 
of this approach has to be investigated by future research. For example, statistical 
findings relate to group findings and the extent to which the instrument screens 
individual patients in the right category has to be validated, e.g. by comparing 
results to other selection methods, such as structured interview assessments, and 
monitoring screened patients over time. It has to be noted that no a priori, 
categorical distinction exists between patients at risk and those not-at risk, since 
the screening instrument used continuous variables for predicting linear 
relationships of the outcome parameters, and an individual only has a relative risk 
of a more or less unfavorable disease outcome. For these reasons, cutoff criteria are 
to some extent artificial boundaries and individuals scoring around the cutoff 
scores have the greatest chance of being incorrectly categorized. It is consequently 
preferable to use screening instruments as a first general selection, followed by 
more extensive assessments, even when reliability and validity of the instruments 
have been shown to be high.
TAILOR-MADE CBT FOR PATIENTS AT RISK
Results of the CBT trial revealed that tailored treatment offered to patients at risk 
at a relatively early stage of the disease was effective for indicators of physical and 
psychological functioning and psychological risk factors. The effects on primary 
outcomes of fatigue and depression were of a moderate magnitude with effect sizes 
of approximately .50, comparable to effect sizes found in meta-analyses for gold 
injections on RA swollen joints (Clark et al., 2002). Magnitude of these effects was 
maintained at the 6-month follow-up. The treatment condition was also 
characterized by relatively low dropouts rates (6%), suggesting high treatment 
acceptance of tailored treatment. It was concluded that, in comparison to findings 
of recently conducted RA meta-analyses (Hawley, 1995; Riemsma et al., 2002), 
offering tailor-made treatment to patients at risk may be a promising way to 
optimize RA treatment effectiveness in terms of treatment acceptance, and 
magnitude and maintenance of effects.
Although results were generally promising, several limitations of the study 
have to be considered. Most importantly, the hypothesis that tailored CBT for 
patients at risk at an early stage of the disease may be superior to general CBT 
treatments for all RA patients was not tested in the present trial. Comparisons to
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other trials are problematic due to differences between studies in type of 
intervention, control groups, designs, outcome measures and settings. To directly 
demonstrate the superior efficacy of the present approach, it is necessary to 
compare the effectiveness of CBT trials for patients screened at risk versus those 
not at risk, for patients with recent versus longstanding RA, and the application of 
tailored versus generic or mismatched treatments. In addition, treatment effects 
were limited to specific indicators of disease outcome and psychological risk 
factors. Most evidently, the trial was unsuccessful in altering primary disease 
outcomes of pain and functional disability, although effects on these outcomes 
have incidentally been found in other CBT and self-management trials with RA 
patients (see Hawley, 1995). The lack of effects in our study may be due to a lack 
of statistical power, since the pain and functional disability module was less 
frequently applied than the other treatment modules. In addition, our study on 
physiological pain-reactivity suggests (chapter 3.3) that it may be beneficial to 
focus this treatment module on physiologically mediated changes, such as the use 
of relaxation and biofeedback in patients with high physiological reactivity to pain. 
Finally, replication of the treatment effects in larger samples with longer-term 
follow-ups, preferably accompanied by cost-effectiveness analyses and use of 
economic outcome measures, such as health care use and drug intake, is warranted.
FUTURE RESESARCH
In addition to validating the tailored intervention approach, future research should 
primarily focus on underlying mechanisms of the psychological predictors 
identified in the prospective studies, studying physiological, cognitive, behavioral 
and social pathways of the predictors in relationship to RA disease outcome. 
Possible relevant concepts, not assessed in the studies of this thesis, are discussed 
below.
Fear-avoidance models assume that beliefs about pain-related fears and 
hypervigilance mediate or precipitate the relationship of avoidance of activity and 
catastrophic pain cognitions to functional disability in chronic pain patients (see 
e.g., Vlaeyen & Linton, 2000). Both concepts have been shown to be possibly 
relevant for patients with RA (McDermid et al., 1996; Strahl et al., 2000). 
However, specific pain-related fears identified in other chronic pain populations, 
such beliefs about fear of movement or reinjury, might not apply to RA 
inflammatory pain with irreversible joint damage. For the possible application of 
recently developed treatments of exposure in vivo in chronic pain patients for 
patients with RA (Vlaeyen et al., 2001), it is necessary to clarify specific pain- 
related fears of patients with RA. In addition, physiological fear reactions or 
hypervigilance to pain may contribute to the effects of the self-reported
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physiological pain reactivity for future pain outcomes. Simultaneous assessment of 
physiological and self-reported autonomic and muscular reactions can clarify the 
extent to which self-reported physiological reactivity is based on specific cognitive 
or physiological mechanisms. In the event that a physiological basis is supported, 
modification procedures aimed at altering autonomic and muscular reactivity, such 
as relaxation and biofeedback, may be applied to RA patients with high 
physiological pain reactivity. Finally, future research has to clarify the possible 
mediating function of physical deconditioning processes and decreased muscle 
strength for the relationship between pain-related avoidance factors and long-term 
pain outcomes (Dekker et al., 1993b; Steultjens et al., 2002).
Several pathways may be responsible for the relationship of avoidance coping 
with stress to RA disease activity. At a cognitive-behavioral level, there is some 
support that an avoidant coping style in daily life lead to less compliance with 
medication prescriptions and less adherence to recommendations of health care 
providers (Sherbourne et al., 1992), possibly accompanied by cognitive processes, 
such as a lack of attention to bodily signals, such as pain, or denial of physical 
signs of inflammation (cf. Steptoe, 1991a). An avoidant coping style may be also 
linked to a lack of processing or expressing affective information, in line with 
previous beneficial effects found for emotional disclosure interventions on RA 
disease activity (Smyth et al., 1999). Finally, physiological pathways, particularly 
the way in which avoidance affects immunological functioning, should have 
priority, in light of empirical findings showing that avoidance is related to future 
disease activity in different immune diseases (Epping-Jordan et al., 1994; Mulder 
et al., 1999).
The predictive value of social support for various physical disease outcomes in 
early RA in the longer-term suggest that social support may be linked to a broad 
range of cognitive, behavioral and physiological reactions to stress and pain (see 
e.g. Wills & Fegan, 2001). Different mechanisms may be responsible for the 
various health effects. For example, stimulation of social activities and health- 
related coping assistance by significant others may decrease functional disability, 
while more favorable immune functioning due to emotional support might be a 
pathway to reduced disease activity. Possible physiological mediators of social 
support have been studied in the general population, particularly immunological 
pathways, and there is relatively convincing evidence that social support indicators, 
such as the size of the social network and perceived support, are related to 
immunological and neuroendocrine variables (see Kiecolt-Glaser et al., 2002; 
Uchino et al., 1996). Social support have also been linked to different cognitive- 
behavioral pathways, such as more information seeking and cognitive 
restructuring, higher activity levels and less pain behaviors (Manne & Zautra, 
1989; Jamison & Virts, 1990). Finally, relationships between interpersonal 
stressors and disease activity (Potter & Zautra, 1997; Zautra et al., 1997) as well as 
the modifying effects of social support on this relationship in RA (Zautra et al.,
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1998) underscore the importance of studying different supportive and problematic 
social aspects in combination with cognitive-behavioral and physiological 
mediators.
The conceptualization of acceptance and perceived benefits as adaptive illness 
cognitions in the face of a chronic disease warrants further validation. It can be 
supposed that the adaptive function of these cognitions varies when individuals are 
confronted by different long-term stressors. To get more insight into the function 
of these cognitions, their predictive value for disease outcomes should be 
compared to control-related cognitions, such as perceived control or self-efficacy, 
when faced with long-term stressors that differ in degree of controllability, 
chronicity or predictability (see e.g., Felton & Revenson, 1984). In addition, 
underlying mechanisms need to be better understood. For example, recent 
theoretical and empirical approaches suggest that, when individuals are faced with 
uncontrollable long-term stress, acceptance may be related to lowered autonomic 
and muscular reactivity, fewer attempts to solve unsolvable problems by excessive 
worrying and an extremely active coping style, as well as higher ability to 
cognitively restructure primary goals and goal setting (e.g., McCracken et al., 
1998; Risdon et al., 2003). Research may finally lead to the development of 
specific modification procedures that foster adaptive cognitions in the face of 
uncontrollable long-term stress. Modification procedures for acceptance may for 
example consist of stimulating processes of loss, exposure to the situation of being 
chronically ill in the case of high avoidance, cognitive restructuring of life goals 
and problem-solving capacities for mastering unavoidable, negative consequences 
in daily life.
CLINICAL IMPLICATIONS
The present studies were conducted to gain more insight into psychological factors 
affecting RA disease outcome to enable the development of more effective 
therapeutic interventions. One main conclusion of the present studies is that 
specific psychological factors, such as illness cogntions, coping and social support, 
can affect longer-term RA disease outcome, underscoring the significance of 
multidisciplinary RA treatment approaches. More importantly, preliminary support 
was provided for the idea that customizing treatments to patient characteristics, in 
terms of patient selection and types and timing of treatment, may optimize 
treatment effectiveness. Specifically, results suggest that tailor-made treatment for 
patients at risk at an early stage of the disease may be a promising way to improved 
effectiveness of psychological interventions in RA. In addition to the preliminary 
empirical support provided in this thesis, this approach seems to closely correspond 
to clinical considerations. For example, offering psychological treatment to
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patients at risk is in line with the clinical views of rheumatologists and nurses that 
psychological factors may play a role primarily in subgroups of patients. Tailor- 
made treatment is supposed to better match patients’ needs and may increase 
patient satisfaction and compliance, while early detection, diagnosis, and treatment 
offers a better chance of decreasing unfavorable long-term disease outcomes.
Reliable and valid screening is a prerequisite to using a tailored treatment 
approach for patients at risk. Self-report questionnaires can supply relatively 
objective information and assist rheumatologists and nurses in their decisions about 
clinical referral and supplementary treatments options. The use of screening 
instruments may be especially relevant for risk factors that are usually not part of 
regular clinical care, such as the way in which patients cope with problems of daily 
life or their social support system. The present screening procedure can be viewed 
as a promising, empirically based approach, but its reliability, validity and 
practicability has to be further supported. Due to treatment decisions for individual 
patients, it has to be considered that screening instruments are preferably used as 
an initial general selection, followed by more extensive assessments, such as 
standardized interviews.
Questions may ultimately arise about the possibility of implementing and 
integrating tailored treatment in standard rheumatology care. Although empirically 
based conclusions can not be drawn, given the present state of research, recent 
developments in multidisciplinary treatment approaches seem to offer possibilities 
for tailored approaches in clinical practice. For multidisciplinary teams of 
rheumatology care (including e.g., rheumatology consultants, physical and 
occupational therapists, psychologists), it may be a fruitful to offer stepwise 
additional treatment options, depending on the type, number and magnitude of the 
patients’ biomedical and psychological risk factors. For example, offering 
education about biomedical and psychological risk factors to all patients, self­
management group treatment for patients with a relatively aggressive disease 
course to optimally manage the consequences, and tailored CBT treatment for 
patients characterized by psychological risk profiles.
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Reumatoïde artritis (RA) is een chronische aandoening die gekenmerkt wordt door 
ontsteking van de gewrichten. De ontstekingen gaan gepaard met functionele 
bewegingsbeperkingen, gewrichtspijn en vermoeidheid en kunnen op den duur 
leiden tot onherstelbare gewrichtsbeschadiging en invaliditeit. De lichamelijke 
klachten kunnen talrijke beperkingen in het dagelijks leven tot gevolg hebben, 
zoals beperkingen in het uitvoeren van dagelijkse activiteiten, verminderde sociale 
contacten, afhankelijkheid van anderen, arbeidsongeschiktheid of financiële 
gevolgen.
Vanaf de jaren 50 vindt er onderzoek naar psychologische factoren bij RA 
plaats. In de beginjaren heeft het onderzoek zich gericht op de rol van 
psychologische factoren voor het ontstaan van RA, zonder dat hiervoor 
ondersteuning werd gevonden. Vanaf begin jaren 80 vond er een verschuiving van 
de aandacht plaats naar het beloop van RA. In deze onderzoekslijn kregen de 
gevolgen van RA voor het dagelijks leven (kwaliteit van leven), hoe patiënten met 
deze gevolgen omgaan (bijv. coping en sociale steun), en hoe deze factoren op hun 
beurt het ziektebeloop kunnen beïnvloeden, meer aandacht. Ook werd de 
effectiviteit van psychologische interventies, zoals zelfredzaamheidtrainingen en 
cognitieve gedragstherapie, onderzocht. Hoewel in sommige interventie studies 
positieve effecten werden gevonden blijkt uit recent uitgevoerde meta-analyses dat 
de effecten klein en van korte duur zijn. De beperkte effectiviteit van 
psychologische interventies voor patiënten met RA was aanleiding voor de studies 
in dit proefschrift. Het doel van dit proefschrift was om meer inzicht te krijgen in 
de rol van psychologische factoren voor het ziektebeloop bij RA, om van daaruit 
meer doelgerichte en effectieve interventies te kunnen ontwikkelen.
Het proefschrift bestaat uit drie onderdelen die betrekking hebben op het meten 
(hoofdstuk 2), voorspellen (hoofdstuk 3) en beïnvloeden (hoofdstuk 4) van het 
ziektebeloop bij RA. In hoofdstuk 2 wordt onderzoek beschreven naar de 
betrouwbaarheid en validiteit van een vragenlijst die verschillende gezondheids- 
dimensies bij RA vast stelt. In hoofdstuk 3 wordt verslag gedaan van een aantal 
studies waarin de invloed van psychologische factoren op het ziektebeloop 
(ziekteactiviteit, lichamelijk en psychisch functioneren) werd onderzocht. 
Aandacht kregen vooral ziektecognities, coping en sociale steun omdat deze 
factoren een aangrijpingspunt vormen voor psychologische interventies. Deze 
factoren kunnen worden omschreven als gedragsfactoren die weergeven welke 
ideeën en opvattingen patiënten over hun ziekte hanteren (ziektecognities), hoe 
patiënten omgaan met stress in het dagelijks leven (stress coping) en met ziekte- 
gerelateerde factoren, zoals pijn (pijn coping), en in welke mate patiënten steun
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ervaren vanuit hun sociale omgeving (sociale steun). Op basis van de resultaten uit 
hoofdstuk 3 wordt in hoofdstuk 4 een ‘tailor-made’ behandeling geëvalueerd. 
Onder ‘tailor-made’ wordt in deze context verstaan dat - in plaats van een 
algemene behandeling voor alle RA patiënten op een willekeurig moment -  een op 
de patiënt afgestemde behandeling voor een geselecteerde groep patiënten in een 
bepaalde fase van de ziekte wordt aangeboden.
METING VAN HET ZIEKTEBELOOP: 
GEZONDHEIDSDIMENSIES B IJ RA
Om de invloed van psychologische factoren en interventies op het ziektebeloop te 
kunnen onderzoeken, dienen de verschillende aspecten of dimensies van het 
ziektebeloop betrouwbaar in kaart te worden gebracht. In aansluiting op meer­
dimensionale definities van de gezondheidstoestand bij RA, zijn er minimaal drie 
dimensies te onderscheiden: ziekteactiviteit, lichamelijk en psychisch 
functioneren.
Ziekteactiviteit reflecteert het meest direct het pathofysiologische proces en 
wordt doorgaans gemeten met klinische en laboratoriummaten, zoals 
gewrichtsscores en bloedbezinking. De dimensie van het lichamelijk functioneren 
omvat de fysieke klachten die gepaard gaan met het ontstekingsproces, zoals 
functionele bewegingsbeperkingen, pijn en vermoeidheid. De mate waarin 
patiënten beperkingen in het dagelijks leven ervaren als gevolg van de lichamelijke 
klachten wordt weerspiegeld in het psychisch functioneren of de psychische 
distress die patiënten ervaren. De meest gebruikelijke manier om het psychisch 
functioneren vast te stellen is door angst en depressieve stemming van patiënten te 
meten.
In tegenstelling tot de ziekteactiviteit worden de dimensies van het lichamelijk 
en psychisch functioneren doorgaans met vragenlijsten gemeten. In de loop der 
jaren zijn er verschillende instrumenten ontwikkeld om de gezondheidstoestand 
van patiënten met reuma in kaart te brengen, zoals bijvoorbeeld de IRGL. Het doel 
van de eerste studie (hoofdstuk 2) was om de betrouwbaarheid en validiteit van de 
IRGL te vergelijken met een internationale vragenlijst, de AIMS2. Beide 
instrumenten brengen de dimensies van het lichamelijk en psychisch functioneren 
in beeld, plus een aantal andere dimensies, zoals het sociaal functioneren en de 
gevolgen van de aandoening voor het dagelijks leven. Bij 284 RA patiënten 
werden beide vragenlijsten afgenomen en een aantal klinische en 
laboratoriummaten bepaald. Uit de resultaten bleek dat de vragenlijsten een 
vergelijkbaar hoge mate van betrouwbaarheid en validiteit hebben. De validiteit 
werd ondersteund door hoge samenhangen tussen de corresponderende schalen 
van de twee vragenlijsten en modale tot hoge samenhangen tussen de schalen voor 
lichamelijk functioneren en de klinische en laboratoriumbepalingen. Er werd
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geconcludeerd dat, in aansluiting op eerder verricht onderzoek, de IRGL een 
betrouwbare en valide vragenlijst is om de gezondheidstoestand van patiënten met 
RA in kaart te brengen.
PREDICTIE VAN HET ZIEKTEBELOOP: 
RISICOFACTOREN B IJ RA
Er zijn aanwijzingen dat psychologische factoren van invloed kunnen zijn op de 
verschillende dimensies van het ziektebeloop bij RA. Het onderzoek naar 
predictoren voor het ziektebeloop is gebaseerd op twee modellen die zijn afgeleid 
van modellen bij chronische (auto)immuun ziekten, chronische pijn aandoeningen 
en andere chronische aandoeningen: stress-vulnerabiliteit-modellen en fear- 
avoidance modellen.
Stress-vulnerabiliteit modellen bij chronische (auto)immuun ziekten en andere 
chronische aandoeningen trachten voornamelijk de ziekteactiviteit, respectievelijk 
het psychisch functioneren, te voorspellen. Deze modellen veronderstellen dat het 
ziektebeloop wordt beïnvloed door externe stressoren, zoals ingrijpende stressvolle 
levensgebeurtenissen (‘major life events’), en interne vulnerabiliteitsfactoren, 
zoals relatief stabiele persoonlijkheidskenmerken. Ziektecognities, stress coping en 
sociale steun kunnen als additionele vulnerabiliteitsfactoren worden beschouwd. 
Deze factoren hebben op hun beurt ook een invloed op de relatie tussen stressoren 
en persoonlijkheidskenmerken en het ziektebeloop. Zo wordt bijvoorbeeld 
verondersteld dat de invloed van stressvolle gebeurtenissen op het psychisch 
functioneren mede wordt bepaald door de manier hoe iemand met stress omgaat 
(stress coping).
Fear-avoidance modellen kunnen als een verbijzondering van stress- 
vulnerabiliteit modellen worden gezien. In fear-avoidance modellen worden 
uitspraken gedaan over de rol van psychologische factoren bij een bepaalde 
stressor, namelijk pijn, om vooral het lichamelijk functioneren bij chronische pijn 
aandoeningen te voorspellen. Fear-avoidance modellen veronderstellen dat 
specifieke vermijdingsfactoren in reactie op pijn het lichamelijk functioneren 
ongunstig beïnvloeden. Deze vermijdingsfactoren bestaan voornamelijk uit het 
vermijden van activiteiten bij pijn, catastroferende gedachten over pijn, en 
fysiologische (vooral autonome en musculaire) reacties op pijn. Een tekort aan 
sociale hulpbronnen of steun, zoals een klein sociaal netwerk of een geringe mate 
van ervaren steun, worden verondersteld de vermijdingsfactoren te bevorderen en 
probleemoplossingvaardigheden te belemmeren waardoor pijn en functionele 
bewegingsbeperkingen in stand worden gehouden of toenemen.
Onderdelen van deze modellen werden in een aantal prospectieve studies van 
dit proefschrift bestudeerd bij patiënten met RA. Aandacht werd vooral besteed 
aan de rol van ziektecognities, coping, sociale steun en fysiologische pijn-
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reactiviteit. In de eerste vijf studies werd de rol van coping (met stress en pijn) en 
sociale steun onderzocht voor het ziektebeloop (ziekteactiviteit, lichamelijk en 
psychisch functioneren) na 1, 3 en 5 jaar bij recent gediagnosticeerde RA 
patiënten. Er zijn aanwijzingen dat coping en sociale steun het korte-termijn 
ziektebeloop van ongeveer 1 jaar bij patiënten met langdurige RA kunnen 
voorspellen. Om meer doelgerichte psychologische interventies te kunnen 
ontwikkelen is het van belang om vast te stellen of deze factoren het ziektebeloop 
reeds in een vroeg stadium van de ziekte en over langere periodes dan 1 jaar 
voorspellen. Het doel van de studies was om vast te stellen of coping en sociale 
steun in een zeer vroeg stadium van de ziekte, ten tijde van de diagnose, het korte 
termijn ziektebeloop na 1 jaar en het langere termijn beloop na 3 en 5 jaar bij RA 
kunnen voorspellen. Naast deze studies werd in twee aanvullende prospectieve 
studies de bijdrage van predictoren bestudeerd die in de psychologische literatuur 
tot nu toe weinig aandacht hebben gekregen: generieke ziektecognities en 
fysiologische pijnreactiviteit. De resultaten van deze studies worden hieronder 
samengevat.
Coping en Sociale Steun
Predictie van ziekteactiviteit. Er is een relatief lange onderzoekstraditie naar de 
invloed van psychologische factoren, vooral stressvolle gebeurtenissen, op 
ziekteactiviteit bij de autoimmuun ziekte RA door de veronderstelde relatie tussen 
stress en het immuunsysteem. Op basis van stress-vulnerabiliteit modellen werd in 
de huidige studie de rol van verschillende stressoren (major life events en ziekte- 
gerelateerde stressoren) en vulnerabiliteitsfactoren (de persoonlijkheidskenmerken 
neuroticisme en extraversie, stress coping en sociale steun) onderzocht bij 78 
recent gediagnosticeerde RA patiënten voor het beloop van ziekteactiviteit 1, 3 en
5 jaar na de diagnose (hoofdstuk 3.1.1). Geen van de stress-vulnerabiliteit factoren 
voorspelde het beloop van ziekteactiviteit na 1 jaar. Dit werd toegeschreven aan 
het effect van de medicatie, zoals bleek uit een sterke daling van de ziekteactiviteit 
in het eerste jaar na de diagnose. Op de langere termijn, na 3 en 5 jaar bleek een 
passief-vermijdende manier van stress coping een ongunstiger beloop van 
ziekteactiviteit te voorspellen. Ook voorspelde een laag niveau van sociale steun 
een ongunstiger beloop van ziekteactiviteit 3 jaar na de diagnose. In 
overeenstemming met eerdere bevindingen bij patiënten met langdurige RA wijzen 
de resultaten erop dat passieve stress coping en een laag niveau van sociale steun 
mogelijke risicofactoren zijn voor een ongunstig langere termijn beloop van 
ziekteactiviteit bij RA patiënten.
Predictie van functionele beperkingen en pijn. Fear-avoidance modellen 
veronderstellen dat vermijdingsfactoren, zoals het vermijden van activiteiten en 
catastroferende gedachten over pijn, en een laag niveau van sociale steun het 
beloop van functionele bewegingsbeperkingen en pijn kunnen beïnvloeden. In 
twee studies werd de rol van cognitief-gedragsmatige vermijdingsfactoren
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(passieve pijn-coping) en sociale steun ten tijde van de diagnose onderzocht voor 
het beloop van functionele beperkingen en pijn bij 91 RA patiënten 1 jaar na de 
diagnose en bij 78 RA patiënten van wie follow-up gegevens beschikbaar waren 
na 3 en 5 jaar (hoofdstukken 3.1.2.1 - 3.1.2.2). Uit de resultaten bleek dat een 
passieve manier van coping met pijn (vermijden van activiteiten en catastroferende 
gedachten over pijn) een ongunstiger beloop van functionele beperkingen 1 en 3 
jaar na de diagnose voorspelden. Ook voorspelde een laag niveau van sociale steun 
een ongunstiger beloop van functionele bewegingsbeperkingen 1, 3 en 5 jaar na de 
diagnose. Minder sociale steun bleek tevens een ongunstiger beloop van pijn na 3 
en 5 jaar te voorspellen. In overeenstemming met fear-avoidance modellen laten 
deze resultaten zien dat cognitieve en gedragsmatige vermijdingsfactoren in het 
omgaan met pijn en een laag niveau van sociale steun een relatief langdurige 
invloed kunnen hebben op het lichamelijk functioneren bij RA patiënten.
Predictie van psychische distress. Stress-vulnerabiliteit modellen beogen te 
verklaren welke factoren ervoor verantwoordelijk zijn dat patiënten met een 
chronische aandoening een verhoogde mate van psychische distress ontwikkelen. 
In twee studies werd de relatieve bijdrage van verschillende stressoren (major life 
events en ziekte-gerelateerde stressoren) en vulnerabiliteitsfactoren (de 
persoonlijkheidskenmerken neuroticisme en extraversie, stress coping en sociale 
steun) onderzocht voor het beloop van het psychisch functioneren (angst en 
depressieve stemming) na 1 jaar bij 91 RA patiënten en na 3 en 5 jaar bij 78 RA 
patiënten van wie follow-up gegevens aanwezig waren (hoofdstukken 3.1.3.1 -
3.1.3.2). In overeenstemming met bevindingen bij langdurige RA bleek dat bij ca. 
30% van de patiënten met vroege RA sprake is van een verhoogde mate van 
psychische distress, vergelijkbaar met subklinische niveaus van angst en depressie. 
Uit de predictie bleek dat een laag niveau van sociale steun een ongunstiger beloop 
van depressieve stemming in het eerste jaar na de diagnose voorspelde. Op de 
langere termijn, 3 en 5 jaar na de diagnose, voorspelde vooral het persoon­
lijkheidskenmerk neuroticisme een ongunstiger beloop van angst en depressieve 
stemming. In overeenstemming met resultaten in de algemene bevolking en bij 
langdurige RA patiënten wijzen deze resultaten op de rol van neuroticisme als 
risicofactor voor het psychisch functioneren van RA patiënten op de langere 
termijn.
Ziektecognities
In de psychologische literatuur over chronische aandoeningen wordt 
verondersteld dat ziektecognities een belangrijke rol spelen voor het ziektebeloop. 
Ondanks verschillen in conceptualisering blijkt uit onderzoek dat specifieke, 
controle-gerelateerde cognities, zoals waargenomen hulpeloosheid ten aanzien van 
de ziekte, het ziektebeloop bij een groot aantal chronisch zieken, inclusief RA 
patiënten, ongunstig beïnvloeden. Tot nu toe zijn er echter geen instrumenten 
beschikbaar waarmee ziektecognities van hulpeloosheid bij verschillende groepen
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chronisch zieken kunnen worden vergeleken. Ook is er nauwelijks iets bekend 
over adaptieve ziektecognities, dat wil zeggen, cognities die een gunstige invloed 
hebben op het ziektebeloop van chronisch zieken. Hoewel bijvoorbeeld een hoge 
mate van waargenomen controle verondersteld wordt een gunstige invloed te 
hebben, werd dit bij chronisch zieken niet altijd bevestigd. Een hoge mate van 
waargenomen controle bleek bij RA patiënten en andere chronisch zieken het 
ziektebeloop juist ongunstig te kunnen beïnvloeden, bijvoorbeeld in fasen wanneer 
de ziekte actief en oncontroleerbaar is. Op grond van deze gegevens werd 
verondersteld dat adaptieve ziektecognities bij chronisch zieken vooral gericht 
moeten zijn op een (her)evaluatie van de negatieve betekenis van de ziekte in 
plaats van op waargenomen controle.
Op basis van de literatuur werd vervolgens een vragenlijst ontwikkeld om de 
volgende generieke ziektecognities bij chronisch zieken in kaart te brengen: 
‘hulpeloosheid’ waardoor de negatieve betekenis van de ziekte wordt versterkt, 
‘acceptatie’ waardoor de negatieve betekenis van de ziekte wordt verminderd, en 
‘perceived benefits’ waardoor een positieve betekenis aan de ziekte wordt 
toegevoegd door ook positieve lange-termijn gevolgen van de ziekte te zien 
(hoofdstuk 3.2). De betrouwbaarheid en validiteit van deze vragenlijst, de Ziekte 
Cognitie Lijst (ZCL), werd bij 263 RA patiënten en 167 patiënten met multiple 
sclerosis (MS) onderzocht. Uit de resultaten bleek dat de ZCL de verschillende 
ziektecognities van hulpeloosheid, acceptatie en perceived benefits betrouwbaar en 
valide in kaart brengt. Ook werd een hoge mate van overeenstemming gevonden 
tussen beide groepen chronisch zieken in de structuur van de vragenlijst en de 
concurrente en predictieve validiteit. Tevens bleken de ziektecognities alle 
dimensies van het ziektebeloop na 1 jaar te voorspellen (ziekteactiviteit, 
lichamelijk en psychisch functioneren), waarbij hulpeloosheid consistent negatief, 
en acceptatie en perceived benefits consistent positief gerelateerd waren aan een 
gunstiger ziektebeloop na 1 jaar bij patiënten met RA en MS. Er werd 
geconcludeerd dat de ZCL een betrouwbare en valide vragenlijst is om generieke, 
maladaptieve en adaptieve ziektecognities bij verschillende groepen chronisch 
zieken vast te stellen.
Fysiologische Pijnreactiviteit
Fear-avoidance modellen veronderstellen dat niet alleen cognitieve en 
gedragsmatige reacties op pijn, maar ook fysiologische reacties op pijn het 
lichamelijk functioneren bij chronische pijn patiënten kunnen beïnvloeden. Met 
name autonome en musculaire reacties op pijn worden verondersteld een 
ongunstige invloed te hebben op het beloop van pijn. Empirische ondersteuning 
voor pijngerelateerde fysiologische reacties werd gevonden in experimenteel 
onderzoek bij RA en andere groepen chronische pijn patiënten. Ook bleek in cross- 
sectioneel onderzoek bij een heterogene groep chronische pijn patiënten een 
hogere, zelfgerapporteerde fysiologische pijnreactiviteit gepaard te gaan met een
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hogere mate van pijn. Er is echter weinig bekend over de directe invloed van 
fysiologische pijnreactiviteit op pijn of andere indicatoren van het lichamelijk 
functioneren bij chronische pijn patiënten. In de huidige studie (hoofdstuk 3.3) 
werd de bijdrage van zelfgerapporteerde fysiologische pijnreactiviteit vergeleken 
met die van cognitief-gedragsmatige vermijdingsfactoren (passieve coping met 
pijn) voor het beloop van pijn na 1 jaar bij 95 RA patiënten. Uit de resultaten bleek 
dat alleen de fysiologische pijnreactiviteit een ongunstig beloop van pijn 
voorspelde. Tevens bleek in Structural Equation Modeling dat neuroticisme 
verband hield met een hogere fysiologische pijnreactiviteit die op zijn beurt weer 
de enige voorspeller was voor een ongunstig pijnbeloop. Er werd geconcludeerd 
dat fysiologische pijnreactiviteit een betere voorspeller voor het beloop van pijn bij 
RA patiënten is dan de cognitieve en gedragsmatige reacties op pijn. Uit de 
analyses van de zelfgerapporteerde, autonome en musculaire reacties bij RA 
patiënten bleek tevens dat hun fysiologische reacties niet overeenkomen met 
gegevens uit ander onderzoek bij heterogene groepen chronische pijn patiënten. 
Dit gegeven wijst mogelijk op een specifiek patroon van fysiologische 
pijnreactiviteit bij RA patiënten.
MODIFICATIE VAN HET ZIEKTEBELOOP: 
TAILOR-MADE BEHANDELING B IJ RA
In eerder onderzoek naar psychologische interventies bij RA werd vooral de 
effectiviteit van gestandaardiseerde groepsprogramma’s onderzocht die voor alle 
patiënten open staan. De interventies kunnen worden ingedeeld in drie categorieën 
die verschillen in de mate waarin ze veranderingen in gedragsfactoren beogen: 
patiënteneducatie, zelfredzaamheidtrainingen en cognitieve gedragstherapie. 
Hoewel in sommige studies positieve effecten van psychologische behandelingen 
werden gevonden, vooral voor cognitieve gedragstherapie, blijkt uit recent 
uitgevoerde meta-analyses dat de effecten klein en van korte duur zijn. In de 
psychologische literatuur over RA en andere chronische pijn aandoeningen wordt 
gesuggereerd dat tailor-made behandelingen, zoals bijvoorbeeld een individueel 
afgestemde behandeling voor geselecteerde patiënten in een bepaalde fase van de 
ziekte, de effectiviteit mogelijk kan vergroten. Op grond van de bevindingen van 
de prospectieve studies in dit proefschrift werd verondersteld dat psychologische 
interventies voor RA patiënten effectiever zijn indien deze individueel afgestemd 
worden op patiënten met een psychologisch risicoprofiel in een relatief vroege fase 
van RA.
In een gerandomiseerde en gecontroleerde studie werd de effectiviteit 
geëvalueerd van een tailor-made behandeling bij 64 RA patiënten met een relatief 
korte ziekteduur en een psychologisch risicoprofiel (hoofdstuk 4). Alle patiënten 
ontvingen de reguliere zorg van de reumatoloog en de reumaconsulent. De helft
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van de patiënten ontving tevens op individuele basis, kortdurende cognitieve 
gedragstherapie die bestond uit twee van de vier mogelijke behandelmodules. De 
keuze van de behandelmodules was gebaseerd op de voorkeur van de patiënten. 
Dit resulteerde in de meest frequente toepassing van de module voor 
vermoeidheid, gevolgd door de modules voor negatieve stemming, sociale relaties 
en tenslotte pijn/functionele beperkingen. De behandeling bleek een gunstig effect 
te hebben op het lichamelijk, psychisch en sociaal functioneren. In vergelijking 
met de controleconditie hadden patiënten uit de behandelconditie minder last van 
vermoeidheid en depressiviteit, zowel direct na afloop van de behandeling als ook 
bij de follow-up meting, 6 maanden later, en ervoeren patiënten meer steun vanuit 
hun omgeving bij de follow-up meting. Ook rapporteerden patiënten minder 
hulpeloosheid ten aanzien van RA direct na afloop van de behandeling en bij de 
follow-up meting, een meer actieve manier van omgaan met stress in het dagelijks 
leven na afloop van de behandeling en een toegenomen therapietrouw ten aanzien 
van de voorgeschreven medicatie bij de follow-up meting in vergelijking met 
patiënten uit de controleconditie. De effecten bleken zowel bij de nameting als ook 
bij de follow-up meting gemiddeld van een modale grootte te zijn (effectgrootte 
tussen .48 en .55 voor het lichamelijk en psychisch functioneren). Ook kenmerkte 
zich de behandeling door een relatief laag percentage uitvallers (6% in de 
behandelconditie). Er werd geconcludeerd dat, in vergelijking met gegevens uit 
recent verschenen meta-analyses, tailor-made behandeling bij RA patiënten een 
veelbelovende manier is om de effectiviteit van psychologische interventies te 
vergroten.
CONCLUSIES EN KLINISCHE IMPLICATIES
De belangrijkste conclusies en klinische implicaties van het onderzoek kunnen als 
volgt worden samengevat:
1. Ziektecognities, coping met stress en pijn en sociale steun beïnvloeden het 
ziektebeloop bij RA en kunnen als psychologische risicofactoren worden 
beschouwd.
2. Psychologische risicofactoren zijn reeds bij de diagnose manifest en 
beïnvloeden het ziektebeloop bij RA op de langere termijn.
3. Kennis over psychologische risicofactoren maakt het mogelijk om RA patiënten 
met een psychologisch risicoprofiel reeds in een vroeg stadium van de ziekte op te 
sporen.
4. Een tailor-made behandeling, dat wil zeggen een op de patiënt afgestemde 
behandeling voor patiënten met een psychologisch risicoprofiel in een vroege fase 
van de ziekte, is een veelbelovende manier om de effectiviteit van psychologische 
interventies bij RA te vergroten.
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Toekomstig onderzoek dient zich vooral te richten op de onderliggende 
mechanismen van de psychologische risicofactoren en de ontwikkeling van daarop 




Een woord van dank aan de velen die hebben bijgedragen aan de studies in dit 
proefschrift.
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CC Control Conditon
CFI Comparative Fit Index
CIS Checklist Individual Strength
CRP C-Reactive Protein
DAS Disease Activity Score
DMARD Disease-Modifying Anti-Rheumatic Drug
EPQ Eysenck Personality Questionnaire
ESR Erythrocyte Sedimentation Rate
HAQ Health Assessment Questionnaire
ICQ Illness Cognition Questionnaire
IFI Incremental Goodness-of-Fit Index
IRGL Impact of Rheumatic Diseases on General Health and Lifestyle
LES Life Experience Survey




NSAID Non-Steroidal Anti-Inflammatory Drug
OA Osteoarthritis
PCI Pain Coping Inventory
RA Rheumatoid Arthritis
SD Standard Deviation
SIP Sickness Impact Profile
STAI State-Trait Anxiety Inventory
TLI Tucker-Lewis Index
UCL Utrecht Coping List
VAS Visual Analogue Scale



